
<html lang="en"     class="pb-page"  data-request-id="74d87994-fdc8-446e-9aef-940878bb1f17"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c00539;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials" /></meta><meta name="dc.Creator" content="Papireddy  Kancharla" /></meta><meta name="dc.Creator" content="Rozalia A.  Dodean" /></meta><meta name="dc.Creator" content="Yuexin  Li" /></meta><meta name="dc.Creator" content="Sovitj  Pou" /></meta><meta name="dc.Creator" content="Brandon  Pybus" /></meta><meta name="dc.Creator" content="Victor  Melendez" /></meta><meta name="dc.Creator" content="Lisa  Read" /></meta><meta name="dc.Creator" content="Charles E.  Bane" /></meta><meta name="dc.Creator" content="Brian  Vesely" /></meta><meta name="dc.Creator" content="Mara  Kreishman-Deitrick" /></meta><meta name="dc.Creator" content="Chad  Black" /></meta><meta name="dc.Creator" content="Qigui  Li" /></meta><meta name="dc.Creator" content="Richard J.  Sciotti" /></meta><meta name="dc.Creator" content="Raul  Olmeda" /></meta><meta name="dc.Creator" content="Thu-Lan  Luong" /></meta><meta name="dc.Creator" content="Heather  Gaona" /></meta><meta name="dc.Creator" content="Brittney  Potter" /></meta><meta name="dc.Creator" content="Jason  Sousa" /></meta><meta name="dc.Creator" content="Sean  Marcsisin" /></meta><meta name="dc.Creator" content="Diana  Caridha" /></meta><meta name="dc.Creator" content="Lisa  Xie" /></meta><meta name="dc.Creator" content="Chau  Vuong" /></meta><meta name="dc.Creator" content="Qiang  Zeng" /></meta><meta name="dc.Creator" content="Jing  Zhang" /></meta><meta name="dc.Creator" content="Ping  Zhang" /></meta><meta name="dc.Creator" content="Hsiuling  Lin" /></meta><meta name="dc.Creator" content="Kirk  Butler" /></meta><meta name="dc.Creator" content="Norma  Roncal" /></meta><meta name="dc.Creator" content="Lacy  Gaynor-Ohnstad" /></meta><meta name="dc.Creator" content="Susan E.  Leed" /></meta><meta name="dc.Creator" content="Christina  Nolan" /></meta><meta name="dc.Creator" content="Frida G.  Ceja" /></meta><meta name="dc.Creator" content="Stephanie A.  Rasmussen" /></meta><meta name="dc.Creator" content="Patrick K.  Tumwebaze" /></meta><meta name="dc.Creator" content="Philip J.  Rosenthal" /></meta><meta name="dc.Creator" content="Jianbing  Mu" /></meta><meta name="dc.Creator" content="Brett R.  Bayles" /></meta><meta name="dc.Creator" content="Roland A.  Cooper" /></meta><meta name="dc.Creator" content="Kevin A.  Reynolds" /></meta><meta name="dc.Creator" content="Martin J.  Smilkstein" /></meta><meta name="dc.Creator" content="Michael K.  Riscoe" /></meta><meta name="dc.Creator" content="Jane X.  Kelly" /></meta><meta name="dc.Description" content="The global impact of malaria remains staggering despite extensive efforts to eradicate the disease. With increasing drug resistance and the absence of a clinically available vaccine, there is an ur..." /></meta><meta name="Description" content="The global impact of malaria remains staggering despite extensive efforts to eradicate the disease. With increasing drug resistance and the absence of a clinically available vaccine, there is an ur..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 11, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00539" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00539" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00539" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00539" /></link>
        
    
    

<title>Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00539" /></meta><meta property="og:title" content="Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0011.jpeg" /></meta><meta property="og:description" content="The global impact of malaria remains staggering despite extensive efforts to eradicate the disease. With increasing drug resistance and the absence of a clinically available vaccine, there is an urgent need for novel, affordable, and safe drugs for prevention and treatment of malaria. Previously, we described a novel antimalarial acridone chemotype that is potent against both blood-stage and liver-stage malaria parasites. Here, we describe an optimization process that has produced a second-generation acridone series with significant improvements in efficacy, metabolic stability, pharmacokinetics, and safety profiles. These findings highlight the therapeutic potential of dual-stage targeting acridones as novel drug candidates for further preclinical development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00539"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00539">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00539&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00539&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00539&amp;href=/doi/10.1021/acs.jmedchem.0c00539" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 6179-6202</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00435" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00542" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Papireddy Kancharla</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Papireddy Kancharla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Portland State University, Portland, Oregon 97201, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#f28293829b80979696b282968adc979687"><span class="__cf_email__" data-cfemail="aadacbdac3d8cfceceeadaced284cfcedf">[emailÂ protected]</span></a>. Tel: +1-503-725-2566.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Papireddy++Kancharla">Papireddy Kancharla</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6381-1236" title="Orcid link">http://orcid.org/0000-0002-6381-1236</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Rozalia A. Dodean</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rozalia A. Dodean</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rozalia+A.++Dodean">Rozalia A. Dodean</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5002-4607" title="Orcid link">http://orcid.org/0000-0001-5002-4607</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Yuexin Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuexin Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuexin++Li">Yuexin Li</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sovitj Pou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sovitj Pou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sovitj++Pou">Sovitj Pou</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Brandon Pybus</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brandon Pybus</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brandon++Pybus">Brandon Pybus</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Victor Melendez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Victor Melendez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Victor++Melendez">Victor Melendez</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Lisa Read</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lisa Read</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Read">Lisa Read</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Charles E. Bane</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Charles E. Bane</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Charles+E.++Bane">Charles E. Bane</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Brian Vesely</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brian Vesely</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Vesely">Brian Vesely</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Mara Kreishman-Deitrick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mara Kreishman-Deitrick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mara++Kreishman-Deitrick">Mara Kreishman-Deitrick</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Chad Black</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chad Black</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chad++Black">Chad Black</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Qigui Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qigui Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qigui++Li">Qigui Li</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Richard J. Sciotti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard J. Sciotti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+J.++Sciotti">Richard J. Sciotti</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Raul Olmeda</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Raul Olmeda</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Raul++Olmeda">Raul Olmeda</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Thu-Lan Luong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thu-Lan Luong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thu-Lan++Luong">Thu-Lan Luong</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Heather Gaona</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heather Gaona</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heather++Gaona">Heather Gaona</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Brittney Potter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brittney Potter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brittney++Potter">Brittney Potter</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jason Sousa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jason Sousa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Sousa">Jason Sousa</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sean Marcsisin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sean Marcsisin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sean++Marcsisin">Sean Marcsisin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Diana Caridha</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diana Caridha</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diana++Caridha">Diana Caridha</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Lisa Xie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lisa Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lisa++Xie">Lisa Xie</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Chau Vuong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chau Vuong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chau++Vuong">Chau Vuong</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Qiang Zeng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qiang Zeng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qiang++Zeng">Qiang Zeng</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jing Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jing Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Zhang">Jing Zhang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ping Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ping Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ping++Zhang">Ping Zhang</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Hsiuling Lin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hsiuling Lin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hsiuling++Lin">Hsiuling Lin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Kirk Butler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kirk Butler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kirk++Butler">Kirk Butler</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Norma Roncal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Norma Roncal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Norma++Roncal">Norma Roncal</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Lacy Gaynor-Ohnstad</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lacy Gaynor-Ohnstad</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lacy++Gaynor-Ohnstad">Lacy Gaynor-Ohnstad</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Susan E. Leed</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Susan E. Leed</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Susan+E.++Leed">Susan E. Leed</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Christina Nolan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christina Nolan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christina++Nolan">Christina Nolan</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Frida G. Ceja</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frida G. Ceja</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, California 94901, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frida+G.++Ceja">Frida G. Ceja</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Stephanie A. Rasmussen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephanie A. Rasmussen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, California 94901, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephanie+A.++Rasmussen">Stephanie A. Rasmussen</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Patrick K. Tumwebaze</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrick K. Tumwebaze</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Infectious Diseases Research Collaboration, Kampala, Uganda</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+K.++Tumwebaze">Patrick K. Tumwebaze</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Philip J. Rosenthal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philip J. Rosenthal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicine, University of California, San Francisco, San Francisco, California 94143, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philip+J.++Rosenthal">Philip J. Rosenthal</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Jianbing Mu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jianbing Mu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland 20852, United States.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jianbing++Mu">Jianbing Mu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6012-8389" title="Orcid link">http://orcid.org/0000-0001-6012-8389</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Brett R. Bayles</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Brett R. Bayles</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, California 94901, United States</div><div class="loa-info-affiliations-info">Global Public Health Program, Dominican University of California, San Rafael, California 94901, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Brett+R.++Bayles">Brett R. Bayles</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Roland A. Cooper</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roland A. Cooper</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, California 94901, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roland+A.++Cooper">Roland A. Cooper</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Kevin A. Reynolds</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin A. Reynolds</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Portland State University, Portland, Oregon 97201, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+A.++Reynolds">Kevin A. Reynolds</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0270-9809" title="Orcid link">http://orcid.org/0000-0003-0270-9809</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Martin J. Smilkstein</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin J. Smilkstein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin+J.++Smilkstein">Martin J. Smilkstein</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Michael K. Riscoe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael K. Riscoe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Portland State University, Portland, Oregon 97201, United States</div><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+K.++Riscoe">Michael K. Riscoe</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Jane X. Kelly</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jane X. Kelly</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Portland State University, Portland, Oregon 97201, United States</div><div class="loa-info-affiliations-info">Department of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#3a515f565643505b7a5552494f145f5e4f"><span class="__cf_email__" data-cfemail="87ece2ebebfeede6c7e8eff4f2a9e2e3f2">[emailÂ protected]</span></a>. Tel: +1-503-220-8262 ex 54356.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jane+X.++Kelly">Jane X. Kelly</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8871-0207" title="Orcid link">http://orcid.org/0000-0001-8871-0207</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00539&amp;href=/doi/10.1021%2Facs.jmedchem.0c00539" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 6179â6202</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 11, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 April 2020</li><li><span class="item_label"><b>Published</b> online</span>11 May 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 June 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00539" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00539</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6179%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPapireddy%2BKancharla%252C%2BRozalia%2BA.%2BDodean%252C%2BYuexin%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D11%26contentID%3Dacs.jmedchem.0c00539%26title%3DLead%2BOptimization%2Bof%2BSecond-Generation%2BAcridones%2Bas%2BBroad-Spectrum%2BAntimalarials%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6202%26publicationDate%3DJune%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00539"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">898</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00539" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Papireddy&quot;,&quot;last_name&quot;:&quot;Kancharla&quot;},{&quot;first_name&quot;:&quot;Rozalia&quot;,&quot;last_name&quot;:&quot;A. Dodean&quot;},{&quot;first_name&quot;:&quot;Yuexin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Sovitj&quot;,&quot;last_name&quot;:&quot;Pou&quot;},{&quot;first_name&quot;:&quot;Brandon&quot;,&quot;last_name&quot;:&quot;Pybus&quot;},{&quot;first_name&quot;:&quot;Victor&quot;,&quot;last_name&quot;:&quot;Melendez&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Read&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;E. Bane&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Vesely&quot;},{&quot;first_name&quot;:&quot;Mara&quot;,&quot;last_name&quot;:&quot;Kreishman-Deitrick&quot;},{&quot;first_name&quot;:&quot;Chad&quot;,&quot;last_name&quot;:&quot;Black&quot;},{&quot;first_name&quot;:&quot;Qigui&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;J. Sciotti&quot;},{&quot;first_name&quot;:&quot;Raul&quot;,&quot;last_name&quot;:&quot;Olmeda&quot;},{&quot;first_name&quot;:&quot;Thu-Lan&quot;,&quot;last_name&quot;:&quot;Luong&quot;},{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;Gaona&quot;},{&quot;first_name&quot;:&quot;Brittney&quot;,&quot;last_name&quot;:&quot;Potter&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Sousa&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;Marcsisin&quot;},{&quot;first_name&quot;:&quot;Diana&quot;,&quot;last_name&quot;:&quot;Caridha&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Chau&quot;,&quot;last_name&quot;:&quot;Vuong&quot;},{&quot;first_name&quot;:&quot;Qiang&quot;,&quot;last_name&quot;:&quot;Zeng&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Ping&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Hsiuling&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Kirk&quot;,&quot;last_name&quot;:&quot;Butler&quot;},{&quot;first_name&quot;:&quot;Norma&quot;,&quot;last_name&quot;:&quot;Roncal&quot;},{&quot;first_name&quot;:&quot;Lacy&quot;,&quot;last_name&quot;:&quot;Gaynor-Ohnstad&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;E. Leed&quot;},{&quot;first_name&quot;:&quot;Christina&quot;,&quot;last_name&quot;:&quot;Nolan&quot;},{&quot;first_name&quot;:&quot;Frida&quot;,&quot;last_name&quot;:&quot;G. Ceja&quot;},{&quot;first_name&quot;:&quot;Stephanie&quot;,&quot;last_name&quot;:&quot;A. Rasmussen&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;K. Tumwebaze&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;J. Rosenthal&quot;},{&quot;first_name&quot;:&quot;Jianbing&quot;,&quot;last_name&quot;:&quot;Mu&quot;},{&quot;first_name&quot;:&quot;Brett&quot;,&quot;last_name&quot;:&quot;R. Bayles&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;A. Cooper&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;A. Reynolds&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;J. Smilkstein&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;K. Riscoe&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;X. Kelly&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;6179-6202&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00539&quot;},&quot;abstract&quot;:&quot;The global impact of malaria remains staggering despite extensive efforts to eradicate the disease. With increasing drug resistance and the absence of a clinically available vaccine, there is an urgent need for novel, affordable, and safe drugs for prevention and treatment of malaria. Previously, we described a novel antimalarial acridone chemotype that is potent against both blood-stage and liver-stage malaria parasites. Here, we describe an optimization process that has produced a second-generation acridone series with significant improvements in efficacy, metabolic stability, pharmacokinetics, and safety profiles. These findings highlight the therapeutic potential of dual-stage targeting acridones as novel drug candidates for further preclinical development.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00539&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00539" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00539&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00539" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00539&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00539" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00539&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00539&amp;href=/doi/10.1021/acs.jmedchem.0c00539" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00539" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00539" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00539%26sid%3Dliteratum%253Aachs%26pmid%3D32390431%26genre%3Darticle%26aulast%3DKancharla%26date%3D2020%26atitle%3DLead%2BOptimization%2Bof%2BSecond-Generation%2BAcridones%2Bas%2BBroad-Spectrum%2BAntimalarials%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D11%26spage%3D6179%26epage%3D6202%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=292227" title="Drug resistance">Drug resistance</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=292457" title="Group 17 compounds">Group 17 compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/jmcmar.2020.63.issue-11/20200611/jmcmar.2020.63.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The global impact of malaria remains staggering despite extensive efforts to eradicate the disease. With increasing drug resistance and the absence of a clinically available vaccine, there is an urgent need for novel, affordable, and safe drugs for prevention and treatment of malaria. Previously, we described a novel antimalarial acridone chemotype that is potent against both blood-stage and liver-stage malaria parasites. Here, we describe an optimization process that has produced a second-generation acridone series with significant improvements in efficacy, metabolic stability, pharmacokinetics, and safety profiles. These findings highlight the therapeutic potential of dual-stage targeting acridones as novel drug candidates for further preclinical development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43742" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43742" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Malaria has been a scourge on humankind down through the centuries of recorded time, and even now, it accounts for over 200 million clinical cases worldwide each year along with roughly half a million deaths.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> The global eradication effort in the past decade has propelled a surge in antimalarial drug development.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3â5)</a> However, many challenges remain for a sustainable elimination campaign, including the failing effectiveness of front line artemisinin-based combination therapy (ACT) due to emerging resistance<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6â8)</a> and safety concerns associated with limited radical cure options for relapsing <i>Plasmodium vivax</i>.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Without any clinically proven vaccine in sight, there is a continuous need to develop new drugs that overcome artemisinin resistance, and ideally, such agents would be active in both treatment of active bloodstream infections and preventing the disease at the liver-stage.<a onclick="showRef(event, 'ref3 ref4 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref11 ref12 ref13">(3,4,11â13)</a></div><div class="NLM_p">We recently described acridones with dual-stage activity against both liver- and blood-stage malaria parasites.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, these acridones only displayed moderate metabolic stability along with an unsatisfactory risk of cardiotoxicity and evidence of cross-resistance to atovaquone (ATV) in <i>Plasmodium falciparum</i>. With the aim of improving metabolic stability, the safety profile, and other desired âdrug-likeâ properties, we created a second generation of acridones by varying the halogen substitution pattern on ring A and placement of aryl groups on ring B (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). A rigorous lead optimization process produced candidates with enhanced potency against blood- and liver-stage malaria parasites, improved metabolic stability and PK profiles, and a diminished risk of cardiotoxicity and cross-resistance with ATV while maintaining a high selectivity index toward killing the parasites.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Transition from the first-generation acridones to the second-generation acridones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65841" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65841" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Our previous structural optimizations of the first-generation acridones demonstrated that halogen substitutions on ring A and (dialkylamino)alkoxy moieties at the 6-position on ring B are required for optimal broad-spectrum antimalarial activity.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Subsequently, we have designed and synthesized a large library of the second-generation acridones with various mono- and disubstitutions on ring A and aryloxy, arylamino, aryl, or benzyloxy moieties at either the 6- or 7-position of ring B via simple and efficient synthetic routes from commercially available and inexpensive starting materials. The synthetic routes for the second-generation acridones are outlined in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> to <named-content content-type="anchor" rid="sch2" type="simple"></named-content><a class="ref internalNav" href="#sch3" aria-label="3">3</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Acridones (<b>18</b>â<b>58</b>) with Aryloxy, Arylamino, and Aryl Groups at the 6-Position of Ring B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) K<sub>2</sub>CO<sub>3</sub>, CuCl, <i>N</i>,<i>N</i>-dimethylglycine, 1-methyl-2-pyrrolidone, MS 4 Ã, 150 Â°C, 4 h; (ii) BCl<sub>3</sub>, DCM, â78 Â°C to rt, 1 h; (iii) Tf<sub>2</sub>O, pyridine, DCM, 0 Â°C to rt, 5 h; (iv) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 110 Â°C, 5 h; (v) BF<sub>3</sub>Â·OEt<sub>2</sub>, mw, 150 Â°C, 1.0 min; (vi) Eatonâs acid, 90 Â°C, 5 h; (vii) Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (9:1), 100 Â°C, 5 h.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Acridones (<b>68</b>â<b>80</b>) with Aryloxy and Arylamino Groups at the 7-Position of Ring B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) K<sub>2</sub>CO<sub>3</sub>, CuCl, <i>N</i>,<i>N</i>-dimethylglycine, 1-methyl-2-pyrrolidone, MS 4 Ã, 150 Â°C, 4 h; (ii) BCl<sub>3</sub>, DCM, â78 Â°C to rt, 1 h; (iii) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 110 Â°C, 5 h; (iv) Tf<sub>2</sub>O, pyridine, DCM, 0 Â°C to rt, 5 h; (v) Eatonâs acid, 90 Â°C, 5 h; (vi) PPA, 110 Â°C, 2 h.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Acridones (<b>86</b>â<b>93</b>, <b>99</b>â<b>102</b>, and <b>107</b>â<b>109</b>) with Benzyloxy Groups at the 6- (Top and Middle Panel) and 7-Positions (Bottom Panel) of Ring B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Tf<sub>2</sub>O, pyridine, DCM, 0 Â°C to rt, 5 h; (ii) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 110 Â°C, 5 h; (iii) BF<sub>3</sub>Â·OEt<sub>2</sub>, mw, 150 Â°C, 1.0 min; (iv) HI, phenol, reflux, 3 h; (v) appropriate benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 3 h; (vi) Eatonâs acid, 90 Â°C, 5 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Synthesis of 6-Aryloxy-, 6-Arylamino-, and 6-Aryl-acridones (<b>18</b>â<b>58</b>)</h3><div class="NLM_p last">The synthesis of the first series of acridones <b>18</b>â<b>58</b> with various mono- and disubstitutions on ring A and aryloxy, arylamino, and aryl moieties at the 6-position of ring B started from commercially available methyl 4-iodo-2-methoxybenzoate (<b>1</b>) and methyl 4-bromo-2-methoxybenzoate (<b>2</b>). Initially, the copper-catalyzed arylation<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> of <b>1</b> with phenols <b>3a</b>â<b>e</b> delivered the corresponding diaryl ether intermediates <b>4a</b>â<b>e</b>, which were then converted into 2-hydroxy-diaryl ethers <b>5a</b>â<b>e</b> by selective deprotection of the methoxy (OMe) group with boron trichloride (BCl<sub>3</sub>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Intermediates <b>5a</b>â<b>e</b> were treated with triflic anhydride (Tf<sub>2</sub>O) in the presence of pyridine to give the triflates <b>6a</b>â<b>e</b>, which were further subjected to BuchwaldâHartwig cross-coupling with various substituted anilines <b>7aâl</b> to give the key anthranilate intermediates <b>8a</b>â<b>q</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref14 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref17">(14,17)</a> Conversely, the synthesis of anthranilate intermediates <b>12a</b>â<b>j</b> and <b>17a</b>â<b>f</b>, key synthons in the synthesis of acridones <b>43</b>â<b>52</b> and <b>53</b>â<b>58</b>, commenced with the coupling of <b>2</b> with corresponding anilines <b>7m</b>â<b>q</b> and boronic acids <b>13a</b>â<b>d</b> under standard BuchwaldâHartwig and Suzuki cross-coupling reaction conditions to derive intermediates <b>9a</b>â<b>e</b> and <b>14a</b>â<b>d</b>, respectively. Intermediates <b>9a</b>â<b>e</b> and <b>14a</b>â<b>d</b> then delivered <b>12a</b>â<b>j</b> and <b>17a</b>â<b>f</b> in good yields via the appropriate intermediates <b>10a</b>â<b>e</b>, <b>11a</b>â<b>e</b> and <b>15a</b>â<b>d</b>, <b>16a</b>â<b>d</b>, respectively. Finally, our recently developed method (boron trifluoride etherate (BF<sub>3</sub>Â·Et<sub>2</sub>O)/microwave irradiation)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> efficiently delivered the desired acridones <b>18</b>â<b>42</b> and <b>53</b>â<b>58</b> in good to excellent yields in a short reaction time (1.0 min) via an intramolecular cyclization of the anthranilate intermediates <b>8a</b>â<b>q</b> and <b>17a</b>â<b>f</b>, respectively (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Similarly, Eatonâs acid-mediated cyclization of <b>12a</b>â<b>j</b> provided the corresponding acridones <b>43</b>â<b>52</b> in good yields.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Positional isomers were separated either by recrystallization or flash column chromatography.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Synthesis of 7-Aryloxy- and 7-Arylamino-acridones (<b>68</b>â<b>80</b>)</h3><div class="NLM_p last">The second series of acridones <b>68</b>â<b>80</b> with disubstitutions on ring A and aryloxy and arylamino moieties at the 7-position of ring B were synthesized from commercially available methyl 5-iodo-2-methoxybenzoate (<b>59</b>) accompanying <b>3a</b> and methyl 5-bromo-2-hydroxybenzoate (<b>60</b>) with appropriate anilines <b>7</b> via the same synthetic methods that are employed in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Eatonâs acid or polyphosphoric acid (PPA)-mediated cyclization of the key anthranilate intermediates <b>66a</b>â<b>c</b> and <b>67a</b>â<b>i</b> provided the desired acridones <b>68</b>â<b>71</b> and <b>72</b>â<b>80</b>, respectively, in good yields (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Synthesis of 6- and 7-Benzyloxy-acridones (<b>86</b>â<b>93</b>, <b>99</b>â<b>102</b>, and <b>107</b>â<b>109</b>)</h3><div class="NLM_p last">The third series of acridones <b>86</b>â<b>93</b>, <b>99</b>â<b>102</b>, and <b>107</b>â<b>109</b> with disubstitutions on ring A and a variety of benzyloxy moieties at either the 6- or 7-position of ring B were synthesized starting with commercially available methyl 2-hydroxy-4-methoxybenzoate (<b>81</b>), methyl 2,4-dihydroxybenzoate (<b>94</b>), and methyl 2-bromo-5-methoxybenzoate (<b>103</b>) (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The key hydroxy-acridone intermediates <b>85a</b>â<b>c</b> and <b>106</b> were synthesized via the same synthetic methods that were employed previously (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). By treating with various benzyl bromides in the presence of anhydrous K<sub>2</sub>CO<sub>3</sub>, <b>85a</b>â<b>c</b> and <b>106</b> provided the corresponding acridones <b>86</b>â<b>93</b> and <b>107</b>â<b>109</b> in good to excellent yields (top and bottom panels; <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Conversely, a different strategy was employed for the synthesis of acridones <b>99</b>â<b>102</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, middle panel) in which the benzyloxy group was installed at the 6-position of ring B before the BuchwaldâHartwig cross-coupling reaction. The synthesis of <b>99</b>â<b>102</b> began with the <i>O</i>-benzylation of <b>94</b> in the presence of appropriate benzyl bromides and K<sub>2</sub>CO<sub>3</sub> to provide the 4-benzyloxy intermediates <b>95a</b> and <b>95b</b>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Intermediates <b>95a</b> and <b>95b</b> were treated with Tf<sub>2</sub>O in the presence of pyridine to give the triflate intermediates <b>96a</b> and <b>96b</b>, which were further subjected to BuchwaldâHartwig cross-coupling with methoxy anilines <b>7</b> to give the anthranilate intermediates <b>97a</b>â<b>d</b>. BF<sub>3</sub>Â·Et<sub>2</sub>O-mediated cyclization of <b>97a</b>â<b>d</b> under microwave irradiation conditions provided the desired acridones <b>99</b>â<b>102</b> as major products along with the 6-hydroxy-acridones <b>98a</b> and <b>98b</b> as minor products. These two products were separated by column chromatography using a mixture of ethyl acetate and MeOH as a mobile phase. Upon treatment with benzyl bromides in the presence of anhydrous K<sub>2</sub>CO<sub>3</sub>, <b>98a</b> and <b>98b</b> efficiently delivered the desired acridones <b>99</b>â<b>102</b> in excellent yields.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> It is noteworthy that this new synthetic strategy (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, middle panel) efficiently generates acridones that contain an OMe group on ring A and benzyloxy groups on ring B.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Biological Activity</h3><div class="NLM_p last">The libraries of second-generation acridones with various mono- and disubstitutions on ring A and aryloxy, arylamino, aryl, or benzyloxy moieties at either the 6- or 7-position of ring B were evaluated for both blood-stage and liver-stage antimalarial efficacy, safety, and metabolic/PK properties. The results are summarized and discussed in the following sections.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro Blood-Stage Activity and StructureâActivity Relationships (SAR) of 6-Aryloxy-acridones (<b>18</b>â<b>42</b>)</h3><div class="NLM_p">In our previous work, a number of first-generation acridones with dihalogens on ring A and (dialkylamino)alkoxy moieties at the 6-position on ring B showed promising potency and efficacy against both blood-stage and liver-stage malarial infections.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Considering that the alkyl moieties are probably easily metabolized in vivo, we hypothesized that the replacement of the (dialkylamino)alkoxy groups on ring B with aryloxy groups might improve the metabolic stability and PK profiles. Therefore, we generated an initial series of acridones <b>18</b>â<b>42</b> bearing mono- and disubstitutions on ring A and aryloxy moieties at the 6-position of ring B (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In vitro antimalarial blood-stage activity of acridone derivatives was tested against a panel of multidrug-resistant (MDR) <i>P. falciparum</i> (D6, Dd2, 7G8, and Tm90-C2B) with different geographic and genetic backgrounds using a SYBR Green-based assay,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and the results are listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Chloroquine (CQ) and atovaquone (ATV) were used as reference drugs in all experiments.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Blood-Stage Antiplasmodial Activity and Selectivity of Acridones (<b>18</b>â<b>42</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0007.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least three determinations, each carried out in triplicate (Â±10%). CQ, chloroquine; ATV, atovaquone; D6, <i>P. falciparum</i> CQ-sensitive strain; Dd2, MDR <i>P. falciparum</i> strain with Old World genetic background; 7G8, MDR <i>P. falciparum</i> strain with New World genetic background; Tm90-C2B, MDR <i>P. falciparum</i> clinical isolate, ATV-resistant.</p></div></div><div></div></div><div class="NLM_p">Starting from our first-generation lead acridone compound T31, the (dialkylamino)alkoxy group at the 6-position on ring B of T31 was first replaced with 4-(trifluoromethoxy)phenyloxy moiety, leading to acridone <b>18</b>. Although <b>18</b> exhibited respectable in vitro antiplasmodial potency with low nanomolar IC<sub>50</sub> values against all tested <i>P. falciparum</i> strains (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), it was less potent than T31 (<b>18</b> IC<sub>50</sub> = 3.2 nM vs T31 IC<sub>50</sub> = 0.022 nM against D6; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Notably, compound <b>18</b> showed reduced cross-resistance with ATV against Tm90-C2B (ATV-resistant clinical isolate) compared to T31 and ATV (the ratio of Tm90-C2B IC<sub>50</sub>/D6 IC<sub>50</sub> for <b>18</b> = 329 vs T31 = 10 363 and ATV = 82 560). These findings demonstrated that the aryloxy moiety at the 6-position of ring B is beneficial for overcoming ATV cross-resistance. Consequently, we retained the aryloxy moiety at the 6-position on ring B in further modifications and introduced various mono- and disubstitutions at different positions on ring A. Shifting the chlorine (Cl) of <b>18</b> from position 1 to position 3 as in <b>19</b> led to a 6-fold reduced antiplasmodial potency (<b>19</b> IC<sub>50</sub> = 21 nM vs <b>18</b> IC<sub>50</sub> = 3.2 nM against D6), whereas acridone <b>20</b> with Cl substitution of <b>18</b> shifting from position 2 to position 3 showed a 6-fold enhanced potency (<b>20</b> IC<sub>50</sub> = 0.52 nM vs <b>18</b> IC<sub>50</sub> = 3.2 nM against D6). Removal of Cl substitution at position 1 of <b>20</b>, as in acridone compound <b>21</b>, showed an 80% decrease in antiplasmodial activity (<b>21</b> IC<sub>50</sub> = 2.6 nM vs <b>20</b> IC<sub>50</sub> = 0.52 nM against D6). Replacement of the dichloro substitutions at positions 1 and 3 of ring A from <b>20</b> with difluoro substitutions, as in acridone compound <b>22</b>, led to a significant increase (>100-fold) in the antiplasmodial potency (<b>22</b> IC<sub>50</sub> = 0.0047 nM vs <b>20</b> IC<sub>50</sub> = 0.52 nM against D6) with excellent selectivity. Only a two-fold antiplasmodial potency loss was observed when the OCF<sub>3</sub> group of 6-aryloxy moiety on ring B of <b>22</b> was replaced with Cl as in <b>23</b> (<b>23</b> IC<sub>50</sub> = 0.010 nM vs <b>22</b> IC<sub>50</sub> = 0.0047 nM against D6). The greatest loss of antiplasmodial potency was observed with monofluoro-substituted acridones <b>24</b> and <b>25</b> (51- and 680-fold, respectively) when compared with the corresponding difluoro-substituted acridones <b>22</b>. Interestingly, the antiplasmodial potency was retained against all tested <i>P. falciparum</i> strains even after introducing a combination of F and Cl substitutions at both positions 1 and 3 on ring A with acridones <b>26</b> (IC<sub>50</sub> = 0.028 nM against D6) and <b>27</b> (IC<sub>50</sub> = 0.050 nM against D6). These results demonstrated that the dihalogen substitutions on the ring A aryloxy moiety at the 6-position on ring B are required for optimal potency. The cross-resistance against the blood-stage parasite Tm90-C2B for mono- and dihalogen-substituted acridone compounds <b>18</b>â<b>27</b> was reduced compared to the first-generation acridones (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p last">To further diminish cross-resistance with ATV, we generated a series of acridones <b>28</b>â<b>42</b> with halogen and methoxy moieties on ring A and aryloxy groups at the 6-position of ring B and then tested for blood-stage antiplasmodial activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The acridones <b>28</b>â<b>30</b>, which contain a halogen at position 1 and the OMe group at position 3 on ring A and an aryloxy moiety at position 6 on ring B, retained the potency against all tested <i>P. falciparum</i> strains as compared to the corresponding dihalogenated acridones <b>20</b>, <b>22</b>, <b>23</b>, <b>26</b>, and <b>27</b>. In contrast, the 6-aryloxy-acridones <b>31</b>â<b>33</b> containing a methoxy group at the 1-position and halogen at the 3-position on ring A showed decreased antiplasmodial activities compared to the corresponding positional isomers <b>28</b>â<b>30</b> (<b>31</b> IC<sub>50</sub> = 28 nM vs <b>28</b> IC<sub>50</sub> = 5.0 nM; <b>32</b> IC<sub>50</sub> = 54 nM vs <b>29</b> IC<sub>50</sub> = 0.65 nM; <b>33</b> IC<sub>50</sub> = 18 nM vs <b>30</b> IC<sub>50</sub> = 0.51 nM against D6). These observations demonstrated that the combination of halogen and OMe groups at positions 1 and 3, respectively, are well tolerated on ring A, regardless of the substitutions on the aryloxy moiety at position 6 of ring B. Shifting the OMe of <b>28</b> from position 3 to position 2 as in <b>34</b> led to a minimal reduction in antiplasmodial potency (<b>34</b> IC<sub>50</sub> = 17 nM vs <b>28</b> IC<sub>50</sub> = 5.0 nM against D6). A nearly 10-fold loss of activity occurred when the Cl of <b>34</b> shifted from position 1 to position 3 on ring A as in acridone <b>35</b> (<b>35</b> IC<sub>50</sub> = 157 nM vs <b>34</b> IC<sub>50</sub> = 17 nM against D6). Complete removal of a halogen substitution at position 3 on ring A of acridone <b>31</b> as with the analogue <b>36</b> showed a minimal effect on the antiplasmodial activity (<b>36</b> IC<sub>50</sub> = 40 nM vs <b>31</b> IC<sub>50</sub> = 28 nM against D6). Interestingly, acridone compound <b>37</b> in which the 3-position of ring A is substituted with the OMe group exhibited a significantly increased antiplasmodial potency compared to the corresponding positional isomer <b>36</b> (<b>37</b> IC<sub>50</sub> = 0.33 nM vs <b>36</b> IC<sub>50</sub> = 40 nM against D6). This work suggested that the OMe group at both positions 1 and 2 on ring A had an adverse effect on antiplasmodial activity, whereas the OMe group was well tolerated at the 3-position on ring A. We next investigated the effect of halogen and OMe substitutions at positions 2 and 3 on ring A. It is noteworthy that the 2,3-disubstituted-acridones <b>38</b>â<b>42</b> with different aryloxy moieties at the 6-position of ring B, containing the OMe group at position 3 on ring A, showed superior antiplasmodial potency with low nanomolar concentrations (IC<sub>50</sub> < 2.8 nM across the entire test panel) and diminished cross-resistance with ATV against Tm90-C2B (ratio of Tm90-C2B IC<sub>50</sub>/D6 IC<sub>50</sub> < 1.5). Most of the acridone compounds containing the OMe group on ring A (compounds <b>31</b>, <b>32</b>, and <b>35</b>â<b>42</b>) also displayed diminished cross-resistance with ATV compared to the first-generation lead candidate T31 and corresponding dihalogenated 6-aryloxy-acridones <b>18</b>, <b>20</b>, <b>22</b>, <b>23</b>, <b>26</b>, and <b>27</b>. Taken together, SAR analyses of acridone compounds <b>18</b>â<b>42</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) demonstrated that a halogen in positions 1 or 2 and the OMe group at position 3 of ring A, along with an aryloxy moiety at the 6-position on ring B, are best tolerated.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vitro Blood-Stage Activity and SAR of 6-Arylamino-acridones <b>43</b>â<b>52</b></h3><div class="NLM_p">Having optimized the impact of various substituents on antimalarial activity of acridones that contain a combination of halogen and OMe substitutions on ring A and an aryloxy moiety at the 6-position of ring B, we next investigated the impact of the arylamino moiety in the place of the aryloxy moiety at the 6-position of ring B on in vitro blood-stage activity. 1,3-Dihalogenated acridones <b>43</b>â<b>45</b> with either 4-(trifluoromethoxy)phenylamino or 4-(chloro)phenylamino moiety at the 6-position of ring B exhibited excellent potency with low IC<sub>50</sub> values against D6 ranging from 0.0060 to 0.55 nM (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). These results were comparable to the corresponding 6-aryloxy-acridones <b>20</b>, <b>22</b>, and <b>23</b> (<b>43</b> IC<sub>50</sub> = 0.55 nM vs <b>20</b> IC<sub>50</sub> = 0.52 nM; <b>44</b> IC<sub>50</sub> = 0.20 nM vs <b>22</b> IC<sub>50</sub> = 0.0047 nM; <b>45</b> IC<sub>50</sub> = 0.0060 nM vs <b>23</b> IC<sub>50</sub> = 0.010 nM against D6). Acridones <b>46</b>â<b>48</b> with a halogen at position 1 and the OMe group at position 3 on ring A and the 4-(trifluoromethoxy)phenylamino and/or 4-(chloro)phenylamino moiety at position 6 of ring B also retained the potency compared to the corresponding 6-aryloxy-acridones <b>28</b>â<b>30</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Significantly, 6-arylamino-acridones <b>49</b>â<b>52</b> containing a halogen at position 2 and the OMe group at position 3 on ring A exhibited optimal antiplasmodial activity at low nanomolar concentrations (IC<sub>50</sub> = 0.81â5.7 nM against D6) and most reduced cross-resistance with ATV against Tm90-C2B. Antiplasmodial potency and cross-resistance pattern were similar to the corresponding 6-aryloxy-acridones <b>38</b>â<b>42</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Taken together, SAR of acridone compounds <b>43</b>â<b>52</b> demonstrated that a halogen substitution at either the 1- or 2-position and the OMe group at the 3-position on ring A and a substituted arylamino moiety at the 6-position on ring B are also well tolerated.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Blood-Stage Antiplasmodial Activity and Selectivity of Acridones (<b>43</b>â<b>58</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0008.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least three determinations, each carried out in triplicate (Â±10%). CQ, chloroquine; ATV, atovaquone; D6, <i>P. falciparum</i> CQ-sensitive strain; Dd2, MDR <i>P. falciparum</i> strain with Old World genetic background; 7G8, MDR <i>P. falciparum</i> strain with New World genetic background; Tm90-C2B, MDR <i>P. falciparum</i> clinical isolate, ATV-resistant.</p></div></div><div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vitro Blood-Stage Activity and SAR of 6-Aryl-acridones <b>53</b>â<b>58</b></h3><div class="NLM_p last">After establishing the halogen and OMe substitutions pattern at the 1- and 3- and 2- and 3-positions of ring A and aryloxy and arylamino groups at the 6-position of ring B of acridones, we next investigated whether the aryl substitutions at the 6-position on ring B are tolerated. We synthesized and screened a series of 6-aryl-acridones <b>53</b>â<b>58</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) with halogens at both positions 1 and 3 and a combination of halogen and OMe substitutions at either positions 1 and 3 or 2 and 3 on ring A. All the 6-aryl-acridones <b>53</b>â<b>58</b> showed great in vitro antiplasmodial potency with low nanomolar concentrations (IC<sub>50</sub> = 0.54â3.5 nM against D6), similar to the SAR and cross-resistance trend observed with the corresponding 6-aryloxy-acridones and 6-arylamino-acridones. In general, SAR analyses of the in vitro blood-stage antiplasmodial activity with acridones <b>18</b>â<b>58</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) unambiguously demonstrated that a halogen either at positions 1 or 2, the OMe group at position 3 on ring A, and the aryloxy, arylamino, and aryl moieties at position 6 on ring B have an important role in potent antiplasmodial activity as well as on mitigating cross-resistance with ATV.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vitro Blood-Stage Activity and SAR of 7-Aryloxy- and 7-Arylamino-acridones <b>68</b>â<b>80</b></h3><div class="NLM_p">We next investigated whether the aryloxy and arylamino substitutions at position 7 on ring B are tolerated for antiplasmodial activities. We synthesized a series of acridones <b>68</b>â<b>80</b> where ring A is substituted with either two halogens or a combination of halogen and methoxy groups, and ring B is substituted with various (trifluoromethoxy)phenyloxy and (trifluoromethoxy)phenylamino moieties and screened for their in vitro blood-stage antiplasmodial activity (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Of the 7-aryloxy-acridones <b>68</b>â<b>71</b>, acridones <b>68</b> and <b>69</b> with difluoro substitutions at positions 1 and 3 and 1-fluoro and 3-methoxy substitutions on ring A, respectively, exhibited the greatest antiplasmodial potency (IC<sub>50</sub> < 0.69 nM against D6). However, the potency of compound <b>68</b> significantly declined compared to the corresponding 6-aryloxy-acridone <b>22</b> (<b>68</b> IC<sub>50</sub> = 0.12 nM vs <b>22</b> IC<sub>50</sub> = 0.0047 nM against D6). Interchange of fluorine and methoxy groups between positions 1 and 3 on ring A as in <b>70</b> resulted in a 25-fold decrease in potency (<b>70</b> IC<sub>50</sub> = 17 nM vs <b>69</b> IC<sub>50</sub> = 0.69 nM against D6). Similarly, shifting of fluorine at position 1 of <b>69</b> to position 2, as in <b>71</b>, the potency significantly declined (>100-fold). It was observed that acridones <b>69</b>â<b>71</b> with a methoxy group on ring A exhibited less cross-resistance with ATV than the difluoro-substituted 7-aryloxy-acridone <b>68</b> (the ratio of Tm90-C2B IC<sub>50</sub>/D6 IC<sub>50</sub> for <b>69</b>â<b>71</b> = 1.9â14 vs <b>68</b> = 167), again suggesting the importance of the methoxy group on ring A. Next, we prepared a series of acridones <b>72</b>â<b>80</b> with dihalogens at positions 1 and 3 and a combination of halogen and methoxy group at positions 2 and 3 on ring A and various (trifluoromethoxy)phenylamino moieties at position 7 on ring B. All of these 7-arylamino-acridones <b>72</b>â<b>80</b>, with the exception of <b>74</b> (IC<sub>50</sub> = 0.048 nM against D6), displayed moderate antiplasmodial activity (IC<sub>50</sub> = 29â1474 nM against D6) than the corresponding 7-aryloxy-acridones and 6-arylamino-acridones. These findings indicate that the arylamino groups at position 7 of ring B were detrimental to optimal antimalarial activities.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Blood-Stage Antiplasmodial Activity and Selectivity of Acridones (<b>68</b>â<b>80</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0009.gif" alt="" id="gr9" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="4" align="center">blood-stage IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> vs <i>P.Â falciparum</i></th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><i>R</i><sup>1</sup></th><th class="colsep0 rowsep0" align="center"><i>R</i><sup>2</sup></th><th class="colsep0 rowsep0" align="center"><i>R</i><sup>3</sup></th><th class="colsep0 rowsep0" align="center">D6</th><th class="colsep0 rowsep0" align="center">Dd2</th><th class="colsep0 rowsep0" align="center">7G8</th><th class="colsep0 rowsep0" align="center">Tm90-C2B</th><th class="colsep0 rowsep0" align="center">cytotoxicity IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> vs HepG2</th><th class="colsep0 rowsep0" align="center">selectivity index vs HepG2 IC<sub>50</sub>/D6 IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">>37 199</td><td class="colsep0 rowsep0" align="left">>309 992</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.69</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">9.8</td><td class="colsep0 rowsep0" align="left">>36 131</td><td class="colsep0 rowsep0" align="left">>52 364</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">1-OMe</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">157</td><td class="colsep0 rowsep0" align="left">>36 131</td><td class="colsep0 rowsep0" align="left">>2125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">99</td><td class="colsep0 rowsep0" align="left">164</td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">187</td><td class="colsep0 rowsep0" align="left">>100 000</td><td class="colsep0 rowsep0" align="left">>1010</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">92</td><td class="colsep0 rowsep0" align="left">>37 289</td><td class="colsep0 rowsep0" align="left">>643</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">3â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">>37 289</td><td class="colsep0 rowsep0" align="left">>1286</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">2â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.048</td><td class="colsep0 rowsep0" align="left">0.047</td><td class="colsep0 rowsep0" align="left">0.73</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">18 673</td><td class="colsep0 rowsep0" align="left">389 021</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">1-Cl</td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">385</td><td class="colsep0 rowsep0" align="left">1402</td><td class="colsep0 rowsep0" align="left">1733</td><td class="colsep0 rowsep0" align="left">748</td><td class="colsep0 rowsep0" align="left">>34 495</td><td class="colsep0 rowsep0" align="left">>89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">1-Cl</td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">3â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1474</td><td class="colsep0 rowsep0" align="left">1690</td><td class="colsep0 rowsep0" align="left">750</td><td class="colsep0 rowsep0" align="left">3017</td><td class="colsep0 rowsep0" align="left">>34 495</td><td class="colsep0 rowsep0" align="left">>23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">156</td><td class="colsep0 rowsep0" align="left">139</td><td class="colsep0 rowsep0" align="left">>36 216</td><td class="colsep0 rowsep0" align="left">>805</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">3â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">145</td><td class="colsep0 rowsep0" align="left">286</td><td class="colsep0 rowsep0" align="left">130</td><td class="colsep0 rowsep0" align="left">>36 216</td><td class="colsep0 rowsep0" align="left">>362</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">82</td><td class="colsep0 rowsep0" align="left">83</td><td class="colsep0 rowsep0" align="left">166</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">>34 846</td><td class="colsep0 rowsep0" align="left">>425</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">3â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">141</td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="left">>34 846</td><td class="colsep0 rowsep0" align="left">>447</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CQ</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">163</td><td class="colsep0 rowsep0" align="left">171</td><td class="colsep0 rowsep0" align="left">208</td><td class="colsep0 rowsep0" align="left">37 577</td><td class="colsep0 rowsep0" align="left">2505</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATV</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">8256</td><td class="colsep0 rowsep0" align="left">23 160</td><td class="colsep0 rowsep0" align="left">231 600</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least three determinations, each carried out in triplicate (Â±10%). CQ, chloroquine; ATV, atovaquone; D6, <i>P. falciparum</i> CQ-sensitive strain; Dd2, MDR <i>P. falciparum</i> strain with Old World genetic background; 7G8, MDR <i>P. falciparum</i> strain with New World genetic background; Tm90-C2B, MDR <i>P. falciparum</i> clinical isolate, ATV-resistant.</p></div></div></div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> In Vitro Blood-Stage Activity and SAR of 6- and 7-Benzyloxy-acridones <b>86</b>â<b>93</b>, <b>99</b>â<b>102</b>, and <b>107</b>â<b>109</b></h3><div class="NLM_p">Our detailed SAR explorations around ring A and ring B of acridones led to valuable insight into the structural features that are required for potent antimalarial activity. Last, we sought to explore whether the substitution of the benzyloxy group in place of the aryloxy group on ring B is tolerated. A series of novel acridones <b>86</b>â<b>93</b>, <b>99</b>â<b>102</b>, and <b>107</b>â<b>109</b> in which ring B is substituted with a variety of benzyloxy moieties at either positions 6 or 7 and ring A is substituted with either halogens or a combination of halogen and methoxy groups were generated and tested for their in vitro blood-stage antimalarial activity (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Remarkably, all of these benzyloxy-acridones <b>86</b>â<b>93</b>, <b>99</b>â<b>102</b>, and <b>107</b>â<b>109</b> showed the highest antiplasmodial activities with many compounds exhibiting picomolar IC<sub>50</sub> values against D6, regardless of the substitution pattern on the benzyloxy moieties of ring B and halogen and methoxy substitutions on ring A. These results unequivocally demonstrated that the benzyloxy moieties at positions 6 and 7 of ring B play a vital role in enhancing antiplasmodial potency. Notably, the 6-benzyloxy-acridones <b>99</b>â<b>102</b> with the OMe group on ring A exhibited equal or comparable potency across the entire <i>P. falciparum</i> test panel (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) with diminished cross-resistance compared to the corresponding benzyloxy-acridones lacking the OMe group on ring A. Overall, the detailed SAR of the second-generation acridones (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> to <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) suggested that aryl, aryloxy, arylamino, and benzyloxy moieties at position 6 on ring B and halogens and the OMe group at either the 1- and 3- or 2- and 3-positions on ring A play key roles in enhancing in vitro blood-stage antimalarial potency with a balanced cross-resistance pattern.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro Blood-Stage Antiplasmodial Activity and Selectivity of Acridones (<b>86</b>â<b>93</b>, <b>99</b>â<b>102</b>, and <b>107</b>â<b>109</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0010.gif" alt="" id="gr10" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="4" align="center">blood-stage IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> vs <i>P.Â falciparum</i></th><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center"><i>R</i><sup>1</sup></th><th class="colsep0 rowsep0" align="center"><i>R</i><sup>2</sup></th><th class="colsep0 rowsep0" align="center"><i>R</i><sup>3</sup></th><th class="colsep0 rowsep0" align="center">D6</th><th class="colsep0 rowsep0" align="center">Dd2</th><th class="colsep0 rowsep0" align="center">7G8</th><th class="colsep0 rowsep0" align="center">Tm90-C2B</th><th class="colsep0 rowsep0" align="center">cytotoxicity IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> vs HepG2</th><th class="colsep0 rowsep0" align="center">selectivity index vs HepG2 IC<sub>50</sub>/D6 IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.031</td><td class="colsep0 rowsep0" align="left">0.046</td><td class="colsep0 rowsep0" align="left">0.54</td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">>29 644</td><td class="colsep0 rowsep0" align="left">>956 258</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.0040</td><td class="colsep0 rowsep0" align="left">0.0065</td><td class="colsep0 rowsep0" align="left">0.020</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">>23 735</td><td class="colsep0 rowsep0" align="left">>5 933 750</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">4â²-SCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.013</td><td class="colsep0 rowsep0" align="left">0.078</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">772</td><td class="colsep0 rowsep0" align="left">59 384</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">4â²-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.042</td><td class="colsep0 rowsep0" align="left">0.063</td><td class="colsep0 rowsep0" align="left">0.045</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">15 617</td><td class="colsep0 rowsep0" align="left">371 833</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">3â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.054</td><td class="colsep0 rowsep0" align="left">0.17</td><td class="colsep0 rowsep0" align="left">0.070</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">>23 735</td><td class="colsep0 rowsep0" align="left">>439 537</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>91</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">3â²-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.084</td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">0.13</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">>24 672</td><td class="colsep0 rowsep0" align="left">>293 714</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>92</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">2â²-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.0030</td><td class="colsep0 rowsep0" align="left">0.0040</td><td class="colsep0 rowsep0" align="left">0.0063</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">>24 672</td><td class="colsep0 rowsep0" align="left">>8 224 000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>93</b></td><td class="colsep0 rowsep0" align="left">1-Cl</td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">4â²-Cl</td><td class="colsep0 rowsep0" align="left">0.033</td><td class="colsep0 rowsep0" align="left">0.038</td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">>24 711</td><td class="colsep0 rowsep0" align="left">>748 818</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>99</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">0.17</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">>22 232</td><td class="colsep0 rowsep0" align="left">>117 010</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>100</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">4â²-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.08</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">0.45</td><td class="colsep0 rowsep0" align="left">0.43</td><td class="colsep0 rowsep0" align="left">>23 052</td><td class="colsep0 rowsep0" align="left">>288 150</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>101</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">>100 000</td><td class="colsep0 rowsep0" align="left">>66 667</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>102</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">4â²-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">7.1</td><td class="colsep0 rowsep0" align="left">10.5</td><td class="colsep0 rowsep0" align="left">>100 000</td><td class="colsep0 rowsep0" align="left">>31 250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>107</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">4â²-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.17</td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">>23 735</td><td class="colsep0 rowsep0" align="left">>139 618</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>108</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">4â²-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.41</td><td class="colsep0 rowsep0" align="left">0.60</td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="left">189</td><td class="colsep0 rowsep0" align="left">>24 672</td><td class="colsep0 rowsep0" align="left">>60 175</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>109</b></td><td class="colsep0 rowsep0" align="left">1-F</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">4â²-Cl</td><td class="colsep0 rowsep0" align="left">0.069</td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">235</td><td class="colsep0 rowsep0" align="left">>26 898</td><td class="colsep0 rowsep0" align="left">>389 826</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CQ</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">163</td><td class="colsep0 rowsep0" align="left">171</td><td class="colsep0 rowsep0" align="left">208</td><td class="colsep0 rowsep0" align="left">37 577</td><td class="colsep0 rowsep0" align="left">2505</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATV</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">8256</td><td class="colsep0 rowsep0" align="left">23 160</td><td class="colsep0 rowsep0" align="left">231 600</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least three determinations, each carried out in triplicate (Â±10%). CQ, chloroquine; ATV, atovaquone; D6, <i>P. falciparum</i> CQ-sensitive strain; Dd2, MDR <i>P. falciparum</i> strain with Old World genetic background; 7G8, MDR <i>P. falciparum</i> strain with New World genetic background; Tm90-C2B, MDR <i>P. falciparum</i> clinical isolate, ATV-resistant.</p></div></div></div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> In Vivo Blood-Stage Efficacy in a Rodent Malaria Model</h3><div class="NLM_p">In vivo antimalarial blood-stage efficacy was determined using a well-established murine 4-day suppression model against <i>Plasmodium yoelii</i>.<a onclick="showRef(event, 'ref14 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref14 ref21 ref22">(14,21,22)</a> Sixty-two acridone compounds were tested in this in vivo model using CQ as a reference drug, and the results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. The in vivo data are expressed as ED<sub>50</sub> and ED<sub>90</sub> values. The animals were considered cured if they survive 28 days after the infection without detectable bloodstream parasites. Most of the acridone derivatives exhibited excellent blood-stage oral efficacy (ED<sub>50</sub> and ED<sub>90</sub> values are shown <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Most significantly, 18 acridone compounds demonstrated superior blood-stage efficacy compared to the first-generation lead compound T31 with ED<sub>50</sub> values less than 1 mg/kg/day. Acridones <b>20</b>, <b>22</b>, <b>26</b>, <b>27</b>, <b>29</b>, and <b>88</b> were curative out to day 28 in this model after treatment of either 10 mg/kg Ã 4 days or 30 mg/kg Ã 4 days, i.e., much lower dosages than required for T31 (80 mg/kg Ã 4 days) to achieve a cure. Notably, acridones <b>18</b> and <b>22</b> were curative out to day 28 in the same model at 5 and 3 mg/kg Ã 4 days, respectively. No overt clinical toxicity or behavior change was observed in mice treated with these acridones. In vitro blood-stage activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> to <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) mostly correlates well with in vivo blood-stage efficacy (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) with the exceptions of compounds <b>23</b>, <b>28</b>, <b>41</b>, <b>42</b>, <b>47</b>, <b>48</b>, <b>54</b>, <b>55</b>, <b>56</b>, <b>68</b>, <b>74</b>, <b>86</b>, <b>87</b>, <b>88</b>, <b>92</b>, <b>93</b>, <b>99</b>, and <b>109</b> where excellent in vitro blood-stage activity did not translate into superior in vivo blood-stage efficacy. Our down-selection process for lead candidates at this stage was primarily driven by superior in vivo efficacy.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vivo Blood-Stage Antimalarial Efficacy against <i>P. yoelii</i> in Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center">blood-stage efficacy vs <i>P.Â yoelii</i> (4 days)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">ED<sub>50</sub> (mg/kg/day)</th><th class="colsep0 rowsep0" align="center">ED<sub>90</sub> (mg/kg/day)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">T31</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.52</td><td class="colsep0 rowsep0" align="left">0.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a><sup>,</sup><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">0.55</td><td class="colsep0 rowsep0" align="left">0.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.045</td><td class="colsep0 rowsep0" align="left">0.098</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">7.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">8.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">0.75</td><td class="colsep0 rowsep0" align="left">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">0.79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">0.96</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">7.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">6.1</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left">14.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">8.9</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">0.30</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">6.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b></td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88</b><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.36</td><td class="colsep0 rowsep0" align="left">0.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89</b></td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b></td><td class="colsep0 rowsep0" align="left">0.17</td><td class="colsep0 rowsep0" align="left">0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>91</b></td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">0.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>92</b></td><td class="colsep0 rowsep0" align="left">0.38</td><td class="colsep0 rowsep0" align="left">0.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>93</b></td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>99</b></td><td class="colsep0 rowsep0" align="left">6.1</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>100</b></td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>101</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>102</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>107</b></td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>108</b></td><td class="colsep0 rowsep0" align="left"><5.0</td><td class="colsep0 rowsep0" align="left"><5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>109</b></td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CQ</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">3.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Curative at 5 mg/kg/day.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Curative at 30 mg/kg/day.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Curative at 10 mg/kg/day</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Curative at 3.0 mg/kg/day.</p></div></div></div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> In Vitro Liver-Stage Antimalarial Activity and SAR of Second-Generation Acridones</h3><div class="NLM_p">In vitro liver-stage activity was assessed utilizing luciferase-expressing <i>Plasmodium berghei</i> sporozoite-infected human hepatocyte HepG2 cells,<a onclick="showRef(event, 'ref14 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref14 ref23 ref24">(14,23,24)</a> and the results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. A number of second-generation acridones exhibited potent activity against liver-stage parasites without an evident toxic effect on the host liver cells. Twenty-one compounds, including 6-aryloxy-acridones <b>18</b>, <b>22</b>, <b>24</b>, <b>26</b>, <b>29</b>, <b>34</b>, <b>38</b>â<b>41</b>, 6-arylamino-acridones <b>44</b> and <b>48</b>, 7-aryloxy-acridone <b>68</b>, 7-arylamino-acridone <b>74</b>, 6-benzyloxy-acridones <b>87</b>, <b>88</b>, <b>90</b>â<b>92</b>, and <b>99</b>, and 7-benzyloxy-acridone <b>107</b>, showed the highest liver-stage antimalarial potency (IC<sub>50</sub> = 0.12â5.9 nM) and were superior to the control drug ATV (IC<sub>50</sub> = 6.5 nM). Surprisingly, the majority of the 6-aryl-acridones and 6- and 7-arylamino-acridones exhibited inferior liver-stage activity, suggesting that aryl and arylamino substitutions on ring B were detrimental to the liver-stage activity. It is noteworthy that all the 7-arylamino-acridones with the exception of <b>74</b> exhibited inferior in vitro antiparasitic activities against both blood-stage and liver-stage parasites. It appears that aryloxy and benzyloxy moieties at either the 6- or 7-position on ring B and halogen and OMe groups at either the 1- and 3- or 2- and 3-positions on ring A are optimal for liver-stage antimalarial activities.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Liver-Stage Antimalarial Activity and In Vivo Liver-Stage Antimalarial Efficacy of Acridones</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="3" align="center">in vivo vs <i>P.Â berghei</i> (IVIS)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">in vitro vs <i>P.Â berghei</i> IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">dose (mg/kg/day)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">clearance rate at 48 h<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">cured mice on day 31<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left">T31</td><td class="colsep0 rowsep0" rowspan="4" align="left">0.50</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">76%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">99%</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">55%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left"><b>22</b></td><td class="colsep0 rowsep0" rowspan="4" align="left">1.6</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">88%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">96%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">99%</td><td class="colsep0 rowsep0" align="left">1/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">3/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">60%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">0.46</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="4" align="left"><b>26</b></td><td class="colsep0 rowsep0" rowspan="4" align="left">4.5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">97%</td><td class="colsep0 rowsep0" align="left">1/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">64%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>29</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">0.45</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">15%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">99%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">63%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">73</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">59</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">824</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">126</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">190</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">71%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>38</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">2.2</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">40%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">29%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>39</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">4.4</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">45%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">86%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">0.41</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">98%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">0.60</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left"><b>43</b></td><td class="colsep0 rowsep0" rowspan="3" align="left">6.8</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">12%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left"><b>44</b></td><td class="colsep0 rowsep0" rowspan="3" align="left">2.4</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">95%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">71%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">23%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">86</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">109</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">816</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">1334</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">327</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">4/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">99%</td><td class="colsep0 rowsep0" align="left">3/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">159</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">0%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">2461</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">1219</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">1429</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">2277</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">164</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="left">1411</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="left">418</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>87</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">0.64</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">95%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">3/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88</b></td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">81%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89</b></td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">67%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left"><b>90</b></td><td class="colsep0 rowsep0" rowspan="3" align="left">0.51</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">99%</td><td class="colsep0 rowsep0" align="left">4/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>91</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">0.12</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">1/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>92</b></td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">56%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>93</b></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">6%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>100</b></td><td class="colsep0 rowsep0" align="left">113</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>107</b></td><td class="colsep0 rowsep0" rowspan="2" align="left">0.70</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">1/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>108</b></td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">10%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>109</b></td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">50%</td><td class="colsep0 rowsep0" align="left">0/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATV</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PQ</td><td class="colsep0 rowsep0" align="left">13 800</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">5/5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CQ</td><td class="colsep0 rowsep0" align="left">>31 262</td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values are the average of at least three determinations, each carried out in triplicate (Â±10%).</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Oral doses of drugs were administered on days â1, 0, and 1 with inoculation of sporozoites on day 0.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">The clearance rate was calculated by the ratio of the mean luminescence signal intensity collected by IVIS in drug-treated mice over vehicle-only control mice.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">The blood parasitemia was measured by flow cytometry up to 31 days after inoculation, and the cure was determined with negative parasitemia on day 31. ATV, atovaquone; PQ, primaquine; CQ, chloroquine.</p></div></div></div></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> In Vivo Liver-Stage Efficacy in a Rodent Malaria Model</h3><div class="NLM_p">In vivo antimalarial liver-stage efficacy was assessed with a real-time in vivo imaging system (IVIS) using transgenic bioluminescent parasites in a rodent malaria model.<a onclick="showRef(event, 'ref14 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref14 ref25 ref26 ref27">(14,25â27)</a> Luciferase-expressing <i>P. berghei</i> sporozoites were inoculated in mice on day 0 with oral doses of acridones administered on days â1, 0, and 1. After the inoculation, bioluminescence signals were measured at 24 and 48 h for liver-stage development and at 72 h for blood-stage infection. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, strong bioluminescence signals were detected in untreated mice at both 24 and 48 h in the liver region followed by intense signals in the whole body at 72 h, resulting from infection in the peripheral blood circulation. Twenty-eight selected second-generation acridones were tested at various oral doses in this animal model, and the results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. Acridones <b>26</b> (T111) and <b>90</b> (T122) provided full protection and cure at 10 mg/kg/day, while acridones <b>91</b> (T124) and <b>107</b> (T129) provided full protection and cure at 40 mg/kg/day without any visible parasites in the liver at 24 and 48 h (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), demonstrating true causal prophylactic efficacy. No blood-stage infections were developed at 72 h (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), and all treated mice were cured without blood-stage parasitemia up to day 31. Most significantly, acridone <b>26</b> (T111) provided full protection and a sustained blood-stage cure even at 4 mg/kg/day (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). These results are comparable or superior to primaquine (full protection/cure at 25 mg/kg/day)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and to the control drug 4-methyl-primaquine (full protection/cure at 5 mg/kg/day). Moreover, at 1 mg/kg/day, acridone <b>26</b> (T111) offered partial parasite reduction with 97% suppression at 48 h and one out of five treated mice was cured out to day 31. In addition to these compounds, eight acridones (<b>22</b>, <b>29</b>, <b>39</b>, <b>40</b>, <b>68</b>, <b>69</b>, <b>87</b>, and <b>88</b>) were able to provide substantial reduction of parasites (>80% suppression) in the liver at 48 h at 40 mg/kg/day or less (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>).</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Bioluminescence and real-time in vivo imaging (IVIS) of parasite load in mice with and without acridone treatment. Mice were inoculated with 10 000 luciferase-expressing <i>P. berghei</i> sporozoite intravenously (i.v.) on day 0, and oral doses of acridones were administered on days â1, 0, and 1. The bioluminescence level represents the parasite burden over the body surface area at 24, 48, and 72 h time points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Ex Vivo Antimalarial Activity against Clinical Isolates</h3><div class="NLM_p">Second-generation representative acridone compounds <b>38</b> and <b>39</b> were also evaluated with up to 50 <i>P. falciparum</i> field clinical isolates collected from malaria patients in Uganda using an ex vivo IC<sub>50</sub> assay.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The IC<sub>50</sub> values of <b>38</b> and <b>39</b> against these clinical isolates ranged from 1.1 to 8.6 nM (geometric mean = 3.9 nM; 95% CI, 3.5â4.5; <i>N</i> = 50) and 1.3 to 12 nM (geometric mean = 5.4 nM; 95% CI, 4.7â6.3; <i>N</i> = 49), respectively (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The IC<sub>50</sub> values for the control antimalarial drugs ranged from 4.1 to 727 nM (geometric mean = 34 nM; 95% CI, 22â52; <i>N</i> = 45) for chloroquine (CQ), reflecting the presence of CQ-resistant parasites circulating in eastern Uganda in 2016.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> For other standard antimalarials, IC<sub>50</sub> values range from 1.0 to 27 nM (geometric mean = 5.9 nM; 95% CI, 4.8â7.3; <i>N</i> = 46) for piperaquine (PIP), 0.3 to 4.4 nM (geometric mean = 1.4 nM; 95% CI, 1.2â1.7; <i>N</i> = 41) for dihydroartemisinin (DHA), 0.1 to 0.6 nM (geometric mean = 0.27 nM; 95% CI, 0.20â0.35; <i>N</i> = 19) for atovaquone (ATV), and 0.6 to 15.0 nM (geometric mean = 4.2 nM; 95% CI, 3.4â5.2; <i>N</i> = 40) for lumefantrine (LUM). There was no statistical difference in median acridone IC<sub>50</sub> values between isolates obtained from a clinical trial or from an outpatient center (data not shown). There was a strong positive correlation between responses to <b>38</b> and <b>39</b> (Spearmanâs rank correlation coefficient = 0.8; <i>p</i> < 0.001.) and also between both compounds and ATV (correlation coefficient for <b>38</b> and ATV = 0.5, <i>p</i> < 0.05; between <b>39</b> and ATV = 0.68, <i>p</i> < 0.05). The latter result is likely due to a mutual target as significant correlations between other antimalarials and the acridones were not observed.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Ex vivo activity of acridones and control antimalarial drugs against <i>P. falciparum</i> clinical isolates in Uganda. Data are presented as geometric means Â± 95% CI. CQ, chloroquine; PIP, piperaquine; DHA, dihydroartemisinin; ATV, atovaquone; LUM, lumefantrine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> In Vitro Cytotoxicity</h3><div class="NLM_p last">In vitro general cytotoxicity was tested using human hepatic HepG2 cells.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30â32)</a> There was no apparent in vitro mammalian cell cytotoxicity with IC<sub>50</sub> values for most acridone compounds above 20 Î¼M (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> to <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), indicating a favorable therapeutic index (selectivity index >10,000 nM).</div></div><div id="sec2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> In Vitro hERG Channel Inhibition</h3><div class="NLM_p">The in vitro effect of second-generation acridones on the hERG (human-ether-a-go-go-related gene) potassium channel current expressed in mammalian cells was evaluated using an automatic parallel patch clamp system<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (Eurofins Inc.), and the results are listed in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>. All of the tested acridones demonstrated an hERG inhibition level considerably lower than CQ with estimated IC<sub>50</sub> values higher than 10 Î¼M, which is a significant improvement compared to the first-generation acridones with similar or higher inhibition levels as CQ.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vitro Cardiotoxicity of Second-Generation Acridones</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">hERG (% inhibition at 10 Î¼M)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">T31</td><td class="colsep0 rowsep0" align="left">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">9.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">9.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CQ</td><td class="colsep0 rowsep0" align="left">39</td></tr></tbody></table></div></div></div><div id="sec2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> In Vitro Metabolic Stability</h3><div class="NLM_p">The assessments of in vitro metabolic stability of acridone derivatives using mouse and human liver microsomes using well-established methods were performed.<a onclick="showRef(event, 'ref14 ref32 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref14 ref32 ref34 ref35">(14,32,34,35)</a> Most of the second-generation acridones appear to be stable for up to 60 min or longer in both human and mouse microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>), strongly suggesting that the introduction of a variety of aryl moieties on ring B of the acridone core significantly increased the metabolic stability.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. In Vitro Metabolic Stability of Second-Generation Acridones</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center">metabolic stability vs microsomes (<i>t</i><sub>1/2</sub> in min)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">T31</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">54</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">6.8</td><td class="colsep0 rowsep0" align="left">9.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">7.4</td><td class="colsep0 rowsep0" align="left">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>79</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88</b></td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>91</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>92</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>93</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>107</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>108</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>109</b></td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CQ</td><td class="colsep0 rowsep0" align="left">>60</td><td class="colsep0 rowsep0" align="left">>60</td></tr></tbody></table></div></div></div><div id="sec2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Pharmacokinetic (PK) Analysis</h3><div class="NLM_p">In vivo pharmacokinetic (PK) studies of acridone lead candidates <b>26</b> (T111), <b>87</b> (T121), <b>90</b> (T122), <b>91</b> (T124), and <b>107</b> (T129) was conducted following a single intragastric (p.o.) administration in mice at 80 mg/kg with blood and liver samples taken at the following time points: 0, 0.5, 1, 2, 4, 7, 24, 48, and 72 h.<a onclick="showRef(event, 'ref14 ref28 ref32'); return false;" href="javascript:void(0);" class="ref ref14 ref28 ref32">(14,28,32)</a> The key PK parameters of the acridone lead candidates in both plasma and liver are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>. The front runner acridone compound <b>26</b> (T111) showed very rapid absorption and reached a plasma peak concentration (<i>T</i><sub>max</sub>) at 0.5 h. The mean <i>C</i><sub>max</sub> and AUC<sub>inf</sub> of <b>26</b> in plasma was 17.2 and 508 ngÂ·h/mL, respectively. The mean elimination half-life of <b>26</b> in plasma was 23.6 h, and the total clearance rate was calculated to be 157 510 mL/h/kg. Since liver-stage active drugs target hepatocytes, the PK profiles in the liver tissue provide important insight into the liver-stage efficacy and facilitate the lead optimization process. <i>T</i><sub>max</sub> for compound <b>26</b> in the liver was 7.0 h, and the mean <i>C</i><sub>max</sub> and AUC<sub>inf</sub> were 1732 ng/mL and 57 122 ngÂ·h/mL, respectively. The mean elimination half-life of <b>26</b> in the liver was shown to be 14.0 h, and the total clearance rate was calculated to be 1697 mL/h/kg. The ratio of the liver AUC to the plasma AUC in animals dosed with <b>26</b> was 112, whereas the liver/plasma ratio was only 21 for reference drug primaquine and 50 for the first-generation acridone lead candidate T31.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Acridone <b>26</b> has a half-life that is 4 times longer in plasma and 3 times longer in the liver than that of T31,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> further evidence for the improved metabolic stability of second-generation acridones. The PK data is supportive of the observed liver-stage efficacy as it is evident that acridones demonstrating a strong prophylactic effect concentrate in the liver, with high liver/plasma ratio.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. PK Parameters of Acridone Lead Candidates in Plasma and Liver Following a Single Oral Dose of 80 mg/kg Administrations in Mice<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">matrix</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center">AUC<sub>last</sub> (ngÂ·h/mL)</th><th class="colsep0 rowsep0" align="center">AUC<sub>inf</sub> (ngÂ·h/mL)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">CL/<i>F</i> (mL/h/kg)</th><th class="colsep0 rowsep0" align="center"><i>Vz</i>/<i>F</i> (mL/kg)</th><th class="colsep0 rowsep0" align="center">MRT b (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>26</b> (T111)</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="left">17.2</td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">392</td><td class="colsep0 rowsep0" align="left">508</td><td class="colsep0 rowsep0" align="left">23.6</td><td class="colsep0 rowsep0" align="left">157 510</td><td class="colsep0 rowsep0" align="left">5 370 641</td><td class="colsep0 rowsep0" align="left">17.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">1732</td><td class="colsep0 rowsep0" align="left">7.0</td><td class="colsep0 rowsep0" align="left">46 232</td><td class="colsep0 rowsep0" align="left">57 122</td><td class="colsep0 rowsep0" align="left">14.0</td><td class="colsep0 rowsep0" align="left">1697</td><td class="colsep0 rowsep0" align="left">34 167</td><td class="colsep0 rowsep0" align="left">19.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>87</b> (T121)</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="left">42.0</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">105</td><td class="colsep0 rowsep0" align="left">518</td><td class="colsep0 rowsep0" align="left">8.70</td><td class="colsep0 rowsep0" align="left">154 543</td><td class="colsep0 rowsep0" align="left">1 940 321</td><td class="colsep0 rowsep0" align="left">7.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">1193</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">20 416</td><td class="colsep0 rowsep0" align="left">20 494</td><td class="colsep0 rowsep0" align="left">6.00</td><td class="colsep0 rowsep0" align="left">3903</td><td class="colsep0 rowsep0" align="left">33 802</td><td class="colsep0 rowsep0" align="left">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>90</b> (T122)</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="left">21.5</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">225</td><td class="colsep0 rowsep0" align="left">236</td><td class="colsep0 rowsep0" align="left">4.90</td><td class="colsep0 rowsep0" align="left">339 065</td><td class="colsep0 rowsep0" align="left">2 402 651</td><td class="colsep0 rowsep0" align="left">10.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">1967</td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">19 188</td><td class="colsep0 rowsep0" align="left">19 271</td><td class="colsep0 rowsep0" align="left">6.10</td><td class="colsep0 rowsep0" align="left">4151</td><td class="colsep0 rowsep0" align="left">36 779</td><td class="colsep0 rowsep0" align="left">7.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>91</b> (T124)</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="left">19.5</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">175</td><td class="colsep0 rowsep0" align="left">187</td><td class="colsep0 rowsep0" align="left">5.90</td><td class="colsep0 rowsep0" align="left">428 286</td><td class="colsep0 rowsep0" align="left">3 648 089</td><td class="colsep0 rowsep0" align="left">6.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">925</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">11 485</td><td class="colsep0 rowsep0" align="left">11 570</td><td class="colsep0 rowsep0" align="left">6.80</td><td class="colsep0 rowsep0" align="left">6914</td><td class="colsep0 rowsep0" align="left">67 596</td><td class="colsep0 rowsep0" align="left">8.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>107</b> (T129)</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">1680</td><td class="colsep0 rowsep0" align="left">1705</td><td class="colsep0 rowsep0" align="left">4.30</td><td class="colsep0 rowsep0" align="left">46 906</td><td class="colsep0 rowsep0" align="left">290 091</td><td class="colsep0 rowsep0" align="left">5.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">684</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">8547</td><td class="colsep0 rowsep0" align="left">8674</td><td class="colsep0 rowsep0" align="left">4.00</td><td class="colsep0 rowsep0" align="left">9223</td><td class="colsep0 rowsep0" align="left">53 720</td><td class="colsep0 rowsep0" align="left">5.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">primaquine</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="left">531</td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">1256</td><td class="colsep0 rowsep0" align="left">1314</td><td class="colsep0 rowsep0" align="left">1.84</td><td class="colsep0 rowsep0" align="left">16 415</td><td class="colsep0 rowsep0" align="left">43 801</td><td class="colsep0 rowsep0" align="left">2.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="left">8148</td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">27 450</td><td class="colsep0 rowsep0" align="left">27 665</td><td class="colsep0 rowsep0" align="left">4.27</td><td class="colsep0 rowsep0" align="left">724</td><td class="colsep0 rowsep0" align="left">4418</td><td class="colsep0 rowsep0" align="left">4.50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last"><i>C</i><sub>max</sub>, maximum plasma or hepatic concentration; <i>T</i><sub>max</sub>, time to <i>C</i><sub>max</sub>; AUX<sub>last</sub>, area under the concentrationâtime curve from 0 up to the last sampling time at which a quantifiable concentration is found; AUC<sub>inf</sub>, area under the concentrationâtime curve from 0 up to infinity; <i>t</i><sub>1/2</sub>, apparent elimination half-life; CL/<i>F</i>, apparent oral clearance; <i>Vz</i>/<i>F</i>, apparent volume of distribution after oral dose; MRT b, mean residence time, body.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85668" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85668" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Building from our first-generation acridone structural optimization, a large library of second-generation acridones was designed and synthesized, and extensive SAR profiling demonstrated that the replacement of (dialkylamino)alkoxy pendants at both the 6- and 7-positions on ring B of first-generation acridones with a variety of aryl, aryloxy, arylamino, and benzyloxy moieties led to enhanced antimalarial activity, improved metabolic stability, PK, and safety profiles as well as diminished cross-resistance with ATV. The lead optimization strategy of varying the substitutions on ring A and ring B produced a new lead acridone candidate <b>26</b> (T111) with the following attributes: (i) inhibition of in vitro <i>P. falciparum</i> blood-stage growth at low concentration against MDR (including ATV-resistant) parasites with a highly favorable therapeutic index; (ii) in vivo curative efficacy via oral administration in the erythrocytic <i>P. yoelii</i> murine model; (iii) prevention of in vitro <i>P. berghei</i> sporozoite-induced development in human hepatocytes at low nanomolar concentration; (iv) full in vivo protection and cure via oral administration against liver-stage <i>P. berghei</i> sporozoite-induced infection in mice; (v) mitigated cardiotoxicity with the in vitro hERG inhibition level considerably lower than CQ and the first-generation acridones; (vi) increased in vitro metabolic stability in both mouse and human liver microsomes; and (vii) improved in vivo PK profiles with rapid absorption, high level drug concentration in the liver, and longer half-time than the first-generation acridones. Having achieved these promising target product profiles from the first acridone analogue with hetero-halogen substituents on ring A (compound <b>26</b>), we have launched further structural modifications focusing on hetero-halogen containing compounds for the next-generation optimization studies and we will ultimately select a late lead candidate for extensive preclinical development.</div><div class="NLM_p last">True causal prophylactic drugs targeting liver-stage malaria offer many advantages,<a onclick="showRef(event, 'ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39">(36â39)</a> such as preventing the onset of symptoms as malaria-associated pathology only occurs during the blood-stage infection, reducing the likelihood of emergence of drug-resistant parasites given the low number of hepatic forms, interrupting transmission as it depends on maturation of gametocytes in the blood-stage, which is after the liver-stage. Most importantly, only liver-stage active drugs could provide the ability for a radical cure to prevent <i>P. vivax</i> and <i>Plasmodium ovale</i> relapses caused by dormant hypnozoites hibernating in host liver cells for long periods of time.<a onclick="showRef(event, 'ref13 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref13 ref40 ref41">(13,40,41)</a> If a global effort to eradicate malaria is to be successful and sustainable, then it must address the gaps and weaknesses in the armamentarium of currently available prevention and treatment therapies. Ongoing needs include affordability, safety in the most vulnerable patients, low susceptibility to drug resistance adaptations, single-dose treatment, aptitude to kill liver-stage parasites with relapses prevention, and ability to block transmission. The novel chemotype described herein represents a broad-spectrum approach with the potential to overcome these challenges.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42016" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42016" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> General</h3><div class="NLM_p">NMR spectra were recorded on a Bruker AMX-400 spectrometer at 400 MHz. NMR experiments were recorded in CDCl<sub>3</sub> and DMSO-<i>d</i><sub>6</sub> at 25 Â°C. Chemical shifts are given in parts per million (ppm) downfield from internal standard Me<sub>4</sub>Si (TMS). High-resolution mass spectra (HRMS) (electrospray ionization (ESI)) were recorded on a vanquish UHPLC/HPLC system coupled with a high-resolution (35000) Q Exactive Orbitrap mass spectrometer. The microwave reactions were conducted using a Biotage Initiator+ microwave synthesizer. Unless otherwise stated, all reagents and solvents were purchased from commercial suppliers and used without further purification. Reactions that required anhydrous conditions were carried out under an atmosphere of argon/nitrogen. Chromatography was executed on Biotag-Isolera and/or CombiFlash instruments using silica gel (230â400 mesh) and/or neutral alumina as the stationary phase and mixtures of ethyl acetate (EtOAc) and hexanes or dichloromethane (DCM) and methanol as eluents. Analytical HPLC analysis was performed on a Supelco Discovery HS C18 column (4.6 mm Ã 250 mm) with a linear elution gradient of water/methanol (containing 10 mM ammonium acetate) ranging from 80:20 to 0:100 for 50 min at flow rate of 0.9 mL/min, at 254 nm. A purity of >95% has been established for all tested compounds.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Representative Procedure for the Synthesis of Methyl 2-Methoxy-4-(4-(trifluoromethoxy)phenoxy)benzoate (<b>4a</b>)</h4><div class="NLM_p last">Methyl 4-iodo-2-methoxybenzoate (<b>1</b>) (10.0 g, 34.2 mmol), 4-(trifluoromethoxy)phenol (<b>3a</b>) (6.1 g, 34.2 mmol), copper(I) chloride (CuCl) (678 mg, 6.8 mmol), <i>N</i>,<i>N</i>-dimethylglycine (706 mg, 6.8 mmol), K<sub>2</sub>CO<sub>3</sub> (9.46 g, 68.5 mmol), and 1-methyl-2-pyrrolidone (50 mL) were placed in a sealed tube with a Teflon-lined cap under an argon atmosphere at room temperature. The reaction mixture was stirred and heated for 4 h at 150 Â°C. After cooling to room temperature, the reaction mixture was added to water (300 mL) and extracted with ethyl acetate (3 Ã 100 mL). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and the solvent was evaporated under reduced pressure. The crude product was chromatographed on silica gel with ethyl acetate/hexanes as eluent to afford the pure diaryl ether intermediate <b>4a</b> (10.7 g, 91%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) Î´ 7.83 (d, <i>J</i> = 8.6 Hz, 1H), 7.23 (d, <i>J</i> = 8.7 Hz, 2H), 7.07 (d, <i>J</i> = 8.7 Hz, 2H), 6.63 (d, <i>J</i> = 1.7 Hz, 1H), 6.50 (dd, <i>J</i> = 8.6, 1.7 Hz, 1H), 3.88 (s, 3H), 3.86 (s, 3H). Diaryl ether intermediates <b>4b</b>â<b>e</b> were synthesized and purified in good yields (56â94%) by the same procedure as described for <b>4a</b> from <b>1</b> and appropriate phenols <b>3</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Synthesis of Methyl 2-Hydroxy-4-(4-(trifluoromethoxy)phenoxy)benzoate (<b>5a</b>)</h4><div class="NLM_p last">To a stirred solution of <b>4a</b> (2.0 g, 5.84 mmol) in anhydrous dichloromethane (DCM) (50 mL) maintained under an argon atmosphere was added dropwise boron trichloride solution (BCl<sub>3</sub>) (7.0 mL, 7.01 mmol, 1.0 M in DCM) at â78 Â°C. Then, the reaction mixture was stirred for 1 h while it was allowed to warm to room temperature. The reaction was quenched with water (100 mL) and extracted with DCM (2 Ã 50 mL). The combined organic layers were washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The organic solvent was evaporated under reduced pressure, and the product was chromatographed on silica gel with ethyl acetate/hexanes as eluent to afford the title compound <b>5a</b> (1.74 g, 91%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) Î´ 10.94 (s, 1H), 7.80 (d, <i>J</i> = 8.8 Hz, 1H), 7.24 (d, <i>J</i> = 8.7 Hz, 2H), 7.09 (d, <i>J</i> = 8.7 Hz, 2H), 6.51 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 6.46 (d, <i>J</i> = 2.1 Hz, 1H), 3.93 (s, 3H). Compounds <b>5b</b>â<b>e</b> were synthesized and purified in excellent yields (90â95%) by the same procedure as described for <b>5a</b> from <b>4b</b>â<b>e</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Representative Procedure for the Synthesis of Methyl 4-(4-(Trifluoromethoxy)phenoxy)-2-(((trifluoromethyl)sulfonyl)oxy)benzoate (<b>6a</b>)</h4><div class="NLM_p last">To a stirred solution of <b>5a</b> (1.50 g, 4.57 mmol) and pyridine (5.0 mL) in anhydrous DCM (25 mL) at 0 Â°C was added dropwise triflic anhydride (Tf<sub>2</sub>O) (1.93 g, 6.85 mmol). Then, the reaction mixture was stirred for 5 h while it was allowed to warm to room temperature. The mixture was poured into ice-cold water (50 mL) and extracted with diethyl ether (2 Ã 25 mL). The combined organic layers were washed with 2 N HCl (2 Ã 25 mL) and brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated under reduced pressure to afford the desired product <b>6a</b> (2.0 g, 95%). The product <b>6a</b> was carried forward into the next reaction without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) Î´ 8.08 (d, <i>J</i> = 8.7 Hz, 1H), 7.29 (d, <i>J</i> = 8.8 Hz, 2H), 7.12 (d, <i>J</i> = 8.8 Hz, 2H), 6.99 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 6.86 (d, <i>J</i> = 2.1 Hz, 1H), 3.95 (s, 3H). Compounds <b>6b</b>â<b>e</b> were synthesized in excellent yields (93â96%) by the same procedure as described for <b>6a</b> from <b>5b</b>â<b>e</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Representative Procedure for the Synthesis of Methyl 2-((3,4-Dichlorophenyl)amino)-4-(4-(trifluoromethoxy)phenoxy)benzoate (<b>8a</b>)</h4><div class="NLM_p">To a degassed solution of <b>6a</b> (1.8 g, 3.91 mmol) and 3,4-dichloroaniline (<b>7a</b>) (760 mg, 4.69 mmol) in toluene (50 mL) at room temperature were added palladium(II) acetate (Pd(OAc)<sub>2</sub>) (53 mg, 0.23 mmol), XPhos (223 mg, 0.47 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (2.54 g, 7.82 mmol). The reaction mixture was again degassed and heated at 110 Â°C for 5 h. After cooling to room temperature, the mixture was filtered through a pad of Celite and washed with DCM (100 mL). The filtrate was concentrated under reduced pressure, and the crude product was chromatographed on silica gel with ethyl acetate/hexanes as the eluent to afford the desired product <b>8a</b> (1.03 g, 56%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) Î´ 9.66 (s, 1H), 7.95 (d, <i>J</i> = 8.9 Hz, 1H), 7.33 (d, <i>J</i> = 8.6 Hz, 1H), 7.29 (d, <i>J</i> = 2.5 Hz, 1H), 7.23 (d, <i>J</i> = 8.9 Hz, 2H), 7.06 (d, <i>J</i> = 8.9 Hz, 2H), 7.01 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 6.75 (d, <i>J</i> = 2.3 Hz, 1H), 6.37 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 3.89 (s, 3H). Compounds <b>8b</b>â<b>q</b> were synthesized and purified in good yields (52%â65%) by the same procedure as described for <b>8a</b> from <b>6a</b>â<b>e</b> and appropriate anilines <b>7</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div><div id="sec4_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> Synthesis of Intermediates <b>9aâe</b></h5><div class="NLM_p last">Compounds <b>9a</b>â<b>e</b> were synthesized and purified in good yields (67â79%) by the same procedure as described for <b>8a</b> from methyl 4-bromo-2-methoxybenzoate (<b>2</b>) and appropriate anilines <b>7</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> Synthesis of Intermediates <b>10aâe</b></h5><div class="NLM_p last">Compounds <b>10a</b>â<b>e</b> were synthesized and purified in excellent yields (90â93%) by the same procedure as described for <b>5a</b> from <b>9a</b>â<b>e</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> Synthesis of Intermediates <b>11aâe</b></h5><div class="NLM_p last">Compounds <b>11a</b>â<b>e</b> were synthesized in excellent yields (92â95%) by the same procedure as described for <b>6a</b> from <b>10a</b>â<b>e</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction without further purification.</div></div><div id="sec4_1_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> Synthesis of Intermediates <b>12aâj</b></h5><div class="NLM_p last">Compounds <b>12a</b>â<b>j</b> were synthesized and purified in good yields (50â65%) by the same procedure as described for <b>8a</b> from <b>11a</b>â<b>e</b> and appropriate anilines <b>7</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Representative Procedure for the Synthesis of Methyl 3-Methoxy-4â²-(trifluoromethoxy)-[1,1â²-biphenyl]-4-carboxylate (<b>14a</b>)</h4><div class="NLM_p">To a degassed stirred solution of <b>2</b> (3.0 g, 12.24 mmol) and 4-chlorophenylboronic acid (<b>13a</b>) (2.86 g, 18.36 mmol) in 10% water/1,4-dioxane (100 mL) were added Pd(PPh<sub>3</sub>)<sub>4</sub> (707 mg, 0.61 mmol) and Na<sub>2</sub>CO<sub>3</sub> (3.89 g, 36.73 mmol). The reaction mixture was stirred for 5 h at 100 Â°C and poured onto water (100 mL). The pH of the solution was lowered to pH 7 with 2 N HCl, and the product was extracted with ethyl acetate (3 Ã 75 mL). The combined organic layers were washed with water and brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated under reduced pressure, and the product was chromatographed on silica gel with ethyl acetate/hexanes as the eluent to afford the pure product <b>14a</b> (2.53 g, 75%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz) Î´ 7.88 (d, <i>J</i> = 8.2 Hz, 1H), 7.13 (d, <i>J</i> = 8.5 Hz, 2H), 7.43 (d, <i>J</i> = 8.5 Hz, 2H), 7.11 (dd, <i>J</i> = 8.2, 1.4 Hz, 1H), 7.11 (d, <i>J</i> = 1.4 Hz, 1H), 3.97 (s, 3H), 3.91 (s, 3H). Compounds <b>14b</b>â<b>d</b> were synthesized and purified in good yields (72â80%) by the same procedure as described for <b>14a</b> from <b>2</b> and <b>13b</b>â<b>d</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div><div id="sec4_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Synthesis of Intermediates <b>15aâd</b></h5><div class="NLM_p last">Compounds <b>15a</b>â<b>d</b> were synthesized and purified in excellent yields (90â94%) by the same procedure as described for <b>5a</b> from <b>14a</b>â<b>d</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> Synthesis of Intermediates <b>16aâd</b></h5><div class="NLM_p last">Compounds <b>16a</b>â<b>d</b> were synthesized in excellent yields (92â95%) by the same procedure as described for <b>6a</b> from <b>15a</b>â<b>d</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction without further purification.</div></div><div id="sec4_1_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> Synthesis of Intermediates <b>17aâf</b></h5><div class="NLM_p last">Compounds <b>17a</b>â<b>f</b> were synthesized and purified in good yields (65â72%) by the same procedure as described for <b>8a</b> from <b>16a</b>â<b>d</b> and appropriate anilines <b>7</b>, and their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Representative Procedure for the Synthesis of 1,2-Dichloro-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>18</b>)</h4><div class="NLM_p last">BF<sub>3</sub>Â·Et<sub>2</sub>O (603 Î¼L, 4.24 mmol) was added to a microwave reaction vial containing <b>8a</b> (1.0 g, 2.12 mmol). Then, the reaction mixture was exposed to microwave irradiation for 1.0 min at 150 Â°C. After cooling to room temperature, the reaction mixture was poured into water (25 mL) and allowed to stir for 5.0 min. The solid material was filtered by a sintered funnel and washed with water (50 mL) to afford a mixture of the acridones <b>18</b> and <b>19</b>. Pure acridones <b>18</b> (451 mg, 48%) and <b>19</b> (111 mg, 12%) were obtained by recrystallization from a mixture of ethyl acetate and MeOH and DCM and acetonitrile, respectively.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1,2-Dichloro-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>18</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.77 (s, 1H), 8.19 (d, <i>J</i> = 8.9 Hz, 1H), 7.82 (d, <i>J</i> = 9.0 Hz, 1H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 7.39 (m, 3H), 7.01 (dd, <i>J</i> = 9.0, 2.3 Hz, 1H), 6.76 (d, <i>J</i> = 2.2 Hz, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>11</sub>Cl<sub>2</sub>F<sub>3</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 440.0063, found 440.0059.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2,3-Dichloro-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>19</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.80 (d, <i>J</i> = 0.4 Hz, 1H), 8.26 (s, 1H), 8.22 (d, <i>J</i> = 9.0 Hz, 1H), 7.63 (s, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 2H), 7.39 (d, <i>J</i> = 8.9 Hz, 2H), 7.03 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 6.81 (d, <i>J</i> = 2.1 Hz, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>11</sub>Cl<sub>2</sub>F<sub>3</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 440.0063, found 440.0062.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1,3-Dichloro-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>20</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.70 (s, 1H), 8.16 (d, <i>J</i> = 9.0 Hz, 1H), 7.53 (d, <i>J</i> = 8.6 Hz, 2H), 7.39â7.35 (m, 3H), 7.28 (s, 1H), 7.00 (dd, <i>J</i> = 8.9, 2.0 Hz, 1H), 6.73 (d, <i>J</i> = 1.9 Hz, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>11</sub>Cl<sub>2</sub>F<sub>3</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 440.0063, found 440.0060.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3-Chloro-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>21</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.70 (s, 1H), 8.24 (d, <i>J</i> = 8.9 Hz, 1H), 8.19 (d, <i>J</i> = 8.7 Hz, 1H), 7.53 (d, <i>J</i> = 8.6 Hz, 2H), 7.44 (d, <i>J</i> = 1.9 Hz, 1H), 7.38 (d, <i>J</i> = 9.0 Hz, 2H), 7.26 (dd, <i>J</i> = 8.6, 2.0 Hz, 1H), 7.02 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.82 (d, <i>J</i> = 2.3 Hz, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>12</sub>ClF<sub>3</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 406.0452, found 406.0450.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 1,3-Difluoro-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>22</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.77 (s, 1H), 8.19â8.17 (m, 1H), 7.52 (d, <i>J</i> = 8.6 Hz, 2H), 7.37 (d, <i>J</i> = 8.9 Hz, 2H), 6.98 (m, 3H), 6.77 (d, <i>J</i> = 1.6 Hz, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>11</sub>F<sub>5</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 408.0654, found 408.0649.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 6-(4-Chlorophenoxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>23</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.74 (d, <i>J</i> = 0.5 Hz, 1H), 8.16 (d, <i>J</i> = 8.9 Hz, 1H), 7.57 (d, <i>J</i> = 7.8 Hz, 2H), 7.29 (d, <i>J</i> = 7.7 Hz, 2H), 6.96 (m, 3H), 6.73 (s, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>11</sub>ClF<sub>2</sub>NO<sub>2</sub> (M + H)<sup>+</sup> 358.0441, found 358.0435.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-Fluoro-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>24</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.67 (d, <i>J</i> = 0.3 Hz, 1H), 8.19 (d, <i>J</i> = 8.9 Hz, 1H), 7.63 (m, 1H), 7.52 (d, <i>J</i> = 8.6 Hz, 2H), 7.38 (d, <i>J</i> = 9.0 Hz, 2H), 7.21 (dd, <i>J</i> = 8.5, 0.2 Hz, 1H), 6.98 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 6.92 (dd, <i>J</i> = 11.8, 8.0 Hz, 1H), 6.80 (d, <i>J</i> = 2.3 Hz, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>12</sub>F<sub>4</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 390.0748, found 390.0740.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 3-Fluoro-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>25</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.69 (s, 1H), 8.27â8.22 (m, 2H), 7.52 (d, <i>J</i> = 8.3 Hz, 2H), 7.38 (d, <i>J</i> = 9.1 Hz, 2H), 7.12 (m, 2H), 7.00 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.82 (d, <i>J</i> = 2.3 Hz, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>12</sub>F<sub>4</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 390.0748, found 390.0743.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 3-Chloro-1-fluoro-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>26</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.75 (s, 1H), 8.17 (d, <i>J</i> = 8.9 Hz, 1H), 7.52 (d, <i>J</i> = 8.2 Hz, 2H), 7.38 (d, <i>J</i> = 8.7 Hz, 2H), 7.22 (s, 1H), 7.11 (d, <i>J</i> = 11.2 Hz, 1H), 7.01 (dd, <i>J</i> = 9.1, 1.4 Hz, 1H), 6.77 (d, <i>J</i> = 1.6 Hz, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>11</sub>ClF<sub>4</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 424.0358, found 424.0353.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 1-Chloro-3-fluoro-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>27</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.72 (s, 1H), 8.17 (d, <i>J</i> = 8.9 Hz, 1H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 7.38 (d, <i>J</i> = 8.9 Hz, 2H), 7.18 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 7.09 (dd, <i>J</i> = 9.7, 2.1 Hz, 1H), 6.99 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 6.74 (d, <i>J</i> = 2.0 Hz, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>11</sub>ClF<sub>4</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 424.0358, found 424.0352.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 1-Chloro-3-methoxy-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>28</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.52 (s, 1H), 8.15 (d, <i>J</i> = 8.9 Hz, 1H), 7.51 (d, <i>J</i> = 8.3 Hz, 2H), 7.36 (d, <i>J</i> = 9.0 Hz, 2H), 6.94 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.84 (d, <i>J</i> = 2.4 Hz, 1H), 6.74 (m, 2H), 3.87 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>ClF<sub>3</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 436.0558, found 436.0555.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-Fluoro-3-methoxy-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>29</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.54 (s, 1H), 8.14 (d, <i>J</i> = 8.9 Hz, 1H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 7.36 (d, <i>J</i> = 9.0 Hz, 2H), 6.94 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 6.76 (d, <i>J</i> = 2.3 Hz, 1H), 6.63â6.59 (m, 2H), 3.86 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>F<sub>4</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 420.0853, found 420.0847.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 6-(4-Chlorophenoxy)-1-fluoro-3-methoxyacridin-9(10<i>H</i>)-one (<b>30</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.52 (s, 1H), 8.13 (d, <i>J</i> = 8.9 Hz, 1H), 7.56 (d, <i>J</i> = 8.9 Hz, 2H), 7.27 (d, <i>J</i> = 8.9 Hz, 2H), 6.92 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.73 (d, <i>J</i> = 2.3 Hz, 1H), 6.63â6.58 (m, 2H), 3.86 (s, 3H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>14</sub>ClFNO<sub>3</sub> (M + H)<sup>+</sup> 370.0641, found 370.0635.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 3-Chloro-1-methoxy-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>31</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.41 (s, 1H), 8.13 (d, <i>J</i> = 8.9 Hz, 1H), 7.51 (d, <i>J</i> = 8.6 Hz, 2H), 7.36 (d, <i>J</i> = 9.0 Hz, 2H), 6.93 (m, 2H), 6.72 (m, 2H), 3.87 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>ClF<sub>3</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 436.0558, found 436.0553.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 3-Fluoro-1-methoxy-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>32</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.45 (s, 1H), 8.13 (d, <i>J</i> = 8.9 Hz, 1H), 7.50 (d, <i>J</i> = 8.3 Hz, 2H), 7.35 (d, <i>J</i> = 9.1 Hz, 2H), 6.93 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.74 (d, <i>J</i> = 2.3 Hz, 2H), 6.62 (m, 2H), 3.86 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>F<sub>4</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 420.0853, found 420.0847.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 6-(4-Chlorophenoxy)-3-fluoro-1-methoxyacridin-9(10<i>H</i>)-one (<b>33</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.52 (s, 1H), 8.13 (d, <i>J</i> = 8.9 Hz, 1H), 7.56 (d, <i>J</i> = 8.8 Hz, 2H), 7.27 (d, <i>J</i> = 8.8 Hz, 2H), 6.92 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 6.73 (d, <i>J</i> = 2.0 Hz, 1H), 6.63â6.59 (m, 2H), 3.86 (s, 3H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>14</sub>ClFNO<sub>3</sub> (M + H)<sup>+</sup> 370.0641, found 370.0636.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 1-Chloro-2-methoxy-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>34</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.51 (s, 1H), 8.18 (d, <i>J</i> = 8.9 Hz, 1H), 7.62 (d, <i>J</i> = 9.2 Hz, 1H), 7.51 (d, <i>J</i> = 8.5 Hz, 2H), 7.38 (m, 3H), 6.94 (dd, <i>J</i> = 8.8, 1.7 Hz, 1H), 6.74 (d, <i>J</i> = 1.9 Hz, 1H), 3.89 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>ClF<sub>3</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 436.0558, found 436.0553.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 3-Chloro-2-methoxy-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>35</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.62 (s, 1H), 8.25 (d, <i>J</i> = 8.9 Hz, 1H), 7.73 (s, 1H), 7.52 (m, 3H), 7.38 (d, <i>J</i> = 9.0 Hz, 2H), 6.99 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 6.80 (d, <i>J</i> = 2.0 Hz, 1H), 3.95 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>ClF<sub>3</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 436.0558, found 436.0554.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 1-Methoxy-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>36</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.32 (s, 1H), 8.13 (d, <i>J</i> = 8.9 Hz, 1H), 7.54 (d, <i>J</i> = 8.2 Hz, 1H), 7.50 (d, <i>J</i> = 8.4 Hz, 2H), 7.35 (d, <i>J</i> = 9.1 Hz, 2H), 6.92â6.90 (m, 2H), 6.76 (d, <i>J</i> = 2.3 Hz, 1H), 6.68 (dd, <i>J</i> = 8.3, 0.7 Hz, 1H), 3.84 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>15</sub>F<sub>3</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 402.0948, found 402.0942.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 3-Methoxy-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>37</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.51 (s, 1H), 8.21 (d, <i>J</i> = 8.8 Hz, 1H), 8.11 (d, <i>J</i> = 8.9 Hz, 1H), 7.51 (d, <i>J</i> = 8.4 Hz, 2H), 7.36 (d, <i>J</i> = 8.8 Hz, 2H), 6.94 (dd, <i>J</i> = 8.8, 1.4 Hz, 1H), 6.86â6.79 (m, 3H), 3.87 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>15</sub>F<sub>3</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 402.0948, found 402.0942.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-Chloro-3-methoxy-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>38</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.68 (s, 1H), 8.20 (d, <i>J</i> = 8.9 Hz, 1H), 8.11 (s, 1H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 7.37â7.35 (m, 2H), 6.97 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 6.92 (s, 1H), 6.83 (d, <i>J</i> = 2.3 Hz, 1H), 3.97 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>ClF<sub>3</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 436.0558, found 436.0554.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-Fluoro-3-methoxy-6-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>39</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.67 (s, 1H), 8.20 (d, <i>J</i> = 8.8 Hz, 1H), 7.83 (d, <i>J</i> = 11.7 Hz, 1H), 7.51 (d, <i>J</i> = 8.6 Hz, 2H), 7.36 (d, <i>J</i> = 9.0 Hz, 2H), 6.97 (m, 2H), 6.84 (d, <i>J</i> = 2.2 Hz, 1H), 3.96 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>F<sub>4</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 421.0853, found 421.0847.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-Chloro-3-methoxy-6-(3-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>40</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.73 (s, 1H), 8.21 (d, <i>J</i> = 8.9 Hz, 1H), 8.12 (s, 1H), 7.63 (t, <i>J</i> = 8.2 Hz, 1H), 7.29 (m, 3H), 6.98 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 6.94 (s, 1H), 6.89 (d, <i>J</i> = 2.1 Hz, 1H), 3.98 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>ClF<sub>3</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 436.0558, found 436.0552.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-Chloro-3-methoxy-6-(2-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>41</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.68 (s, 1H), 8.21 (d, <i>J</i> = 8.9 Hz, 1H), 8.11 (s, 1H), 7.65â7.62 (m, 1H), 7.57â7.53 (m, 1H), 7.45 (m, 2H), 6.95 (dd, <i>J</i> = 8.9, 2.4 Hz, 1H), 6.91 (s, 1H), 6.81 (d, <i>J</i> = 2.4 Hz, 1H), 3.97 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>ClF<sub>3</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 436.0558, found 436.0553.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-Chloro-3-methoxy-6-(4-(morpholinomethyl)phenoxy)acridin-9(10<i>H</i>)-one (<b>42</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.66 (s, 1H), 8.18 (d, <i>J</i> = 8.9 Hz, 1H), 8.11 (s, 1H), 7.43 (d, <i>J</i> = 8.4 Hz, 2H), 7.18 (d, <i>J</i> = 8.4 Hz 2H), 6.95â6.92 (m, 2H), 6.79 (d, <i>J</i> = 2.1 Hz, 1H), 3.96 (s, 3H), 3.60 (t, <i>J</i> = 4.3 Hz, 4H), 3.50 (s, 2H), 2.39 (m, 4H); HRMS (ESI) calcd for C<sub>25</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup> 451.1419, found 451.1413.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Representative Procedure for the Synthesis of 1,3-Dichloro-6-((4-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>43</b>)</h4><div class="NLM_p last">Eatonâs acid (25 mL) was added to a flask containing <b>12a</b> (500 mg, 1.06 mmol), and the reaction mixture was then stirred at 90 Â°C for 5 h. After cooling to room temperature, the reaction mixture was added slowly to water, allowed to stir for 15 min, and then neutralized with 2 N NaOH. The resulting solid material was filtered using a sintered funnel and purified by column chromatography using ethyl acetate with 10% methanol as a mobile phase to obtain the pure compound <b>43</b> (266 mg, 57%). Acridones <b>44</b>â<b>52</b> were synthesized and purified in good yields (55â62%) by the same procedure, as described for <b>43</b> from <b>12b</b>â<b>j</b>.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 1,3-Dichloro-6-((4-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>43</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.50 (s, 1H), 9.08 (s, 1H), 8.00 (d, <i>J</i> = 8.7 Hz, 1H), 7.39â7.35 (m, 4H), 7.22 (d, <i>J</i> = 1.8 Hz, 1H), 6.93â6.89 (m, 3H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>12</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup> 439.0222, found 439.0219.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1,3-Difluoro-6-((4-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>44</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.54 (s, 1H), 9.06 (s, 1H), 8.00 (d, <i>J</i> = 8.8 Hz, 1H), 7.39â7.34 (m, 4H), 6.96â6.88 (m, 4H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>12</sub>F<sub>5</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 407.0813, found 407.0807.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 6-((4-Chlorophenyl)amino)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>45</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.53 (s, 1H), 9.01 (s, 1H), 7.99 (d, <i>J</i> = 8.8 Hz, 1H), 7.41 (d, <i>J</i> = 8.5 Hz, 2H), 7.28 (d, <i>J</i> = 8.5 Hz, 2H), 6.91 (m, 4H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>12</sub>ClF<sub>2</sub>N<sub>2</sub>O (M + H)<sup>+</sup> 357.0601, found 357.0596.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 1-Chloro-3-methoxy-6-((4-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>46</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 8.94 (s, 1H), 7.97 (d, <i>J</i> = 8.8 Hz, 1H), 7.37â7.32 (m, 4H), 6.94 (d, <i>J</i> = 2.0 Hz, 1H), 6.84 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 6.75â6.74 (m, 2H), 3.85 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 435.0718, found 435.0714.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 1-Fluoro-3-methoxy-6-((4-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>47</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.31 (s, 1H), 8.98 (s, 1H), 7.97 (d, <i>J</i> = 8.8 Hz, 1H), 7.37â7.32 (m, 4H), 6.94 (d, <i>J</i> = 1.2 Hz, 1H), 6.86 (dd, <i>J</i> = 8.7, 1.3 Hz, 1H), 6.60 (d, <i>J</i> = 1.1 Hz, 1H), 6.53 (dd, <i>J</i> = 13.6, 1.9 Hz, 1H), 3.86 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>15</sub>F<sub>4</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 419.1013, found 419.1010.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 6-((4-Chlorophenyl)amino)-1-fluoro-3-methoxyacridin-9(10<i>H</i>)-one (<b>48</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.31 (s, 1H), 8.94 (s, 1H), 7.96 (d, <i>J</i> = 8.8 Hz, 1H), 7.40 (d, <i>J</i> = 8.8 Hz, 2H), 7.26 (d, <i>J</i> = 8.8 Hz, 2H), 6.92 (d, <i>J</i> = 2.0 Hz, 1H), 6.85 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 6.60 (d, <i>J</i> = 2.0 Hz, 1H), 6.53 (dd, <i>J</i> = 13.5, 2.3 Hz, 1H), 3.86 (s, 3H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>15</sub>ClFN<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 369.0801, found 369.0791.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2-Fluoro-3-methoxy-6-((4-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>49</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.41 (s, 1H), 9.00 (s, 1H), 8.03 (d, <i>J</i> = 8.7 Hz, 1H), 7.78 (d, <i>J</i> = 11.7 Hz, 1H), 7.36 (m, 4H), 7.01â6.89 (m, 3H), 3.96 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>15</sub>F<sub>4</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 419.1013, found 419.1007.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 2-Fluoro-3-methoxy-6-((3-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>50</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.44 (s, 1H), 9.13 (s, 1H), 8.05 (d, <i>J</i> = 8.8 Hz, 1H), 7.79 (d, <i>J</i> = 11.8 Hz, 1H), 7.47 (d, <i>J</i> = 8.2 Hz, 1H), 7.29 (dd, <i>J</i> = 8.2, 1.3 Hz, 1H), 7.16 (m, 1H), 7.08 (d, <i>J</i> = 2.1 Hz, 1H), 6.99â6.92 (m, 3H), 3.97 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>15</sub>F<sub>4</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 419.1013, found 419.1010.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 2-Fluoro-3-methoxy-6-((2-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>51</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.36 (s, 1H), 8.66 (s, 1H), 8.01 (d, <i>J</i> = 8.7 Hz, 1H), 7.78 (d, <i>J</i> = 11.5 Hz, 1H), 7.57 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.48â7.40 (m, 2H), 7.24 (t, <i>J</i> = 7.4 Hz, 1H), 6.95 (d, <i>J</i> = 7.2 Hz, 1H), 6.90 (dd, <i>J</i> = 8.9, 1.6 Hz, 1H), 6.79 (d, <i>J</i> = 1.8 Hz, 1H), 3.95 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>15</sub>F<sub>4</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 419.1013, found 419.1005.</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 2-Chloro-3-methoxy-6-((4-(morpholinomethyl)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>52</b>)</h4><div class="NLM_p"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.03 (br s, 1H), 8.43 (br s, 1H), 8.10 (d, <i>J</i> = 2.0 Hz, 1H), 8.01 (dd, <i>J</i> = 8.7, 1.7 Hz, 1H), 7.84â7.82 (m, 1H), 7.24â7.16 (m, 3H), 6.91 (s, 1H), 6.82â6.80 (m, 2H), 3.91 (s, 3H), 3.60 (m, 4H), 3.41 (m, 2H), 2.38 (m, 4H); HRMS (ESI) calcd for C<sub>25</sub>H<sub>25</sub>ClN<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 450.1579, found 450.1572.</div><div id="sec4_1_42_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> Synthesis of Acridones <b>53â58</b></h5><div class="NLM_p last">Acridones <b>53</b>â<b>58</b> were synthesized and purified in good yields (65â74%) by the same procedure, as described for <b>18</b> from <b>17a</b>â<b>f</b>.</div></div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 6-(4-Chlorophenyl)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>53</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.98 (s, 1H), 8.23 (d, <i>J</i> = 8.4 Hz, 1H), 7.80 (dd, <i>J</i> = 6.6, 1.9 Hz, 2H), 7.66 (d, <i>J</i> = 1.6 Hz, 1H), 7.63â7.57 (m, 3H), 7.09 (d, <i>J</i> = 10.0 Hz, 1H), 7.05â6.99 (m, 1H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>11</sub>ClF<sub>2</sub>NO (M + H)<sup>+</sup> 342.0492, found 342.0501.</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 1,3-Difluoro-6-(4-(trifluoromethoxy)phenyl)acridin-9(10<i>H</i>)-one (<b>54</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.99 (s, 1H), 8.25 (d, <i>J</i> = 8.4 Hz, 1H), 7.90 (d, <i>J</i> = 8.6 Hz, 2H), 7.68 (s, 1H),7.60 (d, <i>J</i> = 8.4 Hz, 1H), 7.55 (d, <i>J</i> = 8.4 Hz, 2H), 7.09 (dd, <i>J</i> = 9.7 Hz, 1H), 7.05â7.00 (m, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>11</sub>F<sub>5</sub>NO<sub>2</sub> (M + H)<sup>+</sup> 392.0704, found 392.0713.</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 1,3-Difluoro-6-phenylacridin-9(10<i>H</i>)-one (<b>55</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.97 (s, 1H), 8.23 (d, <i>J</i> = 8.4 Hz, 1H), 7.78 (d, <i>J</i> = 8.5 Hz, 2H), 7.67 (d, <i>J</i> = 1.5 Hz, 1H), 7.61â7.54 (m, 3H), 7.49 (d, <i>J</i> = 7.3 Hz, 1H), 7.09 (d, <i>J</i> = 10.0 Hz, 1H), 7.04â6.98 (m, 1H); HRMS (ESI) calcd for C<sub>19</sub>H<sub>12</sub>F<sub>2</sub>NO (M + H)<sup>+</sup> 308.0881, found 308.0893.</div></div><div id="sec4_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 6-(4-Chlorophenyl)-1-fluoro-3-methoxyacridin-9(10<i>H</i>)-one (<b>56</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.83 (s, 1H), 8.20 (d, <i>J</i> = 8.4 Hz, 1H), 7.78 (d, <i>J</i> = 7.9 Hz, 2H), 7.64 (s, 1H), 7.61 (d, <i>J</i> = 7.9 Hz, 2H), 7.52 (d, <i>J</i> = 8.4 Hz, 1H), 6.75 (s, 1H), 6.63 (d, <i>J</i> = 13.4 Hz, 1H), 3.90 (s, 3H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>14</sub>ClFNO<sub>2</sub> (M + H)<sup>+</sup> 354.0692, found 354.0685.</div></div><div id="sec4_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 1-Fluoro-3-methoxy-6-(4-(trifluoromethoxy)phenyl)acridin-9(10<i>H</i>)-one (<b>57</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.73 (s, 1H), 8.21 (d, <i>J</i> = 8.4 Hz, 1H), 7.87 (d, <i>J</i> = 8.6 Hz, 2H), 7.62 (s, 1H), 7.54 (m, 3H), 6.72 (s, 1H), 6.63 (dd, <i>J</i> = 13.4, 1.8 Hz, 1H), 3.90 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>F<sub>4</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 404.0904, found 404.0914.</div></div><div id="sec4_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 2-Chloro-3-methoxy-6-(4-(morpholinomethyl)phenyl)acridin-9(10<i>H</i>)-one (<b>58</b>)</h4><div class="NLM_p"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.85 (s, 1H), 8.25 (d, <i>J</i> = 8.4 Hz, 1H), 8.15 (s, 1H), 7.74â7.69 (m, 3H), 7.56 (dd, <i>J</i> = 8.4, 1.2 Hz, 1H), 7.48 (d, <i>J</i> = 8.0 Hz, 2H), 7.06 (s, 1H), 4.02 (s, 3H), 3.60 (t, <i>J</i> = 4.6 Hz, 4H), 3.54 (s, 2H), 2.40 (t, <i>J</i> = 4.0 Hz, 4H); HRMS (ESI) calcd for C<sub>25</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 435.1470, found 435.1466.</div><div id="sec4_1_48_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i93" class="anchor-spacer"></div><h5 class="article-section__title" id="_i93"> Synthesis of Intermediate <b>61</b></h5><div class="NLM_p last">Compound <b>61</b> was synthesized and purified in good yield (3.35 g, 57%) by the same procedure as described for <b>4a</b> from methyl 5-iodo-2-methoxybenzoate (<b>59</b>) and <b>3a</b>, its identity was confirmed by GCâMS analysis, and it was carried forward into the next reaction.</div></div><div id="sec4_1_48_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> Synthesis of Intermediate <b>62</b></h5><div class="NLM_p last">Compound <b>62</b> was synthesized and purified in good yield (2.69 g, 91%) by the same procedure as described for <b>5a</b> from <b>61</b>, its identity was confirmed by GCâMS analysis, and it was carried forward into the next reaction.</div></div><div id="sec4_1_48_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i95" class="anchor-spacer"></div><h5 class="article-section__title" id="_i95"> Synthesis of Intermediates <b>63aâc</b></h5><div class="NLM_p last">Compounds <b>63a</b>â<b>c</b> were synthesized and purified in good yields (52â63%) by the same procedure as described for <b>8a</b> from methyl 5-bromo-2-hydroxybenzoate (<b>60</b>) and appropriate aniline <b>7</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_48_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i96" class="anchor-spacer"></div><h5 class="article-section__title" id="_i96"> Synthesis of Intermediates <b>64</b> and <b>65aâc</b></h5><div class="NLM_p last">Compounds <b>64</b> and <b>65a</b>â<b>c</b> were synthesized in excellent yields (93â96%) by the same procedure as described for <b>6a</b> from <b>62</b> and <b>63a</b>â<b>c</b>, respectively, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction without further purification.</div></div><div id="sec4_1_48_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i97" class="anchor-spacer"></div><h5 class="article-section__title" id="_i97"> Synthesis of Intermediates <b>66aâc</b> and <b>67aâi</b></h5><div class="NLM_p last">Compounds <b>66a</b>â<b>c</b> and <b>67a</b>â<b>i</b> were synthesized and purified in good yields (64â71%) by the same procedure as described for <b>8a</b> from <b>64</b> and <b>65a</b>â<b>c</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_48_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i98" class="anchor-spacer"></div><h5 class="article-section__title" id="_i98"> Synthesis of Acridones <b>68</b>â<b>71</b></h5><div class="NLM_p last">Acridones <b>68</b>â<b>71</b> were synthesized and purified in good yields (57â65%) by the same procedure, as described for <b>43</b> from <b>66a</b>â<b>c</b>.</div></div></div><div id="sec4_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 1,3-Difluoro-7-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>68</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 12.03 (br s, 1H), 7.64 (d, <i>J</i> = 1.2 Hz, 1H), 7.63 (d, <i>J</i> = 1.2 Hz, 1H), 7.58 (d, <i>J</i> = 2.2 Hz, 1H), 7.42 (d, <i>J</i> = 8.4 Hz, 2H), 7.17 (m, 2H), 7.07â6.97 (m, 2H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>11</sub>F<sub>5</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 408.0654, found 408.0665.</div></div><div id="sec4_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 1-Fluoro-3-methoxy-7-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>69</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.80 (s, 1H), 7.63 (d, <i>J</i> = 2.0 Hz, 1H), 7.54 (m, 2H), 7.42 (d, <i>J</i> = 8.8 Hz, 2H), 7.16 (d, <i>J</i> = 9.0 Hz, 2H), 6.71 (d, <i>J</i> = 1.9 Hz, 1H), 6.62 (dd, <i>J</i> = 13.4, 2.3 Hz, 1H), 3.89 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>F<sub>4</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 420.0853, found 420.0847.</div></div><div id="sec4_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 3-Fluoro-1-methoxy-7-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>70</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.67 (s, 1H), 7.62 (m, 1H), 7.50 (m, 2H), 7.41 (d, <i>J</i> = 8.4 Hz, 2H), 7.15 (d, <i>J</i> = 9.1 Hz, 2H), 6.74 (dd, <i>J</i> = 10.2, 2.3 Hz, 1H), 6.61 (dd, <i>J</i> = 11.9, 2.3 Hz, 1H), 3.86 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>F<sub>4</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 420.0853, found 420.0847.</div></div><div id="sec4_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 2-Fluoro-3-methoxy-7-(4-(trifluoromethoxy)phenoxy)acridin-9(10<i>H</i>)-one (<b>71</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.90 (s, 1H), 7.82 (d, <i>J</i> = 11.7 Hz, 1H), 7.66 (d, <i>J</i> = 2.8 Hz, 1H), 7.60 (m, 1H), 7.56 (m, 1H), 7.41 (d, <i>J</i> = 8.6 Hz, 2H), 7.16 (d, <i>J</i> = 8.6 Hz, 2H), 7.07 (d, <i>J</i> = 7.3 Hz, 1H), 3.99 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>14</sub>F<sub>4</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 420.0853, found 420.0864.</div></div><div id="sec4_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Representative Procedure for the Synthesis of 1,3-Difluoro-7-((4-(trifluoromethoxy)-phenyl)amino)acridin-9(10<i>H</i>)-one (<b>72</b>)</h4><div class="NLM_p last">Polyphosphoric acid (PPA) (5.0 g) was added to a flask containing <b>67a</b> (500 mg, 1.14 mmol), and the reaction mixture was then stirred at 110 Â°C for 2 h. After cooling to room temperature, water was added slowly to the flask and allowed to stir for 15 min. Then, the reaction mixture was neutralized with 2 N NaOH and the solid material was filtered through a sintered funnel and washed with water (100 mL) and methanol (10 mL) to obtain the pure compound <b>72</b> (287 mg, 62%). Acridones <b>73</b>â<b>80</b> were synthesized and purified in good yields (60â65%) by the same procedure, as described for <b>72</b> from <b>67b</b>â<b>i</b>.</div></div><div id="sec4_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 1,3-Difluoro-7-((4-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>72</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.91 (br s, 1H), 8.55 (s, 1H), 7.84 (d, <i>J</i> = 2.3 Hz, 1H), 7.55 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 7.47 (d, <i>J</i> = 8.8 Hz, 1H), 7.24 (d, <i>J</i> = 8.6 Hz, 2H), 7.13 (d, <i>J</i> = 8.6 Hz, 2H), 7.02 (d, <i>J</i> = 10.0 Hz, 1H), 6.93 (m, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>12</sub>F<sub>5</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 407.0813, found 407.0814.</div></div><div id="sec4_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 1,3-Difluoro-7-((3-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>73</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.89 (s, 1H), 8.69 (s, 1H), 7.88 (s, 1H), 7.56 (d, <i>J</i> = 7.3 Hz, 1H), 7.49 (d, <i>J</i> = 8.8 Hz, 1H), 7.34 (d, <i>J</i> = 8.1 Hz, 1H), 7.07â6.94 (m, 4H), 6.76 (d, <i>J</i> = 7.6 Hz, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>12</sub>F<sub>5</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 407.0813, found 407.0816.</div></div><div id="sec4_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 1,3-Difluoro-7-((2-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>74</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.88 (s, 1H), 8.18 (s, 1H), 7.81 (d, <i>J</i> = 2.2 Hz, 1H), 7.57 (m, 1H), 7.46 (d, <i>J</i> = 8.8 Hz, 1H), 7.35 (d, <i>J</i> = 8.2 Hz, 1H), 7.30 (m, 2H), 7.03 (d, <i>J</i> = 10.2 Hz, 1H), 6.97 (m, 2H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>12</sub>F<sub>5</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 407.0813, found 407.0802.</div></div><div id="sec4_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 1,3-Dichloro-7-((4-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>75</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.96 (s, 1H), 8.57 (s, 1H), 7.85 (d, <i>J</i> = 1.7 Hz, 1H), 7.53 (d, <i>J</i> = 1.9 Hz, 1H), 7.48 (d, <i>J</i> = 8.8 Hz, 2H), 7.25 (m, 3H), 7.14 (d, <i>J</i> = 8.8 Hz, 2H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>12</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 439.0222, found 439.0225.</div></div><div id="sec4_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> 1,3-Dichloro-7-((3-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>76</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.86 (s, 1H), 8.70 (s, 1H), 7.88 (s, 1H), 7.56 (d, <i>J</i> = 7.2 Hz, 1H), 7.48 (d, <i>J</i> = 7.4 Hz, 2H), 7.34 (d, <i>J</i> = 7.8 Hz, 1H), 7.25 (s, 1H), 7.08 (d, <i>J</i> = 7.2 Hz, 1H), 6.94 (s, 1H), 6.76 (d, <i>J</i> = 6.4 Hz, 1H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>12</sub>Cl<sub>2</sub>F<sub>3</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 439.0222, found 439.0226.</div></div><div id="sec4_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 2-Fluoro-3-methoxy-7-((4-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>77</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.81 (s, 1H), 8.49 (br s, 1H), 7.87 (d, <i>J</i> = 1.8 Hz, 1H), 7.82 (d, <i>J</i> = 11.8 Hz, 1H), 7.52 (m, 2H), 7.23 (d, <i>J</i> = 8.6 Hz, 2H), 7.12 (m, 2H), 7.07 (m, 1H), 3.98 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>15</sub>F<sub>4</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 419.1013, found 419.1015.</div></div><div id="sec4_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 2-Fluoro-3-methoxy-7-((3-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>78</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.78 (s, 1H), 8.64 (s, 1H), 7.91 (s, 1H), 7.82 (d, <i>J</i> = 11.8 Hz, 1H), 7.53 (m, 2H), 7.34 (d, <i>J</i> = 8.1 Hz, 1H), 7.05 (d, <i>J</i> = 7.4 Hz, 2H), 6.92 (s, 1H), 6.73 (d, <i>J</i> = 7.8 Hz, 1H), 3.99 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>15</sub>F<sub>4</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 419.1013, found 419.1016.</div></div><div id="sec4_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 2-Chloro-3-methoxy-7-((4-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>79</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 8.49 (s, 1H), 8.11 (s, 1H), 7.88 (s, 1H), 7.51 (s, 2H), 7.23 (d, <i>J</i> = 8.6 Hz, 2H), 7.11 (d, <i>J</i> = 8.6 Hz, 2H), 7.04 (s, 1H), 3.98 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 435.0718, found 435.0720.</div></div><div id="sec4_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> 2-Chloro-3-methoxy-7-((3-(trifluoromethoxy)phenyl)amino)acridin-9(10<i>H</i>)-one (<b>80</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.80 (s, 1H), 8.65 (s, 1H), 8.12 (s, 1H), 7.91 (d, <i>J</i> = 1.6 Hz, 1H), 7.54 (m, 2H), 7.34 (d, <i>J</i> = 8.2 Hz, 1H), 7.05 (d, <i>J</i> = 8.2 Hz, 2H), 7.02 (s, 1H), 6.92 (s, 1H), 6.74 (d, <i>J</i> = 7.8 Hz, 1H), 3.99 (s, 3H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 435.0718, found 435.0720.</div></div><div id="sec4_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Synthesis of Methyl 4-Methoxy-2-(((trifluoromethyl)sulfonyl)oxy)benzoate (<b>82</b>)</h4><div class="NLM_p">Compound <b>82</b> was synthesized in excellent yield (16.56 g, 96%) by the same procedure as described for <b>6a</b> from methyl 2-hydroxy-4-methoxybenzoate (<b>81</b>), its identity was confirmed by GCâMS analysis, and it was carried forward into the next reaction without further purification.</div><div id="sec4_1_63_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i114" class="anchor-spacer"></div><h5 class="article-section__title" id="_i114"> Synthesis of Compounds <b>83aâc</b></h5><div class="NLM_p last">Compounds <b>83a</b>â<b>c</b> were synthesized and purified in good yields (65â75%) by the same procedure as described for <b>8a</b> from <b>82</b> and appropriate aniline <b>7</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_63_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i115" class="anchor-spacer"></div><h5 class="article-section__title" id="_i115"> Synthesis of Acridone Intermediates <b>84aâc</b></h5><div class="NLM_p last">Compounds <b>84a</b>â<b>c</b> were synthesized and purified in good yields (93â95%) by the same procedure, as described for <b>18</b> from <b>83a</b>â<b>c</b>, and carried forward into the next reaction.</div></div></div><div id="sec4_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> Representative Procedure for the Synthesis of 1,3-Difluoro-6-hydroxyacridin-9(10<i>H</i>)-one (<b>85a</b>)</h4><div class="NLM_p last">To a stirred solution of <b>84a</b> (3.0 g, 11.49 mmol) in 75 mL of 57% hydroiodic acid (HI) at room temperature was added phenol (17.3 g, 183.9 mmol), and the reaction mixture was stirred at reflux for 3 h. After cooling to room temperature, water was added slowly to the flask and the resulting solid was filtered. Trituration with acetone and water yielded the title compound <b>85a</b> (2.58 g, 91%). Compounds <b>85b</b> and <b>85c</b> were synthesized in excellent yields of 87 and 90%, respectively, by the same procedure as described for <b>85a</b> and carried forward into the next reaction.</div></div><div id="sec4_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> Representative Procedure for the Synthesis of 1,3-Difluoro-6-((4-(trifluoromethoxy)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>86</b>)</h4><div class="NLM_p last">To a stirred solution of <b>85a</b> (200 mg, 0.80 mmol) in anhydrous acetone (100 mL) at room temperature were added K<sub>2</sub>CO<sub>3</sub> (1.67 g, 12.14 mmol) and benzyl bromide (152 mg, 0.89 mmol), and the reaction mixture was stirred at reflux for 3 h. The hot reaction mixture was then filtered, and the solvent was removed by rotary evaporation. The obtained product was washed with methanol (25 mL) to afford the title compound <b>86</b> (202 mg, 74%). Acridones <b>87</b>â<b>93</b> were synthesized and purified in excellent yields (80â86%) by the same procedure, as described for <b>86</b>.</div></div><div id="sec4_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> 6-(Benzyloxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>86</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.77 (br s, 1H), 8.07 (d, <i>J</i> = 8.9 Hz, 1H), 7.50 (d, <i>J</i> = 7.2 Hz, 2H), 7.43 (d, <i>J</i> = 7.2 Hz, 2H), 7.37 (d, <i>J</i> = 7.0 Hz, 1H), 7.10 (d, <i>J</i> = 10.9 Hz, 1H), 6.96 (d, <i>J</i> = 6.8 Hz, 2H), 6.89 (s, 1H), 5.25 (s, 2H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>14</sub>F<sub>2</sub>NO<sub>2</sub> (M + H)<sup>+</sup> 338.0987, found 338.0999.</div></div><div id="sec4_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> 1,3-Difluoro-6-((4-(trifluoromethoxy)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>87</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.77 (br s, 1H), 8.08 (d, <i>J</i> = 8.9 Hz, 1H), 7.64 (d, <i>J</i> = 8.4 Hz, 2H), 7.43 (d, <i>J</i> = 8.4 Hz, 2H), 7.02â6.93 (m, 3H), 6.88 (d, <i>J</i> = 2.0 Hz, 1H), 5.29 (s, 2H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>13</sub>F<sub>5</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 422.0810, found 422.0815.</div></div><div id="sec4_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120"> 1,3-Difluoro-6-((4-((trifluoromethyl)thio)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>88</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.80 (br s, 1H), 8.09 (d, <i>J</i> = 8.9 Hz, 1H), 7.79 (d, <i>J</i> = 8.2 Hz, 2H), 7.66 (d, <i>J</i> = 8.2 Hz, 2H), 7.07â6.96 (m, 3H), 6.89 (d, <i>J</i> = 2.3 Hz, 1H), 5.36 (s, 2H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>13</sub>F<sub>5</sub>NO<sub>2</sub>S (M + H)<sup>+</sup> 438.0582, found 438.0596.</div></div><div id="sec4_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121"> 1,3-Difluoro-6-((4-(trifluoromethyl)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>89</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.78 (br s, 1H), 8.09 (d, <i>J</i> = 8.9 Hz, 1H), 7.81 (d, <i>J</i> = 8.2 Hz, 2H), 7.72 (d, <i>J</i> = 8.2 Hz, 2H), 7.02â6.95 (m, 3H), 6.88 (d, <i>J</i> = 2.0 Hz, 1H), 5.39 (s, 2H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>13</sub>F<sub>5</sub>NO<sub>2</sub> (M + H)<sup>+</sup> 406.0861, found 406.0870.</div></div><div id="sec4_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122"> 1,3-Difluoro-6-((3-(trifluoromethoxy)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>90</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.78 (br s, 1H), 8.08 (d, <i>J</i> = 8.9 Hz, 1H), 7.60â7.53 (m, 2H), 7.50 (s, 1H), 7.37 (d, <i>J</i> = 7.5 Hz, 1H), 7.02â6.93 (m, 3H), 6.88 (d, <i>J</i> = 2.0 Hz, 1H), 5.32 (s, 2H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>13</sub>F<sub>5</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 422.0810, found 422.0818.</div></div><div id="sec4_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> 1,3-Difluoro-6-((3-(trifluoromethyl)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>91</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.79 (br s, 1H), 8.09 (d, <i>J</i> = 8.9 Hz, 1H), 7.87 (s, 1H), 7.82 (d, <i>J</i> = 7.6 Hz, 1H), 7.75 (d, <i>J</i> = 7.7 Hz, 1H), 7.69 (d, <i>J</i> = 7.6 Hz, 1H), 7.02â6.93 (m, 3H), 6.90 (d, <i>J</i> = 2.0 Hz, 1H), 5.36 (s, 2H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>13</sub>F<sub>5</sub>NO<sub>2</sub> (M + H)<sup>+</sup> 406.0861, found 406.0874.</div></div><div id="sec4_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> 1,3-Difluoro-6-((2-(trifluoromethyl)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>92</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.80 (br s, 1H), 8.10 (d, <i>J</i> = 8.9 Hz, 1H), 7.84 (d, <i>J</i> = 8.3 Hz, 1H), 8.81 (s, 1H), 7.76 (d, <i>J</i> = 7.4 Hz, 1H), 7.62 (d, <i>J</i> = 7.6 Hz, 1H), 7.02â6.93 (m, 3H), 6.89 (d, <i>J</i> = 2.3 Hz, 1H), 5.39 (s, 2H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>13</sub>F<sub>5</sub>NO<sub>2</sub> (M + H)<sup>+</sup> 406.0861, found 406.0873.</div></div><div id="sec4_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> 1,2-Dichloro-6-((4-chlorobenzyl)oxy)acridin-9(10<i>H</i>)-one (<b>93</b>)</h4><div class="NLM_p"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.80 (s, 1H), 8.11 (d, <i>J</i> = 9.0 Hz, 1H), 7.83 (d, <i>J</i> = 9.0 Hz, 1H), 7.50 (m, 5H), 6.97 (dd, <i>J</i> = 9.0, 1.3 Hz, 1H), 6.89 (s, 1H), 5.27 (s, 2H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>13</sub>Cl<sub>3</sub>NO<sub>2</sub> (M + H)<sup>+</sup> 404.0006, found 404.0010.</div><div id="sec4_1_73_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i126" class="anchor-spacer"></div><h5 class="article-section__title" id="_i126"> Synthesis of Intermediates <b>95a</b> and <b>95b</b></h5><div class="NLM_p last">Compounds <b>95a</b> and <b>95b</b> were synthesized and purified in good yields (6.82 g, 67%; 6.88 g, 71%, respectively) by the same procedure as described for <b>86</b> from methyl 2,4-dihydroxybenzoate (<b>94</b>) and appropriate benzyl bromides, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_73_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i127" class="anchor-spacer"></div><h5 class="article-section__title" id="_i127"> Synthesis of Intermediates <b>96a</b> and <b>96b</b></h5><div class="NLM_p last">Compounds <b>96a</b> and <b>96b</b> were synthesized and purified in excellent yields (6.37 g, 92%; 6.32 g, 90%, respectively) by the same procedure as described for <b>6a</b> from <b>95a</b> and <b>95b</b>, respectively, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_73_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i128" class="anchor-spacer"></div><h5 class="article-section__title" id="_i128"> Synthesis of Intermediates <b>97aâd</b></h5><div class="NLM_p last">Compounds <b>97a</b>â<b>d</b> were synthesized and purified in good yields (59â67%) by the same procedure as described for <b>8a</b> from <b>96a</b> and <b>96b</b> and appropriate anilines <b>7</b>, their identity was confirmed by GCâMS analysis, and they were carried forward into the next reaction.</div></div><div id="sec4_1_73_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i129" class="anchor-spacer"></div><h5 class="article-section__title" id="_i129"> Synthesis of Acridones <b>99</b>â<b>102</b></h5><div class="NLM_p last">Acridones <b>99</b>â<b>102</b> were synthesized (9<b>â</b>50%) by the same procedure, as described for <b>18</b> from <b>97a</b>â<b>d</b>. 6-Hydroxy acridones <b>98a</b> and <b>98b</b> were also isolated as minor products (23â48%). These two products were separated by column chromatography using a mixture of DCM and MeOH as a mobile phase. Upon treatment with appropriate benzyl bromides and K<sub>2</sub>CO<sub>3</sub>, 6-hydroxy acridones <b>98a</b> and <b>98b</b> furnished the acridones <b>99</b>â<b>102</b> in excellent yields (76â81%).</div></div></div><div id="sec4_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130"> 2-Chloro-3-methoxy-6-((4-(trifluoromethoxy)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>99</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.67 (s, 1H), 8.13â8.10 (m, 2H), 7.65 (d, <i>J</i> = 8.7 Hz, 2H), 7.44â7.42 (m, 2H), 6.99 (s, 1H), 6.95 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 6.92 (d, <i>J</i> = 2.3 Hz, 1H), 5.30 (s, 2H), 3.99 (s, 3H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>16</sub>ClF<sub>3</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 450.0714, found 450.0715.</div></div><div id="sec4_1_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> 2-Chloro-3-methoxy-6-((4-(trifluoromethyl)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>100</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.66 (s, 1H), 8.13â8.10 (m, 2H), 7.80 (d, <i>J</i> = 7.9 Hz, 2H), 7.73 (d, <i>J</i> = 7.7 Hz, 2H), 6.99â6.91 (m, 3H), 5.39 (s, 2H), 3.98 (s, 3H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>16</sub>ClF<sub>3</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 434.0766, found 434.0769.</div></div><div id="sec4_1_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> 2-Fluoro-3-methoxy-6-((4-(trifluoromethoxy)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>101</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.63 (s, 1H), 8.11 (d, <i>J</i> = 8.8 Hz, 1H), 7.81 (d, <i>J</i> = 11.8 Hz, 1H), 7.65 (d, <i>J</i> = 8.6 Hz, 2H), 7.43 (d, <i>J</i> = 8.2 Hz, 2H), 7.03 (d, <i>J</i> = 7.2 Hz, 1H), 6.96â6.92 (m, 2H), 5.30 (s, 2H), 3.98 (s, 3H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>16</sub>F<sub>4</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 434.1010, found 434.1011.</div></div><div id="sec4_1_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133"> 2-Fluoro-3-methoxy-6-((4-(trifluoromethyl)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>102</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.63 (s, 1H), 8.12 (d, <i>J</i> = 8.8 Hz, 1H), 7.83â7.80 (m, 3H), 7.73 (d, <i>J</i> = 8.0 Hz, 2H), 7.03 (d, <i>J</i> = 7.1 Hz, 1H), 6.97 (d, <i>J</i> = 9.1 Hz, 1H), 6.91 (s, 1H), 5.39 (s, 2H), 3.98 (s, 3H); HRMS (ESI) calcd for C<sub>22</sub>H<sub>16</sub>F<sub>4</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 418.1061, found 418.1064.</div></div><div id="sec4_1_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> Synthesis of Methyl 2-((3,5-Difluorophenyl)amino)-5-methoxybenzoate (<b>104</b>)</h4><div class="NLM_p last">Compound <b>104</b> was synthesized and purified in good yield (2.46 g, 68%) by the same procedure as described for <b>8a</b> from methyl 2-bromo-5-methoxybenzoate (<b>103</b>) and 3,5-difluoroaniline (<b>7d</b>), its identity was confirmed by GCâMS analysis, and it was carried forward into the next reaction.</div></div><div id="sec4_1_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> Synthesis of 1,3-Difluoro-7-methoxyacridin-9(10<i>H</i>)-one (<b>105</b>)</h4><div class="NLM_p last">Compound <b>105</b> was synthesized and purified in good yield (1.25 g, 70%) by the same procedure, as described for <b>43</b> from <b>104</b>, and carried forward into the next reaction.</div></div><div id="sec4_1_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> Synthesis of 1,3-Difluoro-7-hydroxyacridin-9(10<i>H</i>)-one (<b>106</b>)</h4><div class="NLM_p">Compound <b>106</b> was synthesized and purified in excellent yield (987 mg, 87%) by the same procedure, as described for <b>85a</b> from <b>105</b>, and carried forward into the next reaction.</div><div id="sec4_1_80_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i137" class="anchor-spacer"></div><h5 class="article-section__title" id="_i137"> Synthesis of Acridones <b>107</b>â<b>109</b></h5><div class="NLM_p last">Acridones <b>107</b>â<b>109</b> were synthesized in excellent yield (81â84%) by the same procedure, as described for <b>86</b> from <b>106</b> and appropriate benzyl bromides.</div></div></div><div id="sec4_1_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i138" class="anchor-spacer"></div><h4 class="article-section__title" id="_i138"> 1,3-Difluoro-7-((4-(trifluoromethoxy)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>107</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.91 (br s, 1H), 7.65â7.63 (m, 3H), 7.49â7.42 (m, 4H), 7.04â6.96 (m, 2H), 5.24 (s, 2H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>13</sub>F<sub>5</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 422.0810, found 422.0822.</div></div><div id="sec4_1_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i139" class="anchor-spacer"></div><h4 class="article-section__title" id="_i139"> 1,3-Difluoro-7-((4-(trifluoromethyl)benzyl)oxy)acridin-9(10<i>H</i>)-one (<b>108</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.89 (br s, 1H), 7.79 (d, <i>J</i> = 8.3 Hz, 2H), 7.12 (d, <i>J</i> = 8.3 Hz, 2H), 7.66 (d, <i>J</i> = 1.8 Hz, 1H), 7.50 (m, 2H), 7.03 (d, <i>J</i> = 10.3 Hz, 1H), 6.99â6.93 (m, 1H), 5.33 (s, 2H); HRMS (ESI) calcd for C<sub>21</sub>H<sub>13</sub>F<sub>5</sub>NO<sub>2</sub> (M + H)<sup>+</sup> 406.0861, found 406.0873.</div></div><div id="sec4_1_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i140" class="anchor-spacer"></div><h4 class="article-section__title" id="_i140"> 7-((4-Chlorobenzyl)oxy)-1,3-difluoroacridin-9(10<i>H</i>)-one (<b>109</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) Î´ 11.90 (s, 1H), 7.65 (s, 1H), 7.54â7.48 (m, 6H), 7.04 (d, <i>J</i> = 10.1 Hz, 1H), 6.96 (t, <i>J</i> = 10.6 Hz, 1H), 5.21 (s, 2H); HRMS (ESI) calcd for C<sub>20</sub>H<sub>13</sub>ClF<sub>2</sub>NO<sub>2</sub> (M + H)<sup>+</sup> 372.0597, found 372.0595.</div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i141">Biological Experiments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18611" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18611" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i142" class="anchor-spacer"></div><h3 class="article-section__title" id="_i142"> Culture Conditions</h3><div class="NLM_p last"><i>P. falciparum</i> strains D6, Dd2, 7G8, and Tm90-C2B were cultured in human erythrocytes at 2% hematocrit in RPMI 1640 containing 0.5% Albumax, 45 Î¼g/L hypoxanthine, and 50 Î¼g/L gentamicin, as previously described.<a onclick="showRef(event, 'ref20 ref42'); return false;" href="javascript:void(0);" class="ref ref20 ref42">(20,42)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i143" class="anchor-spacer"></div><h3 class="article-section__title" id="_i143"> In Vitro Blood-Stage Antimalarial Activity</h3><div class="NLM_p last">In vitro antimalarial activity was determined by the Malaria SYBR Green I-based Fluorescence (MSF) assay described previously with minor modifications.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Acridones were evaluated for antiplasmodial activity with CQ and ATV as controls. Experiments were set up in triplicate in 96-well plates with a total of 100 Î¼L of total volume per well with 2% hematocrit, 0.2% parasitemia, and drug dilutions in complete culture medium described above. Initial drug dilutions were set between 2.5 and 2500 nM and subsequently adjusted to either a lower or higher range to achieve the most accurate IC<sub>50</sub> values. The plates were incubated at 37 Â°C in low-oxygen conditions described previously for 72 h at which point 100 Î¼L of a fluorescent dyeâdetergent mixture (0.2 Î¼L of SYBR Green I:1 mL of lysis buffer) was added, and the plates were incubated in the dark at room temperature for 1 h. After incubation with the fluorescent dye, a 96-well plate reader with an excitation wavelength set at 497 nm and emission at 520 nm was used to measure the fluorescence of each well. Fluorescence readings were plotted as a function of drug concentration, and the IC<sub>50</sub> values (50% inhibitory concentrations) for each compound were calculated by nonlinear regression analysis (GraphPad Prism software) using calculated drug concentration that gave 50% reduction in fluorescence compared to drug-free controls.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i144" class="anchor-spacer"></div><h3 class="article-section__title" id="_i144"> In Vitro Liver-Stage Antimalarial Activity</h3><div class="NLM_p last">In vitro liver-stage activity of each new acridone was assessed utilizing luciferase-expressing <i>P. berghei</i> sporozoite-infected HepG2 hepatocyte cells<a onclick="showRef(event, 'ref14 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref14 ref23 ref24">(14,23,24)</a> (a hepatoma cell line that allows higher rates of sporozoites invasion and full development of <i>P. berghei</i>). Briefly, luciferase-expressing <i>P. berghei</i> (ANKA-676m1cl1) sporozoites were extracted from the salivary glands of infected <i>Anopheles stephensi</i> mosquitoes. HepG2-A16 cells were cultivated, seeded in 96-well plates, and grown for 24 h; then, 10,000 sporozoites were incubated with the HepG2 cells for 3 h after which the wells were washed with media to remove noninvaded sporozoites. Drug solutions were then added, and plates were placed in a 5% CO<sub>2</sub> incubator at 37 Â°C and for 45 h. Luciferin was added, and the plates were incubated for 30 min after which luciferase activity was determined using a luminometer. The IC<sub>50</sub> values (50% inhibitory concentrations) for each compound were calculated by nonlinear regression analysis (GraphPad Prism software).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i145" class="anchor-spacer"></div><h3 class="article-section__title" id="_i145"> In Vivo Blood-Stage Efficacy in a Rodent Malaria Model</h3><div class="NLM_p last">In vivo antimalarial blood-stage efficacy was determined using a well-established modified Thompson 4 day suppression rodent model against <i>P. yoelii</i>.<sup>14,21,22</sup> Four to 5 week-old female CF1 mice (Charles River Laboratories) were infected intravenously with 2.5 Ã 10<sup>5</sup><i>P. yoelii</i> (Kenya strain, MR4 MRA-428) parasitized erythrocytes from a donor animal. Drug administration commenced the day after the animals were inoculated (day 1). The test compounds were dissolved in PEG-400 and administered by oral gavage once daily for 4 successive days; CQ phosphate was used as a positive control. Blood for blood film analysis and body weights were obtained on the day following the last dose and then at weekly intervals through day 28. Blood films were Giemsa-stained and examined microscopically to determine the levels of parasitemia. These blood samples were collected from the tail vein with the aid of a syringe needle. All mice were observed daily to assess their clinical signs, which were recorded. Animals with observable parasitemia following the experiment were euthanized; animals cleared of parasites from their bloodstream were observed daily with assessment of parasitemia performed weekly until day 28 at which point the animal(s) is scored as cured of infection and then euthanized. All treated mice with a negative smear on day 28 were considered cured (100% protection). ED<sub>50</sub> and ED<sub>90</sub> values (mg/kg/day) were derived graphically from the dose required to reduce the parasite burden by 50 and 90%, respectively, relative to drug-free controls.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i146" class="anchor-spacer"></div><h3 class="article-section__title" id="_i146"> Animals and Ethic Statement at the Portland VA Medical Center (PVAMC)</h3><div class="NLM_p last">In vivo blood-stage testing was carried out at the PVAMC, and the procedures were conducted under protocols approved by the PVAMC Institutional Animal Care and Use Committee (protocol number 3147). Research was conducted in an AAALAC-accredited facility in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to the principles stated in the <i>Guide for the Care and Use of Laboratory Animals</i> (NRC Publication, 2011 edition).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i147" class="anchor-spacer"></div><h3 class="article-section__title" id="_i147"> In Vivo Liver-Stage Efficacy in a Rodent Malaria Model</h3><div class="NLM_p last">A real-time in vivo imaging system (IVIS) was used to determine the in vivo liver-stage antimalarial efficacy of selected acridone candidates.<a onclick="showRef(event, 'ref14 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref14 ref25 ref26 ref27">(14,25â27)</a> Luciferase-expressing <i>P. berghei</i> sporozoites were extracted from the salivary glands of <i>A. stephensi</i> mosquitoes. C57BL/6 male albino mice were infected i.v. in the tail vein with 10,000 sporozoites on day 0. Drugs were administered orally on days â1, 0, and +1. All drug solutions were prepared fresh before drug administration by dissolving the needed quantity of drug in cold (4 Â°C) 0.5% (w/v) hydroxyethyl cellulose and 0.2% (v/v) Tween-80 (0.5% HECT) or PEG400. If needed, drugs were ground using a ProScientific 300D homogenizer and the particle size was measured using a Horiba LA-950 V2 particle size analyzer. Formulations of acridones were prepared in PEG 400 and administered orally (PO) at 1.0, 4.0, 10, or 40 mg/kg on days â1, 0, and 1. A vehicle control (PEG 400) group was included as a negative control in all studies. The positive control consisted of three doses of 4-methyl-primaquine, which was dissolved in 0.5% HECT, and was given at 5 mg/kg on days â1, 0, and 1 post-infections. All dosing solutions were given based on the mouseâs body weight measured on the day before infection took place. The <i>P. berghei</i> parasite load in the liver and blood (approximately at 24, 48, and 72 h post-animal infections) was assessed using an IVIS spectrum instrument. Mice were injected IP with 150 Î¼L of <span class="smallcaps smallerCapital">d</span>-luciferin solution (Gold Biotechnology, St. Louis, MO) at a concentration of 200 mg/kg body weight. Three minutes after luciferin injection, the mice were placed in the induction chamber and anesthetized. As soon as the mice were asleep, they were transferred in the IVIS chamber and positioned ventral side down on the heated platform with their noses positioned inside the nose cones. The IVIS camera exposure times were 1 and 5 min for the 24, 48, and 72 h time points with a large binning setting and an f-stop of 1. The IVIS Living Image software (version 4.0) was used to quantitate the bioluminescence in photons per second observed from the liver region or whole animal surface area for the liver-stage and blood-stage efficacy studies. Starting at 6 days after infection, all mice were assessed for blood-stage parasitemia, which was quantitated using flow cytometry conducted using a FC500 MPL flow cytometer (Beckman Coulter, Fullerton, CA). The green photomultiplier tube and filter setting were used in these studies (520â555 nm filter settings for the green PMT and greater than 580 nm settings for the red PMT). Infected erythrocytes, uninfected erythrocytes, and leukocytes were gated on logarithmic forward/side dot plots. The method of FCM sample preparation has been previously described.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In brief, a small 3 Î¼L sample of blood was obtained from the tails of all mice. The blood was transferred into 0.3 mL of 1% heparinized isotonic buffer (PBS saline). Glutaraldehyde (1 mM, 0.04% ) was added to fix each sample, and samples were incubated for 60 min at 4 Â°C followed by centrifugation at 450<i>g</i> for 5 min. The supernatant was removed by aspiration, and the cells were resuspended in 0.5 mL of PBS buffer supplemented with 0.25% (v/v) Triton X-100 for a 10 min incubation at room temperature. After centrifugation, the permeabilized cells were resuspended in 0.5 mL of RNase at 1 mg/mL concentrations and incubated for at least 2 h at 37 Â°C to ensure complete digestion of reticulocytes, which are at high concentrations due to anemia associated with <i>P. berghei</i> infection. The YOYO-1 dye (20 Î¼L) at a concentration of 2500 ng/mL was added to the 0.5 mL sample volume to create a final dye concentration of 100 ng/mL YOYO-1. Parasitemia was monitored for up to 31 days post-infections. Blood samples for parasitemia determination were taken every week or prior to euthanizing the animals sick with malaria that were being removed from the study. Mice that tested negative for parasitemia on day 31 post-infection were considered cured. The minimum curative dose (ED<sub>100</sub>) in 100% of the animals dosed was defined as the lowest dose, which cured all animals for the entire 31 day follow-up period.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i148" class="anchor-spacer"></div><h3 class="article-section__title" id="_i148"> Animals and Ethic Statement at the Walter Reed Army Institute of Research (WRAIR)</h3><div class="NLM_p">Male C57BL/6 Albino mice 6 weeks old (Charles River) were used in this study. The mice were left to acclimatize for 7 days prior to the beginning of research studies. All mice were assigned a study number with an individual ear tag. Cards attached to each mouse cage were also used to identify the study groups. All animals were quarantined for stabilization for 7 days prior to infection. Mice were housed in a designated room with food and water supplied ad libitum and in a 12:12 light/dark cycle.</div><div class="NLM_p last">The animal protocol for this study was approved by the Walter Reed Army Institute of Research, Institutional Animal Care and Use Committee (protocol number 18-ET-12) in accordance with the National and Department of Defense guidelines. Research was conducted in an AAALAC-accredited facility in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to the principles stated in the <i>Guide for the Care and Use of Laboratory Animals</i> (NRC Publication, 2011 edition).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i149" class="anchor-spacer"></div><h3 class="article-section__title" id="_i149"> Ex Vivo Antimalarial Activity against Clinical Isolates in Uganda</h3><div class="NLM_p last">The activity of <b>38</b> and <b>39</b> and the standard antimalarials CQ, PIP, DHA, ATV, and LUM (standard antimalarials from Medicines for Malaria Venture, Geneva, Switzerland) were tested, as previously described, against <i>P. falciparum</i> isolates using a 72 h growth inhibition assay with parasite DNA readout by SYBR Green detection.<a onclick="showRef(event, 'ref20 ref29'); return false;" href="javascript:void(0);" class="ref ref20 ref29">(20,29)</a> These isolates were collected from May to July 2016 from two sources in the Tororo District of Uganda. First, children and adults present at the Tororo District Hospital outpatient clinic with malaria (temperature of â¥37.5 Â°C axillary or history of fever in the previous 24 h and a positive Giemsa-stained blood smear for <i>P. falciparum</i>) and without signs of severe disease were enrolled after informed consent. Second, children enrolled in a clinical trial (registered at <a href="http://ClinicalTrials.gov" class="extLink">ClinicalTrials.gov</a> [NCT02163447]), which compared monthly versus every 3 month intermittent therapy with DHA-PIP to prevent malaria, provided samples if they presented to the study clinic signs of uncomplicated malaria, as defined above.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The relevant clinical trials and analyses of cultured parasites were approved by the Uganda National Council of Science and Technology, the Makerere University Research and Ethics Committee, and the University of California, San Francisco Committee on Human Research. Comparison of median acridone IC<sub>50</sub> values obtained from patients between sites was performed using a MannâWhitney <i>U</i> test. Correlations between the acridones and other standard antimalarials were assessed with Spearmanâs rank correlation coefficient. All tests were two-tailed, and <i>p</i>-values <0.05 were considered statistically significant.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i150" class="anchor-spacer"></div><h3 class="article-section__title" id="_i150"> In Vitro Cytotoxicity Assessment</h3><div class="NLM_p last">To identify toxicity to mammalian cells, an MTT assay using hepatic HepG2 cells was employed.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30â32)</a> Human hepatocarcinoma cells (HepG2) were cultured in complete minimal essential medium (Gibco-Invitrogen, no.11090-099) prepared by supplementing MEM with 0.19% sodium bicarbonate (Gibco-BRL no. 25080-094), 10% heat-inactivated FBS (Gibco-Invitrogen no. 16000-036), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Gibco-Invitrogen no. 25030-081), 0.1 mM MEM nonessential amino acids (Gibco-Invitrogen no. 11140-050), 0.009 mg/mL insulin (Sigma no. I1882), and 1.76 mg/mL bovine serum albumin (Sigma no. A1470). Cell viability was assessed using trypan blue. Ninety-six-well plates were seeded with 2.5 Ã 10<sup>4</sup> cells in 170 Î¼L of culture medium per well and incubated at 37 Â°C overnight in a humidified 5% CO<sub>2</sub> atmosphere. Drug plates were prepared with a Biomek 4000 automated laboratory station and 96-well plates containing 11 duplicate 1.6-fold serial dilutions of each test compound suspended in DMSO. A 30 Î¼L sample of the diluted test compound was then added to 170 Î¼L of media per well. Cells were exposed to drugs with concentrations ranging from 10 to 0.15 Î¼g/mL for 48 h. After incubation, 30 Î¼L of a 1.5 mg/mL solution of MTT diluted in complete MEM media was added to each well, and all plates were subsequently incubated in the dark for 1 h at room temperature. Next, the media and drugs in each well were removed and the plates were then left to dry in a hood for 15 min. Acidified isopropyl alcohol (60 Î¼L) was added to dissolve the formazan dye crystals created by the reduction of MTT. Plates were placed on a 3D rotator for 15â30 min. Absorbance was determined with the PerkinElmer EnSight plate reader. All experiments were run in duplicate, and the 50% inhibitory concentrations (IC<sub>50</sub>) were determined using the GraphPad Prism software using the nonlinear regression equation (sigmoidal doseâresponse, variable slope).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i151" class="anchor-spacer"></div><h3 class="article-section__title" id="_i151"> In Vitro hERG Channel Inhibition</h3><div class="NLM_p last">The measurement of hERG channel inhibitory activity of the test compounds was performed by Eurofins Inc. Basic principles and operation of the IonWorks platform have been described by Schroeder et al.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i152" class="anchor-spacer"></div><h3 class="article-section__title" id="_i152"> In Vitro Metabolic Profile</h3><div class="NLM_p last">The half-lives of lead acridones in mouse and human liver microsomes were determined, as described previously.<a onclick="showRef(event, 'ref14 ref32 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref14 ref32 ref34 ref35">(14,32,34,35)</a> All samples were tested in human and mouse liver microsomal preparations. Sample stocks at 10 or 20 Î¼M (depending on solubility) in DMSO were diluted to a final concentration of 1 Î¼M with a mixture containing 0.5 mg/mL prewarmed pooled human or mouse liver microsomes (BD Gentest), 1.3 Î¼M NADP (Sigma), 3.3 Î¼M MgCl<sub>2</sub> (Sigma), and 0.1 M pH 7.4 PBS using a TECAN Genesis robotic liquid handler. The reaction was started with the addition of 1 U/mL glucose-6-phosphate dehydrogenase (G6PD). The mixture was incubated on a shaking platform at 37 Â°C, and aliquots were taken and quenched with the addition of an equal volume of cold acetonitrile at 0, 10, 20, 30, and 60 min. Samples were centrifuged at 3700 rpm for 10 min at 20 Â°C to remove debris. Sample quantification was carried out by LC/MS, and the metabolic half-life was calculated by log plots of the total ion chromatograph area remaining.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i153" class="anchor-spacer"></div><h3 class="article-section__title" id="_i153"> In Vivo Pharmacokinetic (PK) Studies</h3><div class="NLM_p last">PK studies were conducted using the previously established methods.<a onclick="showRef(event, 'ref14 ref28 ref32'); return false;" href="javascript:void(0);" class="ref ref14 ref28 ref32">(14,28,32)</a> Seven week-old male ICR mice weighing 23 to 28 g (Charles River Laboratories. Inc. Raleigh, NC) were used for the PK evaluations. On arrival, the animals were acclimated for 7 days in quarantine. The animals were housed in a cage maintained in a room with a temperature range of 64â79 Â°F, 34â68% relative humidity, and a 12 h light/dark cycle. Food and water were provided ad libitum during quarantine and throughout the study. The animals were fed a standard rodent maintenance diet. All animal studies were performed under IACUC-approved protocols. These protocols detail the experimental procedures and designs as well as the number of animals that were used. All animal use, care, and handling were performed in accordance with the current <i>Guide for the Care and Use of Laboratory Animals</i> (8th Edition, 2011). PK studies were performed using intragastric (IG) administration. For each time point to be acquired, three male ICR mice per time point were dosed at a single p.o. dosing of 80 mg/kg. The drug vehicle was DD water, administered at 100 Î¼L/20 g. At each time point, blood and plasma samples were collected. Whole blood was collected by cardiac puncture. Blood samples were collected in lithium heparin tubes. Following the separation of appropriate aliquots, plasma was obtained from the whole blood via centrifugation. Liver tissues were isolated. All liquid and tissue samples were immediately preserved on dry ice and later stored at â80 Â°C until analytical work was performed. Drug concentrations were generated for each sample taken from animals dosed with test compounds. A measured plasma or liver drug concentration versus time curve was produced in graphic and tabular forms for each subject on both linear/linear and log/linear scales for the parent compound. Mean plasma drug concentration versus time curves were also prepared separately. Maximum plasma concentration (<i>C</i><sub>max</sub>) and time to maximum concentration (<i>t</i><sub>max</sub>) were obtained from the plasma drug concentrationâtime curves. The elimination half-life (<i>t</i><sub>1/2</sub>) was calculated from (ln 2)/<i>k</i><sub>el</sub>, which is the elimination rate constant calculated from the log concentrationâtime plot. The area under the curve (AUC) was determined by the linear trapezoidal rule with extrapolation to infinity based on the concentration of the last time point divided by the terminal rate constant. The mean residence time (MRT) was determined by dividing the area under the first moment curve (AUMC) by AUC. The volume of the central compartment (<i>Vz</i>) and volume of the tissue compartment (<i>Vz</i>/<i>F</i>) were calculated as the product of CL and MRT.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i154"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00539" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45614" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45614" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00539?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00539</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H NMR spectra of all final compounds and <sup>19</sup>F NMR of <b>26</b> and <b>27</b> and HPLC chromatograms of lead candidates (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00539/suppl_file/jm0c00539_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and in vitro data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00539/suppl_file/jm0c00539_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00539/suppl_file/jm0c00539_si_001.pdf">jm0c00539_si_001.pdf (6.91 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00539/suppl_file/jm0c00539_si_002.csv">jm0c00539_si_002.csv (6.8 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00539" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08628" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08628" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Papireddy Kancharla</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Portland State University, Portland, Oregon 97201, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6381-1236" title="Orcid link">http://orcid.org/0000-0002-6381-1236</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6c1c0d1c051e0908082c1c081442090819"><span class="__cf_email__" data-cfemail="b3c3d2c3dac1d6d7d7f3c3d7cb9dd6d7c6">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane X. Kelly</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Portland State University, Portland, Oregon 97201, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8871-0207" title="Orcid link">http://orcid.org/0000-0001-8871-0207</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7d1618111104171c3d12150e0853181908"><span class="__cf_email__" data-cfemail="88e3ede4e4f1e2e9c8e7e0fbfda6edecfd">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rozalia A. Dodean</span> - <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5002-4607" title="Orcid link">http://orcid.org/0000-0001-5002-4607</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuexin Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sovitj Pou</span> - <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brandon Pybus</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victor Melendez</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Read</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles E. Bane</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Vesely</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mara Kreishman-Deitrick</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chad Black</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qigui Li</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard J. Sciotti</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raul Olmeda</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thu-Lan Luong</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather Gaona</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brittney Potter</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Sousa</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean Marcsisin</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diana Caridha</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa Xie</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chau Vuong</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiang Zeng</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Zhang</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ping Zhang</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hsiuling Lin</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kirk Butler</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Norma Roncal</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lacy Gaynor-Ohnstad</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan E. Leed</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christina Nolan</span> - <span class="hlFld-Affiliation affiliation">Division
of Experimental Therapeutics, Walter Reed
Army Institute of Research, Silver Spring, Maryland 20910, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frida G. Ceja</span> - <span class="hlFld-Affiliation affiliation">Department
of Natural Sciences and Mathematics, Dominican
University of California, San Rafael, California 94901, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephanie A. Rasmussen</span> - <span class="hlFld-Affiliation affiliation">Department
of Natural Sciences and Mathematics, Dominican
University of California, San Rafael, California 94901, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick K. Tumwebaze</span> - <span class="hlFld-Affiliation affiliation">Infectious
Diseases Research Collaboration, Kampala, Uganda</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip J. Rosenthal</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicine, University of California, San
Francisco, San Francisco, California 94143, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianbing Mu</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Malaria and Vector Research, National
Institute of Allergy and Infectious Diseases, National Institutes
of Health, Rockville, Maryland 20852, United States.</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6012-8389" title="Orcid link">http://orcid.org/0000-0001-6012-8389</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brett R. Bayles</span> - <span class="hlFld-Affiliation affiliation">Department
of Natural Sciences and Mathematics, Dominican
University of California, San Rafael, California 94901, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Global
Public Health Program, Dominican University
of California, San Rafael, California 94901, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland A. Cooper</span> - <span class="hlFld-Affiliation affiliation">Department
of Natural Sciences and Mathematics, Dominican
University of California, San Rafael, California 94901, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin A. Reynolds</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Portland State University, Portland, Oregon 97201, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0270-9809" title="Orcid link">http://orcid.org/0000-0003-0270-9809</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin J. Smilkstein</span> - <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael K. Riscoe</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Portland State University, Portland, Oregon 97201, United States</span>;Â 
    <span class="hlFld-Affiliation affiliation">Department
of Veterans Affairs Medical Center, Portland, Oregon 97239, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>P.K., R.A.D., and Y.L. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i156">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This project was supported by NIH/NIAID (award 1R01AI093784) and DOD/PRMRP (award PR160693/W81XWH-17-2-0041). The material has been reviewed by the Walter Reed Army Institute of Research (WRAIR). There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author and are not to be construed as official or as reflecting the true views of the Department of the Army or the Department of Defense. Research was conducted in AAALAC-accredited facilities in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles stated in the <i>Guide for the Care and Use of Laboratory Animals</i> (NRC Publication).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">CQ</td><td class="NLM_def"><p class="first last">chloroquine</p></td></tr><tr><td class="NLM_term">ATV</td><td class="NLM_def"><p class="first last">atovaquone</p></td></tr><tr><td class="NLM_term">PIP</td><td class="NLM_def"><p class="first last">piperaquine</p></td></tr><tr><td class="NLM_term">DHA</td><td class="NLM_def"><p class="first last">dihydroartemisinin</p></td></tr><tr><td class="NLM_term">LUM</td><td class="NLM_def"><p class="first last">lumefantrine</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationship</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug-resistant</p></td></tr><tr><td class="NLM_term">ED<sub>50</sub></td><td class="NLM_def"><p class="first last">50% effective dose</p></td></tr><tr><td class="NLM_term">ED<sub>90</sub></td><td class="NLM_def"><p class="first last">90% effective dose</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">IVIS</td><td class="NLM_def"><p class="first last">in vivo imaging system</p></td></tr><tr><td class="NLM_term">i.v.</td><td class="NLM_def"><p class="first last">intravenously</p></td></tr><tr><td class="NLM_term">p.o.</td><td class="NLM_def"><p class="first last">oral route</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human-ether-a-go-go-related gene</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i158">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">WHO</span>.  <i>World Malaria Report</i>; <span class="NLM_publisher-name">WHO</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=WHO&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Malaria%2520Report%26pub%3DWHO%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manyando, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Huijsduijnen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span> <span> </span><span class="NLM_article-title">Malaria</span>. <i>Nat. Rev. Dis. Primers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">17050</span>, <span class="refDoi">Â DOI: 10.1038/nrdp.2017.50</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1038%2Fnrdp.2017.50" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28770814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BC1cfjvVGhtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=17050&author=M.+A.+Phillipsauthor=J.+N.+Burrowsauthor=C.+Manyandoauthor=R.+H.+van+Huijsduijnenauthor=W.+C.+Van+Voorhisauthor=T.+N.+C.+Wells&title=Malaria&doi=10.1038%2Fnrdp.2017.50"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria</span></div><div class="casAuthors">Phillips Margaret A; Burrows Jeremy N; van Huijsduijnen Rob Hooft; Wells Timothy N C; Manyando Christine; Van Voorhis Wesley C</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17050</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria is caused in humans by five species of single-celled eukaryotic Plasmodium parasites (mainly Plasmodium falciparum and Plasmodium vivax) that are transmitted by the bite of Anopheles spp. mosquitoes.  Malaria remains one of the most serious infectious diseases; it threatens nearly half of the world's population and led to hundreds of thousands of deaths in 2015, predominantly among children in Africa.  Malaria is managed through a combination of vector control approaches (such as insecticide spraying and the use of insecticide-treated bed nets) and drugs for both treatment and prevention.  The widespread use of artemisinin-based combination therapies has contributed to substantial declines in the number of malaria-related deaths; however, the emergence of drug resistance threatens to reverse this progress.  Advances in our understanding of the underlying molecular basis of pathogenesis have fuelled the development of new diagnostics, drugs and insecticides.  Several new combination therapies are in clinical development that have efficacy against drug-resistant parasites and the potential to be used in single-dose regimens to improve compliance.  This ambitious programme to eliminate malaria also includes new approaches that could yield malaria vaccines or novel vector control strategies.  However, despite these achievements, a well-coordinated global effort on multiple fronts is needed if malaria elimination is to be achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcfdgTdv0RVI2y4bB4mnvYfW6udTcc2eY78_nbaToD97ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfjvVGhtg%253D%253D&md5=ec450ab6baef0a6c2b6bd6bac030771a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2017.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2017.50%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DManyando%26aufirst%3DC.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26atitle%3DMalaria%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers%26date%3D2017%26volume%3D3%26spage%3D17050%26doi%3D10.1038%2Fnrdp.2017.50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span> <span> </span><span class="NLM_article-title">Drugs in development for malaria</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">861</span>â <span class="NLM_lpage">879</span>, <span class="refDoi">Â DOI: 10.1007/s40265-018-0911-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1007%2Fs40265-018-0911-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=29802605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOmurnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=861-879&author=E.+A.+Ashleyauthor=A.+P.+Phyo&title=Drugs+in+development+for+malaria&doi=10.1007%2Fs40265-018-0911-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs in Development for Malaria</span></div><div class="casAuthors">Ashley, Elizabeth A.; Phyo, Aung Pyae</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">861-879</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">The last two decades have seen a surge in antimalarial drug development with product development partnerships taking a leading role.  Resistance of Plasmodium falciparum to the artemisinin derivs., piperaquine and mefloquine in Southeast Asia means new antimalarials are needed with some urgency.  There are at least 13 agents in clin. development.  Most of these are blood schizonticides for the treatment of uncomplicated falciparum malaria, under evaluation either singly or as part of two-drug combinations.  Leading candidates progressing through the pipeline are artefenomel-ferroquine and lumefantrine-KAF156, both in Phase 2b.  Treatment of severe malaria continues to rely on two parenteral drugs with ancient forebears: artesunate and quinine, with sevuparin being evaluated as an adjuvant therapy.  Tafenoquine is under review by stringent regulatory authorities for approval as a single-dose treatment for Plasmodium vivax relapse prevention.  This represents an advance over std. 14-day primaquine regimens; however, the risk of acute haemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency remains.  For disease prevention, several of the newer agents show potential but are unlikely to be recommended for use in the main target groups of pregnant women and young children for some years.  Latest predictions are that the malaria burden will continue to be high in the coming decades.  This fact, coupled with the repeated loss of antimalarials to resistance, indicates that new antimalarials will be needed for years to come.  Failure of the artemisinin-based combinations in Southeast Asia has stimulated a reappraisal of current approaches to combination therapy for malaria with incorporation of three or more drugs in a single treatment under consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbu06hSG2TXLVg90H21EOLACvtfcHk0ljBw755McOIKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOmurnK&md5=4cfdcaf7482b5e1d8ed55f3ae126b0e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs40265-018-0911-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-018-0911-9%26sid%3Dliteratum%253Aachs%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26atitle%3DDrugs%2520in%2520development%2520for%2520malaria%26jtitle%3DDrugs%26date%3D2018%26volume%3D78%26spage%3D861%26epage%3D879%26doi%3D10.1007%2Fs40265-018-0911-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hooft
van Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span> <span> </span><span class="NLM_article-title">The antimalarial pipeline</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">6</span>, <span class="refDoi">Â DOI: 10.1016/j.coph.2018.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.coph.2018.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=29860174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVaisrjK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2018&pages=1-6&author=R.+Hooft%0Avan+Huijsduijnenauthor=T.+N.+Wells&title=The+antimalarial+pipeline&doi=10.1016%2Fj.coph.2018.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The antimalarial pipeline</span></div><div class="casAuthors">Hooft van Huijsduijnen, Rob; Wells, Timothy N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past decade, new high-throughput phenotypic assays with malaria parasites have been developed, and these were used to screen millions of compds.  This effort, as well as improving older chem. scaffolds and optimizing compds. against both known and new drug targets has resulted in the discovery of exciting new pipeline drug candidates that are now being evaluated in a no. of clin. trials.  In addn., the pitfalls and opportunities from this experience has led to a better definition of the optimal target compd. and product profiles for new antimalarials, including medicines that treat uncomplicated or severe malaria, provide chemoprevention, or stop disease transmission, covering all stages of the parasite.  An important decision element is how to combine these new mols. with existing ones in today's dynamic resistance landscape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ctGYtwHIqbVg90H21EOLACvtfcHk0lgx3Sfex4Rr8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVaisrjK&md5=96ca4e3c131d9c534ec3a51aa451435e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2018.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2018.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DWells%26aufirst%3DT.%2BN.%26atitle%3DThe%2520antimalarial%2520pipeline%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2018%26volume%3D42%26spage%3D1%26epage%3D6%26doi%3D10.1016%2Fj.coph.2018.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okombo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Recent updates in the discovery and development of novel antimalarial drug candidates</span>. <i>Medchemcomm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">437</span>â <span class="NLM_lpage">453</span>, <span class="refDoi">Â DOI: 10.1039/C7MD00637C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1039%2FC7MD00637C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=30108934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFygs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=437-453&author=J.+Okomboauthor=K.+Chibale&title=Recent+updates+in+the+discovery+and+development+of+novel+antimalarial+drug+candidates&doi=10.1039%2FC7MD00637C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Recent updates in the discovery and development of novel antimalarial drug candidates</span></div><div class="casAuthors">Okombo, John; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-453</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Though morbidity and mortality due to malaria have declined in the last 15 years, emerging resistance to first-line artemisinin-based antimalarials, absence of efficacious vaccines and limited chemotherapeutic alternatives imperil the consolidation of these gains.  As a blueprint to steer future designs of new medicines, malaria drug discovery recently adopted a descriptive proposal for the ideal candidate mols. and drugs likely to successfully progress into the final stages of clin. development.  As an audit of recent developments in the chemotherapy of malaria in the last five years, this review captures a landscape of diverse mols. at various stages of drug development and discusses their progress.  In brief, we also discuss how omics data on Plasmodium has been extensively leveraged to identify potential vaccine candidates and putative targets of mols. in development and clin. use as well as map loci implicit in their modes of resistance.  Future perspective on malaria drug development should involve a reconciliation of some of the challenges of the target candidate profiles (TCPs), specifically TCP3, with the promise of effective anti-hypnozoite medicines.  Similarly, with the recent development of a humanized mouse model that can evaluate the prophylactic potential of candidate drugs, we argue for increased effort at identifying more liver-stage mols., which are often only secondarily prioritized in conventional screening programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvmARzFwQAebVg90H21EOLACvtfcHk0lgx3Sfex4Rr8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFygs7Y%253D&md5=760def6cbcd82971f114de94132b27f7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1039%2FC7MD00637C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00637C%26sid%3Dliteratum%253Aachs%26aulast%3DOkombo%26aufirst%3DJ.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DRecent%2520updates%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520antimalarial%2520drug%2520candidates%26jtitle%3DMedchemcomm%26date%3D2018%26volume%3D9%26spage%3D437%26epage%3D453%26doi%3D10.1039%2FC7MD00637C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhorda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopha, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sovannaroth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukrittayakamee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jittamala, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chutasmit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suchatsoonthorn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runcharoen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hien, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuy-Nhien, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanh, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phu, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Htut, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aye, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokuolu, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olaosebikan, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folaranmi, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayxay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanthavong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hongvanthong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onyamboko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanello, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tshefu, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valecha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashraheil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peshu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faiz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacInnis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozdech, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeeyapant, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheah, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakulthaew, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Intharabut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silamut, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vihokhern, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunasol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodrow, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flegg, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowe, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepniewska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerin, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">Spread of artemisinin resistance in <i>Plasmodium falciparum</i> malaria</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">411</span>â <span class="NLM_lpage">423</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa1314981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1056%2FNEJMoa1314981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=25075834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ers7jF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=411-423&author=E.+A.+Ashleyauthor=M.+Dhordaauthor=R.+M.+Fairhurstauthor=C.+Amaratungaauthor=P.+Limauthor=S.+Suonauthor=S.+Srengauthor=J.+M.+Andersonauthor=S.+Maoauthor=B.+Samauthor=C.+Sophaauthor=C.+M.+Chuorauthor=C.+Nguonauthor=S.+Sovannarothauthor=S.+Pukrittayakameeauthor=P.+Jittamalaauthor=K.+Chotivanichauthor=K.+Chutasmitauthor=C.+Suchatsoonthornauthor=R.+Runcharoenauthor=T.+T.+Hienauthor=N.+T.+Thuy-Nhienauthor=N.+V.+Thanhauthor=N.+H.+Phuauthor=Y.+Htutauthor=K.-T.+Hanauthor=K.+H.+Ayeauthor=O.+A.+Mokuoluauthor=R.+R.+Olaosebikanauthor=O.+O.+Folaranmiauthor=M.+Mayxayauthor=M.+Khanthavongauthor=B.+Hongvanthongauthor=P.+N.+Newtonauthor=M.+A.+Onyambokoauthor=C.+I.+Fanelloauthor=A.+K.+Tshefuauthor=N.+Mishraauthor=N.+Valechaauthor=A.+P.+Phyoauthor=F.+Nostenauthor=P.+Yiauthor=R.+Tripuraauthor=S.+Borrmannauthor=M.+Bashraheilauthor=J.+Peshuauthor=M.+A.+Faizauthor=A.+Ghoseauthor=M.+A.+Hossainauthor=R.+Samadauthor=M.+R.+Rahmanauthor=M.+M.+Hasanauthor=A.+Islamauthor=O.+Miottoauthor=R.+Amatoauthor=B.+MacInnisauthor=J.+Stalkerauthor=D.+P.+Kwiatkowskiauthor=Z.+Bozdechauthor=A.+Jeeyapantauthor=P.+Y.+Cheahauthor=T.+Sakulthaewauthor=J.+Chalkauthor=B.+Intharabutauthor=K.+Silamutauthor=S.+J.+Leeauthor=B.+Vihokhernauthor=C.+Kunasolauthor=M.+Imwongauthor=J.+Tarningauthor=W.+J.+Taylorauthor=S.+Yeungauthor=C.+J.+Woodrowauthor=J.+A.+Fleggauthor=D.+Dasauthor=J.+Smithauthor=M.+Venkatesanauthor=C.+V.+Ploweauthor=K.+Stepniewskaauthor=P.+J.+Guerinauthor=A.+M.+Dondorpauthor=N.+P.+Dayauthor=N.+J.+White&title=Spread+of+artemisinin+resistance+in+Plasmodium+falciparum+malaria&doi=10.1056%2FNEJMoa1314981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Spread of artemisinin resistance in Plasmodium falciparum malaria</span></div><div class="casAuthors">Ashley, E. A.; Dhorda, M.; Fairhurst, R. M.; Amaratunga, C.; Lim, P.; Suon, S.; Sreng, S.; Anderson, J. M.; Mao, S.; Sam, B.; Sopha, C.; Chuor, C. M.; Nguon, C.; Sovannaroth, S.; Pukrittayakamee, S.; Jittamala, P.; Chotivanich, K.; Chutasmit, K.; Suchatsoonthorn, C.; Runcharoen, R.; Hien, T. T.; Thuy-Nhien, N. T.; Thanh, N. V.; Phu, N. H.; Htut, Y.; Han, K.-T.; Aye, K. H.; Mokuolu, O. A.; Olaosebikan, R. R.; Folaranmi, O. O.; Mayxay, M.; Khanthavong, M.; Hongvanthong, B.; Newton, P. N.; Onyamboko, M. A.; Fanello, C. I.; Tshefu, A. K.; Mishra, N.; Valecha, N.; Phyo, A. P.; Nosten, F.; Yi, P.; Tripura, R.; Borrmann, S.; Bashraheil, M.; Peshu, J.; Faiz, M. A.; Ghose, A.; Hossain, M. A.; Samad, R.; Rahman, M. R.; Hasan, M. M.; Islam, A.; Miotto, O.; Amato, R.; MacInnis, B.; Stalker, J.; Kwiatkowski, D. P.; Bozdech, Z.; Jeeyapant, A.; Cheah, P. Y.; Sakulthaew, T.; Chalk, J.; Intharabut, B.; Silamut, K.; Lee, S. J.; Vihokhern, B.; Kunasol, C.; Imwong, M.; Tarning, J.; Taylor, W. J.; Yeung, S.; Woodrow, C. J.; Flegg, J. A.; Das, D.; Smith, J.; Venkatesan, M.; Plowe, C. V.; Stepniewska, K.; Guerin, P. J.; Dondorp, A. M.; Day, N. P.; White, N. J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-423, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia and now poses a threat to the control and elimination of malaria.  Mapping the geog. extent of resistance is essential for planning containment and elimination strategies.  Methods: Between May 2011 and Apr. 2013, we enrolled 1241 adults and children with acute, uncomplicated falciparum malaria in an open-label trial at 15 sites in 10 countries (7 in Asia and 3 in Africa).  Patients received artesunate, administered orally at a daily dose of either 2 mg per kg of body wt. per day or 4 mg per kg, for 3 days, followed by a std. 3-day course of artemisinin-based combination therapy.  Parasite counts in peripheral-blood samples were measured every 6 h, and the parasite clearance half-lives were detd.  Results: The median parasite clearance half-lives ranged from 1.9 h in the Democratic Republic of Congo to 7.0 h at the Thailand-Cambodia border.  Slowly clearing infections (parasite clearance half-life >5 h), strongly assocd. with single point mutations in the "propeller" region of the P. falciparum kelch protein gene on chromosome 13 (kelch13), were detected throughout mainland Southeast Asia from Southern Vietnam to central Myanmar.  The incidence of pre-treatment and post-treatment gametocytemia was higher among patients with slow parasite clearance, suggesting greater potential for transmission.  In Western Cambodia, where artemisinin-based combination therapies are failing, the 6-day course of antimalarial therapy was assocd. with a cure rate of 97.7% (95% confidence interval, 90.9 to 99.4) at 42 days.  Conclusions: Artemisinin resistance to P. falciparum, which is now prevalent across mainland Southeast Asia, is assocd. with mutations in kelch13.  Prolonged courses of artemisinin- based combination therapies are currently efficacious in areas where std. 3-day treatments are failing. (Funded by the U.K. Department of International Development and others).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7aJ4A3O4W8rVg90H21EOLACvtfcHk0lgx3Sfex4Rr8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ers7jF&md5=bb2f2a4d554ba6a1f4c605868be43f6e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1314981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1314981%26sid%3Dliteratum%253Aachs%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DDhorda%26aufirst%3DM.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DSam%26aufirst%3DB.%26aulast%3DSopha%26aufirst%3DC.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DNguon%26aufirst%3DC.%26aulast%3DSovannaroth%26aufirst%3DS.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26aulast%3DJittamala%26aufirst%3DP.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DChutasmit%26aufirst%3DK.%26aulast%3DSuchatsoonthorn%26aufirst%3DC.%26aulast%3DRuncharoen%26aufirst%3DR.%26aulast%3DHien%26aufirst%3DT.%2BT.%26aulast%3DThuy-Nhien%26aufirst%3DN.%2BT.%26aulast%3DThanh%26aufirst%3DN.%2BV.%26aulast%3DPhu%26aufirst%3DN.%2BH.%26aulast%3DHtut%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DK.-T.%26aulast%3DAye%26aufirst%3DK.%2BH.%26aulast%3DMokuolu%26aufirst%3DO.%2BA.%26aulast%3DOlaosebikan%26aufirst%3DR.%2BR.%26aulast%3DFolaranmi%26aufirst%3DO.%2BO.%26aulast%3DMayxay%26aufirst%3DM.%26aulast%3DKhanthavong%26aufirst%3DM.%26aulast%3DHongvanthong%26aufirst%3DB.%26aulast%3DNewton%26aufirst%3DP.%2BN.%26aulast%3DOnyamboko%26aufirst%3DM.%2BA.%26aulast%3DFanello%26aufirst%3DC.%2BI.%26aulast%3DTshefu%26aufirst%3DA.%2BK.%26aulast%3DMishra%26aufirst%3DN.%26aulast%3DValecha%26aufirst%3DN.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DYi%26aufirst%3DP.%26aulast%3DTripura%26aufirst%3DR.%26aulast%3DBorrmann%26aufirst%3DS.%26aulast%3DBashraheil%26aufirst%3DM.%26aulast%3DPeshu%26aufirst%3DJ.%26aulast%3DFaiz%26aufirst%3DM.%2BA.%26aulast%3DGhose%26aufirst%3DA.%26aulast%3DHossain%26aufirst%3DM.%2BA.%26aulast%3DSamad%26aufirst%3DR.%26aulast%3DRahman%26aufirst%3DM.%2BR.%26aulast%3DHasan%26aufirst%3DM.%2BM.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DAmato%26aufirst%3DR.%26aulast%3DMacInnis%26aufirst%3DB.%26aulast%3DStalker%26aufirst%3DJ.%26aulast%3DKwiatkowski%26aufirst%3DD.%2BP.%26aulast%3DBozdech%26aufirst%3DZ.%26aulast%3DJeeyapant%26aufirst%3DA.%26aulast%3DCheah%26aufirst%3DP.%2BY.%26aulast%3DSakulthaew%26aufirst%3DT.%26aulast%3DChalk%26aufirst%3DJ.%26aulast%3DIntharabut%26aufirst%3DB.%26aulast%3DSilamut%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DVihokhern%26aufirst%3DB.%26aulast%3DKunasol%26aufirst%3DC.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DW.%2BJ.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DWoodrow%26aufirst%3DC.%2BJ.%26aulast%3DFlegg%26aufirst%3DJ.%2BA.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DVenkatesan%26aufirst%3DM.%26aulast%3DPlowe%26aufirst%3DC.%2BV.%26aulast%3DStepniewska%26aufirst%3DK.%26aulast%3DGuerin%26aufirst%3DP.%2BJ.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DDay%26aufirst%3DN.%2BP.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DSpread%2520of%2520artemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D411%26epage%3D423%26doi%3D10.1056%2FNEJMoa1314981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ©nard, D.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> resistance to artemisinin derivatives and piperaquine: a major challenge for malaria elimination in Cambodia</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1228</span>â <span class="NLM_lpage">1238</span>, <span class="refDoi">Â DOI: 10.4269/ajtmh.16-0234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.4269%2Fajtmh.16-0234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=27928074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVOksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2016&pages=1228-1238&author=B.+Witkowskiauthor=V.+Duruauthor=D.+M%C3%A9nard&title=Plasmodium+falciparum+resistance+to+artemisinin+derivatives+and+piperaquine%3A+a+major+challenge+for+malaria+elimination+in+Cambodia&doi=10.4269%2Fajtmh.16-0234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum resistance to artemisinin derivatives and piperaquine: a major challenge for malaria elimination in Cambodia</span></div><div class="casAuthors">Duru, Valentine; Witkowski, Benoit; Menard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Tropical Medicine and Hygiene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1228-1238</span>CODEN:
                <span class="NLM_cas:coden">AJTHAB</span>;
        ISSN:<span class="NLM_cas:issn">1476-1645</span>.
    
            (<span class="NLM_cas:orgname">American Society of Tropical Medicine and Hygiene</span>)
        </div><div class="casAbstract">Artemisinin-based combination therapies (ACTs) are the cornerstone of current strategies for fighting malaria.  Over the last decade, ACTs have played a major role in decreasing malaria burden.  However, this progress is being jeopardized by the emergence of artemisinin-resistant Plasmodium falciparum parasites.  Artemisinin resistance was first detected in western Cambodia in 2008 and has since been obsd. in neighboring countries in southeast Asia.  The problem of antimalarial drug resistance has recently worsened in Cambodia, with reports of parasites resistant to piperaquine, the latest generation of partner drug used in combination with dihydroartemisinin, leading to worrying rates of clin. treatment failure.  The monitoring and the comprehension of both types of resistance are crucial to prevent the spread of multidrug-resistant parasites outside southeast Asia, and particularly to Africa, where the public health consequences would be catastrophic.  To this end, new tools are required for studying the biol. and mol. mechanisms underlying resistance to antimalarial drugs and for monitoring the geog. distribution of the resistant parasites.  In this review, we detail the major advances in our understanding of resistance to artemisinin and piperaquine and define the challenges that the malaria community will have to face in the coming years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-aVDzPSnfrVg90H21EOLACvtfcHk0ljhQIDvUUwJmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVOksg%253D%253D&md5=2005343e22603f7997544d2e2ac9c3b1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.16-0234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.16-0234%26sid%3Dliteratum%253Aachs%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DM%25C3%25A9nard%26aufirst%3DD.%26atitle%3DPlasmodium%2520falciparum%2520resistance%2520to%2520artemisinin%2520derivatives%2520and%2520piperaquine%253A%2520a%2520major%2520challenge%2520for%2520malaria%2520elimination%2520in%2520Cambodia%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2016%26volume%3D95%26spage%3D1228%26epage%3D1238%26doi%3D10.4269%2Fajtmh.16-0234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GnÃ¤dig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralph, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Artemisinin action and resistance in <i>Plasmodium falciparum</i></span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">682</span>â <span class="NLM_lpage">696</span>, <span class="refDoi">Â DOI: 10.1016/j.pt.2016.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.pt.2016.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=27289273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC28Xoslamt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=682-696&author=L.+Tilleyauthor=J.+Straimerauthor=N.+F.+Gn%C3%A4digauthor=S.+A.+Ralphauthor=D.+A.+Fidock&title=Artemisinin+action+and+resistance+in+Plasmodium+falciparum&doi=10.1016%2Fj.pt.2016.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin Action and Resistance in Plasmodium falciparum</span></div><div class="casAuthors">Tilley, Leann; Straimer, Judith; Gnadig, Nina F.; Ralph, Stuart A.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">682-696</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The worldwide use of artemisinin-based combination therapies (ACTs) has contributed in recent years to a substantial redn. in deaths resulting from Plasmodium falciparum malaria.  Resistance to artemisinins, however, has emerged in Southeast Asia.  Clin., resistance is defined as a slower rate of parasite clearance in patients treated with an artemisinin deriv. or an ACT.  These slow clearance rates assoc. with enhanced survival rates of ring-stage parasites briefly exposed in vitro to dihydroartemisinin.  We describe recent progress made in defining the mol. basis of artemisinin resistance, which has identified a primary role for the P. falciparum K13 protein.  Using K13 mutations as mol. markers, epidemiol. studies are now tracking the emergence and spread of artemisinin resistance.  Mechanistic studies suggest potential ways to overcome resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTqDTZppoE1bVg90H21EOLACvtfcHk0ljhQIDvUUwJmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xoslamt78%253D&md5=8a1cb66eab2962ca73ea6d6e2cbf8f21</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2016.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2016.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DTilley%26aufirst%3DL.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DRalph%26aufirst%3DS.%2BA.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DArtemisinin%2520action%2520and%2520resistance%2520in%2520Plasmodium%2520falciparum%26jtitle%3DTrends%2520Parasitol.%26date%3D2016%26volume%3D32%26spage%3D682%26epage%3D696%26doi%3D10.1016%2Fj.pt.2016.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tazerouni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundararaj, K. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J. C.</span></span> <span> </span><span class="NLM_article-title">Therapeutic failure of primaquine and need for new medicines in radical cure of <i>Plasmodium vivax</i></span>. <i>Acta. Trop.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">35</span>â <span class="NLM_lpage">38</span>, <span class="refDoi">Â DOI: 10.1016/j.actatropica.2016.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.actatropica.2016.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=27109040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVWksLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2016&pages=35-38&author=D.+Thomasauthor=H.+Tazerouniauthor=K.+G.+S.+Sundararajauthor=J.+C.+Cooper&title=Therapeutic+failure+of+primaquine+and+need+for+new+medicines+in+radical+cure+of+Plasmodium+vivax&doi=10.1016%2Fj.actatropica.2016.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic failure of primaquine and need for new medicines in radical cure of Plasmodium vivax</span></div><div class="casAuthors">Thomas, Dixon; Tazerouni, Hedieh; Sundararaj, Kishore Gnana Sam; Cooper, Jason C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Tropica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-38</span>CODEN:
                <span class="NLM_cas:coden">ACTRAQ</span>;
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Primaquine has been the drug of choice for the prevention of Plasmodium vivax relapse for more than 60 years.  Primaquine tolerant strain of P. vivax was identified in 1944.  Significant mortality and disease burden of P. vivax calls for the need of new drugs.  Primaquine resistance is a complex issue, as the mechanism of resistance is not clear.  Direct evidence of resistance to primaquine by hypnozoites has not yet been shown.  There are some reports detailing risk of primaquine resistance in specific regions, but the overall distribution of primaquine resistance in P. vivax-infected people is largely unknown.  Confounding factors contribute to treatment failures; such as inadequate doses, inappropriate dosing intervals, risk of reinfection, combinations with blood schizontocidals, and compliance.  Therefore, primaquine resistance needs to be addressed along with addnl. important confounding factors.  Tafenoquine is the most studied drug in replacing primaquine for the radical cure of P. vivax malaria.  It has comparable efficacy with primaquine.  The potential advantage of tafenoquine is better compliance with a single dose regimen.  Rational use of primaquine can secure its effectiveness, but it is essential in the future to have better or similar alternatives to treat P. vivax.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrANrL4QAlBcLVg90H21EOLACvtfcHk0ljJA8v28qKpLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVWksLk%253D&md5=7da9e56ab0375a875204e348b88af055</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.actatropica.2016.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.actatropica.2016.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DD.%26aulast%3DTazerouni%26aufirst%3DH.%26aulast%3DSundararaj%26aufirst%3DK.%2BG.%2BS.%26aulast%3DCooper%26aufirst%3DJ.%2BC.%26atitle%3DTherapeutic%2520failure%2520of%2520primaquine%2520and%2520need%2520for%2520new%2520medicines%2520in%2520radical%2520cure%2520of%2520Plasmodium%2520vivax%26jtitle%3DActa.%2520Trop.%26date%3D2016%26volume%3D160%26spage%3D35%26epage%3D38%26doi%3D10.1016%2Fj.actatropica.2016.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Val, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brito-Sousa, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassat, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzzatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacerda, M. V.</span></span> <span> </span><span class="NLM_article-title">Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence</span>. <i>Future Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1261</span>â <span class="NLM_lpage">1279</span>, <span class="refDoi">Â DOI: 10.2217/fmb-2019-0202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.2217%2Ffmb-2019-0202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=31596137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVersb%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1261-1279&author=F.+Valauthor=F.+T.+Costaauthor=L.+Kingauthor=J.+D.+Brito-Sousaauthor=Q.+Bassatauthor=W.+M.+Monteiroauthor=A.+M.+Siqueiraauthor=L.+Luzzattoauthor=M.+V.+Lacerda&title=Tafenoquine+for+the+prophylaxis%2C+treatment+and+elimination+of+malaria%3A+eagerness+must+meet+prudence&doi=10.2217%2Ffmb-2019-0202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence</span></div><div class="casAuthors">Val, Fernando; Costa, Fabio T. M.; King, Liam; Brito-Sousa, Jose D.; Bassat, Quique; Monteiro, Wuelton M.; Siqueira, Andre M.; Luzzatto, Lucio; Lacerda, Marcus V. G.</div><div class="citationInfo"><span class="NLM_cas:title">Future Microbiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1261-1279</span>CODEN:
                <span class="NLM_cas:coden">FMUIAR</span>;
        ISSN:<span class="NLM_cas:issn">1746-0913</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria puts more than 3 billion people at risk of infection and causes high morbidity and mortality.  Plasmodium vivax forms hypnozoites, which may initiate recurrences, even in the absence of reinfection or superinfection.  Until recently, the only drug available for eliminating hypnozoites was primaquine (PQ), which, given its short half-life, requires a relatively long course of treatment.  Tafenoquine (TQ) is a PQ analog with a longer half-life.  This enables radical cure of malaria with a single dose and overcomes adherence issues assocd. with PQ, thereby increasing effectiveness in real-life settings.  Clin. studies have provided sound evidence for TQ's safety and efficacy against malaria, which recently led to its approval by the US FDA.  Here, we review aspects of TQ, including how to avoid hemolytic anemia in G6PD deficient patients.  We believe that TQ promises to be a major advance toward malaria elimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgAPqipba067Vg90H21EOLACvtfcHk0ljJA8v28qKpLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVersb%252FI&md5=98ba1d5836e6965ba38f2666432d5b32</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2217%2Ffmb-2019-0202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffmb-2019-0202%26sid%3Dliteratum%253Aachs%26aulast%3DVal%26aufirst%3DF.%26aulast%3DCosta%26aufirst%3DF.%2BT.%26aulast%3DKing%26aufirst%3DL.%26aulast%3DBrito-Sousa%26aufirst%3DJ.%2BD.%26aulast%3DBassat%26aufirst%3DQ.%26aulast%3DMonteiro%26aufirst%3DW.%2BM.%26aulast%3DSiqueira%26aufirst%3DA.%2BM.%26aulast%3DLuzzatto%26aufirst%3DL.%26aulast%3DLacerda%26aufirst%3DM.%2BV.%26atitle%3DTafenoquine%2520for%2520the%2520prophylaxis%252C%2520treatment%2520and%2520elimination%2520of%2520malaria%253A%2520eagerness%2520must%2520meet%2520prudence%26jtitle%3DFuture%2520Microbiol.%26date%3D2019%26volume%3D14%26spage%3D1261%26epage%3D1279%26doi%3D10.2217%2Ffmb-2019-0202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devine, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¶hrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laleu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creek, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span> <span> </span><span class="NLM_article-title">The development process for discovery and clinical advancement of modern antimalarials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">10526</span>â <span class="NLM_lpage">10562</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b00761</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00761" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFamsrvL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=10526-10562&author=T.+D.+Ashtonauthor=S.+M.+Devineauthor=J.+J.+M%C3%B6hrleauthor=B.+Laleuauthor=J.+N.+Burrowsauthor=S.+A.+Charmanauthor=D.+J.+Creekauthor=B.+E.+Sleebs&title=The+development+process+for+discovery+and+clinical+advancement+of+modern+antimalarials&doi=10.1021%2Facs.jmedchem.9b00761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Development Process for Discovery and Clinical Advancement of Modern Antimalarials</span></div><div class="casAuthors">Ashton, Trent D.; Devine, Shane M.; Mohrle, Jorg J.; Laleu, Benoit; Burrows, Jeremy N.; Charman, Susan A.; Creek, Darren J.; Sleebs, Brad E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10526-10562</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Malaria is a devastating disease caused by Plasmodium parasites resulting in approx. 435,000 deaths in 2018.  The impact of malaria is compounded by the emergence of widespread resistance to current antimalarial therapies.  Recently a new strategy was initiated to screen small mol. collections against the Plasmodium parasite enabling the identification of new antimalarial chemotypes with novel modes of action.  This initiative ushered in the modern era of antimalarial drug development and as a result, numerous lead candidates are advancing towards or are currently in human clin. trials.  In this perspective, we describe the development pathway of four of the most clin. advanced modern antimalarials, KAE609, KAF156, DSM265 and MMV048.  Addnl., the mechanism of action and lifecycle stage-specificity of the four antimalarials is discussed in relation to aligning with global strategies to treat and eliminate malaria.  This perspective serves as a guide to the expectations of modern antimalarial drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy-Wsk49dMLrVg90H21EOLACvtfcHk0lj7KSnU3WI31Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFamsrvL&md5=767c459a589507f646fdbd2816030d8d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00761%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DT.%2BD.%26aulast%3DDevine%26aufirst%3DS.%2BM.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DLaleu%26aufirst%3DB.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26atitle%3DThe%2520development%2520process%2520for%2520discovery%2520and%2520clinical%2520advancement%2520of%2520modern%2520antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D10526%26epage%3D10562%26doi%3D10.1021%2Facs.jmedchem.9b00761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duparc, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft van Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaszubska, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¶hrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span> <span> </span><span class="NLM_article-title">New developments in anti-malarial target candidate and product profiles</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">26</span>, <span class="refDoi">Â DOI: 10.1186/s12936-016-1675-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1186%2Fs12936-016-1675-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28086874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=26&author=J.+N.+Burrowsauthor=S.+Duparcauthor=W.+E.+Gutteridgeauthor=R.+Hooft+van+Huijsduijnenauthor=W.+Kaszubskaauthor=F.+Macintyreauthor=S.+Mazzuriauthor=J.+J.+M%C3%B6hrleauthor=T.+N.+C.+Wells&title=New+developments+in+anti-malarial+target+candidate+and+product+profiles&doi=10.1186%2Fs12936-016-1675-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in anti-malarial target candidate and product profiles</span></div><div class="casAuthors">Burrows, Jeremy N.; Duparc, Stephan; Gutteridge, Winston E.; Hooft van Huijsduijnen, Rob; Kaszubska, Wiweka; MacIntyre, Fiona; Mazzuri, Sebastien; Mohrle, Jorg J.; Wells, Timothy N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26/1-26/29</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A decade of discovery and development of new anti-malarial medicines has led to a renewed focus on malaria elimination and eradication.  Changes in the way new anti-malarial drugs are discovered and developed have led to a dramatic increase in the no. and diversity of new mols. presently in pre-clin. and early clin. development.  The twin challenges faced can be summarized by multi-drug resistant malaria from the Greater Mekong Subregion, and the need to provide simplified medicines.  This review lists changes in anti-malarial target candidate and target product profiles over the last 4 years.  As well as new medicines to treat disease and prevent transmission, there has been increased focus on the longer term goal of finding new medicines for chemoprotection, potentially with long-acting mols., or parenteral formulations.  Other gaps in the malaria armamentarium, such as drugs to treat severe malaria and endectocides (that kill mosquitoes which feed on people who have taken the drug), are defined here.  Ultimately the elimination of malaria requires medicines that are safe and well-tolerated to be used in vulnerable populations: in pregnancy, esp. the first trimester, and in those suffering from malnutrition or co-infection with other pathogens.  These updates reflect the maturing of an understanding of the key challenges in producing the next generation of medicines to control, eliminate and ultimately eradicate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjgdhMYAylM7Vg90H21EOLACvtfcHk0lj7KSnU3WI31Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D&md5=17984994f7a29c9fb184faa5214d4d35</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs12936-016-1675-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-016-1675-x%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DGutteridge%26aufirst%3DW.%2BE.%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DMazzuri%26aufirst%3DS.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26atitle%3DNew%2520developments%2520in%2520anti-malarial%2520target%2520candidate%2520and%2520product%2520profiles%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D26%26doi%3D10.1186%2Fs12936-016-1675-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, J. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the hypnozoite reservoir of <i>Plasmodium vivax</i>: the hidden obstacle to malaria elimination</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">145</span>â <span class="NLM_lpage">151</span>, <span class="refDoi">Â DOI: 10.1016/j.pt.2009.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.pt.2009.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=20133198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BC3c7lsl2itA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=145-151&author=T.+N.+C.+Wellsauthor=J.+N.+Burrowsauthor=J.+K.+Baird&title=Targeting+the+hypnozoite+reservoir+of+Plasmodium+vivax%3A+the+hidden+obstacle+to+malaria+elimination&doi=10.1016%2Fj.pt.2009.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination</span></div><div class="casAuthors">Wells Timothy N C; Burrows Jeremy N; Baird J Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Trends in parasitology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">145-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium vivax is the major species of malaria parasite outside Africa.  It is especially problematic in that the infection can relapse in the absence of mosquitoes by activation of dormant hypnozoites in the liver.  Medicines that target the erythrocytic stages of Plasmodium falciparum are also active against P. vivax, except where these have been compromised by resistance.  However, the only clinical therapy against relapse of vivax malaria is the 8-aminoquinoline, primaquine.  This molecule has the drawback of causing haemolysis in genetically sensitive patients and requires 14 days of treatment.  New, safer and more-easily administered drugs are urgently needed, and this is a crucial gap in the broader malaria-elimination agenda.  New developments in cell biology are starting to open ways to the next generation of drugs against hypnozoites.  This search is urgent, given the time needed to develop a new medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuUmTr4o7U9aqcneEtCi92fW6udTcc2ebfE8yyEGJ2kbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7lsl2itA%253D%253D&md5=0ea69f3316e4d8170a0838a4ec0152f5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2009.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2009.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DBaird%26aufirst%3DJ.%2BK.%26atitle%3DTargeting%2520the%2520hypnozoite%2520reservoir%2520of%2520Plasmodium%2520vivax%253A%2520the%2520hidden%2520obstacle%2520to%2520malaria%2520elimination%26jtitle%3DTrends%2520Parasitol.%26date%3D2010%26volume%3D26%26spage%3D145%26epage%3D151%26doi%3D10.1016%2Fj.pt.2009.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kancharla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bane, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vesely, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreishman-Deitrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciotti, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmeda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaona, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sousa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcsisin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaynor-Ohnstad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leed, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huezo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span> <span> </span><span class="NLM_article-title">Discovery and structural optimization of acridones as broad-spectrum antimalarials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3475</span>â <span class="NLM_lpage">3502</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFegtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3475-3502&author=R.+A.+Dodeanauthor=P.+Kancharlaauthor=Y.+Liauthor=V.+Melendezauthor=L.+Readauthor=C.+E.+Baneauthor=B.+Veselyauthor=M.+Kreishman-Deitrickauthor=C.+Blackauthor=Q.+Liauthor=R.+J.+Sciottiauthor=R.+Olmedaauthor=T.+L.+Luongauthor=H.+Gaonaauthor=B.+Potterauthor=J.+Sousaauthor=S.+Marcsisinauthor=D.+Caridhaauthor=L.+Xieauthor=C.+Vuongauthor=Q.+Zengauthor=J.+Zhangauthor=P.+Zhangauthor=H.+Linauthor=K.+Butlerauthor=N.+Roncalauthor=L.+Gaynor-Ohnstadauthor=S.+E.+Leedauthor=C.+Nolanauthor=S.+J.+Huezoauthor=S.+A.+Rasmussenauthor=M.+T.+Stephensauthor=J.+C.+Tanauthor=R.+A.+Cooperauthor=M.+J.+Smilksteinauthor=S.+Pouauthor=R.+W.+Winterauthor=M.+K.+Riscoeauthor=J.+X.+Kelly&title=Discovery+and+structural+optimization+of+acridones+as+broad-spectrum+antimalarials&doi=10.1021%2Facs.jmedchem.8b01961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials</span></div><div class="casAuthors">Dodean, Rozalia A.; Kancharla, Papireddy; Li, Yuexin; Melendez, Victor; Read, Lisa; Bane, Charles E.; Vesely, Brian; Kreishman-Deitrick, Mara; Black, Chad; Li, Qigui; Sciotti, Richard J.; Olmeda, Raul; Luong, Thu-Lan; Gaona, Heather; Potter, Brittney; Sousa, Jason; Marcsisin, Sean; Caridha, Diana; Xie, Lisa; Vuong, Chau; Zeng, Qiang; Zhang, Jing; Zhang, Ping; Lin, Hsiuling; Butler, Kirk; Roncal, Norma; Gaynor-Ohnstad, Lacy; Leed, Susan E.; Nolan, Christina; Huezo, Stephanie J.; Rasmussen, Stephanie A.; Stephens, Melissa T.; Tan, John C.; Cooper, Roland A.; Smilkstein, Martin J.; Pou, Sovitj; Winter, Rolf W.; Riscoe, Michael K.; Kelly, Jane X.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3475-3502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Malaria remains one of the deadliest diseases in the world today.  Novel chemoprophylactic and chemotherapeutic antimalarials are needed to support the renewed eradication agenda.  We have discovered a novel antimalarial acridone chemotype with dual-stage activity against both liver-stage and blood-stage malaria.  Several lead compds. generated from structural optimization of a large library of novel acridones exhibit efficacy in the following systems: (1) picomolar inhibition of in vitro Plasmodium falciparum blood-stage growth against multi-drug-resistant parasites; (2) curative efficacy after oral administration in an erythrocytic Plasmodium yoelii murine malaria model; (3) prevention of in vitro Plasmodium berghei sporozoite-induced development in human hepatocytes; and (4) protection of in vivo P. berghei sporozoite-induced infection in mice.  This study offers the first account of liver-stage antimalarial activity in an acridone chemotype.  Details of the design, chem., structure-activity relationships, safety, metabolic/pharmacokinetic studies, and mechanistic investigation are presented herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRZ1O0W0RmubVg90H21EOLACvtfcHk0lgQLcbAIMWm5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFegtbY%253D&md5=02b0e991c8efcc4d899fceebfe71eade</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01961%26sid%3Dliteratum%253Aachs%26aulast%3DDodean%26aufirst%3DR.%2BA.%26aulast%3DKancharla%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DRead%26aufirst%3DL.%26aulast%3DBane%26aufirst%3DC.%2BE.%26aulast%3DVesely%26aufirst%3DB.%26aulast%3DKreishman-Deitrick%26aufirst%3DM.%26aulast%3DBlack%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DOlmeda%26aufirst%3DR.%26aulast%3DLuong%26aufirst%3DT.%2BL.%26aulast%3DGaona%26aufirst%3DH.%26aulast%3DPotter%26aufirst%3DB.%26aulast%3DSousa%26aufirst%3DJ.%26aulast%3DMarcsisin%26aufirst%3DS.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DVuong%26aufirst%3DC.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DButler%26aufirst%3DK.%26aulast%3DRoncal%26aufirst%3DN.%26aulast%3DGaynor-Ohnstad%26aufirst%3DL.%26aulast%3DLeed%26aufirst%3DS.%2BE.%26aulast%3DNolan%26aufirst%3DC.%26aulast%3DHuezo%26aufirst%3DS.%2BJ.%26aulast%3DRasmussen%26aufirst%3DS.%2BA.%26aulast%3DStephens%26aufirst%3DM.%2BT.%26aulast%3DTan%26aufirst%3DJ.%2BC.%26aulast%3DCooper%26aufirst%3DR.%2BA.%26aulast%3DSmilkstein%26aufirst%3DM.%2BJ.%26aulast%3DPou%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26atitle%3DDiscovery%2520and%2520structural%2520optimization%2520of%2520acridones%2520as%2520broad-spectrum%2520antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3475%26epage%3D3502%26doi%3D10.1021%2Facs.jmedchem.8b01961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span> <span> </span><span class="NLM_article-title">N,N-dimethyl glycine-promoted Ullmann coupling reaction of phenols and aryl halides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3799</span>â <span class="NLM_lpage">3802</span>, <span class="refDoi">Â DOI: 10.1021/ol0350947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0350947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsFyrurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=3799-3802&author=D.+Maauthor=Q.+Cai&title=N%2CN-dimethyl+glycine-promoted+Ullmann+coupling+reaction+of+phenols+and+aryl+halides&doi=10.1021%2Fol0350947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">N,N-Dimethyl Glycine-Promoted Ullmann Coupling Reaction of Phenols and Aryl Halides</span></div><div class="casAuthors">Ma, Dawei; Cai, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3799-3802</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ullmann-type diaryl ether synthesis can be performed at 90 Â°C using either aryl iodides or aryl bromides as the substrates under the assistance of N,N-dimethylglycine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-5F2Dl8PWTbVg90H21EOLACvtfcHk0lgQLcbAIMWm5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsFyrurs%253D&md5=9d63bfcef4d0f32e18514874d5bd752f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fol0350947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0350947%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DQ.%26atitle%3DN%252CN-dimethyl%2520glycine-promoted%2520Ullmann%2520coupling%2520reaction%2520of%2520phenols%2520and%2520aryl%2520halides%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D3799%26epage%3D3802%26doi%3D10.1021%2Fol0350947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaisalo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latvala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, T.</span></span> <span> </span><span class="NLM_article-title">Selective demethylations in 2, 3, 4-trimethoxyaryl carbonyl compounds</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">645</span>â <span class="NLM_lpage">648</span>, <span class="refDoi">Â DOI: 10.1080/00397918608057734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1080%2F00397918608057734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADyaL2sXks1Wh" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1986&pages=645-648&author=L.+Kaisaloauthor=A.+Latvalaauthor=T.+Hase&title=Selective+demethylations+in+2%2C+3%2C+4-trimethoxyaryl+carbonyl+compounds&doi=10.1080%2F00397918608057734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Selective demethylations in 2,3,4-trimethoxyaryl carbonyl compounds</span></div><div class="casAuthors">Kaisalo, Leena; Latvala, Anita; Hase, Tapio</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">645-8</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">2,3,4-Trimethoxybenzaldehyde, -acetophenone, and -benzoic acid gave the corresponding 2,3-dihydroxy-4-methoxy compds. in 74-84% yields on treatment with BCl3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5eJTvUmT2fbVg90H21EOLACvtfcHk0lgQLcbAIMWm5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXks1Wh&md5=ef35586a0366c642a4fd35a7d30254e0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1080%2F00397918608057734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918608057734%26sid%3Dliteratum%253Aachs%26aulast%3DKaisalo%26aufirst%3DL.%26aulast%3DLatvala%26aufirst%3DA.%26aulast%3DHase%26aufirst%3DT.%26atitle%3DSelective%2520demethylations%2520in%25202%252C%25203%252C%25204-trimethoxyaryl%2520carbonyl%2520compounds%26jtitle%3DSynth.%2520Commun.%26date%3D1986%26volume%3D16%26spage%3D645%26epage%3D648%26doi%3D10.1080%2F00397918608057734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¶rger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julich-Gruner, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JÃ¤ger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KnÃ¶lker, H.-J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, clausine-H, and clausine-K and structural revision of clausine-TY</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_fpage">4741</span>â <span class="NLM_lpage">4752</span>, <span class="refDoi">Â DOI: 10.1002/ejoc.201402495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1002%2Fejoc.201402495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShurrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=4741-4752&author=C.+Schusterauthor=C.+B%C3%B6rgerauthor=K.+K.+Julich-Grunerauthor=R.+Hesseauthor=A.+J%C3%A4gerauthor=G.+Kaufmannauthor=A.+W.+Schmidtauthor=H.-J.+Kn%C3%B6lker&title=Synthesis+of+2-hydroxy-7-methylcarbazole%2C+glycozolicine%2C+mukoline%2C+mukolidine%2C+sansoakamine%2C+clausine-H%2C+and+clausine-K+and+structural+revision+of+clausine-TY&doi=10.1002%2Fejoc.201402495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, clausine-H, and clausine-K and structural revision of Clausine-TY</span></div><div class="casAuthors">Schuster, Christian; Boerger, Carsten; Julich-Gruner, Konstanze K.; Hesse, Ronny; Jaeger, Anne; Kaufmann, Gyoerley; Schmidt, Arndt W.; Knoelker, Hans-Joachim</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4741-4752</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A Buchwald-Hartwig amination and palladium(II)-catalyzed oxidative cyclization reaction sequence provided efficient access to a series of oxygenated tricyclic carbazoles.  In the present work, this approach was applied to the total syntheses of the naturally occurring carbazole alkaloids 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, glycozolidine, clausine-H (clauszoline-C), clausine-K (clauszoline-J), and Me 2-hydroxy-7-methoxycarbazole-3-carboxylate, which was originally proposed as the structure of clausine-TY.  The synthesis of the latter led to the structural reassignment of clausine-TY.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOlrykkK9TyrVg90H21EOLACvtfcHk0lgZmpyWSUywRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShurrO&md5=09d8d57ecf4f0e676a8ef931b820a178</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201402495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201402495%26sid%3Dliteratum%253Aachs%26aulast%3DSchuster%26aufirst%3DC.%26aulast%3DB%25C3%25B6rger%26aufirst%3DC.%26aulast%3DJulich-Gruner%26aufirst%3DK.%2BK.%26aulast%3DHesse%26aufirst%3DR.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DA.%26aulast%3DKaufmann%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DKn%25C3%25B6lker%26aufirst%3DH.-J.%26atitle%3DSynthesis%2520of%25202-hydroxy-7-methylcarbazole%252C%2520glycozolicine%252C%2520mukoline%252C%2520mukolidine%252C%2520sansoakamine%252C%2520clausine-H%252C%2520and%2520clausine-K%2520and%2520structural%2520revision%2520of%2520clausine-TY%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2014%26spage%3D4741%26epage%3D4752%26doi%3D10.1002%2Fejoc.201402495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kancharla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span> <span> </span><span class="NLM_article-title">Boron trifluoride etherate promoted microwave-assisted synthesis of antimalarial acridones</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">42284</span>â <span class="NLM_lpage">42293</span>, <span class="refDoi">Â DOI: 10.1039/C9RA09478D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1039%2FC9RA09478D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVCitLnL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=42284-42293&author=P.+Kancharlaauthor=R.+A.+Dodeanauthor=Y.+Liauthor=J.+X.+Kelly&title=Boron+trifluoride+etherate+promoted+microwave-assisted+synthesis+of+antimalarial+acridones&doi=10.1039%2FC9RA09478D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Boron trifluoride etherate promoted microwave-assisted synthesis of antimalarial acridones</span></div><div class="casAuthors">Kancharla, Papireddy; Dodean, Rozalia A.; Li, Yuexin; Kelly, Jane X.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">72</span>),
    <span class="NLM_cas:pages">42284-42293</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A microwave-assisted, rapid and efficient method using boron trifluoride etherate (BF3.Et2O) for the synthesis of acridones, via an intramol. acylation of N-phenylanthranilic acid derivs., has been developed.  The reaction proceeds under solvent-free conditions, tolerates a wide range of functional groups, and provides rapid access to a range of acridones in good to excellent yields.  Several of the synthesized acridones exhibited potent antimalarial activities against CQ sensitive and multi-drug resistant (MDR) parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrskJPlbIJSTbVg90H21EOLACvtfcHk0lgZmpyWSUywRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVCitLnL&md5=1b1e6069f9e2f44eeeff19c47da22645</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2FC9RA09478D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9RA09478D%26sid%3Dliteratum%253Aachs%26aulast%3DKancharla%26aufirst%3DP.%26aulast%3DDodean%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26atitle%3DBoron%2520trifluoride%2520etherate%2520promoted%2520microwave-assisted%2520synthesis%2520of%2520antimalarial%2520acridones%26jtitle%3DRSC%2520Adv.%26date%3D2019%26spage%3D42284%26epage%3D42293%26doi%3D10.1039%2FC9RA09478D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of dual function acridones as a new antimalarial chemotype</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>459</i></span>,  <span class="NLM_fpage">270</span>â <span class="NLM_lpage">273</span>, <span class="refDoi">Â DOI: 10.1038/nature07937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1038%2Fnature07937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=19357645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Srtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2009&pages=270-273&author=J.+X.+Kellyauthor=M.+J.+Smilksteinauthor=R.+Brunauthor=S.+Wittlinauthor=R.+A.+Cooperauthor=K.+D.+Laneauthor=A.+Janowskyauthor=R.+A.+Johnsonauthor=R.+A.+Dodeanauthor=R.+Winterauthor=D.+J.+Hinrichsauthor=M.+K.+Riscoe&title=Discovery+of+dual+function+acridones+as+a+new+antimalarial+chemotype&doi=10.1038%2Fnature07937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of dual function acridones as a new antimalarial chemotype</span></div><div class="casAuthors">Kelly, Jane X.; Smilkstein, Martin J.; Brun, Reto; Wittlin, Sergio; Cooper, Roland A.; Lane, Kristin D.; Janowsky, Aaron; Johnson, Robert A.; Dodean, Rozalia A.; Winter, Rolf; Hinrichs, David J.; Riscoe, Michael K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">7244</span>),
    <span class="NLM_cas:pages">270-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A new antimalarial chemotype was described that combined the haem-targeting character of acridones, together with a chemosensitizing component that counteracts resistance to quinoline antimalarial drugs.  Beyond the essential intrinsic characteristics common to deserving candidate antimalarials (high potency in vitro against pan-sensitive and multi-drug-resistant Plasmodium falciparum, efficacy and safety in vivo after oral administration, inexpensive synthesis and favorable physicochem. properties), the initial lead compd. I demonstrated unique synergistic properties.  In addn. to verapamil-like' chemosensitization to chloroquine and amodiaquine against quinoline-resistant parasites, I also resulted in an apparently mechanistically distinct synergism with quinine and with piperaquine.  This synergy, evident in both quinoline-sensitive and quinoline-resistant parasites, was demonstrated both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzNhD1G8U2cbVg90H21EOLACvtfcHk0lgZmpyWSUywRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Srtrc%253D&md5=436e58e6dab0365b88144f83e990b4d1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature07937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07937%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DSmilkstein%26aufirst%3DM.%2BJ.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DR.%2BA.%26aulast%3DLane%26aufirst%3DK.%2BD.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DDodean%26aufirst%3DR.%2BA.%26aulast%3DWinter%26aufirst%3DR.%26aulast%3DHinrichs%26aufirst%3DD.%2BJ.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DDiscovery%2520of%2520dual%2520function%2520acridones%2520as%2520a%2520new%2520antimalarial%2520chemotype%26jtitle%3DNature%26date%3D2009%26volume%3D459%26spage%3D270%26epage%3D273%26doi%3D10.1038%2Fnature07937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriwilaijaroen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilairat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M.</span></span> <span> </span><span class="NLM_article-title">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1803</span>â <span class="NLM_lpage">1806</span>, <span class="refDoi">Â DOI: 10.1128/AAC.48.5.1803-1806.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1128%2FAAC.48.5.1803-1806.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=15105138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1803-1806&author=M.+Smilksteinauthor=N.+Sriwilaijaroenauthor=J.+X.+Kellyauthor=P.+Wilairatauthor=M.+Riscoe&title=Simple+and+inexpensive+fluorescence-based+technique+for+high-throughput+antimalarial+drug+screening&doi=10.1128%2FAAC.48.5.1803-1806.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span></div><div class="casAuthors">Smilkstein, Martin; Sriwilaijaroen, Nongluk; Kelly, Jane Xu; Wilairat, Prapon; Riscoe, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1803-1806</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Radioisotopic assays involve expense, multistep protocols, equipment, and radioactivity safety requirements which are problematic in high-throughput drug testing.  This study reports an alternative, simple, robust, inexpensive, one-step fluorescence assay for use in antimalarial drug screening.  Parasite growth is detd. by using SYBR Green 1, a dye with marked fluorescence enhancement upon contact with Plasmodium DNA.  A side-by-side comparison of this fluorescence assay and a std. radioisotopic method was performed by testing known antimalarial agents against Plasmodium falciparum strain D6.  Both assay methods were used to det. the effective concn. of drug that resulted in a 50% redn. in the obsd. counts (EC50) after 48 h of parasite growth in the presence of each drug.  The EC50s of chloroquine, quinine, mefloquine, artemisinin, and 3,6-bis-.vepsiln.-(N,N-diethylamino)-amyloxyanthone were similar or identical by both techniques.  The results obtained with this new fluorescence assay suggest that it may be an ideal method for high-throughput antimalarial drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXZZP9UWQ27Vg90H21EOLACvtfcHk0li9p-IClys4aQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D&md5=84a9721da1d873dfca16d1f2570ed304</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1803-1806.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1803-1806.2004%26sid%3Dliteratum%253Aachs%26aulast%3DSmilkstein%26aufirst%3DM.%26aulast%3DSriwilaijaroen%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DWilairat%26aufirst%3DP.%26aulast%3DRiscoe%26aufirst%3DM.%26atitle%3DSimple%2520and%2520inexpensive%2520fluorescence-based%2520technique%2520for%2520high-throughput%2520antimalarial%2520drug%2520screening%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1803%26epage%3D1806%26doi%3D10.1128%2FAAC.48.5.1803-1806.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaCrue, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forquer, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfurt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrisey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirjanata, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebayang, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noviyanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Diaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathurst, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manetsch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Quinolone-3-diarylethers: a new class of antimalarial drug</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">177ra37</span>, <span class="refDoi">Â DOI: 10.1126/scitranslmed.3005029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1126%2Fscitranslmed.3005029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=23515079" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=177ra37&author=A.+Nilsenauthor=A.+N.+LaCrueauthor=K.+L.+Whiteauthor=I.+P.+Forquerauthor=R.+M.+Crossauthor=J.+Marfurtauthor=M.+W.+Matherauthor=M.+J.+Delvesauthor=D.+M.+Shacklefordauthor=F.+E.+Saenzauthor=J.+M.+Morriseyauthor=J.+Steutenauthor=T.+Mutkaauthor=Y.+Liauthor=G.+Wirjanataauthor=E.+Ryanauthor=S.+Duffyauthor=J.+X.+Kellyauthor=B.+F.+Sebayangauthor=A.-M.+Zeemanauthor=R.+Noviyantiauthor=R.+E.+Sindenauthor=C.+H.+M.+Kockenauthor=R.+N.+Priceauthor=V.+M.+Averyauthor=I.+Angulo-Barturenauthor=M.+B.+Jimenez-Diazauthor=S.+Ferrerauthor=E.+Herrerosauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=I.+Bathurstauthor=J.+N.+Burrowsauthor=P.+Sieglauthor=R.+K.+Guyauthor=R.+W.+Winterauthor=A.+B.+Vaidyaauthor=S.+A.+Charmanauthor=D.+E.+Kyleauthor=R.+Manetschauthor=M.+K.+Riscoe&title=Quinolone-3-diarylethers%3A+a+new+class+of+antimalarial+drug&doi=10.1126%2Fscitranslmed.3005029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3005029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3005029%26sid%3Dliteratum%253Aachs%26aulast%3DNilsen%26aufirst%3DA.%26aulast%3DLaCrue%26aufirst%3DA.%2BN.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DForquer%26aufirst%3DI.%2BP.%26aulast%3DCross%26aufirst%3DR.%2BM.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSaenz%26aufirst%3DF.%2BE.%26aulast%3DMorrisey%26aufirst%3DJ.%2BM.%26aulast%3DSteuten%26aufirst%3DJ.%26aulast%3DMutka%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DSebayang%26aufirst%3DB.%2BF.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DNoviyanti%26aufirst%3DR.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DSiegl%26aufirst%3DP.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DManetsch%26aufirst%3DR.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DQuinolone-3-diarylethers%253A%2520a%2520new%2520class%2520of%2520antimalarial%2520drug%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D177ra37%26doi%3D10.1126%2Fscitranslmed.3005029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayles, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olszewski, B.</span></span> <span> </span><span class="NLM_article-title">PAM 1392 (2,4-diamino-6-(3,4-dichlorobenzylamino) quinazoline) as a chemotherapeutic agent: <i>Plasmodium berghei</i>, <i>P. cynomolgi</i>, <i>P. knowlesi,</i> and <i>Trypanosoma cruzi</i></span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">32</span>â <span class="NLM_lpage">49</span>, <span class="refDoi">Â DOI: 10.1016/0014-4894(69)90050-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2F0014-4894%2869%2990050-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=4983051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADyaF1MXks12itbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1969&pages=32-49&author=P.+E.+Thompsonauthor=A.+Baylesauthor=B.+Olszewski&title=PAM+1392+%282%2C4-diamino-6-%283%2C4-dichlorobenzylamino%29+quinazoline%29+as+a+chemotherapeutic+agent%3A+Plasmodium+berghei%2C+P.+cynomolgi%2C+P.+knowlesi%2C+and+Trypanosoma+cruzi&doi=10.1016%2F0014-4894%2869%2990050-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">PAM 1392 [2,4-diamino-6-(3,4-dichlorobenzylamino)quinazoline] as a chemotherapeutic agent:  Plasmodium berghei, P. cynomolgi, P. knowlesi, and Trypanosoma cruzi</span></div><div class="casAuthors">Thompson, Paul Everett; Bayles, Anita; Olszewski, Bronislawa</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-49</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    </div><div class="casAbstract">PAM 1392 was active orally against blood forms of P. berghei in mice, P. cynomolgi in rhesus monkeys, and P. knowlesi in the latter host.  Against P. berghei, it was 4-11 times as potent as quinine in mice, acted rapidly, suppressed the parasitemia for 6 days in an oral dose of 200 mg./kg., acted synergistically with sulfadiazine without a commensurate increase in apparent toxicity for mice, and was effective against 4 drug-resistant lines.  The latter information suggests that it represents a new mode of action and may be useful in drug-resistant malaria.  In monkeys, it acted somewhat slowly but, when given appropriately, cured infections of P. cynomolgi and knowlesi.  The drug inhibited nuclear division of P. cynomolgi.  Against T. cruzi, PAM 1392 was active in culture against both extracellular and intracellular parasites at nontoxic levels for chick embryo cells.  This activity was partially reversed by folinic acid but not by crithidia factor.  PAM 1392 also was effective in protecting mice against the lethal effects of acute infections by T. cruzi but exhibited little capacity to effect radical cure of the infections.  Based on gross examn., the compd. is of relatively low toxicity to mice and monkeys on short-term administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn4pyMXieVj7Vg90H21EOLACvtfcHk0lgdn-Tt35a86Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXks12itbk%253D&md5=6041ddc17743ad3cc13b017d447f497d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0014-4894%2869%2990050-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-4894%252869%252990050-2%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DBayles%26aufirst%3DA.%26aulast%3DOlszewski%26aufirst%3DB.%26atitle%3DPAM%25201392%2520%25282%252C4-diamino-6-%25283%252C4-dichlorobenzylamino%2529%2520quinazoline%2529%2520as%2520a%2520chemotherapeutic%2520agent%253A%2520Plasmodium%2520berghei%252C%2520P.%2520cynomolgi%252C%2520P.%2520knowlesi%252C%2520and%2520Trypanosoma%2520cruzi%26jtitle%3DExp.%2520Parasitol.%26date%3D1969%26volume%3D25%26spage%3D32%26epage%3D49%26doi%3D10.1016%2F0014-4894%2869%2990050-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janse, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke-Fayard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mair, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matuschewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gemert, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, A. P.</span></span> <span> </span><span class="NLM_article-title">High efficiency transfection of <i>Plasmodium berghei</i> facilitates novel selection procedures</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">60</span>â <span class="NLM_lpage">70</span>, <span class="refDoi">Â DOI: 10.1016/j.molbiopara.2005.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.molbiopara.2005.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=16242190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ors7rE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2006&pages=60-70&author=C.+J.+Janseauthor=B.+Franke-Fayardauthor=G.+R.+Mairauthor=J.+Ramesarauthor=C.+Thielauthor=S.+Engelmannauthor=K.+Matuschewskiauthor=G.+J.+van+Gemertauthor=R.+W.+Sauerweinauthor=A.+P.+Waters&title=High+efficiency+transfection+of+Plasmodium+berghei+facilitates+novel+selection+procedures&doi=10.1016%2Fj.molbiopara.2005.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">High efficiency transfection of Plasmodium berghei facilitates novel selection procedures</span></div><div class="casAuthors">Janse, Chris J.; Franke-Fayard, Blandine; Mair, Gunnar R.; Ramesar, Jai; Thiel, Corinna; Engelmann, Sabine; Matuschewski, Kai; van Gemert, Geert Jan; Sauerwein, Robert W.; Waters, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-70</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The use of transfection in the study of the biol. of malaria parasites has been limited due to poor transfection efficiencies (frequency of 10-6 to 10-9) and a paucity of selectable markers.  Here, a new method of transfection, using non-viral Nucleofector technol., is described for the rodent parasite Plasmodium berghei.  The transfection efficiency obtained (episomal and targeted integration into the genome) is in the range of 10-2 to 10-3.  Such high transfection efficiency strongly reduces the time, no. of lab. animals and amt. of materials required to generate transfected parasites.  Moreover, it allows different exptl. strategies for reverse genetics to be developed and we demonstrate direct selection of stably and non-reversibly transformed, fluorescent protein (FP)-expressing parasites using FACS.  Since there is no need to use a drug-selectable marker, this method increases the (low) no. of selectable markers available for transformation of P. berghei and can in principle be extended to utilize addnl. FP.  Furthermore the FACS-selected, FP-expressing parasites may serve as easily visualized ref. lines that may still be genetically manipulated with the existing drug-selectable markers.  The combination of enhanced transfection efficiency and a versatile rodent model provides a basis for the further development of novel tools for high throughput genome manipulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJCeNdKkjHOrVg90H21EOLACvtfcHk0lgdn-Tt35a86Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ors7rE&md5=6f0aec711668825f48cf2b54067f1be6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2005.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2005.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DJanse%26aufirst%3DC.%2BJ.%26aulast%3DFranke-Fayard%26aufirst%3DB.%26aulast%3DMair%26aufirst%3DG.%2BR.%26aulast%3DRamesar%26aufirst%3DJ.%26aulast%3DThiel%26aufirst%3DC.%26aulast%3DEngelmann%26aufirst%3DS.%26aulast%3DMatuschewski%26aufirst%3DK.%26aulast%3Dvan%2BGemert%26aufirst%3DG.%2BJ.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DWaters%26aufirst%3DA.%2BP.%26atitle%3DHigh%2520efficiency%2520transfection%2520of%2520Plasmodium%2520berghei%2520facilitates%2520novel%2520selection%2520procedures%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2006%26volume%3D145%26spage%3D60%26epage%3D70%26doi%3D10.1016%2Fj.molbiopara.2005.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozar, M. P.</span></span> <span> </span><span class="NLM_article-title">Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage <i>Plasmodium</i> infections in mice</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">57</span>â <span class="NLM_lpage">65</span>, <span class="refDoi">Â DOI: 10.1016/j.nano.2013.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.nano.2013.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=23891618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKqsLbL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=57-65&author=H.+Wangauthor=Q.+Liauthor=S.+Reyesauthor=J.+Zhangauthor=Q.+Zengauthor=P.+Zhangauthor=L.+Xieauthor=P.+J.+Leeauthor=N.+Roncalauthor=V.+Melendezauthor=M.+Hickmanauthor=M.+P.+Kozar&title=Nanoparticle+formulations+of+decoquinate+increase+antimalarial+efficacy+against+liver+stage+Plasmodium+infections+in+mice&doi=10.1016%2Fj.nano.2013.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage Plasmodium infections in mice</span></div><div class="casAuthors">Wang, Hongxing; Li, Qigui; Reyes, Sean; Zhang, Jing; Zeng, Qiang; Zhang, Ping; Xie, Lisa; Lee, Patricia J.; Roncal, Norma; Melendez, Victor; Hickman, Mark; Kozar, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-65</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Decoquinate has potent activity against both Plasmodium hepatic development and red cell replication when tested in vitro.  Decoquinate, however, is practically insol. in water.  To achieve its maximal in vivo efficacy, we generated nanoparticle formulations of decoquinate with a mean particle size less than 400 nm.  Three sep. prepns. at doses of decoquinate 0.5-5 mg/kg were examd. in mice infected with Plasmodium berghei.  Oral administration of nanoparticle decoquinate at a dose of 1.25 mg/kg effectively inhibited the liver-stage parasite growth and provided complete causal prophylactic protection.  This efficacy is 15 fold greater than that obsd. for microparticle decoquinate, which requires minimal dose of 20 mg/kg for the same inhibitory effect.  Further in vitro studies utilizing dose-response assays revealed that decoquinate nanoformulation was substantially more potent than decoquinate microsuspension in killing both liver and blood stage malarial parasites, proving its potential for therapeutic development.  From the Clin. Editor: In this study, a nanoparticle formulation of decoquinate is shown to have superior bioavailability and efficacy in a mouse model of malaria, paving the way to the development of novel, potentially less toxic and more effective therapeutics to combat a disease that still has an enormous impact on a global scale despite the available partially effective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4rPvJMbTsIrVg90H21EOLACvtfcHk0lgdn-Tt35a86Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKqsLbL&md5=50e4582875a2d93c51cbbdf7456a40ac</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2013.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2013.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DReyes%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DP.%2BJ.%26aulast%3DRoncal%26aufirst%3DN.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DKozar%26aufirst%3DM.%2BP.%26atitle%3DNanoparticle%2520formulations%2520of%2520decoquinate%2520increase%2520antimalarial%2520efficacy%2520against%2520liver%2520stage%2520Plasmodium%2520infections%2520in%2520mice%26jtitle%3DNanomedicine%26date%3D2014%26volume%3D10%26spage%3D57%26epage%3D65%26doi%3D10.1016%2Fj.nano.2013.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, L.</span></span> <span> </span><span class="NLM_article-title">Comparative susceptibility of different mouse strains to liver-stage infection with <i>Plasmodium berghei</i> sporozoites assessed using in vivo imaging</span>. <i>Mil. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">360</span>â <span class="NLM_lpage">368</span>, <span class="refDoi">Â DOI: 10.7205/MILMED-D-16-00090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.7205%2FMILMED-D-16-00090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28291500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BC1czmtVSgtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2017&pages=360-368&author=Q.+Liauthor=L.+Xieauthor=D.+Caridhaauthor=N.+Roncalauthor=Q.+Zengauthor=J.+Zhangauthor=P.+Zhangauthor=M.+Hickmanauthor=L.+Read&title=Comparative+susceptibility+of+different+mouse+strains+to+liver-stage+infection+with+Plasmodium+berghei+sporozoites+assessed+using+in+vivo+imaging&doi=10.7205%2FMILMED-D-16-00090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Susceptibility of Different Mouse Strains to Liver-Stage Infection With Plasmodium berghei Sporozoites Assessed Using In Vivo Imaging</span></div><div class="casAuthors">Li Qigui; Xie Lisa; Caridha Diana; Roncal Norma; Zeng Qiang; Zhang Jing; Zhang Ping; Hickman Mark; Read Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Military medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">360-368</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The liver stages of Plasmodium parasites are important targets for the discovery and development of prophylactic drugs.  METHODS:  A real-time in vivo imaging system was used to determine the level of luminescence measured from firefly luciferase expression by sporozoites developing in hepatocytes in different strains of mice.  RESULTS:  The luminescence values (photon counts/sec) measured from the anatomical liver location in the untreated mice infected with 10,000 Plasmodium berghei sporozoites were 8.15 Ã 10(5) for C57BL/6 Albino, 2.12 Ã 10(5) for C3H/HeNCrL, 0.91 Ã 10(5) for C57BL/6 WT, 0.28 Ã 10(5) for BALB/c, and 0.16 Ã 10(5) for ICR/CD-1 mice.  This data suggests that the C57BL/6 Albino strain is most susceptible to luminescent photon, mainly because the less light scattering and absorption from deeper tissues and the skin in the strain of mouse.  The photon count observed in black C57BL/6 wild type mice was shown to be 88.83% lower compared to C57BL/6 Albino mice.  Although the highest growth rate of sporozoites in hepatocytes was found for C57BL/6 wild type mice in this study, the black skin of this mouse significantly reduced parasite-associated bioluminescence.  CONCLUSIONS:  The minimal light scattering and absorption and also enhanced susceptibility to liver infection of C57BL/6 Albino mice makes this strain preferable sensitivity for discovery and development of prophylactic antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPtJC26cYkEYhLSh9fo81bfW6udTcc2ea8cIBgy6J6B7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czmtVSgtQ%253D%253D&md5=9cff5670b545166016ec56d9417dc808</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.7205%2FMILMED-D-16-00090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7205%252FMILMED-D-16-00090%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DRoncal%26aufirst%3DN.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DL.%26atitle%3DComparative%2520susceptibility%2520of%2520different%2520mouse%2520strains%2520to%2520liver-stage%2520infection%2520with%2520Plasmodium%2520berghei%2520sporozoites%2520assessed%2520using%2520in%2520vivo%2520imaging%26jtitle%3DMil.%2520Med.%26date%3D2017%26volume%3D182%26spage%3D360%26epage%3D368%26doi%3D10.7205%2FMILMED-D-16-00090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ploemen, I. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PrudÃªncio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douradinha, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonager, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gemert, G.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luty, A. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermsen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baptista, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowik, C. W. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janse, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke-Fayard, B. M. D.</span></span> <span> </span><span class="NLM_article-title">Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e7881</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0007881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1371%2Fjournal.pone.0007881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=19924309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BD1MjmvFymtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=I.+H.+J.+Ploemenauthor=M.+Prud%C3%AAncioauthor=B.+G.+Douradinhaauthor=J.+Ramesarauthor=J.+Fonagerauthor=G.-J.+van+Gemertauthor=A.+J.+F.+Lutyauthor=C.+C.+Hermsenauthor=R.+W.+Sauerweinauthor=F.+G.+Baptistaauthor=M.+M.+Motaauthor=A.+P.+Watersauthor=I.+Queauthor=C.+W.+G.+M.+Lowikauthor=S.+M.+Khanauthor=C.+J.+Janseauthor=B.+M.+D.+Franke-Fayard&title=Visualisation+and+quantitative+analysis+of+the+rodent+malaria+liver+stage+by+real+time+imaging&doi=10.1371%2Fjournal.pone.0007881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging</span></div><div class="casAuthors">Ploemen Ivo H J; Prudencio Miguel; Douradinha Bruno G; Ramesar Jai; Fonager Jannik; van Gemert Geert-Jan; Luty Adrian J F; Hermsen Cornelus C; Sauerwein Robert W; Baptista Fernanda G; Mota Maria M; Waters Andrew P; Que Ivo; Lowik Clemens W G M; Khan Shahid M; Janse Chris J; Franke-Fayard Blandine M D</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e7881</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The quantitative analysis of Plasmodium development in the liver in laboratory animals in cultured cells is hampered by low parasite infection rates and the complicated methods required to monitor intracellular development.  As a consequence, this important phase of the parasite's life cycle has been poorly studied compared to blood stages, for example in screening anti-malarial drugs.  Here we report the use of a transgenic P. berghei parasite, PbGFP-Luc(con), expressing the bioluminescent reporter protein luciferase to visualize and quantify parasite development in liver cells both in culture and in live mice using real-time luminescence imaging.  The reporter-parasite based quantification in cultured hepatocytes by real-time imaging or using a microplate reader correlates very well with established quantitative RT-PCR methods.  For the first time the liver stage of Plasmodium is visualized in whole bodies of live mice and we were able to discriminate as few as 1-5 infected hepatocytes per liver in mice using 2D-imaging and to identify individual infected hepatocytes by 3D-imaging.  The analysis of liver infections by whole body imaging shows a good correlation with quantitative RT-PCR analysis of extracted livers.  The luminescence-based analysis of the effects of various drugs on in vitro hepatocyte infection shows that this method can effectively be used for in vitro screening of compounds targeting Plasmodium liver stages.  Furthermore, by analysing the effect of primaquine and tafenoquine in vivo we demonstrate the applicability of real time imaging to assess parasite drug sensitivity in the liver.  The simplicity and speed of quantitative analysis of liver-stage development by real-time imaging compared to the PCR methodologies, as well as the possibility to analyse liver development in live mice without surgery, opens up new possibilities for research on Plasmodium liver infections and for validating the effect of drugs and vaccines on the liver stage of Plasmodium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCyN9RipkSqxpyrDyM_m9cfW6udTcc2ea8cIBgy6J6B7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjmvFymtA%253D%253D&md5=b9520a00b344a50b4c0ffe86cea79d65</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007881%26sid%3Dliteratum%253Aachs%26aulast%3DPloemen%26aufirst%3DI.%2BH.%2BJ.%26aulast%3DPrud%25C3%25AAncio%26aufirst%3DM.%26aulast%3DDouradinha%26aufirst%3DB.%2BG.%26aulast%3DRamesar%26aufirst%3DJ.%26aulast%3DFonager%26aufirst%3DJ.%26aulast%3Dvan%2BGemert%26aufirst%3DG.-J.%26aulast%3DLuty%26aufirst%3DA.%2BJ.%2BF.%26aulast%3DHermsen%26aufirst%3DC.%2BC.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DBaptista%26aufirst%3DF.%2BG.%26aulast%3DMota%26aufirst%3DM.%2BM.%26aulast%3DWaters%26aufirst%3DA.%2BP.%26aulast%3DQue%26aufirst%3DI.%26aulast%3DLowik%26aufirst%3DC.%2BW.%2BG.%2BM.%26aulast%3DKhan%26aufirst%3DS.%2BM.%26aulast%3DJanse%26aufirst%3DC.%2BJ.%26aulast%3DFranke-Fayard%26aufirst%3DB.%2BM.%2BD.%26atitle%3DVisualisation%2520and%2520quantitative%2520analysis%2520of%2520the%2520rodent%2520malaria%2520liver%2520stage%2520by%2520real%2520time%2520imaging%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0007881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thiberge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldacci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shorte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ©nard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amino, R.</span></span> <span> </span><span class="NLM_article-title">In vivo imaging of malaria parasites in the murine liver</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1811</span>â <span class="NLM_lpage">1818</span>, <span class="refDoi">Â DOI: 10.1038/nprot.2007.257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1038%2Fnprot.2007.257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=17641649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFahur%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1811-1818&author=S.+Thibergeauthor=S.+Blazquezauthor=P.+Baldacciauthor=O.+Renaudauthor=S.+Shorteauthor=R.+M%C3%A9nardauthor=R.+Amino&title=In+vivo+imaging+of+malaria+parasites+in+the+murine+liver&doi=10.1038%2Fnprot.2007.257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo imaging of malaria parasites in the murine liver</span></div><div class="casAuthors">Thiberge, Sabine; Blazquez, Samantha; Baldacci, Patricia; Renaud, Olivier; Shorte, Spencer; Menard, Robert; Amino, Rogerio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1811-1818</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The form of the malaria parasite inoculated by the mosquito, called the sporozoite, transforms inside the host liver into thousands of a new form of the parasite, called the merozoite, which infects erythrocytes.  The authors present here a protocol to visualize in vivo the behavior of Plasmodium berghei parasites in the hepatic tissue of the murine host.  The use of GFP-expressing parasites and a high-speed spinning disk confocal microscope allows for the acquisition of four-dimensional images, which provide a time lapse view of parasite displacement and development in tissue vols.  These data can be analyzed to give information on the early events of sporozoite penetration of the hepatic tissue, i.e., sporozoite gliding in the liver sinusoids, crossing the sinusoidal barrier, gliding in the parenchyma and traversal of hepatocytes, and invasion of a final hepatocyte, as well as the terminal events of merosome and merozoite release from infected hepatocytes.  Combined with the use of mice expressing fluorescent cell types or cell markers, the system will provide useful information not only on the primary infection process, but also on parasite interactions with the host immune cells in the liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9IWiQ9c9K87Vg90H21EOLACvtfcHk0lh_3fF7XHDKqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFahur%252FO&md5=1e8432d297053d734bb949ff49c4fb2b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.257%26sid%3Dliteratum%253Aachs%26aulast%3DThiberge%26aufirst%3DS.%26aulast%3DBlazquez%26aufirst%3DS.%26aulast%3DBaldacci%26aufirst%3DP.%26aulast%3DRenaud%26aufirst%3DO.%26aulast%3DShorte%26aufirst%3DS.%26aulast%3DM%25C3%25A9nard%26aufirst%3DR.%26aulast%3DAmino%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520malaria%2520parasites%2520in%2520the%2520murine%2520liver%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D1811%26epage%3D1818%26doi%3D10.1038%2Fnprot.2007.257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pybus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span> <span> </span><span class="NLM_article-title">Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">141</span>, <span class="refDoi">Â DOI: 10.1186/1475-2875-13-141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1186%2F1475-2875-13-141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=24731238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gsrfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=141&author=Q.+Liauthor=M.+O%E2%80%99Neilauthor=L.+Xieauthor=D.+Caridhaauthor=Q.+Zengauthor=J.+Zhangauthor=B.+Pybusauthor=M.+Hickmanauthor=V.+Melendez&title=Assessment+of+the+prophylactic+activity+and+pharmacokinetic+profile+of+oral+tafenoquine+compared+to+primaquine+for+inhibition+of+liver+stage+malaria+infections&doi=10.1186%2F1475-2875-13-141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections</span></div><div class="casAuthors">Li, Qigui; O'Neil, Michael; Xie, Lisa; Caridha, Diana; Zeng, Qiang; Zhang, Jing; Pybus, Brandon; Hickman, Mark; Melendez, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141/1-141/13, 13</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: As anti-malarial drug resistance escalates, new safe and effective medications are necessary to prevent and treat malaria infections.  The US Army is developing tafenoquine (TQ), an analog of primaquine (PQ), which is expected to be more effective in preventing malaria in deployed military personnel.  Methods: To compare the prophylactic efficacy of TQ and PQ, a transgenic Plasmodium berghei parasite expressing the bioluminescent reporter protein luciferase was utilized to visualize and quantify parasite development in C57BL/6 albino mice treated with PQ and TQ in single or multiple regimens using a real-time in vivo imaging system (IVIS).  As an addnl. endpoint, blood stage parasitemia was monitored by flow cytometry.  Comparative pharmacokinetic (PK) and liver distribution studies of oral and i.v. PQ and TQ were also performed.  Results: Mice treated orally with three doses of TQ at 5 mg/kg three doses of PQ at 25 mg/kg demonstrated no bioluminescence liver signal and no blood stage parasitemia was obsd. suggesting both drugs showed 100% causal activity at the doses tested.  Single dose oral treatment with 5 mg TQ or 25 mg of PQ, however, yielded different results as only TQ treatment resulted in causal prophylaxis in P. berghei sporozoite-infected mice.  TQ is highly effective for causal prophylaxis in mice at a minimal curative single oral dose of 5 mg/kg, which is a five-fold improvement in potency vs. PQ.  PK studies of the two drugs administered orally to mice showed that the abs. bioavailability of oral TQ was 3.5-fold higher than PQ, and the AUC of oral TQ was 94-fold higher than oral PQ.  The elimination half-life of oral TQ in mice was 28 times longer than PQ, and the liver tissue distribution of TQ revealed an AUC that was 188-fold higher than PQ.  Conclusions: The increased drug exposure levels and longer exposure time of oral TQ in the plasma and livers of mice highlight the lead quality attributes that explain the much improved efficacy of TQ when compared to PQ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLlSzjNwCpw7Vg90H21EOLACvtfcHk0ljwdiSRPMd7pQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gsrfE&md5=bcffa149f5d62a5353706c48153899b7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-13-141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-13-141%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPybus%26aufirst%3DB.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DMelendez%26aufirst%3DV.%26atitle%3DAssessment%2520of%2520the%2520prophylactic%2520activity%2520and%2520pharmacokinetic%2520profile%2520of%2520oral%2520tafenoquine%2520compared%2520to%2520primaquine%2520for%2520inhibition%2520of%2520liver%2520stage%2520malaria%2520infections%26jtitle%3DMalar.%2520J.%26date%3D2014%26volume%3D13%26spage%3D141%26doi%3D10.1186%2F1475-2875-13-141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceja, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumwebaze, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byaruhanga, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katairo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nsobya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, R. A.</span></span> <span> </span><span class="NLM_article-title">Changing antimalarial drug sensitivities in Uganda</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e01516</span>â <span class="NLM_lpage">e01517</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01516-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1128%2FAAC.01516-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28923866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Crtb7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e01516-e01517&author=S.+A.+Rasmussenauthor=F.+G.+Cejaauthor=M.+D.+Conradauthor=P.+K.+Tumwebazeauthor=O.+Byaruhangaauthor=T.+Katairoauthor=S.+L.+Nsobyaauthor=P.+J.+Rosenthalauthor=R.+A.+Cooper&title=Changing+antimalarial+drug+sensitivities+in+Uganda&doi=10.1128%2FAAC.01516-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Changing Antimalarial Drug Sensitivities in Uganda</span></div><div class="casAuthors">Rasmussen, Stephanie A.; Ceja, Frida G.; Conrad, Melissa D.; Tumwebaze, Patrick K.; Byaruhanga, Oswald; Katairo, Thomas; Nsobya, Samuel L.; Rosenthal, Philip J.; Cooper, Roland A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e01516-17/1-e01516-17/11</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Dihydroartemisinin-piperaquine (DP) has demonstrated excellent efficacy for the treatment and prevention of malaria in Uganda.  However, resistance to both components of this regimen has emerged in Southeast Asia.  The efficacy of artemether-lumefantrine, the first-line regimen to treat malaria in Uganda, has also been excellent, but continued pressure may select for parasites with decreased sensitivity to lumefantrine.  To gain insight into current drug sensitivity patterns, ex vivo sensitivities were assessed and genotypes previously assocd. with altered drug sensitivity were characterized for 58 isolates collected in Tororo, Uganda, from subjects presenting in 2016 with malaria from the community or as part of a clin. trial comparing DP chemoprevention regimens.  Compared to community isolates, those from trial subjects had lower sensitivities to the aminoquinolines chloroquine, monodesethyl amodiaquine, and piperaquine and greater sensitivities to lumefantrine and mefloquine, an observation consistent with DP selection pressure.  Compared to results for isolates from 2010 to 2013, the sensitivities of 2016 community isolates to chloroquine, amodiaquine, and piperaquine improved (geometric mean 50% inhibitory concns. [IC50] = 248, 76.9, and 19.1 nM in 2010 to 2013 and 33.4, 14.9, and 7.5 nM in 2016, resp. [P < 0.001 for all comparisons]), the sensitivity to lumefantrine decreased (IC50 = 3.0 nM in 2010 to 2013 and 5.4 nM in 2016 [P < 0.001]), and the sensitivity to dihydroartemisinin was unchanged (IC50 = 1.4 nM).  These changes were accompanied by decreased prevalence of transporter mutations assocd. with aminoquinoline resistance and low prevalence of polymorphisms recently assocd. with resistance to artemisinins or piperaquine.  Antimalarial drug sensitivities are changing in Uganda, but novel genotypes assocd. with DP treatment failure in Asia are not prevalent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLcmYAqeEnqLVg90H21EOLACvtfcHk0ljwdiSRPMd7pQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Crtb7M&md5=fb8a53f991d000575149db4b026359b4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FAAC.01516-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01516-17%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DS.%2BA.%26aulast%3DCeja%26aufirst%3DF.%2BG.%26aulast%3DConrad%26aufirst%3DM.%2BD.%26aulast%3DTumwebaze%26aufirst%3DP.%2BK.%26aulast%3DByaruhanga%26aufirst%3DO.%26aulast%3DKatairo%26aufirst%3DT.%26aulast%3DNsobya%26aufirst%3DS.%2BL.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DCooper%26aufirst%3DR.%2BA.%26atitle%3DChanging%2520antimalarial%2520drug%2520sensitivities%2520in%2520Uganda%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De01516%26epage%3De01517%26doi%3D10.1128%2FAAC.01516-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yourick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabezas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span> <span> </span><span class="NLM_article-title">Mefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">684</span>â <span class="NLM_lpage">693</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00874-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1128%2FAAC.00874-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=17999964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWjsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=684-693&author=D.+Caridhaauthor=D.+Yourickauthor=M.+Cabezasauthor=L.+Wolfauthor=T.+H.+Hudsonauthor=G.+S.+Dow&title=Mefloquine-induced+disruption+of+calcium+homeostasis+in+mammalian+cells+is+similar+to+that+induced+by+ionomycin&doi=10.1128%2FAAC.00874-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Mefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin</span></div><div class="casAuthors">Caridha, D.; Yourick, D.; Cabezas, M.; Wolf, L.; Hudson, T. H.; Dow, G. S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">684-693</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In previous studies, we have shown that mefloquine disrupts calcium homeostasis in neurons by depletion of endoplasmic reticulum (ER) stores, followed by an influx of external calcium across the plasma membrane.  In this study, we explore two hypotheses concerning the mechanism(s) of action of mefloquine.  First, we investigated the possibility that mefloquine activates non-N-methyl-D-aspartic acid receptors and the inositol phosphate 3 (IP3) signaling cascade leading to ER calcium release.  Second, we compared the disruptive effects of mefloquine on calcium homeostasis to those of ionomycin in neuronal and nonneuronal cells.  Ionomycin is known to discharge the ER calcium store (through an undefined mechanism), which induces capacitative calcium entry (CCE).  In radioligand binding assays, mefloquine showed no affinity for the known binding sites of several glutamate receptor subtypes.  The pattern of neuroprotection induced by a panel of glutamate receptor antagonists was dissimilar to that of mefloquine.  Both mefloquine and ionomycin exhibited dose-related and qual. similar disruptions of calcium homeostasis in both neurons and macrophages.  The influx of external calcium was blocked by the inhibitors of CCE in a dose-related fashion.  Both mefloquine and ionomycin upregulated the IP3 pathway in a manner that we interpret to be secondary to CCE.  Collectively, these data suggest that mefloquine does not activate glutamate receptors and that it disrupts calcium homeostasis in mammalian cells in a manner similar to that of ionomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqepHyEkIKrnrVg90H21EOLACvtfcHk0ljwdiSRPMd7pQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWjsrc%253D&md5=456ca97c2533ab8cdfcdbdfb8aa3a7b9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2FAAC.00874-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00874-07%26sid%3Dliteratum%253Aachs%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DYourick%26aufirst%3DD.%26aulast%3DCabezas%26aufirst%3DM.%26aulast%3DWolf%26aufirst%3DL.%26aulast%3DHudson%26aufirst%3DT.%2BH.%26aulast%3DDow%26aufirst%3DG.%2BS.%26atitle%3DMefloquine-induced%2520disruption%2520of%2520calcium%2520homeostasis%2520in%2520mammalian%2520cells%2520is%2520similar%2520to%2520that%2520induced%2520by%2520ionomycin%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D684%26epage%3D693%26doi%3D10.1128%2FAAC.00874-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornasiero, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isetta, A. M.</span></span> <span> </span><span class="NLM_article-title">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">165</span>â <span class="NLM_lpage">172</span>, <span class="refDoi">Â DOI: 10.1016/0022-1759(90)90187-Z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2F0022-1759%2890%2990187-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=2391427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=1990&pages=165-172&author=M.+Ferrariauthor=M.+C.+Fornasieroauthor=A.+M.+Isetta&title=MTT+colorimetric+assay+for+testing+macrophage+cytotoxic+activity+in+vitro&doi=10.1016%2F0022-1759%2890%2990187-Z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span></div><div class="casAuthors">Ferrari, Mario; Fornasiero, Maria Chiara; Isetta, Anna Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-72</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">The MTT [3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide] cleavage assay, originally described by T. Mosmann (1983) for measuring cell survival/proliferation, was used successfully to quantitate macrophage-mediated cytotoxicity.  Peritoneal macrophages, from control or pyran copolymer MVE2-treated mice and from TU5 and L929 murine cell lines, were used as effectors and targets resp. in a 48 h cytotoxicity test, at 3 effector: target ratios (10:1, 5:1, 2:1).  The amt. of MTT reduced by cells to its blue formazan deriv. during an addnl. 4 h of culture was quantified spectrophotometrically at 570 nm using an ELISA reader.  A linear relationship between the formazan generated and the no. of viable TU5 and L929 cells was demonstrated, together with time-dependent growth characteristics for these cells.  The formazan produced by macrophages was independent of their functional state and did not interfere with the target cell signal.  MVE2-activated macrophages strongly inhibited the survival/growth of target cells in a dose-related way, whereas the cytotoxic activity of control macrophages was very low.  Finally, the MTT method compared favorably with the 3H-TdR uptake method in evaluating macrophage cytotoxicity, and both of them were more sensitive than the 3H-TdR release assay.  The MTT cleavage method is a useful alternative to radioisotopic methods for quantitating macrophage cytotoxicity for actively growing in vitro targets.  Its main advantages are: (a) sensitivity and reproducibility; (b) elimination of the need for radioactive compds.; (c) ease with which it can be performed and quantified; and (d) rapidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrezxA3w4p2ebVg90H21EOLACvtfcHk0lhTJ35XgixnIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D&md5=e0b83e032dccb6f10faa9fc8a8ca16ce</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2890%2990187-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252890%252990187-Z%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DM.%26aulast%3DFornasiero%26aufirst%3DM.%2BC.%26aulast%3DIsetta%26aufirst%3DA.%2BM.%26atitle%3DMTT%2520colorimetric%2520assay%2520for%2520testing%2520macrophage%2520cytotoxic%2520activity%2520in%2520vitro%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1990%26volume%3D131%26spage%3D165%26epage%3D172%26doi%3D10.1016%2F0022-1759%2890%2990187-Z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korotchenko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathunuru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreishman-Deitrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A. J.</span></span> <span> </span><span class="NLM_article-title">Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3411</span>â <span class="NLM_lpage">3431</span>, <span class="refDoi">Â DOI: 10.1021/jm501809x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501809x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Shu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3411-3431&author=V.+Korotchenkoauthor=R.+Sathunuruauthor=L.+Gerenaauthor=D.+Caridhaauthor=Q.+Liauthor=M.+Kreishman-Deitrickauthor=P.+L.+Smithauthor=A.+J.+Lin&title=Antimalarial+activity+of+4-amidinoquinoline+and+10-amidinobenzonaphthyridine+derivatives&doi=10.1021%2Fjm501809x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial Activity of 4-Amidinoquinoline and 10-Amidinobenzonaphthyridine Derivatives</span></div><div class="casAuthors">Korotchenko, Vasiliy; Sathunuru, Ramadas; Gerena, Lucia; Caridha, Diana; Li, Qigui; Kreishman-Deitrick, Mara; Smith, Philip L.; Lin, Ai J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3411-3431</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chloroquine (CQ) has been used as first line malaria therapeutic drug for decades.  Emergence of CQ drug-resistant Plasmodium falciparum malaria throughout endemic areas of the world has limited its clin. value.  Mefloquine (MQ) has been used as an effective malaria prophylactic drug due to its being long-acting and having a high potency against blood stage P. falciparum (Pf).  However, serious CNS toxicity of MQ has compromised its clin. value as a prophylaxis drug.  Therefore, new and inexpensive antimalarial drugs with no cross-resistance to CQ or CNS toxicity are urgently needed to combat this deadly human disease.  In this study, a series of new 4-amidinoquinoline (4-AMQ) and 10-amidinobenzonaphthyridine (10-AMB) derivs. were designed, prepd., and assessed to search for new therapeutic agents to replace CQ and MQ.  The new derivs. displayed high activity in vitro and in vivo, with no cross-resistance to CQ, and none were toxic in mice up to 160 mpk Ã 3.  The best compd. shows IC50 < 1 ng/mL against D6, W2 and C235 Pf clones, low inhibitory activity in hERG K+ channel blockage testing, negativity in the Ames test, and 5/5 cure @ <15 mpk Ã 3 in mice infected with Plasmodium berghei.  In addn. to these desirable pharmacol. profiles, compd. I, one of the most active compds., is metabolically stable in both human and mouse liver microsomal prepns. and has a plasma t1/2 of 50 h in mice, which made it a good MQ replacement candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-hMlYNpOBpbVg90H21EOLACvtfcHk0lhTJ35XgixnIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Shu78%253D&md5=b3042cd96745a072ee7631a99fd4ce54</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm501809x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501809x%26sid%3Dliteratum%253Aachs%26aulast%3DKorotchenko%26aufirst%3DV.%26aulast%3DSathunuru%26aufirst%3DR.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DKreishman-Deitrick%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DLin%26aufirst%3DA.%2BJ.%26atitle%3DAntimalarial%2520activity%2520of%25204-amidinoquinoline%2520and%252010-amidinobenzonaphthyridine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3411%26epage%3D3431%26doi%3D10.1021%2Fjm501809x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagle, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trezise, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worley, J.</span></span> <span> </span><span class="NLM_article-title">Ionworks HT: a new high-throughput electrophysiology measurement platform</span>. <i>J. Biomol. Screen</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">50</span>â <span class="NLM_lpage">64</span>, <span class="refDoi">Â DOI: 10.1177/1087057102239667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1177%2F1087057102239667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=12854998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlSqu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=50-64&author=K.+Schroederauthor=B.+Neagleauthor=D.+J.+Treziseauthor=J.+Worley&title=Ionworks+HT%3A+a+new+high-throughput+electrophysiology+measurement+platform&doi=10.1177%2F1087057102239667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">IonWorks HT: A new high-throughput electrophysiology measurement platform</span></div><div class="casAuthors">Schroeder, Kirk; Neagle, Brad; Trezise, Derek J.; Worley, Jennings</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-64</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">To address the throughput restrictions of classical patch clamp electrophysiol., Essen Instruments has developed a plate-based electrophysiol. measurement platform.  The instrument is an integrated platform that consists of computer-controlled fluid handling, recording electronics, and processing tools capable of voltage clamp whole-cell recordings from thousands of individual cells per day.  To establish a recording, the system uses a planar, multi-well substrate (a PatchPlate).  The system effectively positions 1 cell into a hole sepg. 2 fluid compartments in each well of the substrate.  Voltage control and current recordings from the cell membrane are made subsequent to gaining access to the cell interior by applying a permeabilizing agent to the intracellular side.  Based on the multi-well design of the PatchPlate, voltage clamp recordings of up to 384 individual cells can be made in minutes and are comparable to measurements made using traditional electrophysiol. techniques.  An integrated pipetting system allows for up to 2 addns. of modulation agents.  Typical throughput, measurement fidelity, stability, and comparative pharmacol. of a recombinant voltage-dependent sodium channel (hNav1.3) and a voltage-gated potassium channel (hKv1.5) exogenously expressed in CHO cells are presented.  The IonWorks HT device can be used in biophys. and pharmacol. profiling of ion channels in an environment compatible with high-capacity screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99MfVnFuXs7Vg90H21EOLACvtfcHk0lhTJ35XgixnIA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlSqu70%253D&md5=3a161db49dbb3c39e1db2d74e46e6bfb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1177%2F1087057102239667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057102239667%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DK.%26aulast%3DNeagle%26aufirst%3DB.%26aulast%3DTrezise%26aufirst%3DD.%2BJ.%26aulast%3DWorley%26aufirst%3DJ.%26atitle%3DIonworks%2520HT%253A%2520a%2520new%2520high-throughput%2520electrophysiology%2520measurement%2520platform%26jtitle%3DJ.%2520Biomol.%2520Screen%26date%3D2003%26volume%3D8%26spage%3D50%26epage%3D64%26doi%3D10.1177%2F1087057102239667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaldia, N.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3467</span>â <span class="NLM_lpage">3477</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00439-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1128%2FAAC.00439-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=18644969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3467-3477&author=G.+S.+Dowauthor=Y.+Chenauthor=K.+T.+Andrewsauthor=D.+Caridhaauthor=L.+Gerenaauthor=M.+Gettayacaminauthor=J.+Johnsonauthor=Q.+Liauthor=V.+Melendezauthor=N.+Obaldiaauthor=T.+N.+Tranauthor=A.+P.+Kozikowski&title=Antimalarial+activity+of+phenylthiazolyl-bearing+hydroxamate-based+histone+deacetylase+inhibitors&doi=10.1128%2FAAC.00439-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors</span></div><div class="casAuthors">Dow, Geoffrey S.; Chen, Yufeng; Andrews, Katherine T.; Cardiha, Diana; Gerena, Lucia; Gettayacamin, Montip; Johnson, Jacob; Li, Qigui; Melendez, Victor; Obaldia, Nicanor, III; Tran, Thanh N.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3467-3477</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The antimalarial activity and pharmacol. of a series of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors (HDACIs) was evaluated.  In in-vitro growth inhibition assays approx. 50 analogs were evaluated against four drug resistant strains of Plasmodium falciparum.  The range of 50% inhibitory concns. (IC50s) was 0.0005 to >1 Î¼M.  Five analogs exhibited IC50s of <3 nM, and three of these exhibited selectivity indexes of >600.  The most potent compd., WR301801 (YC-2-88) was shown to cause hyperacetylation of P. falciparum histones, which is a marker for HDAC inhibition in eukaryotic cells.  The compd. also inhibited malarial and mammalian HDAC activity in functional assays at low nanomolar concns.  WR301801 did not exhibit cures in P. berghei-infected mice at oral doses as high as 640 mg/kg/day for 3 days or in P. falciparum-infected Aotus lemurinus monkeys at oral doses of 32 mg/kg/day for 3 days, despite high relative bioavailability.  The failure of monotherapy in mice may be due to a short half-life, since the compd. was rapidly hydrolyzed to an inactive acid metabolite by loss of its hydroxamate group in vitro (half-life of 11 min in mouse microsomes) and in vivo (half-life in mice of 3.5 h after a single oral dose of 50 mg/kg).  However, WR301801 exhibited cures in P. berghei-infected mice when combined at doses of 52 mg/kg/day orally with subcurative doses of chloroquine.  Next-generation HDACIs with greater metabolic stability than WR301801 may be useful as antimalarials if combined appropriately with conventional antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdVfao8vD3e7Vg90H21EOLACvtfcHk0liNDvouFuCdLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM&md5=461a53d115d420024a013aafe84df1af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.00439-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00439-08%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DObaldia%26aufirst%3DN.%26aulast%3DTran%26aufirst%3DT.%2BN.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DAntimalarial%2520activity%2520of%2520phenylthiazolyl-bearing%2520hydroxamate-based%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3467%26epage%3D3477%26doi%3D10.1128%2FAAC.00439-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathunuru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozar, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A. J.</span></span> <span> </span><span class="NLM_article-title">New imidazolidinedione derivatives as antimalarial agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1541</span>â <span class="NLM_lpage">1549</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2010.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.bmc.2010.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=21282058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFKhtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1541-1549&author=L.+Zhangauthor=R.+Sathunuruauthor=T.+Luongauthor=V.+Melendezauthor=M.+P.+Kozarauthor=A.+J.+Lin&title=New+imidazolidinedione+derivatives+as+antimalarial+agents&doi=10.1016%2Fj.bmc.2010.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">New imidazolidinedione derivatives as antimalarial agents</span></div><div class="casAuthors">Zhang, Liang; Sathunuru, Ramadas; Luong, Thu Lan; Melendez, Victor; Kozar, Michael P.; Lin, Ai J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1541-1549</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of new N-alky- and N-alkoxy-imidazolidinediones was prepd. and assessed for prophylactic and radical curative activities in mouse and Rhesus monkey models.  New compds. are generally metabolically stable, weakly active in vitro against Plasmodium falciparum clones (D6 and W2) and in mice infected with Plasmodium berghei sporozoites.  Representative compds. 8e and 9c (I) showed good causal prophylactic activity in Rhesus monkeys dosed 30 mg/kg/day for 3 consecutive days by IM, delayed patency for 19-21 days and 54-86 days, resp., as compared to the untreated control.  By oral, 9c showed only marginal activity in causal prophylactic and radical curative tests at 50 mg/kg/day Ã 3 and 30 mg/kg/day Ã 7 plus chloroquine 10 mg/kg for 7 days, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbDcL_hB_MaLVg90H21EOLACvtfcHk0liNDvouFuCdLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFKhtLk%253D&md5=64410e36bc5112cdb4f9cedf2453727b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSathunuru%26aufirst%3DR.%26aulast%3DLuong%26aufirst%3DT.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DKozar%26aufirst%3DM.%2BP.%26aulast%3DLin%26aufirst%3DA.%2BJ.%26atitle%3DNew%2520imidazolidinedione%2520derivatives%2520as%2520antimalarial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1541%26epage%3D1549%26doi%3D10.1016%2Fj.bmc.2010.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, S. H. I.</span></span> <span> </span><span class="NLM_article-title">Malaria parasite pre-erythrocytic infection: preparation meets opportunity</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">316</span>â <span class="NLM_lpage">324</span>, <span class="refDoi">Â DOI: 10.1111/j.1462-5822.2011.01734.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1111%2Fj.1462-5822.2011.01734.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=22151703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVOjs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=316-324&author=S.+E.+Lindnerauthor=J.+L.+Millerauthor=S.+H.+I.+Kappe&title=Malaria+parasite+pre-erythrocytic+infection%3A+preparation+meets+opportunity&doi=10.1111%2Fj.1462-5822.2011.01734.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria parasite pre-erythrocytic infection: preparation meets opportunity</span></div><div class="casAuthors">Lindner, Scott E.; Miller, Jessica L.; Kappe, Stefan H. I.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-324</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  For those stricken with malaria, the classic clin. symptoms are caused by the parasite's cyclic infection of red blood cells.  However, this erythrocytic phase of the parasite's life cycle initiates from an asymptomatic pre-erythrocytic phase: the injection of sporozoites via the bite of a parasite-carrying Anopheline mosquito, and the ensuing infection of the liver.  With the increased capabilities of studying liver stages in mice, much progress was made elucidating the cellular and mol. basis of the parasite's progression through this bottleneck of its life cycle.  Here we review relevant findings on how sporozoites prep. for infection of the liver and factors crucial to liver stage development as well as key host/parasite interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0M19yfzes2bVg90H21EOLACvtfcHk0liNDvouFuCdLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVOjs7Y%253D&md5=12008701e239bba5150a4792d215bf21</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2011.01734.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2011.01734.x%26sid%3Dliteratum%253Aachs%26aulast%3DLindner%26aufirst%3DS.%2BE.%26aulast%3DMiller%26aufirst%3DJ.%2BL.%26aulast%3DKappe%26aufirst%3DS.%2BH.%2BI.%26atitle%3DMalaria%2520parasite%2520pre-erythrocytic%2520infection%253A%2520preparation%2520meets%2520opportunity%26jtitle%3DCell.%2520Microbiol.%26date%3D2012%26volume%3D14%26spage%3D316%26epage%3D324%26doi%3D10.1111%2Fj.1462-5822.2011.01734.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RÃ©nia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snounou, G.</span></span> <span> </span><span class="NLM_article-title">A pre-emptive strike against malariaâs stealthy hepatic forms</span>. <i>Nat. Rev. Drug. Discov.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">854</span>â <span class="NLM_lpage">864</span>, <span class="refDoi">Â DOI: 10.1038/nrd2960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1038%2Fnrd2960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=19876040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtr3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=854-864&author=D.+Mazierauthor=L.+R%C3%A9niaauthor=G.+Snounou&title=A+pre-emptive+strike+against+malaria%E2%80%99s+stealthy+hepatic+forms&doi=10.1038%2Fnrd2960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A pre-emptive strike against malaria's stealthy hepatic forms</span></div><div class="casAuthors">Mazier, Dominique; Renia, Laurent; Snounou, Georges</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">854-864</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Almost all the drugs that are widely used today against Plasmodium spp., the causative agent of malaria, target the asexual blood stages of the parasite.  Widespread drug resistance severely restricts our ability to control malaria and makes it necessary to seek novel antimalarial compds.  Here, we advocate the development of true causal chemoprophylactic drugs that will fully inhibit the obligate short-lived hepatic forms that precede blood infections.  Such drugs will prevent pathol. and interrupt transmission, and could therefore have an important role in the control of malaria and its eventual eradication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBUI7UkUUorrVg90H21EOLACvtfcHk0lgSElsrap0wdw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtr3I&md5=74f3b2bfb151cb856fda56fd2392442c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnrd2960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2960%26sid%3Dliteratum%253Aachs%26aulast%3DMazier%26aufirst%3DD.%26aulast%3DR%25C3%25A9nia%26aufirst%3DL.%26aulast%3DSnounou%26aufirst%3DG.%26atitle%3DA%2520pre-emptive%2520strike%2520against%2520malaria%25E2%2580%2599s%2520stealthy%2520hepatic%2520forms%26jtitle%3DNat.%2520Rev.%2520Drug.%2520Discov.%26date%3D2009%26volume%3D8%26spage%3D854%26epage%3D864%26doi%3D10.1038%2Fnrd2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PrudÃªncio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, F.</span></span> <span> </span><span class="NLM_article-title">Targeting the liver stage of malaria parasites: a yet unmet goal</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">995</span>â <span class="NLM_lpage">1012</span>, <span class="refDoi">Â DOI: 10.1021/jm201095h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201095h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFejtbrE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=995-1012&author=T.+Rodriguesauthor=M.+Prud%C3%AAncioauthor=R.+Moreiraauthor=M.+M.+Motaauthor=F.+Lopes&title=Targeting+the+liver+stage+of+malaria+parasites%3A+a+yet+unmet+goal&doi=10.1021%2Fjm201095h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Liver Stage of Malaria Parasites: A Yet Unmet Goal</span></div><div class="casAuthors">Rodrigues, Tiago; Prudencio, Miguel; Moreira, Rui; Mota, Maria M.; Lopes, Francisca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">995-1012</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  An overview of Plasmodium liver stages malaria (LS) and inhibitors targeting the LS; special emphasis is given to structure-activity relationships (SARs) and to recent developments in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3to30Pz23MLVg90H21EOLACvtfcHk0lgSElsrap0wdw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFejtbrE&md5=3a24c7c84968b0801fb56a4d90fb177f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm201095h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201095h%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DPrud%25C3%25AAncio%26aufirst%3DM.%26aulast%3DMoreira%26aufirst%3DR.%26aulast%3DMota%26aufirst%3DM.%2BM.%26aulast%3DLopes%26aufirst%3DF.%26atitle%3DTargeting%2520the%2520liver%2520stage%2520of%2520malaria%2520parasites%253A%2520a%2520yet%2520unmet%2520goal%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D995%26epage%3D1012%26doi%3D10.1021%2Fjm201095h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, S. H. I.</span></span> <span> </span><span class="NLM_article-title">Malaria parasite liver infection and exoerythrocytic biology</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">a025486</span>, <span class="refDoi">Â DOI: 10.1101/cshperspect.a025486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1101%2Fcshperspect.a025486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28242785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisFKqtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=a025486&author=A.+M.+Vaughanauthor=S.+H.+I.+Kappe&title=Malaria+parasite+liver+infection+and+exoerythrocytic+biology&doi=10.1101%2Fcshperspect.a025486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria parasite liver infection and exoerythrocytic biology</span></div><div class="casAuthors">Vaughan, Ashley M.; Kappe, Stefan H. I.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">a025486/1-a025486/22</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">In their infection cycle, malaria parasites undergo replication and population expansions within the vertebrate host and the mosquito vector.  Host infection initiates with sporozoite invasion of hepatocytes, followed by a dramatic parasite amplification event during liver stage parasite growth and replication within hepatocytes.  Each liver stage forms up to 90,000 exoerythrocytic merozoites, which are in turn capable of initiating a blood stage infection.  Liver stages not only exploit host hepatocyte resources for nutritional needs but also endeavor to prevent hepatocyte cell death and detection by the host's immune system.  Research over the past decade has identified numerous parasite factors that play a crit. role during liver infection and has started to delineate a complex web of parasite-host interactions that sustain successful parasite colonization of the mammalian host.  Targeting the parasites' obligatory infection of the liver as a gateway to the blood, with drugs and vaccines, constitutes the most effective strategy for malaria eradication, as it would prevent clin. disease and onward transmission of the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIS0RapO9sOrVg90H21EOLACvtfcHk0lgSElsrap0wdw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisFKqtLg%253D&md5=196be5869532275ff5569d64aa1d04c3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025486%26sid%3Dliteratum%253Aachs%26aulast%3DVaughan%26aufirst%3DA.%2BM.%26aulast%3DKappe%26aufirst%3DS.%2BH.%2BI.%26atitle%3DMalaria%2520parasite%2520liver%2520infection%2520and%2520exoerythrocytic%2520biology%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2017%26volume%3D7%26spage%3Da025486%26doi%3D10.1101%2Fcshperspect.a025486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, I.</span></span> <span> </span><span class="NLM_article-title">The biology of <i>Plasmodium vivax</i></span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">a025585</span>, <span class="refDoi">Â DOI: 10.1101/cshperspect.a025585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1101%2Fcshperspect.a025585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28490540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvFKns7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=a025585&author=J.+H.+Adamsauthor=I.+Mueller&title=The+biology+of+Plasmodium+vivax&doi=10.1101%2Fcshperspect.a025585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The Biology of Plasmodium vivax</span></div><div class="casAuthors">Adams, John H.; Mueller, Ivo</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">a025585/1-a025585/13</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Plasmodium vivax is the second most prevalent cause of malaria worldwide and the leading cause of malaria outside of Africa.  Although infections are seldom fatal clin. disease can be debilitating and imposes significant health and economic impacts on affected populations.  Ests. of transmission and prevalence intensity can be problematic because many episodes of vivax originate from hypnozoite stages in the liver that have remained dormant from previous infections by an unknown mechanism.  Lack of treatment options to clear hypnozoites and the ability to infect mosquitoes before disease symptoms present represent major challenges for control and eradication of vivax malaria.  Compounding these challenges is the unique biol. of P. vivax and limited progress in development of exptl. research tools, thereby hindering development of new drugs and vaccines.  Renewed emphasis on vivax malaria research is beginning to make progress in overcoming some of these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNRZd0EMtsHrVg90H21EOLACvtfcHk0ljMyMg9VcBAVA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvFKns7k%253D&md5=f54184731bfe0783014bf131d256fe7b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025585%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BH.%26aulast%3DMueller%26aufirst%3DI.%26atitle%3DThe%2520biology%2520of%2520Plasmodium%2520vivax%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2017%26volume%3D7%26spage%3Da025585%26doi%3D10.1101%2Fcshperspect.a025585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesche, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span> <span> </span><span class="NLM_article-title">Killing the hypnozoite-drug discovery approaches to prevent relapse in <i>Plasmodium vivax</i></span>. <i>Pathog. Glob. Health</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">107</span>â <span class="NLM_lpage">122</span>, <span class="refDoi">Â DOI: 10.1179/2047773215Y.0000000013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1179%2F2047773215Y.0000000013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=25891812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvVyks7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2015&pages=107-122&author=B.+Campoauthor=O.+Vandalauthor=D.+L.+Wescheauthor=J.+N.+Burrows&title=Killing+the+hypnozoite-drug+discovery+approaches+to+prevent+relapse+in+Plasmodium+vivax&doi=10.1179%2F2047773215Y.0000000013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Killing the hypnozoite - drug discovery approaches to prevent relapse in Plasmodium vivax</span></div><div class="casAuthors">Campo, Brice; Vandal, Omar; Wesche, David L.; Burrows, Jeremy N.</div><div class="citationInfo"><span class="NLM_cas:title">Pathogens and Global Health</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">107-122</span>CODEN:
                <span class="NLM_cas:coden">PGHAB7</span>;
        ISSN:<span class="NLM_cas:issn">2047-7724</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">A review.  The eradication of malaria will only be possible if effective, well-tolerated medicines kill hypnozoites in vivax and ovale malaria, and thus prevent relapses in patients.  Despite progress in the 8-aminoquinoline series, with tafenoquine in Phase III showing clear benefits over primaquine, the drug discovery challenge to identify hypnozoiticidal or hypnozoite-activating compds. has been hampered by the dearth of biol. tools and assays, which in turn has been limited by the immense scientific and logistical challenges assocd. with accessing relevant human tissue and sporozoites.  This review summarises the existing drug discovery series and approaches concerning the goal to block relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZobuvLqmY8rVg90H21EOLACvtfcHk0ljMyMg9VcBAVA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvVyks7k%253D&md5=5b8e1091c3df8331cc6b72fb943fdbb6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1179%2F2047773215Y.0000000013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F2047773215Y.0000000013%26sid%3Dliteratum%253Aachs%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DVandal%26aufirst%3DO.%26aulast%3DWesche%26aufirst%3DD.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26atitle%3DKilling%2520the%2520hypnozoite-drug%2520discovery%2520approaches%2520to%2520prevent%2520relapse%2520in%2520Plasmodium%2520vivax%26jtitle%3DPathog.%2520Glob.%2520Health%26date%3D2015%26volume%3D109%26spage%3D107%26epage%3D122%26doi%3D10.1179%2F2047773215Y.0000000013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, F. L.</span></span> <span> </span><span class="NLM_article-title">Cultivation of <i>Plasmodium</i> spp</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">355</span>â <span class="NLM_lpage">364</span>, <span class="refDoi">Â DOI: 10.1128/CMR.15.3.355-364.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1128%2FCMR.15.3.355-364.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=12097244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BD38zlsVarsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=355-364&author=F.+L.+Schuster&title=Cultivation+of+Plasmodium+spp&doi=10.1128%2FCMR.15.3.355-364.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Cultivation of plasmodium spp</span></div><div class="casAuthors">Schuster Frederick L</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-64</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">Cultivation of both human and non-human species of Plasmodium spp., the causal agent of malaria, has been a major research success, leading to a greater understanding of the parasite.  Efforts at cultivating the organisms in vitro are complicated by the parasites' alternating between a human host and an arthropod vector, each having its own set of physiological, metabolic, and nutritional parameters.  Life cycle stages of the four species that infect humans have been established in vitro.  Of these four, P. falciparum remains the only species for which all stages have been cultured in vitro; different degrees of success have been achieved with the other human Plasmodium spp.  The life cycle includes the exoerythrocytic stage (within liver cells), the erythrocytic stage (within erythrocytes or precursor reticulocytes), and the sporogonic stage (within the vector).  Culture media generally consist of a basic tissue culture medium (e.g., minimal essential medium or RPMI 1640) to which serum and erythrocytes are added.  Most of the efforts have been directed toward the stage found in the erythrocyte.  This stage has been cultivated in petri plates or other growth vessels in a candle jar to generate elevated CO(2) levels or in a more controlled CO(2) atmosphere.  Later developments have employed continuous-flow systems to reduce the labor-intensive nature of medium changing.  The exoerythrocytic and sporogonic life cycle stages have also been cultivated in vitro.  A number of avian, rodent, and simian malarial parasites have also been established in vitro.  Although cultivation is of great help in understanding the biology of Plasmodium, it does not lend itself to use for diagnostic purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfFDLq8A5cJb0AGQpJZWpJfW6udTcc2eZgwa-bhee60bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zlsVarsw%253D%253D&md5=6b99b63121cddd6547b6f78480cb559c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FCMR.15.3.355-364.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.15.3.355-364.2002%26sid%3Dliteratum%253Aachs%26aulast%3DSchuster%26aufirst%3DF.%2BL.%26atitle%3DCultivation%2520of%2520Plasmodium%2520spp%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2002%26volume%3D15%26spage%3D355%26epage%3D364%26doi%3D10.1128%2FCMR.15.3.355-364.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milhous, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D.</span></span> <span> </span><span class="NLM_article-title">Development and validation of flow cytometric measurement for parasitaemia using autofluorescence and YOYO-1 in rodent malaria</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">1151</span>â <span class="NLM_lpage">1162</span>, <span class="refDoi">Â DOI: 10.1017/S0031182007002661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1017%2FS0031182007002661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=17445324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BD2svjsVCjuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2007&pages=1151-1162&author=L.+Xieauthor=Q.+Liauthor=J.+Johnsonauthor=J.+Zhangauthor=W.+Milhousauthor=D.+Kyle&title=Development+and+validation+of+flow+cytometric+measurement+for+parasitaemia+using+autofluorescence+and+YOYO-1+in+rodent+malaria&doi=10.1017%2FS0031182007002661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of flow cytometric measurement for parasitaemia using autofluorescence and YOYO-1 in rodent malaria</span></div><div class="casAuthors">Xie L; Li Q; Johnson J; Zhang J; Milhous W; Kyle D</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">Pt 9</span>),
    <span class="NLM_cas:pages">1151-62</span>
        ISSN:<span class="NLM_cas:issn">0031-1820</span>.
    </div><div class="casAbstract">An automated flow cytometric (FCM) detection method has been developed and validated with a simple diagnostic procedure in parasitized erythrocytes of Plasmodium berghei-infected rats using the nucleic acid-binding fluorescent dye YOYO-1.  High levels of reticulocytes were detected during the course of the infection, ranging from 1.2-51.2%, but any RNA potentially confounding the assay could be removed by digestion with RNAse.  The cell counts of uninfected, infected, and nucleated cells occurred with high precision.  The cells were divided into different populations according to their physical or chemical properties but various factors within the assay such as cell fixation, RNA digestion, and compensation required optimization.  In this study, FCM greatly simplified and accelerated parasite detection, with a mean precision of 4.4%, specificity of 98.9% and accuracy of 101.3%.  The detection and quantitation limits in the assay were 0.024% and 0.074% parasitaemia, respectively.  Overall, the parasite counts by FCM measurement correlated highly (r2=0.954-0.988) with the parasitaemia measured by light microscopical analysis when animals treated with suppressive, clearance, and curative doses of novel antimalarial drugs were examined.  The lower levels of parasitaemia (30%) detected by microscopy compared to FCM may be related to a number of schizonts externally attached to the erythrocyte membranes that normally would not be included in microscopy counting.  Lower sampling error and reliable identification of rodent erythrocyte parasites based on the principles of FCM have replaced the traditional blood smear in our laboratory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSe2_1BH9qNY2mbXvSEQle5fW6udTcc2ebTVBV9VQVpL7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svjsVCjuw%253D%253D&md5=7d54eeba1d4d0f02821752a2f0c51fd6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1017%2FS0031182007002661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182007002661%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMilhous%26aufirst%3DW.%26aulast%3DKyle%26aufirst%3DD.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520flow%2520cytometric%2520measurement%2520for%2520parasitaemia%2520using%2520autofluorescence%2520and%2520YOYO-1%2520in%2520rodent%2520malaria%26jtitle%3DParasitology%26date%3D2007%26volume%3D134%26spage%3D1151%26epage%3D1162%26doi%3D10.1017%2FS0031182007002661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">P. Holland Alday, Erin V. McConnell, Jan M. Boitz Zarella, Rozalia A. Dodean, Papireddy Kancharla, Jane X. Kelly, <span class="NLM_string-name hlFld-ContribAuthor">J. Stone Doggett</span>. </span><span class="cited-content_cbyCitation_article-title">Acridones Are Highly Potent Inhibitors of Toxoplasma gondii Tachyzoites. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (7)
                                     , 1877-1884. <a href="https://doi.org/10.1021/acsinfecdis.1c00016" title="DOI URL">https://doi.org/10.1021/acsinfecdis.1c00016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.1c00016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.1c00016%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DAcridones%252BAre%252BHighly%252BPotent%252BInhibitors%252Bof%252BToxoplasma%252Bgondii%252BTachyzoites%26aulast%3DAlday%26aufirst%3DP.%2BHolland%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12012021%26date%3D16032021%26volume%3D7%26issue%3D7%26spage%3D1877%26epage%3D1884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Papireddy Kancharla, Yuexin Li, Monish Yeluguri, Rozalia A. Dodean, Kevin A. Reynolds, <span class="NLM_string-name hlFld-ContribAuthor">Jane X. Kelly</span>. </span><span class="cited-content_cbyCitation_article-title">Total Synthesis and Antimalarial Activity of 2-(p-Hydroxybenzyl)-prodigiosins, Isoheptylprodigiosin, and Geometric Isomers of Tambjamine MYP1 Isolated from Marine Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8739-8754. <a href="https://doi.org/10.1021/acs.jmedchem.1c00748" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00748</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00748%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTotal%252BSynthesis%252Band%252BAntimalarial%252BActivity%252Bof%252B2-%252528p-Hydroxybenzyl%252529-prodigiosins%25252C%252BIsoheptylprodigiosin%25252C%252Band%252BGeometric%252BIsomers%252Bof%252BTambjamine%252BMYP1%252BIsolated%252Bfrom%252BMarine%252BBacteria%26aulast%3DKancharla%26aufirst%3DPapireddy%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D25042021%26date%3D10062021%26volume%3D64%26issue%3D12%26spage%3D8739%26epage%3D8754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Adamczyk-WoÅºniak</span>, <span class="hlFld-ContribAuthor ">Jan T.  Gozdalik</span>, <span class="hlFld-ContribAuthor ">Ewa  Kaczorowska</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Durka</span>, <span class="hlFld-ContribAuthor ">Dorota  Wieczorek</span>, <span class="hlFld-ContribAuthor ">Dorota  ZarzeczaÅska</span>, <span class="hlFld-ContribAuthor ">Andrzej  SporzyÅski</span>. </span><span class="cited-content_cbyCitation_article-title">(Trifluoromethoxy)Phenylboronic Acids: Structures, Properties, and Antibacterial Activity. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (7)
                                     , 2007. <a href="https://doi.org/10.3390/molecules26072007" title="DOI URL">https://doi.org/10.3390/molecules26072007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26072007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26072007%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3D%252528Trifluoromethoxy%252529Phenylboronic%252BAcids%25253A%252BStructures%25252C%252BProperties%25252C%252Band%252BAntibacterial%252BActivity%26aulast%3DAdamczyk-Wo%25C5%25BAniak%26aufirst%3DAgnieszka%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D7%26spage%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Transition from the first-generation acridones to the second-generation acridones.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Acridones (<b>18</b>â<b>58</b>) with Aryloxy, Arylamino, and Aryl Groups at the 6-Position of Ring B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) K<sub>2</sub>CO<sub>3</sub>, CuCl, <i>N</i>,<i>N</i>-dimethylglycine, 1-methyl-2-pyrrolidone, MS 4 Ã, 150 Â°C, 4 h; (ii) BCl<sub>3</sub>, DCM, â78 Â°C to rt, 1 h; (iii) Tf<sub>2</sub>O, pyridine, DCM, 0 Â°C to rt, 5 h; (iv) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 110 Â°C, 5 h; (v) BF<sub>3</sub>Â·OEt<sub>2</sub>, mw, 150 Â°C, 1.0 min; (vi) Eatonâs acid, 90 Â°C, 5 h; (vii) Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (9:1), 100 Â°C, 5 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Acridones (<b>68</b>â<b>80</b>) with Aryloxy and Arylamino Groups at the 7-Position of Ring B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) K<sub>2</sub>CO<sub>3</sub>, CuCl, <i>N</i>,<i>N</i>-dimethylglycine, 1-methyl-2-pyrrolidone, MS 4 Ã, 150 Â°C, 4 h; (ii) BCl<sub>3</sub>, DCM, â78 Â°C to rt, 1 h; (iii) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 110 Â°C, 5 h; (iv) Tf<sub>2</sub>O, pyridine, DCM, 0 Â°C to rt, 5 h; (v) Eatonâs acid, 90 Â°C, 5 h; (vi) PPA, 110 Â°C, 2 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Acridones (<b>86</b>â<b>93</b>, <b>99</b>â<b>102</b>, and <b>107</b>â<b>109</b>) with Benzyloxy Groups at the 6- (Top and Middle Panel) and 7-Positions (Bottom Panel) of Ring B<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Tf<sub>2</sub>O, pyridine, DCM, 0 Â°C to rt, 5 h; (ii) Pd(OAc)<sub>2</sub>, XPhos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, 110 Â°C, 5 h; (iii) BF<sub>3</sub>Â·OEt<sub>2</sub>, mw, 150 Â°C, 1.0 min; (iv) HI, phenol, reflux, 3 h; (v) appropriate benzyl bromide, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 3 h; (vi) Eatonâs acid, 90 Â°C, 5 h.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Bioluminescence and real-time in vivo imaging (IVIS) of parasite load in mice with and without acridone treatment. Mice were inoculated with 10 000 luciferase-expressing <i>P. berghei</i> sporozoite intravenously (i.v.) on day 0, and oral doses of acridones were administered on days â1, 0, and 1. The bioluminescence level represents the parasite burden over the body surface area at 24, 48, and 72 h time points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/medium/jm0c00539_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Ex vivo activity of acridones and control antimalarial drugs against <i>P. falciparum</i> clinical isolates in Uganda. Data are presented as geometric means Â± 95% CI. CQ, chloroquine; PIP, piperaquine; DHA, dihydroartemisinin; ATV, atovaquone; LUM, lumefantrine.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00539/20200604/images/large/jm0c00539_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00539&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i158">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">WHO</span>.  <i>World Malaria Report</i>; <span class="NLM_publisher-name">WHO</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=WHO&title=World+Malaria+Report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Malaria%2520Report%26pub%3DWHO%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manyando, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Huijsduijnen, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Voorhis, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span> <span> </span><span class="NLM_article-title">Malaria</span>. <i>Nat. Rev. Dis. Primers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">17050</span>, <span class="refDoi">Â DOI: 10.1038/nrdp.2017.50</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1038%2Fnrdp.2017.50" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28770814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BC1cfjvVGhtg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=17050&author=M.+A.+Phillipsauthor=J.+N.+Burrowsauthor=C.+Manyandoauthor=R.+H.+van+Huijsduijnenauthor=W.+C.+Van+Voorhisauthor=T.+N.+C.+Wells&title=Malaria&doi=10.1038%2Fnrdp.2017.50"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria</span></div><div class="casAuthors">Phillips Margaret A; Burrows Jeremy N; van Huijsduijnen Rob Hooft; Wells Timothy N C; Manyando Christine; Van Voorhis Wesley C</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Disease primers</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17050</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria is caused in humans by five species of single-celled eukaryotic Plasmodium parasites (mainly Plasmodium falciparum and Plasmodium vivax) that are transmitted by the bite of Anopheles spp. mosquitoes.  Malaria remains one of the most serious infectious diseases; it threatens nearly half of the world's population and led to hundreds of thousands of deaths in 2015, predominantly among children in Africa.  Malaria is managed through a combination of vector control approaches (such as insecticide spraying and the use of insecticide-treated bed nets) and drugs for both treatment and prevention.  The widespread use of artemisinin-based combination therapies has contributed to substantial declines in the number of malaria-related deaths; however, the emergence of drug resistance threatens to reverse this progress.  Advances in our understanding of the underlying molecular basis of pathogenesis have fuelled the development of new diagnostics, drugs and insecticides.  Several new combination therapies are in clinical development that have efficacy against drug-resistant parasites and the potential to be used in single-dose regimens to improve compliance.  This ambitious programme to eliminate malaria also includes new approaches that could yield malaria vaccines or novel vector control strategies.  However, despite these achievements, a well-coordinated global effort on multiple fronts is needed if malaria elimination is to be achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcfdgTdv0RVI2y4bB4mnvYfW6udTcc2ebdjSrObslGIrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfjvVGhtg%253D%253D&md5=ec450ab6baef0a6c2b6bd6bac030771a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrdp.2017.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrdp.2017.50%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DM.%2BA.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DManyando%26aufirst%3DC.%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DVan%2BVoorhis%26aufirst%3DW.%2BC.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26atitle%3DMalaria%26jtitle%3DNat.%2520Rev.%2520Dis.%2520Primers%26date%3D2017%26volume%3D3%26spage%3D17050%26doi%3D10.1038%2Fnrdp.2017.50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span> <span> </span><span class="NLM_article-title">Drugs in development for malaria</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">861</span>â <span class="NLM_lpage">879</span>, <span class="refDoi">Â DOI: 10.1007/s40265-018-0911-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1007%2Fs40265-018-0911-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=29802605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOmurnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=861-879&author=E.+A.+Ashleyauthor=A.+P.+Phyo&title=Drugs+in+development+for+malaria&doi=10.1007%2Fs40265-018-0911-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs in Development for Malaria</span></div><div class="casAuthors">Ashley, Elizabeth A.; Phyo, Aung Pyae</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">861-879</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">The last two decades have seen a surge in antimalarial drug development with product development partnerships taking a leading role.  Resistance of Plasmodium falciparum to the artemisinin derivs., piperaquine and mefloquine in Southeast Asia means new antimalarials are needed with some urgency.  There are at least 13 agents in clin. development.  Most of these are blood schizonticides for the treatment of uncomplicated falciparum malaria, under evaluation either singly or as part of two-drug combinations.  Leading candidates progressing through the pipeline are artefenomel-ferroquine and lumefantrine-KAF156, both in Phase 2b.  Treatment of severe malaria continues to rely on two parenteral drugs with ancient forebears: artesunate and quinine, with sevuparin being evaluated as an adjuvant therapy.  Tafenoquine is under review by stringent regulatory authorities for approval as a single-dose treatment for Plasmodium vivax relapse prevention.  This represents an advance over std. 14-day primaquine regimens; however, the risk of acute haemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency remains.  For disease prevention, several of the newer agents show potential but are unlikely to be recommended for use in the main target groups of pregnant women and young children for some years.  Latest predictions are that the malaria burden will continue to be high in the coming decades.  This fact, coupled with the repeated loss of antimalarials to resistance, indicates that new antimalarials will be needed for years to come.  Failure of the artemisinin-based combinations in Southeast Asia has stimulated a reappraisal of current approaches to combination therapy for malaria with incorporation of three or more drugs in a single treatment under consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbu06hSG2TXLVg90H21EOLACvtfcHk0ljH81N_00qLxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOmurnK&md5=4cfdcaf7482b5e1d8ed55f3ae126b0e8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2Fs40265-018-0911-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-018-0911-9%26sid%3Dliteratum%253Aachs%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26atitle%3DDrugs%2520in%2520development%2520for%2520malaria%26jtitle%3DDrugs%26date%3D2018%26volume%3D78%26spage%3D861%26epage%3D879%26doi%3D10.1007%2Fs40265-018-0911-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hooft
van Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N.</span></span> <span> </span><span class="NLM_article-title">The antimalarial pipeline</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">6</span>, <span class="refDoi">Â DOI: 10.1016/j.coph.2018.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.coph.2018.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=29860174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVaisrjK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2018&pages=1-6&author=R.+Hooft%0Avan+Huijsduijnenauthor=T.+N.+Wells&title=The+antimalarial+pipeline&doi=10.1016%2Fj.coph.2018.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The antimalarial pipeline</span></div><div class="casAuthors">Hooft van Huijsduijnen, Rob; Wells, Timothy N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past decade, new high-throughput phenotypic assays with malaria parasites have been developed, and these were used to screen millions of compds.  This effort, as well as improving older chem. scaffolds and optimizing compds. against both known and new drug targets has resulted in the discovery of exciting new pipeline drug candidates that are now being evaluated in a no. of clin. trials.  In addn., the pitfalls and opportunities from this experience has led to a better definition of the optimal target compd. and product profiles for new antimalarials, including medicines that treat uncomplicated or severe malaria, provide chemoprevention, or stop disease transmission, covering all stages of the parasite.  An important decision element is how to combine these new mols. with existing ones in today's dynamic resistance landscape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ctGYtwHIqbVg90H21EOLACvtfcHk0lgAcyZwuT_PNw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVaisrjK&md5=96ca4e3c131d9c534ec3a51aa451435e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2018.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2018.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DWells%26aufirst%3DT.%2BN.%26atitle%3DThe%2520antimalarial%2520pipeline%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2018%26volume%3D42%26spage%3D1%26epage%3D6%26doi%3D10.1016%2Fj.coph.2018.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okombo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Recent updates in the discovery and development of novel antimalarial drug candidates</span>. <i>Medchemcomm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">437</span>â <span class="NLM_lpage">453</span>, <span class="refDoi">Â DOI: 10.1039/C7MD00637C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1039%2FC7MD00637C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=30108934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFygs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=437-453&author=J.+Okomboauthor=K.+Chibale&title=Recent+updates+in+the+discovery+and+development+of+novel+antimalarial+drug+candidates&doi=10.1039%2FC7MD00637C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Recent updates in the discovery and development of novel antimalarial drug candidates</span></div><div class="casAuthors">Okombo, John; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-453</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Though morbidity and mortality due to malaria have declined in the last 15 years, emerging resistance to first-line artemisinin-based antimalarials, absence of efficacious vaccines and limited chemotherapeutic alternatives imperil the consolidation of these gains.  As a blueprint to steer future designs of new medicines, malaria drug discovery recently adopted a descriptive proposal for the ideal candidate mols. and drugs likely to successfully progress into the final stages of clin. development.  As an audit of recent developments in the chemotherapy of malaria in the last five years, this review captures a landscape of diverse mols. at various stages of drug development and discusses their progress.  In brief, we also discuss how omics data on Plasmodium has been extensively leveraged to identify potential vaccine candidates and putative targets of mols. in development and clin. use as well as map loci implicit in their modes of resistance.  Future perspective on malaria drug development should involve a reconciliation of some of the challenges of the target candidate profiles (TCPs), specifically TCP3, with the promise of effective anti-hypnozoite medicines.  Similarly, with the recent development of a humanized mouse model that can evaluate the prophylactic potential of candidate drugs, we argue for increased effort at identifying more liver-stage mols., which are often only secondarily prioritized in conventional screening programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvmARzFwQAebVg90H21EOLACvtfcHk0lgAcyZwuT_PNw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFygs7Y%253D&md5=760def6cbcd82971f114de94132b27f7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1039%2FC7MD00637C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7MD00637C%26sid%3Dliteratum%253Aachs%26aulast%3DOkombo%26aufirst%3DJ.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DRecent%2520updates%2520in%2520the%2520discovery%2520and%2520development%2520of%2520novel%2520antimalarial%2520drug%2520candidates%26jtitle%3DMedchemcomm%26date%3D2018%26volume%3D9%26spage%3D437%26epage%3D453%26doi%3D10.1039%2FC7MD00637C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhorda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairhurst, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sopha, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuor, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sovannaroth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pukrittayakamee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jittamala, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chotivanich, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chutasmit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suchatsoonthorn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runcharoen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hien, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuy-Nhien, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanh, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phu, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Htut, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aye, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokuolu, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olaosebikan, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folaranmi, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayxay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanthavong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hongvanthong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onyamboko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanello, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tshefu, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valecha, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bashraheil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peshu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faiz, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacInnis, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stalker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozdech, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeeyapant, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheah, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakulthaew, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Intharabut, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silamut, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vihokhern, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunasol, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imwong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarning, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodrow, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flegg, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plowe, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepniewska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerin, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, N. J.</span></span> <span> </span><span class="NLM_article-title">Spread of artemisinin resistance in <i>Plasmodium falciparum</i> malaria</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">411</span>â <span class="NLM_lpage">423</span>, <span class="refDoi">Â DOI: 10.1056/NEJMoa1314981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1056%2FNEJMoa1314981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=25075834" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ers7jF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=411-423&author=E.+A.+Ashleyauthor=M.+Dhordaauthor=R.+M.+Fairhurstauthor=C.+Amaratungaauthor=P.+Limauthor=S.+Suonauthor=S.+Srengauthor=J.+M.+Andersonauthor=S.+Maoauthor=B.+Samauthor=C.+Sophaauthor=C.+M.+Chuorauthor=C.+Nguonauthor=S.+Sovannarothauthor=S.+Pukrittayakameeauthor=P.+Jittamalaauthor=K.+Chotivanichauthor=K.+Chutasmitauthor=C.+Suchatsoonthornauthor=R.+Runcharoenauthor=T.+T.+Hienauthor=N.+T.+Thuy-Nhienauthor=N.+V.+Thanhauthor=N.+H.+Phuauthor=Y.+Htutauthor=K.-T.+Hanauthor=K.+H.+Ayeauthor=O.+A.+Mokuoluauthor=R.+R.+Olaosebikanauthor=O.+O.+Folaranmiauthor=M.+Mayxayauthor=M.+Khanthavongauthor=B.+Hongvanthongauthor=P.+N.+Newtonauthor=M.+A.+Onyambokoauthor=C.+I.+Fanelloauthor=A.+K.+Tshefuauthor=N.+Mishraauthor=N.+Valechaauthor=A.+P.+Phyoauthor=F.+Nostenauthor=P.+Yiauthor=R.+Tripuraauthor=S.+Borrmannauthor=M.+Bashraheilauthor=J.+Peshuauthor=M.+A.+Faizauthor=A.+Ghoseauthor=M.+A.+Hossainauthor=R.+Samadauthor=M.+R.+Rahmanauthor=M.+M.+Hasanauthor=A.+Islamauthor=O.+Miottoauthor=R.+Amatoauthor=B.+MacInnisauthor=J.+Stalkerauthor=D.+P.+Kwiatkowskiauthor=Z.+Bozdechauthor=A.+Jeeyapantauthor=P.+Y.+Cheahauthor=T.+Sakulthaewauthor=J.+Chalkauthor=B.+Intharabutauthor=K.+Silamutauthor=S.+J.+Leeauthor=B.+Vihokhernauthor=C.+Kunasolauthor=M.+Imwongauthor=J.+Tarningauthor=W.+J.+Taylorauthor=S.+Yeungauthor=C.+J.+Woodrowauthor=J.+A.+Fleggauthor=D.+Dasauthor=J.+Smithauthor=M.+Venkatesanauthor=C.+V.+Ploweauthor=K.+Stepniewskaauthor=P.+J.+Guerinauthor=A.+M.+Dondorpauthor=N.+P.+Dayauthor=N.+J.+White&title=Spread+of+artemisinin+resistance+in+Plasmodium+falciparum+malaria&doi=10.1056%2FNEJMoa1314981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Spread of artemisinin resistance in Plasmodium falciparum malaria</span></div><div class="casAuthors">Ashley, E. A.; Dhorda, M.; Fairhurst, R. M.; Amaratunga, C.; Lim, P.; Suon, S.; Sreng, S.; Anderson, J. M.; Mao, S.; Sam, B.; Sopha, C.; Chuor, C. M.; Nguon, C.; Sovannaroth, S.; Pukrittayakamee, S.; Jittamala, P.; Chotivanich, K.; Chutasmit, K.; Suchatsoonthorn, C.; Runcharoen, R.; Hien, T. T.; Thuy-Nhien, N. T.; Thanh, N. V.; Phu, N. H.; Htut, Y.; Han, K.-T.; Aye, K. H.; Mokuolu, O. A.; Olaosebikan, R. R.; Folaranmi, O. O.; Mayxay, M.; Khanthavong, M.; Hongvanthong, B.; Newton, P. N.; Onyamboko, M. A.; Fanello, C. I.; Tshefu, A. K.; Mishra, N.; Valecha, N.; Phyo, A. P.; Nosten, F.; Yi, P.; Tripura, R.; Borrmann, S.; Bashraheil, M.; Peshu, J.; Faiz, M. A.; Ghose, A.; Hossain, M. A.; Samad, R.; Rahman, M. R.; Hasan, M. M.; Islam, A.; Miotto, O.; Amato, R.; MacInnis, B.; Stalker, J.; Kwiatkowski, D. P.; Bozdech, Z.; Jeeyapant, A.; Cheah, P. Y.; Sakulthaew, T.; Chalk, J.; Intharabut, B.; Silamut, K.; Lee, S. J.; Vihokhern, B.; Kunasol, C.; Imwong, M.; Tarning, J.; Taylor, W. J.; Yeung, S.; Woodrow, C. J.; Flegg, J. A.; Das, D.; Smith, J.; Venkatesan, M.; Plowe, C. V.; Stepniewska, K.; Guerin, P. J.; Dondorp, A. M.; Day, N. P.; White, N. J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-423, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia and now poses a threat to the control and elimination of malaria.  Mapping the geog. extent of resistance is essential for planning containment and elimination strategies.  Methods: Between May 2011 and Apr. 2013, we enrolled 1241 adults and children with acute, uncomplicated falciparum malaria in an open-label trial at 15 sites in 10 countries (7 in Asia and 3 in Africa).  Patients received artesunate, administered orally at a daily dose of either 2 mg per kg of body wt. per day or 4 mg per kg, for 3 days, followed by a std. 3-day course of artemisinin-based combination therapy.  Parasite counts in peripheral-blood samples were measured every 6 h, and the parasite clearance half-lives were detd.  Results: The median parasite clearance half-lives ranged from 1.9 h in the Democratic Republic of Congo to 7.0 h at the Thailand-Cambodia border.  Slowly clearing infections (parasite clearance half-life >5 h), strongly assocd. with single point mutations in the "propeller" region of the P. falciparum kelch protein gene on chromosome 13 (kelch13), were detected throughout mainland Southeast Asia from Southern Vietnam to central Myanmar.  The incidence of pre-treatment and post-treatment gametocytemia was higher among patients with slow parasite clearance, suggesting greater potential for transmission.  In Western Cambodia, where artemisinin-based combination therapies are failing, the 6-day course of antimalarial therapy was assocd. with a cure rate of 97.7% (95% confidence interval, 90.9 to 99.4) at 42 days.  Conclusions: Artemisinin resistance to P. falciparum, which is now prevalent across mainland Southeast Asia, is assocd. with mutations in kelch13.  Prolonged courses of artemisinin- based combination therapies are currently efficacious in areas where std. 3-day treatments are failing. (Funded by the U.K. Department of International Development and others).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7aJ4A3O4W8rVg90H21EOLACvtfcHk0lhRFl_7-x5P8g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ers7jF&md5=bb2f2a4d554ba6a1f4c605868be43f6e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1314981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1314981%26sid%3Dliteratum%253Aachs%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DDhorda%26aufirst%3DM.%26aulast%3DFairhurst%26aufirst%3DR.%2BM.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DLim%26aufirst%3DP.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DSreng%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DSam%26aufirst%3DB.%26aulast%3DSopha%26aufirst%3DC.%26aulast%3DChuor%26aufirst%3DC.%2BM.%26aulast%3DNguon%26aufirst%3DC.%26aulast%3DSovannaroth%26aufirst%3DS.%26aulast%3DPukrittayakamee%26aufirst%3DS.%26aulast%3DJittamala%26aufirst%3DP.%26aulast%3DChotivanich%26aufirst%3DK.%26aulast%3DChutasmit%26aufirst%3DK.%26aulast%3DSuchatsoonthorn%26aufirst%3DC.%26aulast%3DRuncharoen%26aufirst%3DR.%26aulast%3DHien%26aufirst%3DT.%2BT.%26aulast%3DThuy-Nhien%26aufirst%3DN.%2BT.%26aulast%3DThanh%26aufirst%3DN.%2BV.%26aulast%3DPhu%26aufirst%3DN.%2BH.%26aulast%3DHtut%26aufirst%3DY.%26aulast%3DHan%26aufirst%3DK.-T.%26aulast%3DAye%26aufirst%3DK.%2BH.%26aulast%3DMokuolu%26aufirst%3DO.%2BA.%26aulast%3DOlaosebikan%26aufirst%3DR.%2BR.%26aulast%3DFolaranmi%26aufirst%3DO.%2BO.%26aulast%3DMayxay%26aufirst%3DM.%26aulast%3DKhanthavong%26aufirst%3DM.%26aulast%3DHongvanthong%26aufirst%3DB.%26aulast%3DNewton%26aufirst%3DP.%2BN.%26aulast%3DOnyamboko%26aufirst%3DM.%2BA.%26aulast%3DFanello%26aufirst%3DC.%2BI.%26aulast%3DTshefu%26aufirst%3DA.%2BK.%26aulast%3DMishra%26aufirst%3DN.%26aulast%3DValecha%26aufirst%3DN.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DYi%26aufirst%3DP.%26aulast%3DTripura%26aufirst%3DR.%26aulast%3DBorrmann%26aufirst%3DS.%26aulast%3DBashraheil%26aufirst%3DM.%26aulast%3DPeshu%26aufirst%3DJ.%26aulast%3DFaiz%26aufirst%3DM.%2BA.%26aulast%3DGhose%26aufirst%3DA.%26aulast%3DHossain%26aufirst%3DM.%2BA.%26aulast%3DSamad%26aufirst%3DR.%26aulast%3DRahman%26aufirst%3DM.%2BR.%26aulast%3DHasan%26aufirst%3DM.%2BM.%26aulast%3DIslam%26aufirst%3DA.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DAmato%26aufirst%3DR.%26aulast%3DMacInnis%26aufirst%3DB.%26aulast%3DStalker%26aufirst%3DJ.%26aulast%3DKwiatkowski%26aufirst%3DD.%2BP.%26aulast%3DBozdech%26aufirst%3DZ.%26aulast%3DJeeyapant%26aufirst%3DA.%26aulast%3DCheah%26aufirst%3DP.%2BY.%26aulast%3DSakulthaew%26aufirst%3DT.%26aulast%3DChalk%26aufirst%3DJ.%26aulast%3DIntharabut%26aufirst%3DB.%26aulast%3DSilamut%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DVihokhern%26aufirst%3DB.%26aulast%3DKunasol%26aufirst%3DC.%26aulast%3DImwong%26aufirst%3DM.%26aulast%3DTarning%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DW.%2BJ.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DWoodrow%26aufirst%3DC.%2BJ.%26aulast%3DFlegg%26aufirst%3DJ.%2BA.%26aulast%3DDas%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DVenkatesan%26aufirst%3DM.%26aulast%3DPlowe%26aufirst%3DC.%2BV.%26aulast%3DStepniewska%26aufirst%3DK.%26aulast%3DGuerin%26aufirst%3DP.%2BJ.%26aulast%3DDondorp%26aufirst%3DA.%2BM.%26aulast%3DDay%26aufirst%3DN.%2BP.%26aulast%3DWhite%26aufirst%3DN.%2BJ.%26atitle%3DSpread%2520of%2520artemisinin%2520resistance%2520in%2520Plasmodium%2520falciparum%2520malaria%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D411%26epage%3D423%26doi%3D10.1056%2FNEJMoa1314981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witkowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duru, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ©nard, D.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> resistance to artemisinin derivatives and piperaquine: a major challenge for malaria elimination in Cambodia</span>. <i>Am. J. Trop. Med. Hyg.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1228</span>â <span class="NLM_lpage">1238</span>, <span class="refDoi">Â DOI: 10.4269/ajtmh.16-0234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.4269%2Fajtmh.16-0234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=27928074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVOksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2016&pages=1228-1238&author=B.+Witkowskiauthor=V.+Duruauthor=D.+M%C3%A9nard&title=Plasmodium+falciparum+resistance+to+artemisinin+derivatives+and+piperaquine%3A+a+major+challenge+for+malaria+elimination+in+Cambodia&doi=10.4269%2Fajtmh.16-0234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum resistance to artemisinin derivatives and piperaquine: a major challenge for malaria elimination in Cambodia</span></div><div class="casAuthors">Duru, Valentine; Witkowski, Benoit; Menard, Didier</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Tropical Medicine and Hygiene</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1228-1238</span>CODEN:
                <span class="NLM_cas:coden">AJTHAB</span>;
        ISSN:<span class="NLM_cas:issn">1476-1645</span>.
    
            (<span class="NLM_cas:orgname">American Society of Tropical Medicine and Hygiene</span>)
        </div><div class="casAbstract">Artemisinin-based combination therapies (ACTs) are the cornerstone of current strategies for fighting malaria.  Over the last decade, ACTs have played a major role in decreasing malaria burden.  However, this progress is being jeopardized by the emergence of artemisinin-resistant Plasmodium falciparum parasites.  Artemisinin resistance was first detected in western Cambodia in 2008 and has since been obsd. in neighboring countries in southeast Asia.  The problem of antimalarial drug resistance has recently worsened in Cambodia, with reports of parasites resistant to piperaquine, the latest generation of partner drug used in combination with dihydroartemisinin, leading to worrying rates of clin. treatment failure.  The monitoring and the comprehension of both types of resistance are crucial to prevent the spread of multidrug-resistant parasites outside southeast Asia, and particularly to Africa, where the public health consequences would be catastrophic.  To this end, new tools are required for studying the biol. and mol. mechanisms underlying resistance to antimalarial drugs and for monitoring the geog. distribution of the resistant parasites.  In this review, we detail the major advances in our understanding of resistance to artemisinin and piperaquine and define the challenges that the malaria community will have to face in the coming years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-aVDzPSnfrVg90H21EOLACvtfcHk0lhRFl_7-x5P8g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVOksg%253D%253D&md5=2005343e22603f7997544d2e2ac9c3b1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4269%2Fajtmh.16-0234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4269%252Fajtmh.16-0234%26sid%3Dliteratum%253Aachs%26aulast%3DWitkowski%26aufirst%3DB.%26aulast%3DDuru%26aufirst%3DV.%26aulast%3DM%25C3%25A9nard%26aufirst%3DD.%26atitle%3DPlasmodium%2520falciparum%2520resistance%2520to%2520artemisinin%2520derivatives%2520and%2520piperaquine%253A%2520a%2520major%2520challenge%2520for%2520malaria%2520elimination%2520in%2520Cambodia%26jtitle%3DAm.%2520J.%2520Trop.%2520Med.%2520Hyg.%26date%3D2016%26volume%3D95%26spage%3D1228%26epage%3D1238%26doi%3D10.4269%2Fajtmh.16-0234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straimer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">GnÃ¤dig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralph, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span> <span> </span><span class="NLM_article-title">Artemisinin action and resistance in <i>Plasmodium falciparum</i></span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">682</span>â <span class="NLM_lpage">696</span>, <span class="refDoi">Â DOI: 10.1016/j.pt.2016.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.pt.2016.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=27289273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC28Xoslamt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=682-696&author=L.+Tilleyauthor=J.+Straimerauthor=N.+F.+Gn%C3%A4digauthor=S.+A.+Ralphauthor=D.+A.+Fidock&title=Artemisinin+action+and+resistance+in+Plasmodium+falciparum&doi=10.1016%2Fj.pt.2016.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Artemisinin Action and Resistance in Plasmodium falciparum</span></div><div class="casAuthors">Tilley, Leann; Straimer, Judith; Gnadig, Nina F.; Ralph, Stuart A.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">682-696</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The worldwide use of artemisinin-based combination therapies (ACTs) has contributed in recent years to a substantial redn. in deaths resulting from Plasmodium falciparum malaria.  Resistance to artemisinins, however, has emerged in Southeast Asia.  Clin., resistance is defined as a slower rate of parasite clearance in patients treated with an artemisinin deriv. or an ACT.  These slow clearance rates assoc. with enhanced survival rates of ring-stage parasites briefly exposed in vitro to dihydroartemisinin.  We describe recent progress made in defining the mol. basis of artemisinin resistance, which has identified a primary role for the P. falciparum K13 protein.  Using K13 mutations as mol. markers, epidemiol. studies are now tracking the emergence and spread of artemisinin resistance.  Mechanistic studies suggest potential ways to overcome resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTqDTZppoE1bVg90H21EOLACvtfcHk0lhRFl_7-x5P8g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xoslamt78%253D&md5=8a1cb66eab2962ca73ea6d6e2cbf8f21</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2016.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2016.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DTilley%26aufirst%3DL.%26aulast%3DStraimer%26aufirst%3DJ.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DRalph%26aufirst%3DS.%2BA.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26atitle%3DArtemisinin%2520action%2520and%2520resistance%2520in%2520Plasmodium%2520falciparum%26jtitle%3DTrends%2520Parasitol.%26date%3D2016%26volume%3D32%26spage%3D682%26epage%3D696%26doi%3D10.1016%2Fj.pt.2016.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tazerouni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundararaj, K. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, J. C.</span></span> <span> </span><span class="NLM_article-title">Therapeutic failure of primaquine and need for new medicines in radical cure of <i>Plasmodium vivax</i></span>. <i>Acta. Trop.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>160</i></span>,  <span class="NLM_fpage">35</span>â <span class="NLM_lpage">38</span>, <span class="refDoi">Â DOI: 10.1016/j.actatropica.2016.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.actatropica.2016.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=27109040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVWksLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2016&pages=35-38&author=D.+Thomasauthor=H.+Tazerouniauthor=K.+G.+S.+Sundararajauthor=J.+C.+Cooper&title=Therapeutic+failure+of+primaquine+and+need+for+new+medicines+in+radical+cure+of+Plasmodium+vivax&doi=10.1016%2Fj.actatropica.2016.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic failure of primaquine and need for new medicines in radical cure of Plasmodium vivax</span></div><div class="casAuthors">Thomas, Dixon; Tazerouni, Hedieh; Sundararaj, Kishore Gnana Sam; Cooper, Jason C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Tropica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-38</span>CODEN:
                <span class="NLM_cas:coden">ACTRAQ</span>;
        ISSN:<span class="NLM_cas:issn">0001-706X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Primaquine has been the drug of choice for the prevention of Plasmodium vivax relapse for more than 60 years.  Primaquine tolerant strain of P. vivax was identified in 1944.  Significant mortality and disease burden of P. vivax calls for the need of new drugs.  Primaquine resistance is a complex issue, as the mechanism of resistance is not clear.  Direct evidence of resistance to primaquine by hypnozoites has not yet been shown.  There are some reports detailing risk of primaquine resistance in specific regions, but the overall distribution of primaquine resistance in P. vivax-infected people is largely unknown.  Confounding factors contribute to treatment failures; such as inadequate doses, inappropriate dosing intervals, risk of reinfection, combinations with blood schizontocidals, and compliance.  Therefore, primaquine resistance needs to be addressed along with addnl. important confounding factors.  Tafenoquine is the most studied drug in replacing primaquine for the radical cure of P. vivax malaria.  It has comparable efficacy with primaquine.  The potential advantage of tafenoquine is better compliance with a single dose regimen.  Rational use of primaquine can secure its effectiveness, but it is essential in the future to have better or similar alternatives to treat P. vivax.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrANrL4QAlBcLVg90H21EOLACvtfcHk0lg0WDYSxPbBgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVWksLk%253D&md5=7da9e56ab0375a875204e348b88af055</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.actatropica.2016.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.actatropica.2016.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DD.%26aulast%3DTazerouni%26aufirst%3DH.%26aulast%3DSundararaj%26aufirst%3DK.%2BG.%2BS.%26aulast%3DCooper%26aufirst%3DJ.%2BC.%26atitle%3DTherapeutic%2520failure%2520of%2520primaquine%2520and%2520need%2520for%2520new%2520medicines%2520in%2520radical%2520cure%2520of%2520Plasmodium%2520vivax%26jtitle%3DActa.%2520Trop.%26date%3D2016%26volume%3D160%26spage%3D35%26epage%3D38%26doi%3D10.1016%2Fj.actatropica.2016.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Val, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brito-Sousa, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassat, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzzatto, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacerda, M. V.</span></span> <span> </span><span class="NLM_article-title">Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence</span>. <i>Future Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1261</span>â <span class="NLM_lpage">1279</span>, <span class="refDoi">Â DOI: 10.2217/fmb-2019-0202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.2217%2Ffmb-2019-0202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=31596137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVersb%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2019&pages=1261-1279&author=F.+Valauthor=F.+T.+Costaauthor=L.+Kingauthor=J.+D.+Brito-Sousaauthor=Q.+Bassatauthor=W.+M.+Monteiroauthor=A.+M.+Siqueiraauthor=L.+Luzzattoauthor=M.+V.+Lacerda&title=Tafenoquine+for+the+prophylaxis%2C+treatment+and+elimination+of+malaria%3A+eagerness+must+meet+prudence&doi=10.2217%2Ffmb-2019-0202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Tafenoquine for the prophylaxis, treatment and elimination of malaria: eagerness must meet prudence</span></div><div class="casAuthors">Val, Fernando; Costa, Fabio T. M.; King, Liam; Brito-Sousa, Jose D.; Bassat, Quique; Monteiro, Wuelton M.; Siqueira, Andre M.; Luzzatto, Lucio; Lacerda, Marcus V. G.</div><div class="citationInfo"><span class="NLM_cas:title">Future Microbiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1261-1279</span>CODEN:
                <span class="NLM_cas:coden">FMUIAR</span>;
        ISSN:<span class="NLM_cas:issn">1746-0913</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Malaria puts more than 3 billion people at risk of infection and causes high morbidity and mortality.  Plasmodium vivax forms hypnozoites, which may initiate recurrences, even in the absence of reinfection or superinfection.  Until recently, the only drug available for eliminating hypnozoites was primaquine (PQ), which, given its short half-life, requires a relatively long course of treatment.  Tafenoquine (TQ) is a PQ analog with a longer half-life.  This enables radical cure of malaria with a single dose and overcomes adherence issues assocd. with PQ, thereby increasing effectiveness in real-life settings.  Clin. studies have provided sound evidence for TQ's safety and efficacy against malaria, which recently led to its approval by the US FDA.  Here, we review aspects of TQ, including how to avoid hemolytic anemia in G6PD deficient patients.  We believe that TQ promises to be a major advance toward malaria elimination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgAPqipba067Vg90H21EOLACvtfcHk0lg0WDYSxPbBgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVersb%252FI&md5=98ba1d5836e6965ba38f2666432d5b32</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2217%2Ffmb-2019-0202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffmb-2019-0202%26sid%3Dliteratum%253Aachs%26aulast%3DVal%26aufirst%3DF.%26aulast%3DCosta%26aufirst%3DF.%2BT.%26aulast%3DKing%26aufirst%3DL.%26aulast%3DBrito-Sousa%26aufirst%3DJ.%2BD.%26aulast%3DBassat%26aufirst%3DQ.%26aulast%3DMonteiro%26aufirst%3DW.%2BM.%26aulast%3DSiqueira%26aufirst%3DA.%2BM.%26aulast%3DLuzzatto%26aufirst%3DL.%26aulast%3DLacerda%26aufirst%3DM.%2BV.%26atitle%3DTafenoquine%2520for%2520the%2520prophylaxis%252C%2520treatment%2520and%2520elimination%2520of%2520malaria%253A%2520eagerness%2520must%2520meet%2520prudence%26jtitle%3DFuture%2520Microbiol.%26date%3D2019%26volume%3D14%26spage%3D1261%26epage%3D1279%26doi%3D10.2217%2Ffmb-2019-0202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashton, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devine, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¶hrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laleu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creek, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleebs, B. E.</span></span> <span> </span><span class="NLM_article-title">The development process for discovery and clinical advancement of modern antimalarials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">10526</span>â <span class="NLM_lpage">10562</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b00761</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00761" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFamsrvL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=10526-10562&author=T.+D.+Ashtonauthor=S.+M.+Devineauthor=J.+J.+M%C3%B6hrleauthor=B.+Laleuauthor=J.+N.+Burrowsauthor=S.+A.+Charmanauthor=D.+J.+Creekauthor=B.+E.+Sleebs&title=The+development+process+for+discovery+and+clinical+advancement+of+modern+antimalarials&doi=10.1021%2Facs.jmedchem.9b00761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The Development Process for Discovery and Clinical Advancement of Modern Antimalarials</span></div><div class="casAuthors">Ashton, Trent D.; Devine, Shane M.; Mohrle, Jorg J.; Laleu, Benoit; Burrows, Jeremy N.; Charman, Susan A.; Creek, Darren J.; Sleebs, Brad E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10526-10562</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Malaria is a devastating disease caused by Plasmodium parasites resulting in approx. 435,000 deaths in 2018.  The impact of malaria is compounded by the emergence of widespread resistance to current antimalarial therapies.  Recently a new strategy was initiated to screen small mol. collections against the Plasmodium parasite enabling the identification of new antimalarial chemotypes with novel modes of action.  This initiative ushered in the modern era of antimalarial drug development and as a result, numerous lead candidates are advancing towards or are currently in human clin. trials.  In this perspective, we describe the development pathway of four of the most clin. advanced modern antimalarials, KAE609, KAF156, DSM265 and MMV048.  Addnl., the mechanism of action and lifecycle stage-specificity of the four antimalarials is discussed in relation to aligning with global strategies to treat and eliminate malaria.  This perspective serves as a guide to the expectations of modern antimalarial drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy-Wsk49dMLrVg90H21EOLACvtfcHk0lgP_iSNA_8J1g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFamsrvL&md5=767c459a589507f646fdbd2816030d8d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00761%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DT.%2BD.%26aulast%3DDevine%26aufirst%3DS.%2BM.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DLaleu%26aufirst%3DB.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DCreek%26aufirst%3DD.%2BJ.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26atitle%3DThe%2520development%2520process%2520for%2520discovery%2520and%2520clinical%2520advancement%2520of%2520modern%2520antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D10526%26epage%3D10562%26doi%3D10.1021%2Facs.jmedchem.9b00761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duparc, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft van Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaszubska, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ¶hrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span> <span> </span><span class="NLM_article-title">New developments in anti-malarial target candidate and product profiles</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">26</span>, <span class="refDoi">Â DOI: 10.1186/s12936-016-1675-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1186%2Fs12936-016-1675-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28086874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=26&author=J.+N.+Burrowsauthor=S.+Duparcauthor=W.+E.+Gutteridgeauthor=R.+Hooft+van+Huijsduijnenauthor=W.+Kaszubskaauthor=F.+Macintyreauthor=S.+Mazzuriauthor=J.+J.+M%C3%B6hrleauthor=T.+N.+C.+Wells&title=New+developments+in+anti-malarial+target+candidate+and+product+profiles&doi=10.1186%2Fs12936-016-1675-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in anti-malarial target candidate and product profiles</span></div><div class="casAuthors">Burrows, Jeremy N.; Duparc, Stephan; Gutteridge, Winston E.; Hooft van Huijsduijnen, Rob; Kaszubska, Wiweka; MacIntyre, Fiona; Mazzuri, Sebastien; Mohrle, Jorg J.; Wells, Timothy N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26/1-26/29</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A decade of discovery and development of new anti-malarial medicines has led to a renewed focus on malaria elimination and eradication.  Changes in the way new anti-malarial drugs are discovered and developed have led to a dramatic increase in the no. and diversity of new mols. presently in pre-clin. and early clin. development.  The twin challenges faced can be summarized by multi-drug resistant malaria from the Greater Mekong Subregion, and the need to provide simplified medicines.  This review lists changes in anti-malarial target candidate and target product profiles over the last 4 years.  As well as new medicines to treat disease and prevent transmission, there has been increased focus on the longer term goal of finding new medicines for chemoprotection, potentially with long-acting mols., or parenteral formulations.  Other gaps in the malaria armamentarium, such as drugs to treat severe malaria and endectocides (that kill mosquitoes which feed on people who have taken the drug), are defined here.  Ultimately the elimination of malaria requires medicines that are safe and well-tolerated to be used in vulnerable populations: in pregnancy, esp. the first trimester, and in those suffering from malnutrition or co-infection with other pathogens.  These updates reflect the maturing of an understanding of the key challenges in producing the next generation of medicines to control, eliminate and ultimately eradicate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjgdhMYAylM7Vg90H21EOLACvtfcHk0lgP_iSNA_8J1g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D&md5=17984994f7a29c9fb184faa5214d4d35</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs12936-016-1675-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-016-1675-x%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DGutteridge%26aufirst%3DW.%2BE.%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DMazzuri%26aufirst%3DS.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26atitle%3DNew%2520developments%2520in%2520anti-malarial%2520target%2520candidate%2520and%2520product%2520profiles%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D26%26doi%3D10.1186%2Fs12936-016-1675-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baird, J. K.</span></span> <span> </span><span class="NLM_article-title">Targeting the hypnozoite reservoir of <i>Plasmodium vivax</i>: the hidden obstacle to malaria elimination</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">145</span>â <span class="NLM_lpage">151</span>, <span class="refDoi">Â DOI: 10.1016/j.pt.2009.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.pt.2009.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=20133198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BC3c7lsl2itA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2010&pages=145-151&author=T.+N.+C.+Wellsauthor=J.+N.+Burrowsauthor=J.+K.+Baird&title=Targeting+the+hypnozoite+reservoir+of+Plasmodium+vivax%3A+the+hidden+obstacle+to+malaria+elimination&doi=10.1016%2Fj.pt.2009.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination</span></div><div class="casAuthors">Wells Timothy N C; Burrows Jeremy N; Baird J Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Trends in parasitology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">145-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Plasmodium vivax is the major species of malaria parasite outside Africa.  It is especially problematic in that the infection can relapse in the absence of mosquitoes by activation of dormant hypnozoites in the liver.  Medicines that target the erythrocytic stages of Plasmodium falciparum are also active against P. vivax, except where these have been compromised by resistance.  However, the only clinical therapy against relapse of vivax malaria is the 8-aminoquinoline, primaquine.  This molecule has the drawback of causing haemolysis in genetically sensitive patients and requires 14 days of treatment.  New, safer and more-easily administered drugs are urgently needed, and this is a crucial gap in the broader malaria-elimination agenda.  New developments in cell biology are starting to open ways to the next generation of drugs against hypnozoites.  This search is urgent, given the time needed to develop a new medication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuUmTr4o7U9aqcneEtCi92fW6udTcc2eYR_M1KGnJeRbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7lsl2itA%253D%253D&md5=0ea69f3316e4d8170a0838a4ec0152f5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2009.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2009.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DBaird%26aufirst%3DJ.%2BK.%26atitle%3DTargeting%2520the%2520hypnozoite%2520reservoir%2520of%2520Plasmodium%2520vivax%253A%2520the%2520hidden%2520obstacle%2520to%2520malaria%2520elimination%26jtitle%3DTrends%2520Parasitol.%26date%3D2010%26volume%3D26%26spage%3D145%26epage%3D151%26doi%3D10.1016%2Fj.pt.2009.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kancharla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bane, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vesely, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreishman-Deitrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciotti, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmeda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaona, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sousa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcsisin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaynor-Ohnstad, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leed, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huezo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span> <span> </span><span class="NLM_article-title">Discovery and structural optimization of acridones as broad-spectrum antimalarials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3475</span>â <span class="NLM_lpage">3502</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.8b01961</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFegtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3475-3502&author=R.+A.+Dodeanauthor=P.+Kancharlaauthor=Y.+Liauthor=V.+Melendezauthor=L.+Readauthor=C.+E.+Baneauthor=B.+Veselyauthor=M.+Kreishman-Deitrickauthor=C.+Blackauthor=Q.+Liauthor=R.+J.+Sciottiauthor=R.+Olmedaauthor=T.+L.+Luongauthor=H.+Gaonaauthor=B.+Potterauthor=J.+Sousaauthor=S.+Marcsisinauthor=D.+Caridhaauthor=L.+Xieauthor=C.+Vuongauthor=Q.+Zengauthor=J.+Zhangauthor=P.+Zhangauthor=H.+Linauthor=K.+Butlerauthor=N.+Roncalauthor=L.+Gaynor-Ohnstadauthor=S.+E.+Leedauthor=C.+Nolanauthor=S.+J.+Huezoauthor=S.+A.+Rasmussenauthor=M.+T.+Stephensauthor=J.+C.+Tanauthor=R.+A.+Cooperauthor=M.+J.+Smilksteinauthor=S.+Pouauthor=R.+W.+Winterauthor=M.+K.+Riscoeauthor=J.+X.+Kelly&title=Discovery+and+structural+optimization+of+acridones+as+broad-spectrum+antimalarials&doi=10.1021%2Facs.jmedchem.8b01961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials</span></div><div class="casAuthors">Dodean, Rozalia A.; Kancharla, Papireddy; Li, Yuexin; Melendez, Victor; Read, Lisa; Bane, Charles E.; Vesely, Brian; Kreishman-Deitrick, Mara; Black, Chad; Li, Qigui; Sciotti, Richard J.; Olmeda, Raul; Luong, Thu-Lan; Gaona, Heather; Potter, Brittney; Sousa, Jason; Marcsisin, Sean; Caridha, Diana; Xie, Lisa; Vuong, Chau; Zeng, Qiang; Zhang, Jing; Zhang, Ping; Lin, Hsiuling; Butler, Kirk; Roncal, Norma; Gaynor-Ohnstad, Lacy; Leed, Susan E.; Nolan, Christina; Huezo, Stephanie J.; Rasmussen, Stephanie A.; Stephens, Melissa T.; Tan, John C.; Cooper, Roland A.; Smilkstein, Martin J.; Pou, Sovitj; Winter, Rolf W.; Riscoe, Michael K.; Kelly, Jane X.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3475-3502</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Malaria remains one of the deadliest diseases in the world today.  Novel chemoprophylactic and chemotherapeutic antimalarials are needed to support the renewed eradication agenda.  We have discovered a novel antimalarial acridone chemotype with dual-stage activity against both liver-stage and blood-stage malaria.  Several lead compds. generated from structural optimization of a large library of novel acridones exhibit efficacy in the following systems: (1) picomolar inhibition of in vitro Plasmodium falciparum blood-stage growth against multi-drug-resistant parasites; (2) curative efficacy after oral administration in an erythrocytic Plasmodium yoelii murine malaria model; (3) prevention of in vitro Plasmodium berghei sporozoite-induced development in human hepatocytes; and (4) protection of in vivo P. berghei sporozoite-induced infection in mice.  This study offers the first account of liver-stage antimalarial activity in an acridone chemotype.  Details of the design, chem., structure-activity relationships, safety, metabolic/pharmacokinetic studies, and mechanistic investigation are presented herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRZ1O0W0RmubVg90H21EOLACvtfcHk0ljbWj_pAQ0w7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFegtbY%253D&md5=02b0e991c8efcc4d899fceebfe71eade</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01961%26sid%3Dliteratum%253Aachs%26aulast%3DDodean%26aufirst%3DR.%2BA.%26aulast%3DKancharla%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DRead%26aufirst%3DL.%26aulast%3DBane%26aufirst%3DC.%2BE.%26aulast%3DVesely%26aufirst%3DB.%26aulast%3DKreishman-Deitrick%26aufirst%3DM.%26aulast%3DBlack%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DOlmeda%26aufirst%3DR.%26aulast%3DLuong%26aufirst%3DT.%2BL.%26aulast%3DGaona%26aufirst%3DH.%26aulast%3DPotter%26aufirst%3DB.%26aulast%3DSousa%26aufirst%3DJ.%26aulast%3DMarcsisin%26aufirst%3DS.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DVuong%26aufirst%3DC.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DButler%26aufirst%3DK.%26aulast%3DRoncal%26aufirst%3DN.%26aulast%3DGaynor-Ohnstad%26aufirst%3DL.%26aulast%3DLeed%26aufirst%3DS.%2BE.%26aulast%3DNolan%26aufirst%3DC.%26aulast%3DHuezo%26aufirst%3DS.%2BJ.%26aulast%3DRasmussen%26aufirst%3DS.%2BA.%26aulast%3DStephens%26aufirst%3DM.%2BT.%26aulast%3DTan%26aufirst%3DJ.%2BC.%26aulast%3DCooper%26aufirst%3DR.%2BA.%26aulast%3DSmilkstein%26aufirst%3DM.%2BJ.%26aulast%3DPou%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26atitle%3DDiscovery%2520and%2520structural%2520optimization%2520of%2520acridones%2520as%2520broad-spectrum%2520antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3475%26epage%3D3502%26doi%3D10.1021%2Facs.jmedchem.8b01961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span> <span> </span><span class="NLM_article-title">N,N-dimethyl glycine-promoted Ullmann coupling reaction of phenols and aryl halides</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3799</span>â <span class="NLM_lpage">3802</span>, <span class="refDoi">Â DOI: 10.1021/ol0350947</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0350947" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsFyrurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=3799-3802&author=D.+Maauthor=Q.+Cai&title=N%2CN-dimethyl+glycine-promoted+Ullmann+coupling+reaction+of+phenols+and+aryl+halides&doi=10.1021%2Fol0350947"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">N,N-Dimethyl Glycine-Promoted Ullmann Coupling Reaction of Phenols and Aryl Halides</span></div><div class="casAuthors">Ma, Dawei; Cai, Qian</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3799-3802</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ullmann-type diaryl ether synthesis can be performed at 90 Â°C using either aryl iodides or aryl bromides as the substrates under the assistance of N,N-dimethylglycine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-5F2Dl8PWTbVg90H21EOLACvtfcHk0ljbWj_pAQ0w7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsFyrurs%253D&md5=9d63bfcef4d0f32e18514874d5bd752f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fol0350947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0350947%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%26aulast%3DCai%26aufirst%3DQ.%26atitle%3DN%252CN-dimethyl%2520glycine-promoted%2520Ullmann%2520coupling%2520reaction%2520of%2520phenols%2520and%2520aryl%2520halides%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D3799%26epage%3D3802%26doi%3D10.1021%2Fol0350947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaisalo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latvala, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, T.</span></span> <span> </span><span class="NLM_article-title">Selective demethylations in 2, 3, 4-trimethoxyaryl carbonyl compounds</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">645</span>â <span class="NLM_lpage">648</span>, <span class="refDoi">Â DOI: 10.1080/00397918608057734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1080%2F00397918608057734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADyaL2sXks1Wh" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1986&pages=645-648&author=L.+Kaisaloauthor=A.+Latvalaauthor=T.+Hase&title=Selective+demethylations+in+2%2C+3%2C+4-trimethoxyaryl+carbonyl+compounds&doi=10.1080%2F00397918608057734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Selective demethylations in 2,3,4-trimethoxyaryl carbonyl compounds</span></div><div class="casAuthors">Kaisalo, Leena; Latvala, Anita; Hase, Tapio</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">645-8</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    </div><div class="casAbstract">2,3,4-Trimethoxybenzaldehyde, -acetophenone, and -benzoic acid gave the corresponding 2,3-dihydroxy-4-methoxy compds. in 74-84% yields on treatment with BCl3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5eJTvUmT2fbVg90H21EOLACvtfcHk0ljbWj_pAQ0w7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXks1Wh&md5=ef35586a0366c642a4fd35a7d30254e0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1080%2F00397918608057734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397918608057734%26sid%3Dliteratum%253Aachs%26aulast%3DKaisalo%26aufirst%3DL.%26aulast%3DLatvala%26aufirst%3DA.%26aulast%3DHase%26aufirst%3DT.%26atitle%3DSelective%2520demethylations%2520in%25202%252C%25203%252C%25204-trimethoxyaryl%2520carbonyl%2520compounds%26jtitle%3DSynth.%2520Commun.%26date%3D1986%26volume%3D16%26spage%3D645%26epage%3D648%26doi%3D10.1080%2F00397918608057734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">BÃ¶rger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julich-Gruner, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JÃ¤ger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KnÃ¶lker, H.-J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, clausine-H, and clausine-K and structural revision of clausine-TY</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_fpage">4741</span>â <span class="NLM_lpage">4752</span>, <span class="refDoi">Â DOI: 10.1002/ejoc.201402495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1002%2Fejoc.201402495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShurrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=4741-4752&author=C.+Schusterauthor=C.+B%C3%B6rgerauthor=K.+K.+Julich-Grunerauthor=R.+Hesseauthor=A.+J%C3%A4gerauthor=G.+Kaufmannauthor=A.+W.+Schmidtauthor=H.-J.+Kn%C3%B6lker&title=Synthesis+of+2-hydroxy-7-methylcarbazole%2C+glycozolicine%2C+mukoline%2C+mukolidine%2C+sansoakamine%2C+clausine-H%2C+and+clausine-K+and+structural+revision+of+clausine-TY&doi=10.1002%2Fejoc.201402495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, clausine-H, and clausine-K and structural revision of Clausine-TY</span></div><div class="casAuthors">Schuster, Christian; Boerger, Carsten; Julich-Gruner, Konstanze K.; Hesse, Ronny; Jaeger, Anne; Kaufmann, Gyoerley; Schmidt, Arndt W.; Knoelker, Hans-Joachim</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2014</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4741-4752</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A Buchwald-Hartwig amination and palladium(II)-catalyzed oxidative cyclization reaction sequence provided efficient access to a series of oxygenated tricyclic carbazoles.  In the present work, this approach was applied to the total syntheses of the naturally occurring carbazole alkaloids 2-hydroxy-7-methylcarbazole, glycozolicine, mukoline, mukolidine, sansoakamine, glycozolidine, clausine-H (clauszoline-C), clausine-K (clauszoline-J), and Me 2-hydroxy-7-methoxycarbazole-3-carboxylate, which was originally proposed as the structure of clausine-TY.  The synthesis of the latter led to the structural reassignment of clausine-TY.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOlrykkK9TyrVg90H21EOLACvtfcHk0ljZZvc0hOD8hw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShurrO&md5=09d8d57ecf4f0e676a8ef931b820a178</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201402495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201402495%26sid%3Dliteratum%253Aachs%26aulast%3DSchuster%26aufirst%3DC.%26aulast%3DB%25C3%25B6rger%26aufirst%3DC.%26aulast%3DJulich-Gruner%26aufirst%3DK.%2BK.%26aulast%3DHesse%26aufirst%3DR.%26aulast%3DJ%25C3%25A4ger%26aufirst%3DA.%26aulast%3DKaufmann%26aufirst%3DG.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DKn%25C3%25B6lker%26aufirst%3DH.-J.%26atitle%3DSynthesis%2520of%25202-hydroxy-7-methylcarbazole%252C%2520glycozolicine%252C%2520mukoline%252C%2520mukolidine%252C%2520sansoakamine%252C%2520clausine-H%252C%2520and%2520clausine-K%2520and%2520structural%2520revision%2520of%2520clausine-TY%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2014%26spage%3D4741%26epage%3D4752%26doi%3D10.1002%2Fejoc.201402495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kancharla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span> <span> </span><span class="NLM_article-title">Boron trifluoride etherate promoted microwave-assisted synthesis of antimalarial acridones</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">42284</span>â <span class="NLM_lpage">42293</span>, <span class="refDoi">Â DOI: 10.1039/C9RA09478D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1039%2FC9RA09478D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVCitLnL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=42284-42293&author=P.+Kancharlaauthor=R.+A.+Dodeanauthor=Y.+Liauthor=J.+X.+Kelly&title=Boron+trifluoride+etherate+promoted+microwave-assisted+synthesis+of+antimalarial+acridones&doi=10.1039%2FC9RA09478D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Boron trifluoride etherate promoted microwave-assisted synthesis of antimalarial acridones</span></div><div class="casAuthors">Kancharla, Papireddy; Dodean, Rozalia A.; Li, Yuexin; Kelly, Jane X.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">72</span>),
    <span class="NLM_cas:pages">42284-42293</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A microwave-assisted, rapid and efficient method using boron trifluoride etherate (BF3.Et2O) for the synthesis of acridones, via an intramol. acylation of N-phenylanthranilic acid derivs., has been developed.  The reaction proceeds under solvent-free conditions, tolerates a wide range of functional groups, and provides rapid access to a range of acridones in good to excellent yields.  Several of the synthesized acridones exhibited potent antimalarial activities against CQ sensitive and multi-drug resistant (MDR) parasites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrskJPlbIJSTbVg90H21EOLACvtfcHk0ljZZvc0hOD8hw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVCitLnL&md5=1b1e6069f9e2f44eeeff19c47da22645</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2FC9RA09478D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9RA09478D%26sid%3Dliteratum%253Aachs%26aulast%3DKancharla%26aufirst%3DP.%26aulast%3DDodean%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26atitle%3DBoron%2520trifluoride%2520etherate%2520promoted%2520microwave-assisted%2520synthesis%2520of%2520antimalarial%2520acridones%26jtitle%3DRSC%2520Adv.%26date%3D2019%26spage%3D42284%26epage%3D42293%26doi%3D10.1039%2FC9RA09478D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinrichs, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of dual function acridones as a new antimalarial chemotype</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>459</i></span>,  <span class="NLM_fpage">270</span>â <span class="NLM_lpage">273</span>, <span class="refDoi">Â DOI: 10.1038/nature07937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1038%2Fnature07937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=19357645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkt1Srtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2009&pages=270-273&author=J.+X.+Kellyauthor=M.+J.+Smilksteinauthor=R.+Brunauthor=S.+Wittlinauthor=R.+A.+Cooperauthor=K.+D.+Laneauthor=A.+Janowskyauthor=R.+A.+Johnsonauthor=R.+A.+Dodeanauthor=R.+Winterauthor=D.+J.+Hinrichsauthor=M.+K.+Riscoe&title=Discovery+of+dual+function+acridones+as+a+new+antimalarial+chemotype&doi=10.1038%2Fnature07937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of dual function acridones as a new antimalarial chemotype</span></div><div class="casAuthors">Kelly, Jane X.; Smilkstein, Martin J.; Brun, Reto; Wittlin, Sergio; Cooper, Roland A.; Lane, Kristin D.; Janowsky, Aaron; Johnson, Robert A.; Dodean, Rozalia A.; Winter, Rolf; Hinrichs, David J.; Riscoe, Michael K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">7244</span>),
    <span class="NLM_cas:pages">270-273</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A new antimalarial chemotype was described that combined the haem-targeting character of acridones, together with a chemosensitizing component that counteracts resistance to quinoline antimalarial drugs.  Beyond the essential intrinsic characteristics common to deserving candidate antimalarials (high potency in vitro against pan-sensitive and multi-drug-resistant Plasmodium falciparum, efficacy and safety in vivo after oral administration, inexpensive synthesis and favorable physicochem. properties), the initial lead compd. I demonstrated unique synergistic properties.  In addn. to verapamil-like' chemosensitization to chloroquine and amodiaquine against quinoline-resistant parasites, I also resulted in an apparently mechanistically distinct synergism with quinine and with piperaquine.  This synergy, evident in both quinoline-sensitive and quinoline-resistant parasites, was demonstrated both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzNhD1G8U2cbVg90H21EOLACvtfcHk0ljZZvc0hOD8hw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkt1Srtrc%253D&md5=436e58e6dab0365b88144f83e990b4d1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature07937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07937%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DSmilkstein%26aufirst%3DM.%2BJ.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DR.%2BA.%26aulast%3DLane%26aufirst%3DK.%2BD.%26aulast%3DJanowsky%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DR.%2BA.%26aulast%3DDodean%26aufirst%3DR.%2BA.%26aulast%3DWinter%26aufirst%3DR.%26aulast%3DHinrichs%26aufirst%3DD.%2BJ.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DDiscovery%2520of%2520dual%2520function%2520acridones%2520as%2520a%2520new%2520antimalarial%2520chemotype%26jtitle%3DNature%26date%3D2009%26volume%3D459%26spage%3D270%26epage%3D273%26doi%3D10.1038%2Fnature07937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smilkstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriwilaijaroen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilairat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M.</span></span> <span> </span><span class="NLM_article-title">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1803</span>â <span class="NLM_lpage">1806</span>, <span class="refDoi">Â DOI: 10.1128/AAC.48.5.1803-1806.2004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1128%2FAAC.48.5.1803-1806.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=15105138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2004&pages=1803-1806&author=M.+Smilksteinauthor=N.+Sriwilaijaroenauthor=J.+X.+Kellyauthor=P.+Wilairatauthor=M.+Riscoe&title=Simple+and+inexpensive+fluorescence-based+technique+for+high-throughput+antimalarial+drug+screening&doi=10.1128%2FAAC.48.5.1803-1806.2004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span></div><div class="casAuthors">Smilkstein, Martin; Sriwilaijaroen, Nongluk; Kelly, Jane Xu; Wilairat, Prapon; Riscoe, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1803-1806</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Radioisotopic assays involve expense, multistep protocols, equipment, and radioactivity safety requirements which are problematic in high-throughput drug testing.  This study reports an alternative, simple, robust, inexpensive, one-step fluorescence assay for use in antimalarial drug screening.  Parasite growth is detd. by using SYBR Green 1, a dye with marked fluorescence enhancement upon contact with Plasmodium DNA.  A side-by-side comparison of this fluorescence assay and a std. radioisotopic method was performed by testing known antimalarial agents against Plasmodium falciparum strain D6.  Both assay methods were used to det. the effective concn. of drug that resulted in a 50% redn. in the obsd. counts (EC50) after 48 h of parasite growth in the presence of each drug.  The EC50s of chloroquine, quinine, mefloquine, artemisinin, and 3,6-bis-.vepsiln.-(N,N-diethylamino)-amyloxyanthone were similar or identical by both techniques.  The results obtained with this new fluorescence assay suggest that it may be an ideal method for high-throughput antimalarial drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzXZZP9UWQ27Vg90H21EOLACvtfcHk0lhfxK7ZG9590w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjslGltLw%253D&md5=84a9721da1d873dfca16d1f2570ed304</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.48.5.1803-1806.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.48.5.1803-1806.2004%26sid%3Dliteratum%253Aachs%26aulast%3DSmilkstein%26aufirst%3DM.%26aulast%3DSriwilaijaroen%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DWilairat%26aufirst%3DP.%26aulast%3DRiscoe%26aufirst%3DM.%26atitle%3DSimple%2520and%2520inexpensive%2520fluorescence-based%2520technique%2520for%2520high-throughput%2520antimalarial%2520drug%2520screening%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2004%26volume%3D48%26spage%3D1803%26epage%3D1806%26doi%3D10.1128%2FAAC.48.5.1803-1806.2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nilsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaCrue, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forquer, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cross, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfurt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrisey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steuten, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirjanata, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebayang, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noviyanti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez-Diaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herreros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bathurst, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaidya, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manetsch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riscoe, M. K.</span></span> <span> </span><span class="NLM_article-title">Quinolone-3-diarylethers: a new class of antimalarial drug</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">177ra37</span>, <span class="refDoi">Â DOI: 10.1126/scitranslmed.3005029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1126%2Fscitranslmed.3005029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=23515079" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=177ra37&author=A.+Nilsenauthor=A.+N.+LaCrueauthor=K.+L.+Whiteauthor=I.+P.+Forquerauthor=R.+M.+Crossauthor=J.+Marfurtauthor=M.+W.+Matherauthor=M.+J.+Delvesauthor=D.+M.+Shacklefordauthor=F.+E.+Saenzauthor=J.+M.+Morriseyauthor=J.+Steutenauthor=T.+Mutkaauthor=Y.+Liauthor=G.+Wirjanataauthor=E.+Ryanauthor=S.+Duffyauthor=J.+X.+Kellyauthor=B.+F.+Sebayangauthor=A.-M.+Zeemanauthor=R.+Noviyantiauthor=R.+E.+Sindenauthor=C.+H.+M.+Kockenauthor=R.+N.+Priceauthor=V.+M.+Averyauthor=I.+Angulo-Barturenauthor=M.+B.+Jimenez-Diazauthor=S.+Ferrerauthor=E.+Herrerosauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=I.+Bathurstauthor=J.+N.+Burrowsauthor=P.+Sieglauthor=R.+K.+Guyauthor=R.+W.+Winterauthor=A.+B.+Vaidyaauthor=S.+A.+Charmanauthor=D.+E.+Kyleauthor=R.+Manetschauthor=M.+K.+Riscoe&title=Quinolone-3-diarylethers%3A+a+new+class+of+antimalarial+drug&doi=10.1126%2Fscitranslmed.3005029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3005029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3005029%26sid%3Dliteratum%253Aachs%26aulast%3DNilsen%26aufirst%3DA.%26aulast%3DLaCrue%26aufirst%3DA.%2BN.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DForquer%26aufirst%3DI.%2BP.%26aulast%3DCross%26aufirst%3DR.%2BM.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DMather%26aufirst%3DM.%2BW.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSaenz%26aufirst%3DF.%2BE.%26aulast%3DMorrisey%26aufirst%3DJ.%2BM.%26aulast%3DSteuten%26aufirst%3DJ.%26aulast%3DMutka%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DJ.%2BX.%26aulast%3DSebayang%26aufirst%3DB.%2BF.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DNoviyanti%26aufirst%3DR.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DJimenez-Diaz%26aufirst%3DM.%2BB.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DHerreros%26aufirst%3DE.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DBathurst%26aufirst%3DI.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DSiegl%26aufirst%3DP.%26aulast%3DGuy%26aufirst%3DR.%2BK.%26aulast%3DWinter%26aufirst%3DR.%2BW.%26aulast%3DVaidya%26aufirst%3DA.%2BB.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKyle%26aufirst%3DD.%2BE.%26aulast%3DManetsch%26aufirst%3DR.%26aulast%3DRiscoe%26aufirst%3DM.%2BK.%26atitle%3DQuinolone-3-diarylethers%253A%2520a%2520new%2520class%2520of%2520antimalarial%2520drug%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D177ra37%26doi%3D10.1126%2Fscitranslmed.3005029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayles, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olszewski, B.</span></span> <span> </span><span class="NLM_article-title">PAM 1392 (2,4-diamino-6-(3,4-dichlorobenzylamino) quinazoline) as a chemotherapeutic agent: <i>Plasmodium berghei</i>, <i>P. cynomolgi</i>, <i>P. knowlesi,</i> and <i>Trypanosoma cruzi</i></span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1969</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">32</span>â <span class="NLM_lpage">49</span>, <span class="refDoi">Â DOI: 10.1016/0014-4894(69)90050-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2F0014-4894%2869%2990050-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=4983051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADyaF1MXks12itbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1969&pages=32-49&author=P.+E.+Thompsonauthor=A.+Baylesauthor=B.+Olszewski&title=PAM+1392+%282%2C4-diamino-6-%283%2C4-dichlorobenzylamino%29+quinazoline%29+as+a+chemotherapeutic+agent%3A+Plasmodium+berghei%2C+P.+cynomolgi%2C+P.+knowlesi%2C+and+Trypanosoma+cruzi&doi=10.1016%2F0014-4894%2869%2990050-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">PAM 1392 [2,4-diamino-6-(3,4-dichlorobenzylamino)quinazoline] as a chemotherapeutic agent:  Plasmodium berghei, P. cynomolgi, P. knowlesi, and Trypanosoma cruzi</span></div><div class="casAuthors">Thompson, Paul Everett; Bayles, Anita; Olszewski, Bronislawa</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">1969</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32-49</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    </div><div class="casAbstract">PAM 1392 was active orally against blood forms of P. berghei in mice, P. cynomolgi in rhesus monkeys, and P. knowlesi in the latter host.  Against P. berghei, it was 4-11 times as potent as quinine in mice, acted rapidly, suppressed the parasitemia for 6 days in an oral dose of 200 mg./kg., acted synergistically with sulfadiazine without a commensurate increase in apparent toxicity for mice, and was effective against 4 drug-resistant lines.  The latter information suggests that it represents a new mode of action and may be useful in drug-resistant malaria.  In monkeys, it acted somewhat slowly but, when given appropriately, cured infections of P. cynomolgi and knowlesi.  The drug inhibited nuclear division of P. cynomolgi.  Against T. cruzi, PAM 1392 was active in culture against both extracellular and intracellular parasites at nontoxic levels for chick embryo cells.  This activity was partially reversed by folinic acid but not by crithidia factor.  PAM 1392 also was effective in protecting mice against the lethal effects of acute infections by T. cruzi but exhibited little capacity to effect radical cure of the infections.  Based on gross examn., the compd. is of relatively low toxicity to mice and monkeys on short-term administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn4pyMXieVj7Vg90H21EOLACvtfcHk0lhfxK7ZG9590w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1MXks12itbk%253D&md5=6041ddc17743ad3cc13b017d447f497d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0014-4894%2869%2990050-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-4894%252869%252990050-2%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DBayles%26aufirst%3DA.%26aulast%3DOlszewski%26aufirst%3DB.%26atitle%3DPAM%25201392%2520%25282%252C4-diamino-6-%25283%252C4-dichlorobenzylamino%2529%2520quinazoline%2529%2520as%2520a%2520chemotherapeutic%2520agent%253A%2520Plasmodium%2520berghei%252C%2520P.%2520cynomolgi%252C%2520P.%2520knowlesi%252C%2520and%2520Trypanosoma%2520cruzi%26jtitle%3DExp.%2520Parasitol.%26date%3D1969%26volume%3D25%26spage%3D32%26epage%3D49%26doi%3D10.1016%2F0014-4894%2869%2990050-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janse, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke-Fayard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mair, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matuschewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gemert, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, A. P.</span></span> <span> </span><span class="NLM_article-title">High efficiency transfection of <i>Plasmodium berghei</i> facilitates novel selection procedures</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">60</span>â <span class="NLM_lpage">70</span>, <span class="refDoi">Â DOI: 10.1016/j.molbiopara.2005.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.molbiopara.2005.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=16242190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ors7rE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2006&pages=60-70&author=C.+J.+Janseauthor=B.+Franke-Fayardauthor=G.+R.+Mairauthor=J.+Ramesarauthor=C.+Thielauthor=S.+Engelmannauthor=K.+Matuschewskiauthor=G.+J.+van+Gemertauthor=R.+W.+Sauerweinauthor=A.+P.+Waters&title=High+efficiency+transfection+of+Plasmodium+berghei+facilitates+novel+selection+procedures&doi=10.1016%2Fj.molbiopara.2005.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">High efficiency transfection of Plasmodium berghei facilitates novel selection procedures</span></div><div class="casAuthors">Janse, Chris J.; Franke-Fayard, Blandine; Mair, Gunnar R.; Ramesar, Jai; Thiel, Corinna; Engelmann, Sabine; Matuschewski, Kai; van Gemert, Geert Jan; Sauerwein, Robert W.; Waters, Andrew P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular & Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-70</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The use of transfection in the study of the biol. of malaria parasites has been limited due to poor transfection efficiencies (frequency of 10-6 to 10-9) and a paucity of selectable markers.  Here, a new method of transfection, using non-viral Nucleofector technol., is described for the rodent parasite Plasmodium berghei.  The transfection efficiency obtained (episomal and targeted integration into the genome) is in the range of 10-2 to 10-3.  Such high transfection efficiency strongly reduces the time, no. of lab. animals and amt. of materials required to generate transfected parasites.  Moreover, it allows different exptl. strategies for reverse genetics to be developed and we demonstrate direct selection of stably and non-reversibly transformed, fluorescent protein (FP)-expressing parasites using FACS.  Since there is no need to use a drug-selectable marker, this method increases the (low) no. of selectable markers available for transformation of P. berghei and can in principle be extended to utilize addnl. FP.  Furthermore the FACS-selected, FP-expressing parasites may serve as easily visualized ref. lines that may still be genetically manipulated with the existing drug-selectable markers.  The combination of enhanced transfection efficiency and a versatile rodent model provides a basis for the further development of novel tools for high throughput genome manipulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJCeNdKkjHOrVg90H21EOLACvtfcHk0lirpIPdZ2MH-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ors7rE&md5=6f0aec711668825f48cf2b54067f1be6</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.molbiopara.2005.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molbiopara.2005.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DJanse%26aufirst%3DC.%2BJ.%26aulast%3DFranke-Fayard%26aufirst%3DB.%26aulast%3DMair%26aufirst%3DG.%2BR.%26aulast%3DRamesar%26aufirst%3DJ.%26aulast%3DThiel%26aufirst%3DC.%26aulast%3DEngelmann%26aufirst%3DS.%26aulast%3DMatuschewski%26aufirst%3DK.%26aulast%3Dvan%2BGemert%26aufirst%3DG.%2BJ.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DWaters%26aufirst%3DA.%2BP.%26atitle%3DHigh%2520efficiency%2520transfection%2520of%2520Plasmodium%2520berghei%2520facilitates%2520novel%2520selection%2520procedures%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2006%26volume%3D145%26spage%3D60%26epage%3D70%26doi%3D10.1016%2Fj.molbiopara.2005.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozar, M. P.</span></span> <span> </span><span class="NLM_article-title">Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage <i>Plasmodium</i> infections in mice</span>. <i>Nanomedicine</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">57</span>â <span class="NLM_lpage">65</span>, <span class="refDoi">Â DOI: 10.1016/j.nano.2013.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.nano.2013.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=23891618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlKqsLbL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=57-65&author=H.+Wangauthor=Q.+Liauthor=S.+Reyesauthor=J.+Zhangauthor=Q.+Zengauthor=P.+Zhangauthor=L.+Xieauthor=P.+J.+Leeauthor=N.+Roncalauthor=V.+Melendezauthor=M.+Hickmanauthor=M.+P.+Kozar&title=Nanoparticle+formulations+of+decoquinate+increase+antimalarial+efficacy+against+liver+stage+Plasmodium+infections+in+mice&doi=10.1016%2Fj.nano.2013.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage Plasmodium infections in mice</span></div><div class="casAuthors">Wang, Hongxing; Li, Qigui; Reyes, Sean; Zhang, Jing; Zeng, Qiang; Zhang, Ping; Xie, Lisa; Lee, Patricia J.; Roncal, Norma; Melendez, Victor; Hickman, Mark; Kozar, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-65</span>CODEN:
                <span class="NLM_cas:coden">NANOBF</span>;
        ISSN:<span class="NLM_cas:issn">1549-9634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Decoquinate has potent activity against both Plasmodium hepatic development and red cell replication when tested in vitro.  Decoquinate, however, is practically insol. in water.  To achieve its maximal in vivo efficacy, we generated nanoparticle formulations of decoquinate with a mean particle size less than 400 nm.  Three sep. prepns. at doses of decoquinate 0.5-5 mg/kg were examd. in mice infected with Plasmodium berghei.  Oral administration of nanoparticle decoquinate at a dose of 1.25 mg/kg effectively inhibited the liver-stage parasite growth and provided complete causal prophylactic protection.  This efficacy is 15 fold greater than that obsd. for microparticle decoquinate, which requires minimal dose of 20 mg/kg for the same inhibitory effect.  Further in vitro studies utilizing dose-response assays revealed that decoquinate nanoformulation was substantially more potent than decoquinate microsuspension in killing both liver and blood stage malarial parasites, proving its potential for therapeutic development.  From the Clin. Editor: In this study, a nanoparticle formulation of decoquinate is shown to have superior bioavailability and efficacy in a mouse model of malaria, paving the way to the development of novel, potentially less toxic and more effective therapeutics to combat a disease that still has an enormous impact on a global scale despite the available partially effective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4rPvJMbTsIrVg90H21EOLACvtfcHk0lirpIPdZ2MH-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlKqsLbL&md5=50e4582875a2d93c51cbbdf7456a40ac</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.nano.2013.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nano.2013.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DReyes%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DP.%2BJ.%26aulast%3DRoncal%26aufirst%3DN.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DKozar%26aufirst%3DM.%2BP.%26atitle%3DNanoparticle%2520formulations%2520of%2520decoquinate%2520increase%2520antimalarial%2520efficacy%2520against%2520liver%2520stage%2520Plasmodium%2520infections%2520in%2520mice%26jtitle%3DNanomedicine%26date%3D2014%26volume%3D10%26spage%3D57%26epage%3D65%26doi%3D10.1016%2Fj.nano.2013.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, L.</span></span> <span> </span><span class="NLM_article-title">Comparative susceptibility of different mouse strains to liver-stage infection with <i>Plasmodium berghei</i> sporozoites assessed using in vivo imaging</span>. <i>Mil. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">360</span>â <span class="NLM_lpage">368</span>, <span class="refDoi">Â DOI: 10.7205/MILMED-D-16-00090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.7205%2FMILMED-D-16-00090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28291500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BC1czmtVSgtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2017&pages=360-368&author=Q.+Liauthor=L.+Xieauthor=D.+Caridhaauthor=N.+Roncalauthor=Q.+Zengauthor=J.+Zhangauthor=P.+Zhangauthor=M.+Hickmanauthor=L.+Read&title=Comparative+susceptibility+of+different+mouse+strains+to+liver-stage+infection+with+Plasmodium+berghei+sporozoites+assessed+using+in+vivo+imaging&doi=10.7205%2FMILMED-D-16-00090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative Susceptibility of Different Mouse Strains to Liver-Stage Infection With Plasmodium berghei Sporozoites Assessed Using In Vivo Imaging</span></div><div class="casAuthors">Li Qigui; Xie Lisa; Caridha Diana; Roncal Norma; Zeng Qiang; Zhang Jing; Zhang Ping; Hickman Mark; Read Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Military medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">S1</span>),
    <span class="NLM_cas:pages">360-368</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The liver stages of Plasmodium parasites are important targets for the discovery and development of prophylactic drugs.  METHODS:  A real-time in vivo imaging system was used to determine the level of luminescence measured from firefly luciferase expression by sporozoites developing in hepatocytes in different strains of mice.  RESULTS:  The luminescence values (photon counts/sec) measured from the anatomical liver location in the untreated mice infected with 10,000 Plasmodium berghei sporozoites were 8.15 Ã 10(5) for C57BL/6 Albino, 2.12 Ã 10(5) for C3H/HeNCrL, 0.91 Ã 10(5) for C57BL/6 WT, 0.28 Ã 10(5) for BALB/c, and 0.16 Ã 10(5) for ICR/CD-1 mice.  This data suggests that the C57BL/6 Albino strain is most susceptible to luminescent photon, mainly because the less light scattering and absorption from deeper tissues and the skin in the strain of mouse.  The photon count observed in black C57BL/6 wild type mice was shown to be 88.83% lower compared to C57BL/6 Albino mice.  Although the highest growth rate of sporozoites in hepatocytes was found for C57BL/6 wild type mice in this study, the black skin of this mouse significantly reduced parasite-associated bioluminescence.  CONCLUSIONS:  The minimal light scattering and absorption and also enhanced susceptibility to liver infection of C57BL/6 Albino mice makes this strain preferable sensitivity for discovery and development of prophylactic antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPtJC26cYkEYhLSh9fo81bfW6udTcc2eaYCCRI6GXe5Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czmtVSgtQ%253D%253D&md5=9cff5670b545166016ec56d9417dc808</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.7205%2FMILMED-D-16-00090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7205%252FMILMED-D-16-00090%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DRoncal%26aufirst%3DN.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DRead%26aufirst%3DL.%26atitle%3DComparative%2520susceptibility%2520of%2520different%2520mouse%2520strains%2520to%2520liver-stage%2520infection%2520with%2520Plasmodium%2520berghei%2520sporozoites%2520assessed%2520using%2520in%2520vivo%2520imaging%26jtitle%3DMil.%2520Med.%26date%3D2017%26volume%3D182%26spage%3D360%26epage%3D368%26doi%3D10.7205%2FMILMED-D-16-00090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ploemen, I. H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PrudÃªncio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douradinha, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonager, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gemert, G.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luty, A. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermsen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baptista, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Que, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowik, C. W. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janse, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke-Fayard, B. M. D.</span></span> <span> </span><span class="NLM_article-title">Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e7881</span> <span class="refDoi">Â DOI: 10.1371/journal.pone.0007881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1371%2Fjournal.pone.0007881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=19924309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BD1MjmvFymtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&author=I.+H.+J.+Ploemenauthor=M.+Prud%C3%AAncioauthor=B.+G.+Douradinhaauthor=J.+Ramesarauthor=J.+Fonagerauthor=G.-J.+van+Gemertauthor=A.+J.+F.+Lutyauthor=C.+C.+Hermsenauthor=R.+W.+Sauerweinauthor=F.+G.+Baptistaauthor=M.+M.+Motaauthor=A.+P.+Watersauthor=I.+Queauthor=C.+W.+G.+M.+Lowikauthor=S.+M.+Khanauthor=C.+J.+Janseauthor=B.+M.+D.+Franke-Fayard&title=Visualisation+and+quantitative+analysis+of+the+rodent+malaria+liver+stage+by+real+time+imaging&doi=10.1371%2Fjournal.pone.0007881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging</span></div><div class="casAuthors">Ploemen Ivo H J; Prudencio Miguel; Douradinha Bruno G; Ramesar Jai; Fonager Jannik; van Gemert Geert-Jan; Luty Adrian J F; Hermsen Cornelus C; Sauerwein Robert W; Baptista Fernanda G; Mota Maria M; Waters Andrew P; Que Ivo; Lowik Clemens W G M; Khan Shahid M; Janse Chris J; Franke-Fayard Blandine M D</div><div class="citationInfo"><span class="NLM_cas:title">PloS one</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e7881</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The quantitative analysis of Plasmodium development in the liver in laboratory animals in cultured cells is hampered by low parasite infection rates and the complicated methods required to monitor intracellular development.  As a consequence, this important phase of the parasite's life cycle has been poorly studied compared to blood stages, for example in screening anti-malarial drugs.  Here we report the use of a transgenic P. berghei parasite, PbGFP-Luc(con), expressing the bioluminescent reporter protein luciferase to visualize and quantify parasite development in liver cells both in culture and in live mice using real-time luminescence imaging.  The reporter-parasite based quantification in cultured hepatocytes by real-time imaging or using a microplate reader correlates very well with established quantitative RT-PCR methods.  For the first time the liver stage of Plasmodium is visualized in whole bodies of live mice and we were able to discriminate as few as 1-5 infected hepatocytes per liver in mice using 2D-imaging and to identify individual infected hepatocytes by 3D-imaging.  The analysis of liver infections by whole body imaging shows a good correlation with quantitative RT-PCR analysis of extracted livers.  The luminescence-based analysis of the effects of various drugs on in vitro hepatocyte infection shows that this method can effectively be used for in vitro screening of compounds targeting Plasmodium liver stages.  Furthermore, by analysing the effect of primaquine and tafenoquine in vivo we demonstrate the applicability of real time imaging to assess parasite drug sensitivity in the liver.  The simplicity and speed of quantitative analysis of liver-stage development by real-time imaging compared to the PCR methodologies, as well as the possibility to analyse liver development in live mice without surgery, opens up new possibilities for research on Plasmodium liver infections and for validating the effect of drugs and vaccines on the liver stage of Plasmodium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRCyN9RipkSqxpyrDyM_m9cfW6udTcc2eZMrznNRIVWZ7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjmvFymtA%253D%253D&md5=b9520a00b344a50b4c0ffe86cea79d65</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007881%26sid%3Dliteratum%253Aachs%26aulast%3DPloemen%26aufirst%3DI.%2BH.%2BJ.%26aulast%3DPrud%25C3%25AAncio%26aufirst%3DM.%26aulast%3DDouradinha%26aufirst%3DB.%2BG.%26aulast%3DRamesar%26aufirst%3DJ.%26aulast%3DFonager%26aufirst%3DJ.%26aulast%3Dvan%2BGemert%26aufirst%3DG.-J.%26aulast%3DLuty%26aufirst%3DA.%2BJ.%2BF.%26aulast%3DHermsen%26aufirst%3DC.%2BC.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DBaptista%26aufirst%3DF.%2BG.%26aulast%3DMota%26aufirst%3DM.%2BM.%26aulast%3DWaters%26aufirst%3DA.%2BP.%26aulast%3DQue%26aufirst%3DI.%26aulast%3DLowik%26aufirst%3DC.%2BW.%2BG.%2BM.%26aulast%3DKhan%26aufirst%3DS.%2BM.%26aulast%3DJanse%26aufirst%3DC.%2BJ.%26aulast%3DFranke-Fayard%26aufirst%3DB.%2BM.%2BD.%26atitle%3DVisualisation%2520and%2520quantitative%2520analysis%2520of%2520the%2520rodent%2520malaria%2520liver%2520stage%2520by%2520real%2520time%2520imaging%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26doi%3D10.1371%2Fjournal.pone.0007881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thiberge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blazquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldacci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shorte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MÃ©nard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amino, R.</span></span> <span> </span><span class="NLM_article-title">In vivo imaging of malaria parasites in the murine liver</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1811</span>â <span class="NLM_lpage">1818</span>, <span class="refDoi">Â DOI: 10.1038/nprot.2007.257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1038%2Fnprot.2007.257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=17641649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFahur%252FO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1811-1818&author=S.+Thibergeauthor=S.+Blazquezauthor=P.+Baldacciauthor=O.+Renaudauthor=S.+Shorteauthor=R.+M%C3%A9nardauthor=R.+Amino&title=In+vivo+imaging+of+malaria+parasites+in+the+murine+liver&doi=10.1038%2Fnprot.2007.257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo imaging of malaria parasites in the murine liver</span></div><div class="casAuthors">Thiberge, Sabine; Blazquez, Samantha; Baldacci, Patricia; Renaud, Olivier; Shorte, Spencer; Menard, Robert; Amino, Rogerio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1811-1818</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The form of the malaria parasite inoculated by the mosquito, called the sporozoite, transforms inside the host liver into thousands of a new form of the parasite, called the merozoite, which infects erythrocytes.  The authors present here a protocol to visualize in vivo the behavior of Plasmodium berghei parasites in the hepatic tissue of the murine host.  The use of GFP-expressing parasites and a high-speed spinning disk confocal microscope allows for the acquisition of four-dimensional images, which provide a time lapse view of parasite displacement and development in tissue vols.  These data can be analyzed to give information on the early events of sporozoite penetration of the hepatic tissue, i.e., sporozoite gliding in the liver sinusoids, crossing the sinusoidal barrier, gliding in the parenchyma and traversal of hepatocytes, and invasion of a final hepatocyte, as well as the terminal events of merosome and merozoite release from infected hepatocytes.  Combined with the use of mice expressing fluorescent cell types or cell markers, the system will provide useful information not only on the primary infection process, but also on parasite interactions with the host immune cells in the liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9IWiQ9c9K87Vg90H21EOLACvtfcHk0lguLg1srPGT6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFahur%252FO&md5=1e8432d297053d734bb949ff49c4fb2b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.257%26sid%3Dliteratum%253Aachs%26aulast%3DThiberge%26aufirst%3DS.%26aulast%3DBlazquez%26aufirst%3DS.%26aulast%3DBaldacci%26aufirst%3DP.%26aulast%3DRenaud%26aufirst%3DO.%26aulast%3DShorte%26aufirst%3DS.%26aulast%3DM%25C3%25A9nard%26aufirst%3DR.%26aulast%3DAmino%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520malaria%2520parasites%2520in%2520the%2520murine%2520liver%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D1811%26epage%3D1818%26doi%3D10.1038%2Fnprot.2007.257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">OâNeil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pybus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span> <span> </span><span class="NLM_article-title">Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">141</span>, <span class="refDoi">Â DOI: 10.1186/1475-2875-13-141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1186%2F1475-2875-13-141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=24731238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gsrfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=141&author=Q.+Liauthor=M.+O%E2%80%99Neilauthor=L.+Xieauthor=D.+Caridhaauthor=Q.+Zengauthor=J.+Zhangauthor=B.+Pybusauthor=M.+Hickmanauthor=V.+Melendez&title=Assessment+of+the+prophylactic+activity+and+pharmacokinetic+profile+of+oral+tafenoquine+compared+to+primaquine+for+inhibition+of+liver+stage+malaria+infections&doi=10.1186%2F1475-2875-13-141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections</span></div><div class="casAuthors">Li, Qigui; O'Neil, Michael; Xie, Lisa; Caridha, Diana; Zeng, Qiang; Zhang, Jing; Pybus, Brandon; Hickman, Mark; Melendez, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141/1-141/13, 13</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: As anti-malarial drug resistance escalates, new safe and effective medications are necessary to prevent and treat malaria infections.  The US Army is developing tafenoquine (TQ), an analog of primaquine (PQ), which is expected to be more effective in preventing malaria in deployed military personnel.  Methods: To compare the prophylactic efficacy of TQ and PQ, a transgenic Plasmodium berghei parasite expressing the bioluminescent reporter protein luciferase was utilized to visualize and quantify parasite development in C57BL/6 albino mice treated with PQ and TQ in single or multiple regimens using a real-time in vivo imaging system (IVIS).  As an addnl. endpoint, blood stage parasitemia was monitored by flow cytometry.  Comparative pharmacokinetic (PK) and liver distribution studies of oral and i.v. PQ and TQ were also performed.  Results: Mice treated orally with three doses of TQ at 5 mg/kg three doses of PQ at 25 mg/kg demonstrated no bioluminescence liver signal and no blood stage parasitemia was obsd. suggesting both drugs showed 100% causal activity at the doses tested.  Single dose oral treatment with 5 mg TQ or 25 mg of PQ, however, yielded different results as only TQ treatment resulted in causal prophylaxis in P. berghei sporozoite-infected mice.  TQ is highly effective for causal prophylaxis in mice at a minimal curative single oral dose of 5 mg/kg, which is a five-fold improvement in potency vs. PQ.  PK studies of the two drugs administered orally to mice showed that the abs. bioavailability of oral TQ was 3.5-fold higher than PQ, and the AUC of oral TQ was 94-fold higher than oral PQ.  The elimination half-life of oral TQ in mice was 28 times longer than PQ, and the liver tissue distribution of TQ revealed an AUC that was 188-fold higher than PQ.  Conclusions: The increased drug exposure levels and longer exposure time of oral TQ in the plasma and livers of mice highlight the lead quality attributes that explain the much improved efficacy of TQ when compared to PQ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLlSzjNwCpw7Vg90H21EOLACvtfcHk0lh8Bm1KcKaSbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gsrfE&md5=bcffa149f5d62a5353706c48153899b7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-13-141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-13-141%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DPybus%26aufirst%3DB.%26aulast%3DHickman%26aufirst%3DM.%26aulast%3DMelendez%26aufirst%3DV.%26atitle%3DAssessment%2520of%2520the%2520prophylactic%2520activity%2520and%2520pharmacokinetic%2520profile%2520of%2520oral%2520tafenoquine%2520compared%2520to%2520primaquine%2520for%2520inhibition%2520of%2520liver%2520stage%2520malaria%2520infections%26jtitle%3DMalar.%2520J.%26date%3D2014%26volume%3D13%26spage%3D141%26doi%3D10.1186%2F1475-2875-13-141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceja, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumwebaze, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byaruhanga, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katairo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nsobya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, R. A.</span></span> <span> </span><span class="NLM_article-title">Changing antimalarial drug sensitivities in Uganda</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">e01516</span>â <span class="NLM_lpage">e01517</span>, <span class="refDoi">Â DOI: 10.1128/AAC.01516-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1128%2FAAC.01516-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28923866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Crtb7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e01516-e01517&author=S.+A.+Rasmussenauthor=F.+G.+Cejaauthor=M.+D.+Conradauthor=P.+K.+Tumwebazeauthor=O.+Byaruhangaauthor=T.+Katairoauthor=S.+L.+Nsobyaauthor=P.+J.+Rosenthalauthor=R.+A.+Cooper&title=Changing+antimalarial+drug+sensitivities+in+Uganda&doi=10.1128%2FAAC.01516-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Changing Antimalarial Drug Sensitivities in Uganda</span></div><div class="casAuthors">Rasmussen, Stephanie A.; Ceja, Frida G.; Conrad, Melissa D.; Tumwebaze, Patrick K.; Byaruhanga, Oswald; Katairo, Thomas; Nsobya, Samuel L.; Rosenthal, Philip J.; Cooper, Roland A.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e01516-17/1-e01516-17/11</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Dihydroartemisinin-piperaquine (DP) has demonstrated excellent efficacy for the treatment and prevention of malaria in Uganda.  However, resistance to both components of this regimen has emerged in Southeast Asia.  The efficacy of artemether-lumefantrine, the first-line regimen to treat malaria in Uganda, has also been excellent, but continued pressure may select for parasites with decreased sensitivity to lumefantrine.  To gain insight into current drug sensitivity patterns, ex vivo sensitivities were assessed and genotypes previously assocd. with altered drug sensitivity were characterized for 58 isolates collected in Tororo, Uganda, from subjects presenting in 2016 with malaria from the community or as part of a clin. trial comparing DP chemoprevention regimens.  Compared to community isolates, those from trial subjects had lower sensitivities to the aminoquinolines chloroquine, monodesethyl amodiaquine, and piperaquine and greater sensitivities to lumefantrine and mefloquine, an observation consistent with DP selection pressure.  Compared to results for isolates from 2010 to 2013, the sensitivities of 2016 community isolates to chloroquine, amodiaquine, and piperaquine improved (geometric mean 50% inhibitory concns. [IC50] = 248, 76.9, and 19.1 nM in 2010 to 2013 and 33.4, 14.9, and 7.5 nM in 2016, resp. [P < 0.001 for all comparisons]), the sensitivity to lumefantrine decreased (IC50 = 3.0 nM in 2010 to 2013 and 5.4 nM in 2016 [P < 0.001]), and the sensitivity to dihydroartemisinin was unchanged (IC50 = 1.4 nM).  These changes were accompanied by decreased prevalence of transporter mutations assocd. with aminoquinoline resistance and low prevalence of polymorphisms recently assocd. with resistance to artemisinins or piperaquine.  Antimalarial drug sensitivities are changing in Uganda, but novel genotypes assocd. with DP treatment failure in Asia are not prevalent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLcmYAqeEnqLVg90H21EOLACvtfcHk0lh8Bm1KcKaSbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Crtb7M&md5=fb8a53f991d000575149db4b026359b4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FAAC.01516-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01516-17%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DS.%2BA.%26aulast%3DCeja%26aufirst%3DF.%2BG.%26aulast%3DConrad%26aufirst%3DM.%2BD.%26aulast%3DTumwebaze%26aufirst%3DP.%2BK.%26aulast%3DByaruhanga%26aufirst%3DO.%26aulast%3DKatairo%26aufirst%3DT.%26aulast%3DNsobya%26aufirst%3DS.%2BL.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DCooper%26aufirst%3DR.%2BA.%26atitle%3DChanging%2520antimalarial%2520drug%2520sensitivities%2520in%2520Uganda%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De01516%26epage%3De01517%26doi%3D10.1128%2FAAC.01516-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yourick, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabezas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span> <span> </span><span class="NLM_article-title">Mefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">684</span>â <span class="NLM_lpage">693</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00874-07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1128%2FAAC.00874-07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=17999964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlWjsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=684-693&author=D.+Caridhaauthor=D.+Yourickauthor=M.+Cabezasauthor=L.+Wolfauthor=T.+H.+Hudsonauthor=G.+S.+Dow&title=Mefloquine-induced+disruption+of+calcium+homeostasis+in+mammalian+cells+is+similar+to+that+induced+by+ionomycin&doi=10.1128%2FAAC.00874-07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Mefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin</span></div><div class="casAuthors">Caridha, D.; Yourick, D.; Cabezas, M.; Wolf, L.; Hudson, T. H.; Dow, G. S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">684-693</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In previous studies, we have shown that mefloquine disrupts calcium homeostasis in neurons by depletion of endoplasmic reticulum (ER) stores, followed by an influx of external calcium across the plasma membrane.  In this study, we explore two hypotheses concerning the mechanism(s) of action of mefloquine.  First, we investigated the possibility that mefloquine activates non-N-methyl-D-aspartic acid receptors and the inositol phosphate 3 (IP3) signaling cascade leading to ER calcium release.  Second, we compared the disruptive effects of mefloquine on calcium homeostasis to those of ionomycin in neuronal and nonneuronal cells.  Ionomycin is known to discharge the ER calcium store (through an undefined mechanism), which induces capacitative calcium entry (CCE).  In radioligand binding assays, mefloquine showed no affinity for the known binding sites of several glutamate receptor subtypes.  The pattern of neuroprotection induced by a panel of glutamate receptor antagonists was dissimilar to that of mefloquine.  Both mefloquine and ionomycin exhibited dose-related and qual. similar disruptions of calcium homeostasis in both neurons and macrophages.  The influx of external calcium was blocked by the inhibitors of CCE in a dose-related fashion.  Both mefloquine and ionomycin upregulated the IP3 pathway in a manner that we interpret to be secondary to CCE.  Collectively, these data suggest that mefloquine does not activate glutamate receptors and that it disrupts calcium homeostasis in mammalian cells in a manner similar to that of ionomycin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqepHyEkIKrnrVg90H21EOLACvtfcHk0lh8Bm1KcKaSbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlWjsrc%253D&md5=456ca97c2533ab8cdfcdbdfb8aa3a7b9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1128%2FAAC.00874-07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00874-07%26sid%3Dliteratum%253Aachs%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DYourick%26aufirst%3DD.%26aulast%3DCabezas%26aufirst%3DM.%26aulast%3DWolf%26aufirst%3DL.%26aulast%3DHudson%26aufirst%3DT.%2BH.%26aulast%3DDow%26aufirst%3DG.%2BS.%26atitle%3DMefloquine-induced%2520disruption%2520of%2520calcium%2520homeostasis%2520in%2520mammalian%2520cells%2520is%2520similar%2520to%2520that%2520induced%2520by%2520ionomycin%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D684%26epage%3D693%26doi%3D10.1128%2FAAC.00874-07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fornasiero, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isetta, A. M.</span></span> <span> </span><span class="NLM_article-title">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">165</span>â <span class="NLM_lpage">172</span>, <span class="refDoi">Â DOI: 10.1016/0022-1759(90)90187-Z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2F0022-1759%2890%2990187-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=2391427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=1990&pages=165-172&author=M.+Ferrariauthor=M.+C.+Fornasieroauthor=A.+M.+Isetta&title=MTT+colorimetric+assay+for+testing+macrophage+cytotoxic+activity+in+vitro&doi=10.1016%2F0022-1759%2890%2990187-Z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">MTT colorimetric assay for testing macrophage cytotoxic activity in vitro</span></div><div class="casAuthors">Ferrari, Mario; Fornasiero, Maria Chiara; Isetta, Anna Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-72</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">The MTT [3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide] cleavage assay, originally described by T. Mosmann (1983) for measuring cell survival/proliferation, was used successfully to quantitate macrophage-mediated cytotoxicity.  Peritoneal macrophages, from control or pyran copolymer MVE2-treated mice and from TU5 and L929 murine cell lines, were used as effectors and targets resp. in a 48 h cytotoxicity test, at 3 effector: target ratios (10:1, 5:1, 2:1).  The amt. of MTT reduced by cells to its blue formazan deriv. during an addnl. 4 h of culture was quantified spectrophotometrically at 570 nm using an ELISA reader.  A linear relationship between the formazan generated and the no. of viable TU5 and L929 cells was demonstrated, together with time-dependent growth characteristics for these cells.  The formazan produced by macrophages was independent of their functional state and did not interfere with the target cell signal.  MVE2-activated macrophages strongly inhibited the survival/growth of target cells in a dose-related way, whereas the cytotoxic activity of control macrophages was very low.  Finally, the MTT method compared favorably with the 3H-TdR uptake method in evaluating macrophage cytotoxicity, and both of them were more sensitive than the 3H-TdR release assay.  The MTT cleavage method is a useful alternative to radioisotopic methods for quantitating macrophage cytotoxicity for actively growing in vitro targets.  Its main advantages are: (a) sensitivity and reproducibility; (b) elimination of the need for radioactive compds.; (c) ease with which it can be performed and quantified; and (d) rapidity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrezxA3w4p2ebVg90H21EOLACvtfcHk0liDaBwR4LAGzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXmtV2nsLo%253D&md5=e0b83e032dccb6f10faa9fc8a8ca16ce</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2890%2990187-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252890%252990187-Z%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DM.%26aulast%3DFornasiero%26aufirst%3DM.%2BC.%26aulast%3DIsetta%26aufirst%3DA.%2BM.%26atitle%3DMTT%2520colorimetric%2520assay%2520for%2520testing%2520macrophage%2520cytotoxic%2520activity%2520in%2520vitro%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1990%26volume%3D131%26spage%3D165%26epage%3D172%26doi%3D10.1016%2F0022-1759%2890%2990187-Z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korotchenko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathunuru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreishman-Deitrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A. J.</span></span> <span> </span><span class="NLM_article-title">Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3411</span>â <span class="NLM_lpage">3431</span>, <span class="refDoi">Â DOI: 10.1021/jm501809x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501809x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Shu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3411-3431&author=V.+Korotchenkoauthor=R.+Sathunuruauthor=L.+Gerenaauthor=D.+Caridhaauthor=Q.+Liauthor=M.+Kreishman-Deitrickauthor=P.+L.+Smithauthor=A.+J.+Lin&title=Antimalarial+activity+of+4-amidinoquinoline+and+10-amidinobenzonaphthyridine+derivatives&doi=10.1021%2Fjm501809x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial Activity of 4-Amidinoquinoline and 10-Amidinobenzonaphthyridine Derivatives</span></div><div class="casAuthors">Korotchenko, Vasiliy; Sathunuru, Ramadas; Gerena, Lucia; Caridha, Diana; Li, Qigui; Kreishman-Deitrick, Mara; Smith, Philip L.; Lin, Ai J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3411-3431</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chloroquine (CQ) has been used as first line malaria therapeutic drug for decades.  Emergence of CQ drug-resistant Plasmodium falciparum malaria throughout endemic areas of the world has limited its clin. value.  Mefloquine (MQ) has been used as an effective malaria prophylactic drug due to its being long-acting and having a high potency against blood stage P. falciparum (Pf).  However, serious CNS toxicity of MQ has compromised its clin. value as a prophylaxis drug.  Therefore, new and inexpensive antimalarial drugs with no cross-resistance to CQ or CNS toxicity are urgently needed to combat this deadly human disease.  In this study, a series of new 4-amidinoquinoline (4-AMQ) and 10-amidinobenzonaphthyridine (10-AMB) derivs. were designed, prepd., and assessed to search for new therapeutic agents to replace CQ and MQ.  The new derivs. displayed high activity in vitro and in vivo, with no cross-resistance to CQ, and none were toxic in mice up to 160 mpk Ã 3.  The best compd. shows IC50 < 1 ng/mL against D6, W2 and C235 Pf clones, low inhibitory activity in hERG K+ channel blockage testing, negativity in the Ames test, and 5/5 cure @ <15 mpk Ã 3 in mice infected with Plasmodium berghei.  In addn. to these desirable pharmacol. profiles, compd. I, one of the most active compds., is metabolically stable in both human and mouse liver microsomal prepns. and has a plasma t1/2 of 50 h in mice, which made it a good MQ replacement candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-hMlYNpOBpbVg90H21EOLACvtfcHk0liDaBwR4LAGzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Shu78%253D&md5=b3042cd96745a072ee7631a99fd4ce54</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm501809x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501809x%26sid%3Dliteratum%253Aachs%26aulast%3DKorotchenko%26aufirst%3DV.%26aulast%3DSathunuru%26aufirst%3DR.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DKreishman-Deitrick%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DLin%26aufirst%3DA.%2BJ.%26atitle%3DAntimalarial%2520activity%2520of%25204-amidinoquinoline%2520and%252010-amidinobenzonaphthyridine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3411%26epage%3D3431%26doi%3D10.1021%2Fjm501809x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neagle, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trezise, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worley, J.</span></span> <span> </span><span class="NLM_article-title">Ionworks HT: a new high-throughput electrophysiology measurement platform</span>. <i>J. Biomol. Screen</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">50</span>â <span class="NLM_lpage">64</span>, <span class="refDoi">Â DOI: 10.1177/1087057102239667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1177%2F1087057102239667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=12854998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlSqu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=50-64&author=K.+Schroederauthor=B.+Neagleauthor=D.+J.+Treziseauthor=J.+Worley&title=Ionworks+HT%3A+a+new+high-throughput+electrophysiology+measurement+platform&doi=10.1177%2F1087057102239667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">IonWorks HT: A new high-throughput electrophysiology measurement platform</span></div><div class="casAuthors">Schroeder, Kirk; Neagle, Brad; Trezise, Derek J.; Worley, Jennings</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-64</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">To address the throughput restrictions of classical patch clamp electrophysiol., Essen Instruments has developed a plate-based electrophysiol. measurement platform.  The instrument is an integrated platform that consists of computer-controlled fluid handling, recording electronics, and processing tools capable of voltage clamp whole-cell recordings from thousands of individual cells per day.  To establish a recording, the system uses a planar, multi-well substrate (a PatchPlate).  The system effectively positions 1 cell into a hole sepg. 2 fluid compartments in each well of the substrate.  Voltage control and current recordings from the cell membrane are made subsequent to gaining access to the cell interior by applying a permeabilizing agent to the intracellular side.  Based on the multi-well design of the PatchPlate, voltage clamp recordings of up to 384 individual cells can be made in minutes and are comparable to measurements made using traditional electrophysiol. techniques.  An integrated pipetting system allows for up to 2 addns. of modulation agents.  Typical throughput, measurement fidelity, stability, and comparative pharmacol. of a recombinant voltage-dependent sodium channel (hNav1.3) and a voltage-gated potassium channel (hKv1.5) exogenously expressed in CHO cells are presented.  The IonWorks HT device can be used in biophys. and pharmacol. profiling of ion channels in an environment compatible with high-capacity screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr99MfVnFuXs7Vg90H21EOLACvtfcHk0liDaBwR4LAGzQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlSqu70%253D&md5=3a161db49dbb3c39e1db2d74e46e6bfb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1177%2F1087057102239667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057102239667%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DK.%26aulast%3DNeagle%26aufirst%3DB.%26aulast%3DTrezise%26aufirst%3DD.%2BJ.%26aulast%3DWorley%26aufirst%3DJ.%26atitle%3DIonworks%2520HT%253A%2520a%2520new%2520high-throughput%2520electrophysiology%2520measurement%2520platform%26jtitle%3DJ.%2520Biomol.%2520Screen%26date%3D2003%26volume%3D8%26spage%3D50%26epage%3D64%26doi%3D10.1177%2F1087057102239667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dow, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerena, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaldia, N.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">3467</span>â <span class="NLM_lpage">3477</span>, <span class="refDoi">Â DOI: 10.1128/AAC.00439-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1128%2FAAC.00439-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=18644969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=3467-3477&author=G.+S.+Dowauthor=Y.+Chenauthor=K.+T.+Andrewsauthor=D.+Caridhaauthor=L.+Gerenaauthor=M.+Gettayacaminauthor=J.+Johnsonauthor=Q.+Liauthor=V.+Melendezauthor=N.+Obaldiaauthor=T.+N.+Tranauthor=A.+P.+Kozikowski&title=Antimalarial+activity+of+phenylthiazolyl-bearing+hydroxamate-based+histone+deacetylase+inhibitors&doi=10.1128%2FAAC.00439-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors</span></div><div class="casAuthors">Dow, Geoffrey S.; Chen, Yufeng; Andrews, Katherine T.; Cardiha, Diana; Gerena, Lucia; Gettayacamin, Montip; Johnson, Jacob; Li, Qigui; Melendez, Victor; Obaldia, Nicanor, III; Tran, Thanh N.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3467-3477</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The antimalarial activity and pharmacol. of a series of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors (HDACIs) was evaluated.  In in-vitro growth inhibition assays approx. 50 analogs were evaluated against four drug resistant strains of Plasmodium falciparum.  The range of 50% inhibitory concns. (IC50s) was 0.0005 to >1 Î¼M.  Five analogs exhibited IC50s of <3 nM, and three of these exhibited selectivity indexes of >600.  The most potent compd., WR301801 (YC-2-88) was shown to cause hyperacetylation of P. falciparum histones, which is a marker for HDAC inhibition in eukaryotic cells.  The compd. also inhibited malarial and mammalian HDAC activity in functional assays at low nanomolar concns.  WR301801 did not exhibit cures in P. berghei-infected mice at oral doses as high as 640 mg/kg/day for 3 days or in P. falciparum-infected Aotus lemurinus monkeys at oral doses of 32 mg/kg/day for 3 days, despite high relative bioavailability.  The failure of monotherapy in mice may be due to a short half-life, since the compd. was rapidly hydrolyzed to an inactive acid metabolite by loss of its hydroxamate group in vitro (half-life of 11 min in mouse microsomes) and in vivo (half-life in mice of 3.5 h after a single oral dose of 50 mg/kg).  However, WR301801 exhibited cures in P. berghei-infected mice when combined at doses of 52 mg/kg/day orally with subcurative doses of chloroquine.  Next-generation HDACIs with greater metabolic stability than WR301801 may be useful as antimalarials if combined appropriately with conventional antimalarial drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdVfao8vD3e7Vg90H21EOLACvtfcHk0ljOi1DIO7PVtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1SrtbjM&md5=461a53d115d420024a013aafe84df1af</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.00439-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00439-08%26sid%3Dliteratum%253Aachs%26aulast%3DDow%26aufirst%3DG.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DK.%2BT.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DGerena%26aufirst%3DL.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DObaldia%26aufirst%3DN.%26aulast%3DTran%26aufirst%3DT.%2BN.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DAntimalarial%2520activity%2520of%2520phenylthiazolyl-bearing%2520hydroxamate-based%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D3467%26epage%3D3477%26doi%3D10.1128%2FAAC.00439-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sathunuru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melendez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozar, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A. J.</span></span> <span> </span><span class="NLM_article-title">New imidazolidinedione derivatives as antimalarial agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1541</span>â <span class="NLM_lpage">1549</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2010.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1016%2Fj.bmc.2010.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=21282058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFKhtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1541-1549&author=L.+Zhangauthor=R.+Sathunuruauthor=T.+Luongauthor=V.+Melendezauthor=M.+P.+Kozarauthor=A.+J.+Lin&title=New+imidazolidinedione+derivatives+as+antimalarial+agents&doi=10.1016%2Fj.bmc.2010.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">New imidazolidinedione derivatives as antimalarial agents</span></div><div class="casAuthors">Zhang, Liang; Sathunuru, Ramadas; Luong, Thu Lan; Melendez, Victor; Kozar, Michael P.; Lin, Ai J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1541-1549</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of new N-alky- and N-alkoxy-imidazolidinediones was prepd. and assessed for prophylactic and radical curative activities in mouse and Rhesus monkey models.  New compds. are generally metabolically stable, weakly active in vitro against Plasmodium falciparum clones (D6 and W2) and in mice infected with Plasmodium berghei sporozoites.  Representative compds. 8e and 9c (I) showed good causal prophylactic activity in Rhesus monkeys dosed 30 mg/kg/day for 3 consecutive days by IM, delayed patency for 19-21 days and 54-86 days, resp., as compared to the untreated control.  By oral, 9c showed only marginal activity in causal prophylactic and radical curative tests at 50 mg/kg/day Ã 3 and 30 mg/kg/day Ã 7 plus chloroquine 10 mg/kg for 7 days, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbDcL_hB_MaLVg90H21EOLACvtfcHk0ljOi1DIO7PVtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFKhtLk%253D&md5=64410e36bc5112cdb4f9cedf2453727b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSathunuru%26aufirst%3DR.%26aulast%3DLuong%26aufirst%3DT.%26aulast%3DMelendez%26aufirst%3DV.%26aulast%3DKozar%26aufirst%3DM.%2BP.%26aulast%3DLin%26aufirst%3DA.%2BJ.%26atitle%3DNew%2520imidazolidinedione%2520derivatives%2520as%2520antimalarial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1541%26epage%3D1549%26doi%3D10.1016%2Fj.bmc.2010.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lindner, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, S. H. I.</span></span> <span> </span><span class="NLM_article-title">Malaria parasite pre-erythrocytic infection: preparation meets opportunity</span>. <i>Cell. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">316</span>â <span class="NLM_lpage">324</span>, <span class="refDoi">Â DOI: 10.1111/j.1462-5822.2011.01734.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1111%2Fj.1462-5822.2011.01734.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=22151703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVOjs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=316-324&author=S.+E.+Lindnerauthor=J.+L.+Millerauthor=S.+H.+I.+Kappe&title=Malaria+parasite+pre-erythrocytic+infection%3A+preparation+meets+opportunity&doi=10.1111%2Fj.1462-5822.2011.01734.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria parasite pre-erythrocytic infection: preparation meets opportunity</span></div><div class="casAuthors">Lindner, Scott E.; Miller, Jessica L.; Kappe, Stefan H. I.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-324</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  For those stricken with malaria, the classic clin. symptoms are caused by the parasite's cyclic infection of red blood cells.  However, this erythrocytic phase of the parasite's life cycle initiates from an asymptomatic pre-erythrocytic phase: the injection of sporozoites via the bite of a parasite-carrying Anopheline mosquito, and the ensuing infection of the liver.  With the increased capabilities of studying liver stages in mice, much progress was made elucidating the cellular and mol. basis of the parasite's progression through this bottleneck of its life cycle.  Here we review relevant findings on how sporozoites prep. for infection of the liver and factors crucial to liver stage development as well as key host/parasite interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0M19yfzes2bVg90H21EOLACvtfcHk0ljOi1DIO7PVtA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVOjs7Y%253D&md5=12008701e239bba5150a4792d215bf21</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fj.1462-5822.2011.01734.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1462-5822.2011.01734.x%26sid%3Dliteratum%253Aachs%26aulast%3DLindner%26aufirst%3DS.%2BE.%26aulast%3DMiller%26aufirst%3DJ.%2BL.%26aulast%3DKappe%26aufirst%3DS.%2BH.%2BI.%26atitle%3DMalaria%2520parasite%2520pre-erythrocytic%2520infection%253A%2520preparation%2520meets%2520opportunity%26jtitle%3DCell.%2520Microbiol.%26date%3D2012%26volume%3D14%26spage%3D316%26epage%3D324%26doi%3D10.1111%2Fj.1462-5822.2011.01734.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mazier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RÃ©nia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snounou, G.</span></span> <span> </span><span class="NLM_article-title">A pre-emptive strike against malariaâs stealthy hepatic forms</span>. <i>Nat. Rev. Drug. Discov.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">854</span>â <span class="NLM_lpage">864</span>, <span class="refDoi">Â DOI: 10.1038/nrd2960</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1038%2Fnrd2960" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=19876040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtr3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=854-864&author=D.+Mazierauthor=L.+R%C3%A9niaauthor=G.+Snounou&title=A+pre-emptive+strike+against+malaria%E2%80%99s+stealthy+hepatic+forms&doi=10.1038%2Fnrd2960"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A pre-emptive strike against malaria's stealthy hepatic forms</span></div><div class="casAuthors">Mazier, Dominique; Renia, Laurent; Snounou, Georges</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">854-864</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Almost all the drugs that are widely used today against Plasmodium spp., the causative agent of malaria, target the asexual blood stages of the parasite.  Widespread drug resistance severely restricts our ability to control malaria and makes it necessary to seek novel antimalarial compds.  Here, we advocate the development of true causal chemoprophylactic drugs that will fully inhibit the obligate short-lived hepatic forms that precede blood infections.  Such drugs will prevent pathol. and interrupt transmission, and could therefore have an important role in the control of malaria and its eventual eradication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBUI7UkUUorrVg90H21EOLACvtfcHk0lgJ72-Q4VzVBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCjtr3I&md5=74f3b2bfb151cb856fda56fd2392442c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnrd2960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2960%26sid%3Dliteratum%253Aachs%26aulast%3DMazier%26aufirst%3DD.%26aulast%3DR%25C3%25A9nia%26aufirst%3DL.%26aulast%3DSnounou%26aufirst%3DG.%26atitle%3DA%2520pre-emptive%2520strike%2520against%2520malaria%25E2%2580%2599s%2520stealthy%2520hepatic%2520forms%26jtitle%3DNat.%2520Rev.%2520Drug.%2520Discov.%26date%3D2009%26volume%3D8%26spage%3D854%26epage%3D864%26doi%3D10.1038%2Fnrd2960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">PrudÃªncio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mota, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, F.</span></span> <span> </span><span class="NLM_article-title">Targeting the liver stage of malaria parasites: a yet unmet goal</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">995</span>â <span class="NLM_lpage">1012</span>, <span class="refDoi">Â DOI: 10.1021/jm201095h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201095h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFejtbrE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=995-1012&author=T.+Rodriguesauthor=M.+Prud%C3%AAncioauthor=R.+Moreiraauthor=M.+M.+Motaauthor=F.+Lopes&title=Targeting+the+liver+stage+of+malaria+parasites%3A+a+yet+unmet+goal&doi=10.1021%2Fjm201095h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Liver Stage of Malaria Parasites: A Yet Unmet Goal</span></div><div class="casAuthors">Rodrigues, Tiago; Prudencio, Miguel; Moreira, Rui; Mota, Maria M.; Lopes, Francisca</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">995-1012</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  An overview of Plasmodium liver stages malaria (LS) and inhibitors targeting the LS; special emphasis is given to structure-activity relationships (SARs) and to recent developments in the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3to30Pz23MLVg90H21EOLACvtfcHk0lgJ72-Q4VzVBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFejtbrE&md5=3a24c7c84968b0801fb56a4d90fb177f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm201095h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201095h%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DPrud%25C3%25AAncio%26aufirst%3DM.%26aulast%3DMoreira%26aufirst%3DR.%26aulast%3DMota%26aufirst%3DM.%2BM.%26aulast%3DLopes%26aufirst%3DF.%26atitle%3DTargeting%2520the%2520liver%2520stage%2520of%2520malaria%2520parasites%253A%2520a%2520yet%2520unmet%2520goal%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D995%26epage%3D1012%26doi%3D10.1021%2Fjm201095h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappe, S. H. I.</span></span> <span> </span><span class="NLM_article-title">Malaria parasite liver infection and exoerythrocytic biology</span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">a025486</span>, <span class="refDoi">Â DOI: 10.1101/cshperspect.a025486</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1101%2Fcshperspect.a025486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28242785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisFKqtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=a025486&author=A.+M.+Vaughanauthor=S.+H.+I.+Kappe&title=Malaria+parasite+liver+infection+and+exoerythrocytic+biology&doi=10.1101%2Fcshperspect.a025486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Malaria parasite liver infection and exoerythrocytic biology</span></div><div class="casAuthors">Vaughan, Ashley M.; Kappe, Stefan H. I.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">a025486/1-a025486/22</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">In their infection cycle, malaria parasites undergo replication and population expansions within the vertebrate host and the mosquito vector.  Host infection initiates with sporozoite invasion of hepatocytes, followed by a dramatic parasite amplification event during liver stage parasite growth and replication within hepatocytes.  Each liver stage forms up to 90,000 exoerythrocytic merozoites, which are in turn capable of initiating a blood stage infection.  Liver stages not only exploit host hepatocyte resources for nutritional needs but also endeavor to prevent hepatocyte cell death and detection by the host's immune system.  Research over the past decade has identified numerous parasite factors that play a crit. role during liver infection and has started to delineate a complex web of parasite-host interactions that sustain successful parasite colonization of the mammalian host.  Targeting the parasites' obligatory infection of the liver as a gateway to the blood, with drugs and vaccines, constitutes the most effective strategy for malaria eradication, as it would prevent clin. disease and onward transmission of the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIS0RapO9sOrVg90H21EOLACvtfcHk0lgJ72-Q4VzVBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisFKqtLg%253D&md5=196be5869532275ff5569d64aa1d04c3</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025486%26sid%3Dliteratum%253Aachs%26aulast%3DVaughan%26aufirst%3DA.%2BM.%26aulast%3DKappe%26aufirst%3DS.%2BH.%2BI.%26atitle%3DMalaria%2520parasite%2520liver%2520infection%2520and%2520exoerythrocytic%2520biology%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2017%26volume%3D7%26spage%3Da025486%26doi%3D10.1101%2Fcshperspect.a025486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, I.</span></span> <span> </span><span class="NLM_article-title">The biology of <i>Plasmodium vivax</i></span>. <i>Cold Spring Harbor Perspect. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">a025585</span>, <span class="refDoi">Â DOI: 10.1101/cshperspect.a025585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1101%2Fcshperspect.a025585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=28490540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjvFKns7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=a025585&author=J.+H.+Adamsauthor=I.+Mueller&title=The+biology+of+Plasmodium+vivax&doi=10.1101%2Fcshperspect.a025585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The Biology of Plasmodium vivax</span></div><div class="casAuthors">Adams, John H.; Mueller, Ivo</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">a025585/1-a025585/13</span>CODEN:
                <span class="NLM_cas:coden">CSHPFV</span>;
        ISSN:<span class="NLM_cas:issn">2157-1422</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Plasmodium vivax is the second most prevalent cause of malaria worldwide and the leading cause of malaria outside of Africa.  Although infections are seldom fatal clin. disease can be debilitating and imposes significant health and economic impacts on affected populations.  Ests. of transmission and prevalence intensity can be problematic because many episodes of vivax originate from hypnozoite stages in the liver that have remained dormant from previous infections by an unknown mechanism.  Lack of treatment options to clear hypnozoites and the ability to infect mosquitoes before disease symptoms present represent major challenges for control and eradication of vivax malaria.  Compounding these challenges is the unique biol. of P. vivax and limited progress in development of exptl. research tools, thereby hindering development of new drugs and vaccines.  Renewed emphasis on vivax malaria research is beginning to make progress in overcoming some of these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNRZd0EMtsHrVg90H21EOLACvtfcHk0lgJ72-Q4VzVBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjvFKns7k%253D&md5=f54184731bfe0783014bf131d256fe7b</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a025585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a025585%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BH.%26aulast%3DMueller%26aufirst%3DI.%26atitle%3DThe%2520biology%2520of%2520Plasmodium%2520vivax%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Med.%26date%3D2017%26volume%3D7%26spage%3Da025585%26doi%3D10.1101%2Fcshperspect.a025585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesche, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span> <span> </span><span class="NLM_article-title">Killing the hypnozoite-drug discovery approaches to prevent relapse in <i>Plasmodium vivax</i></span>. <i>Pathog. Glob. Health</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">107</span>â <span class="NLM_lpage">122</span>, <span class="refDoi">Â DOI: 10.1179/2047773215Y.0000000013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1179%2F2047773215Y.0000000013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=25891812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvVyks7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2015&pages=107-122&author=B.+Campoauthor=O.+Vandalauthor=D.+L.+Wescheauthor=J.+N.+Burrows&title=Killing+the+hypnozoite-drug+discovery+approaches+to+prevent+relapse+in+Plasmodium+vivax&doi=10.1179%2F2047773215Y.0000000013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Killing the hypnozoite - drug discovery approaches to prevent relapse in Plasmodium vivax</span></div><div class="casAuthors">Campo, Brice; Vandal, Omar; Wesche, David L.; Burrows, Jeremy N.</div><div class="citationInfo"><span class="NLM_cas:title">Pathogens and Global Health</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">107-122</span>CODEN:
                <span class="NLM_cas:coden">PGHAB7</span>;
        ISSN:<span class="NLM_cas:issn">2047-7724</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">A review.  The eradication of malaria will only be possible if effective, well-tolerated medicines kill hypnozoites in vivax and ovale malaria, and thus prevent relapses in patients.  Despite progress in the 8-aminoquinoline series, with tafenoquine in Phase III showing clear benefits over primaquine, the drug discovery challenge to identify hypnozoiticidal or hypnozoite-activating compds. has been hampered by the dearth of biol. tools and assays, which in turn has been limited by the immense scientific and logistical challenges assocd. with accessing relevant human tissue and sporozoites.  This review summarises the existing drug discovery series and approaches concerning the goal to block relapse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZobuvLqmY8rVg90H21EOLACvtfcHk0lj5juBiVyjl-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvVyks7k%253D&md5=5b8e1091c3df8331cc6b72fb943fdbb6</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1179%2F2047773215Y.0000000013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F2047773215Y.0000000013%26sid%3Dliteratum%253Aachs%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DVandal%26aufirst%3DO.%26aulast%3DWesche%26aufirst%3DD.%2BL.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26atitle%3DKilling%2520the%2520hypnozoite-drug%2520discovery%2520approaches%2520to%2520prevent%2520relapse%2520in%2520Plasmodium%2520vivax%26jtitle%3DPathog.%2520Glob.%2520Health%26date%3D2015%26volume%3D109%26spage%3D107%26epage%3D122%26doi%3D10.1179%2F2047773215Y.0000000013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuster, F. L.</span></span> <span> </span><span class="NLM_article-title">Cultivation of <i>Plasmodium</i> spp</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">355</span>â <span class="NLM_lpage">364</span>, <span class="refDoi">Â DOI: 10.1128/CMR.15.3.355-364.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1128%2FCMR.15.3.355-364.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=12097244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BD38zlsVarsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=355-364&author=F.+L.+Schuster&title=Cultivation+of+Plasmodium+spp&doi=10.1128%2FCMR.15.3.355-364.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Cultivation of plasmodium spp</span></div><div class="casAuthors">Schuster Frederick L</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-64</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">Cultivation of both human and non-human species of Plasmodium spp., the causal agent of malaria, has been a major research success, leading to a greater understanding of the parasite.  Efforts at cultivating the organisms in vitro are complicated by the parasites' alternating between a human host and an arthropod vector, each having its own set of physiological, metabolic, and nutritional parameters.  Life cycle stages of the four species that infect humans have been established in vitro.  Of these four, P. falciparum remains the only species for which all stages have been cultured in vitro; different degrees of success have been achieved with the other human Plasmodium spp.  The life cycle includes the exoerythrocytic stage (within liver cells), the erythrocytic stage (within erythrocytes or precursor reticulocytes), and the sporogonic stage (within the vector).  Culture media generally consist of a basic tissue culture medium (e.g., minimal essential medium or RPMI 1640) to which serum and erythrocytes are added.  Most of the efforts have been directed toward the stage found in the erythrocyte.  This stage has been cultivated in petri plates or other growth vessels in a candle jar to generate elevated CO(2) levels or in a more controlled CO(2) atmosphere.  Later developments have employed continuous-flow systems to reduce the labor-intensive nature of medium changing.  The exoerythrocytic and sporogonic life cycle stages have also been cultivated in vitro.  A number of avian, rodent, and simian malarial parasites have also been established in vitro.  Although cultivation is of great help in understanding the biology of Plasmodium, it does not lend itself to use for diagnostic purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfFDLq8A5cJb0AGQpJZWpJfW6udTcc2eZaqBuAi3MjArntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zlsVarsw%253D%253D&md5=6b99b63121cddd6547b6f78480cb559c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1128%2FCMR.15.3.355-364.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.15.3.355-364.2002%26sid%3Dliteratum%253Aachs%26aulast%3DSchuster%26aufirst%3DF.%2BL.%26atitle%3DCultivation%2520of%2520Plasmodium%2520spp%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2002%26volume%3D15%26spage%3D355%26epage%3D364%26doi%3D10.1128%2FCMR.15.3.355-364.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milhous, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D.</span></span> <span> </span><span class="NLM_article-title">Development and validation of flow cytometric measurement for parasitaemia using autofluorescence and YOYO-1 in rodent malaria</span>. <i>Parasitology</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">1151</span>â <span class="NLM_lpage">1162</span>, <span class="refDoi">Â DOI: 10.1017/S0031182007002661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=10.1017%2FS0031182007002661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=17445324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;key=1%3ACAS%3A280%3ADC%252BD2svjsVCjuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2007&pages=1151-1162&author=L.+Xieauthor=Q.+Liauthor=J.+Johnsonauthor=J.+Zhangauthor=W.+Milhousauthor=D.+Kyle&title=Development+and+validation+of+flow+cytometric+measurement+for+parasitaemia+using+autofluorescence+and+YOYO-1+in+rodent+malaria&doi=10.1017%2FS0031182007002661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of flow cytometric measurement for parasitaemia using autofluorescence and YOYO-1 in rodent malaria</span></div><div class="casAuthors">Xie L; Li Q; Johnson J; Zhang J; Milhous W; Kyle D</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">Pt 9</span>),
    <span class="NLM_cas:pages">1151-62</span>
        ISSN:<span class="NLM_cas:issn">0031-1820</span>.
    </div><div class="casAbstract">An automated flow cytometric (FCM) detection method has been developed and validated with a simple diagnostic procedure in parasitized erythrocytes of Plasmodium berghei-infected rats using the nucleic acid-binding fluorescent dye YOYO-1.  High levels of reticulocytes were detected during the course of the infection, ranging from 1.2-51.2%, but any RNA potentially confounding the assay could be removed by digestion with RNAse.  The cell counts of uninfected, infected, and nucleated cells occurred with high precision.  The cells were divided into different populations according to their physical or chemical properties but various factors within the assay such as cell fixation, RNA digestion, and compensation required optimization.  In this study, FCM greatly simplified and accelerated parasite detection, with a mean precision of 4.4%, specificity of 98.9% and accuracy of 101.3%.  The detection and quantitation limits in the assay were 0.024% and 0.074% parasitaemia, respectively.  Overall, the parasite counts by FCM measurement correlated highly (r2=0.954-0.988) with the parasitaemia measured by light microscopical analysis when animals treated with suppressive, clearance, and curative doses of novel antimalarial drugs were examined.  The lower levels of parasitaemia (30%) detected by microscopy compared to FCM may be related to a number of schizonts externally attached to the erythrocyte membranes that normally would not be included in microscopy counting.  Lower sampling error and reliable identification of rodent erythrocyte parasites based on the principles of FCM have replaced the traditional blood smear in our laboratory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSe2_1BH9qNY2mbXvSEQle5fW6udTcc2eZaqBuAi3MjArntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svjsVCjuw%253D%253D&md5=7d54eeba1d4d0f02821752a2f0c51fd6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1017%2FS0031182007002661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0031182007002661%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMilhous%26aufirst%3DW.%26aulast%3DKyle%26aufirst%3DD.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520flow%2520cytometric%2520measurement%2520for%2520parasitaemia%2520using%2520autofluorescence%2520and%2520YOYO-1%2520in%2520rodent%2520malaria%26jtitle%3DParasitology%26date%3D2007%26volume%3D134%26spage%3D1151%26epage%3D1162%26doi%3D10.1017%2FS0031182007002661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i154"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00539">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_05218"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00539?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00539</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H NMR spectra of all final compounds and <sup>19</sup>F NMR of <b>26</b> and <b>27</b> and HPLC chromatograms of lead candidates (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00539/suppl_file/jm0c00539_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and in vitro data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00539/suppl_file/jm0c00539_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00539/suppl_file/jm0c00539_si_001.pdf">jm0c00539_si_001.pdf (6.91 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00539/suppl_file/jm0c00539_si_002.csv">jm0c00539_si_002.csv (6.8 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00539&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00539%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00539" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a3cdfae583cbe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
